SynGap Missense Server

Table of SynGAP1 Isoform α2 (UniProt Q96PV0-1) Missense Variants.

c.dna Variant SGM Consensus Domain and Structure information: based on WT protein Annotated databases Deep learning-based pathogenicity predictions Folding stability-based pathogenicity predictions Sequence/structure-based pathogenicity predictions Phase Separation Evolutionary/physical properties Molecular Dynamics-based analysis DOI
Domain IUPred2 ANCHOR2 AlphaFold MobiDB PhosphoSitePlus ClinVar gnomAD ESM1b AlphaMissense FoldX Rosetta Foldetta PremPS REVEL PROVEAN PolyPhen-2 HumDiv PolyPhen-2 HumVar FATHMM SIFT PSMutPred PAM Physical SASA Normalized B-factor backbone Normalized B-factor sidechain SynGAP Structural Annotation
Score Prediction Score Prediction pLDDT disorder disorder LTP HTP KL PTM Clinical Status Review Subm. ID Allele count Allele freq. LLR score Prediction Pathogenicity Class Optimized Average ΔΔG Prediction StdDev ΔΔG Prediction ΔΔG Prediction ΔΔG Prediction Score Prediction Score Prediction pph2_prob Prediction pph2_prob Prediction Nervous System Score Prediction Prediction Status Conservation Sequences IP RF SP RF Prediction PAM250 PAM120 Hydropathy Δ MW Δ Average Δ Δ StdDev Δ StdDev Secondary Tertiary bonds Inside out GAP-Ras interface At membrane No effect MD Alert Verdict Description
c.1448T>G
I483R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I483R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include only FATHMM, whereas all other evaluated algorithms—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the variant as pathogenic. High‑accuracy methods further support a deleterious impact: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. No prediction or folding stability result is missing or inconclusive. Based on the overwhelming consensus of pathogenic predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because the variant is not yet catalogued in ClinVar.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.206376Structured0.415850Uncertain0.7980.2540.000-17.066Likely Pathogenic0.995Likely PathogenicLikely Pathogenic5.14Destabilizing0.44.09Destabilizing4.62Destabilizing1.97Destabilizing0.595Likely Pathogenic-6.50Deleterious0.997Probably Damaging0.991Probably Damaging3.14Benign0.00Affected0.11200.0870-2-3-9.043.03
c.1481T>G
I494R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I494R is listed in ClinVar as Pathogenic (ClinVar ID 1685460.0) and is not reported in gnomAD. Prediction tools that assess functional impact all converge on a pathogenic outcome: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all indicate pathogenicity. No tool predicts a benign effect. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. Thus, the variant is most likely pathogenic, and this prediction aligns with its ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.155435Structured0.353330Uncertain0.9410.1570.000Likely Pathogenic 1-15.758Likely Pathogenic0.995Likely PathogenicLikely Pathogenic6.71Destabilizing0.33.40Destabilizing5.06Destabilizing2.19Destabilizing0.911Likely Pathogenic-6.43Deleterious0.999Probably Damaging0.957Probably Damaging-1.41Pathogenic0.00Affected3.37350.11800.0870-2-3-9.043.03273.9-59.80.00.00.00.1XXXXPotentially PathogenicThe sec-butyl side chain of Ile494, located in an α-helix (res. Leu489-Glu519), packs against hydrophobic residues (e.g., Phe484, Leu465, Trp572, Ala493, Met468) in an inter-helix space (res. Leu489-Glu519 and res. Ala461-Phe476). In the variant simulations, the bulkier and positively charged residue, Arg494, weakens the integrity of the opposing helix. Additionally, the bulkier Arg494 stacks with Phe484, causing the α-helices to move farther apart to accommodate it. This mutation could have substantial negative effects due to the fundamental role of hydrophobic packing, which is disrupted by Arg494 during protein folding.
c.191T>G
I64R
2D
AIThe SynGAP1 missense variant I64R is not reported in ClinVar and has no entry in gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumVar, ESM1b, FATHMM, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), which classifies the variant as “Likely Benign.” Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, SIFT, and AlphaMissense‑Default. The high‑accuracy AlphaMissense‑Optimized score is uncertain, and the Foldetta protein‑folding stability assessment is unavailable. Overall, the majority of evidence points to a benign impact. This conclusion is consistent with the absence of a ClinVar assertion, so there is no contradiction with existing clinical database status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.422041Structured0.475481Uncertain0.4780.7470.125-2.108Likely Benign0.936Likely PathogenicAmbiguous0.165Likely Benign-0.54Neutral0.842Possibly Damaging0.068Benign4.05Benign0.00Affected0.11030.0940-2-3-9.043.03
c.806T>G
I269R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I269R is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a deleterious effect: the benign group contains only SIFT, whereas the pathogenic group includes SGM‑Consensus (Likely Pathogenic), REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. FoldX and Rosetta give uncertain results, and Foldetta is also uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, SGM‑Consensus as Likely Pathogenic, and Foldetta as unavailable. Based on the preponderance of pathogenic predictions, the variant is most likely pathogenic, and this assessment does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.216401Structured0.343787Uncertain0.9370.2440.125-14.567Likely Pathogenic0.994Likely PathogenicLikely Pathogenic1.34Ambiguous0.11.99Ambiguous1.67Ambiguous1.50Destabilizing0.765Likely Pathogenic-5.23Deleterious0.999Probably Damaging0.998Probably Damaging1.69Pathogenic0.07Tolerated0.11080.0870-2-3-9.043.03
c.1448T>A
I483K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I483K is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include only FATHMM, whereas all other evaluated algorithms—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the variant as pathogenic. High‑accuracy methods further support a deleterious impact: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. No prediction or folding stability result is missing or inconclusive. Based on the overwhelming agreement among these tools, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because the variant is not yet catalogued in ClinVar.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.206376Structured0.415850Uncertain0.7980.2540.000-18.260Likely Pathogenic0.998Likely PathogenicLikely Pathogenic3.53Destabilizing0.15.15Destabilizing4.34Destabilizing2.01Destabilizing0.585Likely Pathogenic-6.50Deleterious0.962Probably Damaging0.991Probably Damaging3.14Benign0.00Affected0.08680.0670-2-3-8.415.01
c.1481T>A
I494K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I494K is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that assess pathogenicity uniformly classify the variant as deleterious: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict a pathogenic effect. No tool in the dataset predicts a benign outcome. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. Based on the unanimous computational evidence, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.155435Structured0.353330Uncertain0.9410.1570.000-15.950Likely Pathogenic0.997Likely PathogenicLikely Pathogenic4.23Destabilizing0.25.33Destabilizing4.78Destabilizing1.89Destabilizing0.925Likely Pathogenic-6.40Deleterious0.987Probably Damaging0.937Probably Damaging-1.41Pathogenic0.00Affected0.10150.0870-2-3-8.415.01
c.191T>A
I64K
2D
AIThe SynGAP1 missense variant I64K is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and FATHMM. Tools that predict a pathogenic effect are SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, while the SGM‑Consensus remains benign; Foldetta results are unavailable. Overall, the majority of predictions lean toward a benign impact, and this conclusion does not contradict the ClinVar status, which contains no report for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.422041Structured0.475481Uncertain0.4780.7470.125-3.206Likely Benign0.964Likely PathogenicLikely Pathogenic0.159Likely Benign-0.47Neutral0.334Benign0.029Benign4.07Benign0.00Affected0.08780.0740-2-3-8.415.01
c.806T>A
I269K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I269K is not reported in ClinVar and has no entries in gnomAD. Functional prediction tools largely agree on a deleterious effect: SIFT is the sole benign predictor, whereas the remaining methods—SGM‑Consensus, REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the change as pathogenic. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts pathogenicity, the SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates pathogenicity, and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, is inconclusive. FoldX and Rosetta individually report uncertain effects, and Foldetta remains unavailable. Overall, the consensus of the majority of evidence points to a pathogenic impact, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.216401Structured0.343787Uncertain0.9370.2440.125-14.609Likely Pathogenic0.997Likely PathogenicLikely Pathogenic1.45Ambiguous0.11.86Ambiguous1.66Ambiguous1.55Destabilizing0.763Likely Pathogenic-5.10Deleterious0.999Probably Damaging0.998Probably Damaging1.76Pathogenic0.06Tolerated0.08780.0713-2-3-8.415.01
c.1034T>G
L345R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L345R is not reported in ClinVar (ClinVar ID None) and has no entries in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect are REVEL and AlphaMissense‑Optimized, whereas the majority of tools predict pathogenicity: SGM‑Consensus, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. High‑accuracy assessments further support this: AlphaMissense‑Optimized classifies the variant as benign, while the SGM Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) yields a pathogenic prediction. Foldetta, which integrates FoldX‑MD and Rosetta outputs, is inconclusive. Consequently, the variant is most likely pathogenic based on the collective predictions, and this assessment does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.260850Structured0.354989Uncertain0.9360.4780.125-10.325Likely Pathogenic0.635Likely PathogenicLikely Benign0.96Ambiguous0.11.66Ambiguous1.31Ambiguous1.28Destabilizing0.247Likely Benign-3.98Deleterious0.993Probably Damaging0.796Possibly Damaging1.81Pathogenic0.04Affected0.11400.0685-3-2-8.343.03
c.1058T>G
L353R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L353R is not reported in ClinVar and is absent from gnomAD. In silico predictors largely agree on a deleterious effect: benign predictions are limited to REVEL, whereas the remaining tools—FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN)—all classify the variant as pathogenic. High‑accuracy assessments further support this view: AlphaMissense‑Optimized is uncertain, SGM‑Consensus predicts likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. No prediction contradicts the ClinVar status, which is currently unreported. Overall, the preponderance of evidence indicates that the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.137348Structured0.373584Uncertain0.9260.3150.000-11.213Likely Pathogenic0.950Likely PathogenicAmbiguous3.60Destabilizing0.52.48Destabilizing3.04Destabilizing1.91Destabilizing0.444Likely Benign-4.15Deleterious0.947Possibly Damaging0.454Possibly Damaging1.33Pathogenic0.01Affected0.13040.1145-3-2-8.343.03
c.1100T>G
L367R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 L367R missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b. Those that predict a pathogenic effect are SIFT, FATHMM, and Rosetta. Tools with uncertain or inconclusive results are FoldX, premPS, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) as pathogenic. Overall, the majority of evidence points to a benign impact, with a minority of pathogenic predictions. The variant’s status is not contradicted by ClinVar, as it is not yet classified there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.370445Structured0.441805Uncertain0.7900.6570.250-6.527Likely Benign0.515AmbiguousLikely Benign0.68Ambiguous0.46.63Destabilizing3.66Destabilizing0.70Ambiguous0.196Likely Benign-0.39Neutral0.146Benign0.057Benign1.66Pathogenic0.02Affected0.16080.1173-3-2-8.343.03
c.1205T>G
L402R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L402R is listed in ClinVar as Pathogenic (ClinVar ID 559657.0) and is not reported in gnomAD. Prediction tools that agree on a benign effect include only FATHMM; all other evaluated algorithms (REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) predict a pathogenic impact. High‑accuracy methods give the following results: AlphaMissense‑Optimized predicts Pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts Pathogenic. Based on the overwhelming agreement among pathogenic predictions and the concordance with ClinVar, the variant is most likely pathogenic, and this assessment does not contradict the ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.243554Structured0.431978Uncertain0.9610.3830.000Likely Pathogenic1-13.800Likely Pathogenic0.997Likely PathogenicLikely Pathogenic4.10Destabilizing0.23.82Destabilizing3.96Destabilizing2.24Destabilizing0.522Likely Pathogenic-4.69Deleterious0.967Probably Damaging0.459Possibly Damaging3.69Benign0.00Affected3.38280.14670.1173-3-2-8.343.03259.5-55.40.00.01.40.0XXXPotentially PathogenicThe iso-butyl side chain of Leu402, located in an anti-parallel β sheet strand (res. Ala399-Ile411), packs with residues inside the hydrophobic core of the C2 domain (e.g., Ile268, Ala404, Leu266, Val400). In the variant simulations, the positively charged guanidinium group of the Arg402 side chain is not suitable for the hydrophobic niche. Consequently, the side chain moves outward from the hydrophobic C2 domain core and stacks with the phenol ring of Tyr363 or forms H-bonds with the carboxamide group of the Gln361 side chain in the β sheet strand (res. Thr359-Tyr364). This movement induces extensive negative effects on the C2 domain structure.
c.1247T>G
L416R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 L416R missense variant is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic outcome are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b. The remaining tools (FoldX, Rosetta, Foldetta, premPS, AlphaMissense‑Default) give uncertain or inconclusive results. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also leans toward benign, while Foldetta remains uncertain. Overall, the majority of reliable predictors classify the variant as benign, and this conclusion does not contradict the lack of ClinVar annotation. Thus, the variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.104810Structured0.336105Uncertain0.9350.2270.000-8.600Likely Pathogenic0.511AmbiguousLikely Benign0.71Ambiguous0.00.97Ambiguous0.84Ambiguous0.84Ambiguous0.238Likely Benign-2.05Neutral0.999Probably Damaging0.992Probably Damaging3.35Benign0.43Tolerated0.14450.0702-3-2-8.343.03
c.1292T>G
L431R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L431R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include only FATHMM, whereas all other evaluated algorithms—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized scores the variant as pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates a likely pathogenic outcome; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also predicts pathogenicity. No prediction or folding stability result is missing or inconclusive. Based on the collective evidence, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because the variant is not yet catalogued in ClinVar.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.094817Structured0.374755Uncertain0.9590.3000.000-14.777Likely Pathogenic0.995Likely PathogenicLikely Pathogenic3.45Destabilizing0.04.76Destabilizing4.11Destabilizing1.93Destabilizing0.654Likely Pathogenic-5.47Deleterious0.997Probably Damaging0.833Possibly Damaging2.93Benign0.00Affected0.11910.0730-3-2-8.343.03
c.1316T>G
L439R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense change L439R lies in the GAP domain. ClinVar has no entry for this variant, and it is not reported in gnomAD. Prediction tools that agree on a benign effect are limited to FATHMM, while the remaining evaluated algorithms (SGM‑Consensus, REVEL, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) uniformly predict a pathogenic or likely pathogenic impact; FoldX is uncertain and is treated as unavailable. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized reports pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts pathogenic. Consequently, the variant is most likely pathogenic based on the collective predictions, and this assessment does not contradict any ClinVar status, as none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.222385Structured0.281542Uncertain0.9420.2650.000-12.870Likely Pathogenic0.985Likely PathogenicLikely Pathogenic1.90Ambiguous0.52.62Destabilizing2.26Destabilizing1.40Destabilizing0.554Likely Pathogenic-5.25Deleterious0.996Probably Damaging0.983Probably Damaging3.22Benign0.01Affected0.12170.0488-3-2-8.343.03
c.1352T>G
L451R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L451R is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). All available in‑silico predictors classify the substitution as pathogenic: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a benign effect. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates likely pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) reports a pathogenic effect. Based on the unanimous pathogenic predictions and the absence of benign calls, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.281712Structured0.314017Uncertain0.9780.2320.000-16.162Likely Pathogenic0.999Likely PathogenicLikely Pathogenic3.32Destabilizing0.13.76Destabilizing3.54Destabilizing2.25Destabilizing0.726Likely Pathogenic-5.82Deleterious0.999Probably Damaging0.992Probably Damaging2.43Pathogenic0.00Affected0.11300.0558-3-2-8.343.03
c.1364T>G
L455R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L455R resides in the GAP domain. ClinVar has no entry for this variant, and it is not reported in gnomAD. Prediction tools that agree on a benign effect include only FATHMM; all other evaluated algorithms (SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) uniformly predict a pathogenic or likely pathogenic impact. High‑accuracy assessments further support this: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also predicts pathogenic. No prediction or stability result is missing or inconclusive. Based on the collective evidence, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status because none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.188120Structured0.310377Uncertain0.9630.1680.000-16.347Likely Pathogenic0.998Likely PathogenicLikely Pathogenic6.36Destabilizing0.24.96Destabilizing5.66Destabilizing2.08Destabilizing0.648Likely Pathogenic-5.73Deleterious0.999Probably Damaging0.992Probably Damaging3.24Benign0.00Affected0.11260.0600-3-2-8.343.03
c.1394T>G
L465R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L465R is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly indicate a deleterious effect. Benign predictions: none. Pathogenic predictions: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) reports Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, also predicts pathogenic. No inconclusive or missing results are present. Based on the consensus of all available predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation (none available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.346032Structured0.319240Uncertain0.9560.2020.000-17.976Likely Pathogenic0.999Likely PathogenicLikely Pathogenic4.52Destabilizing0.74.44Destabilizing4.48Destabilizing2.41Destabilizing0.761Likely Pathogenic-5.97Deleterious0.999Probably Damaging0.998Probably Damaging2.29Pathogenic0.00Affected0.15970.0963-3-2-8.343.03
c.1445T>G
L482R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L482R is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely converge on a deleterious effect: REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all indicate pathogenicity, while FoldX, Rosetta, and Foldetta return uncertain results. In a consensus framework, the SGM‑Consensus score is “Likely Pathogenic,” reflecting the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN. High‑accuracy assessments further support a damaging outcome: AlphaMissense‑Optimized predicts pathogenicity, SGM‑Consensus is Likely Pathogenic, and Foldetta remains inconclusive. Taken together, the overwhelming majority of evidence points to a pathogenic effect. Thus, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.254060Structured0.426236Uncertain0.7950.2480.000-14.684Likely Pathogenic0.976Likely PathogenicLikely Pathogenic0.74Ambiguous0.11.31Ambiguous1.03Ambiguous1.53Destabilizing0.878Likely Pathogenic-5.92Deleterious0.998Probably Damaging0.996Probably Damaging-1.27Pathogenic0.01Affected0.12550.0679-3-2-8.343.03
c.1466T>G
L489R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L489R is not reported in ClinVar and is absent from gnomAD. Prediction tools that assess pathogenicity are unanimous: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as pathogenic. No tool in the dataset predicts a benign effect. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized indicates pathogenicity; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also reports Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts a destabilizing, pathogenic effect. Based on the collective evidence, the variant is most likely pathogenic, and this conclusion does not contradict the ClinVar status, which simply lacks an entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.191378Structured0.326126Uncertain0.9490.2340.125-15.365Likely Pathogenic0.999Likely PathogenicLikely Pathogenic4.32Destabilizing0.34.90Destabilizing4.61Destabilizing1.74Destabilizing0.949Likely Pathogenic-5.86Deleterious1.000Probably Damaging0.998Probably Damaging-1.61Pathogenic0.00Affected0.13060.1145-3-2-8.343.03
c.1499T>G
L500R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L500R is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify the variant as pathogenic include REVEL, FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). No tool predicts a benign effect; the benign group is empty. Predictions that are uncertain or inconclusive are Rosetta, Foldetta, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as likely pathogenic, and Foldetta as uncertain. Based on the overwhelming agreement among pathogenic predictors and the lack of any benign calls, the variant is most likely pathogenic, and this conclusion does not contradict the ClinVar status (which has no entry).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.066181Structured0.382942Uncertain0.8930.1500.000-15.576Likely Pathogenic0.789Likely PathogenicAmbiguous2.23Destabilizing0.11.04Ambiguous1.64Ambiguous1.11Destabilizing0.794Likely Pathogenic-5.97Deleterious1.000Probably Damaging0.998Probably Damaging-1.02Pathogenic0.03Affected0.12040.0488-3-2-8.343.03
c.1517T>G
L506R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L506R is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that assess pathogenicity unanimously classify the variant as deleterious: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a benign effect. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts Pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts Pathogenic. Thus, all available evidence indicates that the variant is most likely pathogenic, with no contradiction to ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.034884Structured0.279180Uncertain0.9240.1960.000-14.119Likely Pathogenic0.979Likely PathogenicLikely Pathogenic4.92Destabilizing0.65.85Destabilizing5.39Destabilizing1.77Destabilizing0.738Likely Pathogenic-5.97Deleterious0.999Probably Damaging0.998Probably Damaging1.54Pathogenic0.00Affected0.12070.0488-3-2-8.343.03
c.1550T>G
L517R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L517R is not reported in ClinVar (ClinVar status: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a pathogenic effect include SGM‑Consensus (Likely Pathogenic), REVEL, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized; the only tool with an uncertain outcome is FoldX. High‑accuracy methods give consistent results: AlphaMissense‑Optimized predicts Pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts Likely Pathogenic, and Foldetta predicts Pathogenic. Based on the overwhelming agreement among these predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.118441Structured0.147645Uncertain0.9380.2960.000-14.761Likely Pathogenic0.996Likely PathogenicLikely Pathogenic1.75Ambiguous0.24.33Destabilizing3.04Destabilizing1.83Destabilizing0.936Likely Pathogenic-5.79Deleterious1.000Probably Damaging0.998Probably Damaging-1.50Pathogenic0.00Affected0.12020.0688-3-2-8.343.03
c.1628T>G
L543R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L543R is not reported in ClinVar (ClinVar status: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that assess pathogenicity all agree that the variant is deleterious: SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify it as pathogenic. No tool predicts a benign effect. High‑accuracy methods reinforce this consensus: AlphaMissense‑Optimized predicts pathogenicity; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also predicts pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, indicates a pathogenic impact. All available predictions are concordant and supportive. Based on these computational assessments, the variant is most likely pathogenic, and this conclusion does not contradict any existing ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.048328Structured0.020918Uncertain0.9630.3140.000-18.563Likely Pathogenic0.998Likely PathogenicLikely Pathogenic3.47Destabilizing1.28.02Destabilizing5.75Destabilizing1.64Destabilizing0.739Likely Pathogenic-5.97Deleterious1.000Probably Damaging0.998Probably Damaging1.89Pathogenic0.00Affected0.12290.0488-3-2-8.343.03
c.1652T>G
L551R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L551R is not reported in ClinVar (ClinVar status: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a pathogenic effect include REVEL, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized; the only tool with an uncertain outcome is FoldX. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized predicts pathogenicity, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts pathogenicity. Based on the concordant predictions from multiple independent algorithms and the absence of benign evidence, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.009977Structured0.006653Uncertain0.9600.2540.000-15.420Likely Pathogenic0.992Likely PathogenicLikely Pathogenic1.81Ambiguous0.22.35Destabilizing2.08Destabilizing2.09Destabilizing0.949Likely Pathogenic-3.85Deleterious1.000Probably Damaging0.998Probably Damaging-1.60Pathogenic0.01Affected0.12780.0530-3-2-8.343.03
c.167T>G
L56R
2D
AIThe SynGAP1 missense variant L56R is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, and FATHMM. Tools that agree on a pathogenic effect include polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments are mixed: AlphaMissense‑Optimized is uncertain; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (2 vs 2), and Foldetta results are unavailable. Overall, the majority of available predictions (5 pathogenic vs 3 benign) indicate a likely pathogenic impact. This conclusion is not contradicted by ClinVar status, as the variant has no existing ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.342579Structured0.476218Uncertain0.4950.6570.000-10.194Likely Pathogenic0.918Likely PathogenicAmbiguous0.264Likely Benign-1.92Neutral0.943Possibly Damaging0.944Probably Damaging3.79Benign0.00Affected0.11910.0685-3-2-8.343.03
c.1694T>G
L565R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L565R is not reported in ClinVar (ClinVar status: not listed) but is present in the gnomAD database (gnomAD ID: 6‑33440746‑T‑G). Prediction tools that agree on a benign effect include only FATHMM, whereas the remaining tools—REVEL, FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, Foldetta, and the SGM Consensus—consistently predict a pathogenic impact. The Rosetta stability assessment is inconclusive and is therefore treated as unavailable. High‑accuracy methods all support pathogenicity: AlphaMissense‑Optimized is pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. Based on the collective predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar evidence (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.034884Structured0.045819Uncertain0.9220.2050.0006-33440746-T-G-16.070Likely Pathogenic0.998Likely PathogenicLikely Pathogenic4.71Destabilizing0.11.88Ambiguous3.30Destabilizing2.66Destabilizing0.547Likely Pathogenic-5.97Deleterious0.999Probably Damaging0.998Probably Damaging2.74Benign0.00Affected3.37350.13730.0615-2-3-8.343.03
c.170T>G
L57R
2D
AIThe SynGAP1 missense variant L57R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), which collectively classify the variant as likely benign. In contrast, polyPhen‑2 (HumDiv and HumVar), SIFT, and AlphaMissense‑Default predict a pathogenic impact. The high‑accuracy AlphaMissense‑Optimized result is uncertain, and Foldetta (combining FoldX‑MD and Rosetta outputs) is not available for this variant. Overall, the balance of evidence leans toward a benign interpretation, and this assessment does not contradict any ClinVar status because no ClinVar entry exists for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.254060Structured0.481044Uncertain0.5540.6420.000-6.034Likely Benign0.810Likely PathogenicAmbiguous0.213Likely Benign-1.55Neutral0.943Possibly Damaging0.944Probably Damaging3.91Benign0.00Affected0.12450.0685-3-2-8.343.03
c.1721T>G
L574R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L574R is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, PROVEAN, SIFT, polyPhen‑2 HumVar, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are polyPhen‑2 HumDiv, ESM1b, and FATHMM. Two tools remain inconclusive: Rosetta (Uncertain) and AlphaMissense‑Default (Uncertain). High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as benign, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic. Overall, the majority of individual predictors (seven benign vs. three pathogenic) support a benign classification, and this conclusion does not contradict the ClinVar status, which contains no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.083462Structured0.026427Uncertain0.9270.2460.000-8.702Likely Pathogenic0.563AmbiguousLikely Benign0.04Likely Benign0.20.88Ambiguous0.46Likely Benign-0.12Likely Benign0.322Likely Benign0.30Neutral0.907Possibly Damaging0.292Benign-1.22Pathogenic0.52Tolerated0.14190.0530-3-2-8.343.03
c.1763T>G
L588R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L588R is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that assess pathogenicity uniformly classify the variant as pathogenic: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a benign effect. High‑accuracy methods corroborate this: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. All available evidence points to a deleterious impact. Thus, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.038042Structured0.082229Uncertain0.8870.2140.000-15.602Likely Pathogenic0.998Likely PathogenicLikely Pathogenic6.96Destabilizing0.46.14Destabilizing6.55Destabilizing2.07Destabilizing0.942Likely Pathogenic-5.98Deleterious1.000Probably Damaging0.998Probably Damaging-1.42Pathogenic0.00Affected0.12090.0530-3-2-8.343.03
c.176T>G
L59R
2D
AISynGAP1 missense variant L59R is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify the variant as benign include SGM‑Consensus (Likely Benign), REVEL, PROVEAN, ESM1b, and FATHMM. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, while the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates a likely benign outcome; Foldetta results are unavailable. The predictions are therefore split, with an equal number of benign and pathogenic calls, and the high‑accuracy tools provide contradictory signals. Consequently, the variant is most likely pathogenic based on the presence of multiple pathogenic predictions and the high‑accuracy AlphaMissense‑Optimized result, and this assessment does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.212910Structured0.484882Uncertain0.5100.6680.000-4.037Likely Benign0.960Likely PathogenicLikely Pathogenic0.266Likely Benign-2.09Neutral0.943Possibly Damaging0.944Probably Damaging3.26Benign0.00Affected0.12980.0600-3-2-8.343.03
c.1778T>G
L593R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L593R is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include only FATHMM, whereas the remaining 13 tools (SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) uniformly predict a pathogenic impact. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized scores the variant as pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, predicts a destabilizing, pathogenic effect. Based on the collective evidence, the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.009728Structured0.110534Uncertain0.9410.1510.000-16.139Likely Pathogenic0.998Likely PathogenicLikely Pathogenic4.27Destabilizing0.33.39Destabilizing3.83Destabilizing2.11Destabilizing0.740Likely Pathogenic-5.87Deleterious1.000Probably Damaging0.998Probably Damaging2.77Benign0.00Affected0.14400.0615-3-2-8.343.03
c.1784T>G
L595R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L595R is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include only FATHMM, while the majority of tools (SGM‑Consensus, REVEL, Rosetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) predict a pathogenic impact; FoldX and Foldetta are uncertain. High‑accuracy methods give a pathogenic signal: AlphaMissense‑Optimized is pathogenic, SGM‑Consensus is likely pathogenic, and Foldetta remains uncertain. Overall, the evidence strongly favors a pathogenic effect, and this conclusion does not contradict any ClinVar annotation, as no ClinVar record exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.015344Structured0.128444Uncertain0.9200.1500.000-14.601Likely Pathogenic0.989Likely PathogenicLikely Pathogenic1.22Ambiguous0.02.20Destabilizing1.71Ambiguous1.52Destabilizing0.707Likely Pathogenic-5.97Deleterious1.000Probably Damaging0.998Probably Damaging2.76Benign0.00Affected0.13440.1005-3-2-8.343.03
c.1793T>G
L598R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L598R is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include only FATHMM, whereas the remaining tools—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. High‑accuracy methods give the following results: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates likely pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. Based on the overwhelming agreement among these tools, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.007259Structured0.147872Uncertain0.9530.1540.000-17.392Likely Pathogenic0.994Likely PathogenicLikely Pathogenic2.70Destabilizing0.53.06Destabilizing2.88Destabilizing2.23Destabilizing0.682Likely Pathogenic-5.87Deleterious0.999Probably Damaging0.973Probably Damaging3.10Benign0.00Affected0.12970.0679-3-2-8.343.03
c.1820T>G
L607R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L607R is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include only FoldX, which scores the variant as benign. All other evaluated algorithms—REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—predict a pathogenic impact. Rosetta and Foldetta provide uncertain results and are therefore treated as unavailable evidence. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized is pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is “Likely Pathogenic,” while Foldetta remains uncertain. Based on the preponderance of pathogenic predictions and the high‑accuracy consensus, the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.048328Structured0.194229Uncertain0.8690.2500.000-14.234Likely Pathogenic0.978Likely PathogenicLikely Pathogenic-0.15Likely Benign0.11.48Ambiguous0.67Ambiguous1.24Destabilizing0.920Likely Pathogenic-5.98Deleterious0.998Probably Damaging0.998Probably Damaging-1.51Pathogenic0.01Affected0.14900.0615-3-2-8.343.03
c.1829T>G
L610R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L610R is not reported in ClinVar and is absent from gnomAD. Prediction tools that assess pathogenicity are unanimous: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as pathogenic. No tool in the dataset predicts a benign effect. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized reports a pathogenic outcome; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, predicts a pathogenic impact. Consequently, the variant is most likely pathogenic based on the available predictions, and this assessment does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.271506Structured0.209504Uncertain0.8880.2530.000-13.855Likely Pathogenic0.956Likely PathogenicLikely Pathogenic5.14Destabilizing0.54.60Destabilizing4.87Destabilizing1.89Destabilizing0.949Likely Pathogenic-5.94Deleterious0.998Probably Damaging0.998Probably Damaging-1.58Pathogenic0.00Affected0.13340.0615-3-2-8.343.03
c.1868T>G
L623R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L623R is not reported in ClinVar (ClinVar status: not listed) and is absent from gnomAD (gnomAD ID: none). Prediction tools that assess pathogenicity unanimously classify the variant as deleterious: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a benign effect. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. All available evidence points to a pathogenic impact. Thus, the variant is most likely pathogenic, with no contradiction to ClinVar status because the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.175930Structured0.060667Uncertain0.9620.2110.000-13.718Likely Pathogenic0.998Likely PathogenicLikely Pathogenic4.08Destabilizing1.43.28Destabilizing3.68Destabilizing2.31Destabilizing0.795Likely Pathogenic-5.98Deleterious1.000Probably Damaging0.998Probably Damaging1.55Pathogenic0.00Affected0.13270.0615-3-2-8.343.03
c.1874T>G
L625R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L625R is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include only FATHMM, whereas all other evaluated algorithms (SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) uniformly predict a pathogenic or likely pathogenic impact. High‑accuracy assessments further support this: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also predicts pathogenic. Based on the preponderance of evidence, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.229226Structured0.045896Uncertain0.9660.2150.000-14.507Likely Pathogenic0.984Likely PathogenicLikely Pathogenic2.31Destabilizing0.74.21Destabilizing3.26Destabilizing1.88Destabilizing0.733Likely Pathogenic-5.93Deleterious1.000Probably Damaging0.998Probably Damaging2.99Benign0.00Affected0.10910.0615-3-2-8.343.03
c.1898T>G
L633R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L633R is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include only FATHMM, whereas all other evaluated algorithms—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the variant as pathogenic. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized predicts pathogenicity, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts pathogenicity. Based on the overwhelming consensus of pathogenic predictions and the absence of any benign signal, the variant is most likely pathogenic, and this conclusion does not contradict the current ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.045352Structured0.045407Uncertain0.9520.2520.000-14.360Likely Pathogenic0.994Likely PathogenicLikely Pathogenic4.41Destabilizing0.24.85Destabilizing4.63Destabilizing2.15Destabilizing0.667Likely Pathogenic-5.98Deleterious0.999Probably Damaging0.998Probably Damaging2.70Benign0.00Affected0.16740.0518-3-2-8.343.03
c.1937T>G
L646R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L646R is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split: benign calls come from REVEL, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM, whereas pathogenic calls are made by FoldX, Rosetta, Foldetta, premPS, PROVEAN, SIFT, ESM1b, and AlphaMissense‑Default. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, labels the variant as Likely Pathogenic. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized is uncertain, SGM Consensus is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts a pathogenic impact. Overall, the preponderance of evidence points to a pathogenic effect for L646R, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.048328Structured0.303751Uncertain0.9410.3440.000-12.393Likely Pathogenic0.920Likely PathogenicAmbiguous4.44Destabilizing0.23.94Destabilizing4.19Destabilizing2.75Destabilizing0.455Likely Benign-3.56Deleterious0.014Benign0.002Benign3.17Benign0.03Affected0.23040.1405-3-2-8.343.03
c.1958T>G
L653R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense change L653R lies in the GAP domain. ClinVar has no entry for this variant, and it is not reported in gnomAD. Prediction tools that agree on a benign effect are limited to FATHMM, whereas the remaining 13 tools (SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) uniformly predict a pathogenic impact. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized scores the variant as pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) reports it as likely pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, also predicts a pathogenic effect. Based on the collective evidence, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar claim exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.049374Structured0.335213Uncertain0.9630.3320.000-16.078Likely Pathogenic0.995Likely PathogenicLikely Pathogenic6.92Destabilizing1.15.84Destabilizing6.38Destabilizing2.55Destabilizing0.649Likely Pathogenic-5.75Deleterious0.997Probably Damaging0.806Possibly Damaging3.09Benign0.00Affected0.15010.0805-3-2-8.343.03
c.1964T>G
L655R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L655R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Functional prediction tools uniformly indicate a benign effect: SIFT, PolyPhen‑2 (HumDiv and HumVar), REVEL, PROVEAN, premPS, FoldX, and the majority of consensus methods (AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) all score the variant as benign. The only inconclusive result comes from Rosetta, which is treated as unavailable. High‑accuracy assessments reinforce this benign prediction: AlphaMissense‑Optimized reports benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is “Likely Benign,” and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts benign. Thus, based on the available predictions, the variant is most likely benign, with no conflict with ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.015344Structured0.268808Uncertain0.9610.2740.000-4.848Likely Benign0.284Likely BenignLikely Benign-0.40Likely Benign0.00.54Ambiguous0.07Likely Benign-0.09Likely Benign0.160Likely Benign0.46Neutral0.006Benign0.001Benign3.50Benign0.60Tolerated0.15890.0615-3-2-8.343.03
c.2009T>G
L670R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L670R is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic impact are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b. The remaining tools—FoldX, Rosetta, Foldetta, premPS, and AlphaMissense‑Default—return uncertain or inconclusive results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as benign, and Foldetta as uncertain. Overall, the majority of reliable predictions indicate a benign effect. There is no ClinVar annotation to contradict this assessment, so the variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.161087Structured0.090855Uncertain0.8120.3850.000-9.801Likely Pathogenic0.552AmbiguousLikely Benign0.64Ambiguous0.11.42Ambiguous1.03Ambiguous0.67Ambiguous0.193Likely Benign-1.74Neutral0.993Probably Damaging0.755Possibly Damaging3.43Benign0.41Tolerated0.13270.1145-3-2-8.343.03
c.200T>G
L67R
2D
AIThe SynGAP1 missense variant L67R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, and FATHMM, while those that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments show AlphaMissense‑Optimized as Uncertain, SGM‑Consensus as Likely Benign, and Foldetta results are unavailable. Overall, the balance of evidence leans toward a benign interpretation, with no conflict with ClinVar status because no ClinVar assertion exists. Thus, the variant is most likely benign based on current predictive tools.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.458154Structured0.473668Uncertain0.4280.7610.125-3.430Likely Benign0.814Likely PathogenicAmbiguous0.115Likely Benign-0.84Neutral0.943Possibly Damaging0.766Possibly Damaging4.09Benign0.00Affected0.11590.0719-3-2-8.343.03
c.2018T>G
L673R
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant L673R is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split: benign calls come from REVEL, polyPhen‑2 HumVar, FATHMM, and AlphaMissense‑Optimized; pathogenic calls come from Rosetta, premPS, PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, AlphaMissense‑Default, and the SGM Consensus (majority vote). FoldX and Foldetta are inconclusive. High‑accuracy assessments give a benign result from AlphaMissense‑Optimized, a likely pathogenic verdict from the SGM Consensus, and an uncertain outcome from Foldetta. Overall, the majority of evidence points toward pathogenicity, and this conclusion does not conflict with the ClinVar status, which currently has no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.060549Structured0.104692Uncertain0.5450.3690.000-14.474Likely Pathogenic0.714Likely PathogenicLikely Benign1.10Ambiguous0.22.04Destabilizing1.57Ambiguous1.23Destabilizing0.178Likely Benign-3.81Deleterious0.991Probably Damaging0.433Benign3.36Benign0.03Affected0.13480.1015-3-2-8.343.03
c.203T>G
L68R
2D
AIThe SynGAP1 missense variant L68R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), which collectively suggest a likely benign impact. In contrast, polyPhen‑2 (HumDiv and HumVar), SIFT, and AlphaMissense‑Default predict a pathogenic effect. The high‑accuracy AlphaMissense‑Optimized result is uncertain, and Foldetta stability analysis is unavailable. Overall, the balance of evidence leans toward a benign interpretation, and this assessment does not contradict any ClinVar annotation because no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.534167Disordered0.470567Uncertain0.4050.7680.250-3.427Likely Benign0.865Likely PathogenicAmbiguous0.147Likely Benign-0.61Neutral0.943Possibly Damaging0.766Possibly Damaging4.13Benign0.00Affected0.11780.0519-3-2-8.343.03
c.2066T>G
L689R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L689R is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely converge on a deleterious effect: SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (both HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized all indicate pathogenicity, whereas only FATHMM predicts a benign outcome. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, is pathogenic. No predictions are missing or inconclusive. Consequently, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation (none available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.042364Structured0.227227Uncertain0.9630.2480.000-17.776Likely Pathogenic0.998Likely PathogenicLikely Pathogenic5.91Destabilizing0.65.61Destabilizing5.76Destabilizing2.14Destabilizing0.609Likely Pathogenic-5.98Deleterious1.000Probably Damaging0.932Probably Damaging3.15Benign0.00Affected0.12080.0530-3-2-8.343.03
c.2075T>G
L692R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L692R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include only FATHMM, whereas all other evaluated algorithms—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized scores the variant as pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates a likely pathogenic outcome; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also predicts pathogenicity. No prediction or folding stability result is missing or inconclusive. Based on the collective evidence, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because the variant is not yet catalogued in ClinVar.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.064632Structured0.295225Uncertain0.9660.2430.000-16.656Likely Pathogenic0.999Likely PathogenicLikely Pathogenic4.34Destabilizing0.05.51Destabilizing4.93Destabilizing1.96Destabilizing0.611Likely Pathogenic-5.98Deleterious0.999Probably Damaging0.895Possibly Damaging3.07Benign0.00Affected0.12040.0488-3-2-8.343.03
c.2084T>G
L695R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L695R is not reported in ClinVar and is absent from gnomAD. Prediction tools largely agree on a deleterious effect: benign predictions are limited to FATHMM, while the remaining 13 tools (SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default) all classify the variant as pathogenic. AlphaMissense‑Optimized returns an uncertain result. High‑accuracy assessments further support pathogenicity: the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is also pathogenic. Overall, the evidence overwhelmingly indicates that the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.118441Structured0.373419Uncertain0.9420.2580.000-15.582Likely Pathogenic0.873Likely PathogenicAmbiguous2.05Destabilizing0.12.66Destabilizing2.36Destabilizing1.57Destabilizing0.605Likely Pathogenic-5.92Deleterious0.993Probably Damaging0.588Possibly Damaging3.17Benign0.00Affected0.12200.0530-3-2-8.343.03
c.2087T>G
L696R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L696R is not reported in ClinVar and is absent from gnomAD. Prediction tools largely agree on a deleterious effect: all available predictors except FATHMM (which flags it as benign) report pathogenicity. The benign group contains only FATHMM; the pathogenic group includes SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts pathogenic. No prediction or stability result is missing or inconclusive. Based on the collective evidence, the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.200174Structured0.390093Uncertain0.9620.2670.000-19.609Likely Pathogenic0.998Likely PathogenicLikely Pathogenic3.67Destabilizing0.05.36Destabilizing4.52Destabilizing2.44Destabilizing0.624Likely Pathogenic-5.68Deleterious0.999Probably Damaging0.992Probably Damaging3.01Benign0.00Affected0.12000.0688-3-2-8.343.03
c.2099T>G
L700R
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant L700R is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a deleterious effect: benign calls come from REVEL, polyPhen‑2 HumVar, and FATHMM, whereas pathogenic calls are made by Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, and AlphaMissense‑Default. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, labels the variant as Likely Pathogenic. High‑accuracy assessments are mixed: AlphaMissense‑Optimized is inconclusive, SGM Consensus remains Likely Pathogenic, and Foldetta predicts a destabilizing, pathogenic effect. Overall, the preponderance of evidence points to a pathogenic impact, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.113710Structured0.416255Uncertain0.9270.3310.000-12.389Likely Pathogenic0.938Likely PathogenicAmbiguous1.82Ambiguous0.14.19Destabilizing3.01Destabilizing1.89Destabilizing0.485Likely Benign-4.29Deleterious0.728Possibly Damaging0.249Benign3.35Benign0.01Affected0.12100.0488-3-2-8.343.03
c.2108T>G
L703R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L703R is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include REVEL and FATHMM, whereas the majority of other in silico predictors (FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, and the SGM Consensus) all classify the change as pathogenic. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM Consensus as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as pathogenic. The preponderance of pathogenic predictions, together with the high‑accuracy tools’ positive results, suggests that L703R is most likely pathogenic. This conclusion is not contradicted by ClinVar, which contains no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.144935Structured0.388282Uncertain0.9290.3530.000-13.244Likely Pathogenic0.935Likely PathogenicAmbiguous2.85Destabilizing0.03.74Destabilizing3.30Destabilizing1.79Destabilizing0.459Likely Benign-4.92Deleterious0.994Probably Damaging0.806Possibly Damaging3.13Benign0.00Affected0.12230.0488-3-2-8.343.03
c.2123T>G
L708R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L708R is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, and AlphaMissense‑Default; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also reports it as Likely Pathogenic. FoldX, Rosetta, and Foldetta give uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM Consensus as Likely Pathogenic, and Foldetta as uncertain. Overall, the majority of tools (six pathogenic vs. four benign) and the SGM Consensus support a pathogenic classification, whereas AlphaMissense‑Optimized suggests benign. The variant is most likely pathogenic based on the collective predictions, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.250310Structured0.365875Uncertain0.9310.3780.000-9.154Likely Pathogenic0.638Likely PathogenicLikely Benign0.87Ambiguous0.00.90Ambiguous0.89Ambiguous1.24Destabilizing0.249Likely Benign-4.18Deleterious0.988Probably Damaging0.598Possibly Damaging3.27Benign0.19Tolerated0.10910.0488-3-2-8.343.03
c.2126T>G
L709R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L709R is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, PROVEAN, SIFT, polyPhen‑2 HumVar, and FATHMM. Those that predict a pathogenic effect are polyPhen‑2 HumDiv and ESM1b. Tools with uncertain or inconclusive results are Rosetta, premPS, and AlphaMissense‑Default. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized predicts benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields a benign consensus; and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts benign. Overall, the majority of evidence indicates a benign impact for the variant, and this conclusion does not contradict the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.243554Structured0.365830Uncertain0.9340.3790.000-8.636Likely Pathogenic0.482AmbiguousLikely Benign0.22Likely Benign0.00.68Ambiguous0.45Likely Benign0.62Ambiguous0.061Likely Benign-1.56Neutral0.906Possibly Damaging0.314Benign3.50Benign0.44Tolerated0.11270.0488-3-2-8.343.03
c.2132T>G
L711R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L711R lies in the GAP domain. ClinVar has no entry for this variant, and it is not present in gnomAD. Prediction tools that agree on a benign effect are REVEL and FATHMM; all other evaluated algorithms (FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) predict a pathogenic impact, and the SGM‑Consensus score is “Likely Pathogenic.” High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. No predictions or stability results are missing or inconclusive. Based on the overwhelming majority of computational evidence, the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.308712Structured0.377436Uncertain0.9500.3640.000-14.009Likely Pathogenic0.994Likely PathogenicLikely Pathogenic3.71Destabilizing0.03.98Destabilizing3.85Destabilizing2.13Destabilizing0.432Likely Benign-5.71Deleterious0.999Probably Damaging0.992Probably Damaging3.35Benign0.00Affected0.13450.0488-3-2-8.343.03
c.2141T>G
L714R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L714R is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL and FATHMM, whereas the remaining tools (FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) uniformly predict a pathogenic impact. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is “Likely Pathogenic”; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, also predicts pathogenicity. No prediction or folding stability result is missing or inconclusive. Based on the preponderance of evidence, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status (none available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.314870Structured0.402311Uncertain0.9610.3690.000-12.763Likely Pathogenic0.999Likely PathogenicLikely Pathogenic4.38Destabilizing0.27.54Destabilizing5.96Destabilizing2.09Destabilizing0.402Likely Benign-5.62Deleterious0.999Probably Damaging0.992Probably Damaging3.09Benign0.00Affected0.11860.0558-3-2-8.343.03
c.2150T>G
L717R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L717R is not reported in ClinVar and is absent from gnomAD. Prediction tools cluster into two groups: benign predictions come from REVEL and FATHMM, while the remaining 13 tools (SGM‑Consensus, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the majority‑vote SGM Consensus) predict pathogenicity; FoldX is uncertain. High‑accuracy methods reinforce a pathogenic verdict: AlphaMissense‑Optimized scores it as pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta also predicts pathogenic. No prediction is missing or inconclusive. Consequently, the variant is most likely pathogenic, and this assessment does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.239899Structured0.429342Uncertain0.9690.3970.000-11.352Likely Pathogenic0.973Likely PathogenicLikely Pathogenic1.66Ambiguous0.13.78Destabilizing2.72Destabilizing1.57Destabilizing0.353Likely Benign-4.98Deleterious0.999Probably Damaging0.992Probably Damaging3.28Benign0.00Affected0.11690.0558-3-2-8.343.03
c.2153T>G
L718R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L718R is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include only REVEL, which scores the variant as benign. All other evaluated algorithms—FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the variant as pathogenic. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized predicts pathogenicity; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates “Likely Pathogenic”; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, also predicts pathogenicity. Based on the overwhelming agreement among these tools, the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.298791Structured0.438417Uncertain0.9660.3850.000-16.119Likely Pathogenic0.997Likely PathogenicLikely Pathogenic5.90Destabilizing0.25.05Destabilizing5.48Destabilizing2.57Destabilizing0.484Likely Benign-5.69Deleterious1.000Probably Damaging0.998Probably Damaging1.28Pathogenic0.00Affected0.12540.0600-3-2-8.343.03
c.2174T>G
L725R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L725R is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include only REVEL, which scores the variant as benign. All other evaluated algorithms—polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, PROVEAN, AlphaMissense‑Default, AlphaMissense‑Optimized, premPS, Rosetta, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN)—classify the variant as pathogenic. FoldX and Foldetta report uncertain results and are therefore not considered evidence for either side. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts pathogenic, SGM‑Consensus indicates likely pathogenic, while Foldetta remains uncertain. Based on the overwhelming majority of pathogenic predictions and the lack of benign consensus, the variant is most likely pathogenic, which is consistent with the absence of a ClinVar entry and gnomAD observation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.557691Disordered0.455613Uncertain0.9110.4910.625-15.383Likely Pathogenic0.961Likely PathogenicLikely Pathogenic0.69Ambiguous0.32.16Destabilizing1.43Ambiguous1.49Destabilizing0.345Likely Benign-5.46Deleterious0.999Probably Damaging0.998Probably Damaging1.28Pathogenic0.00Affected0.13740.0846-3-2-8.343.03
c.2243T>G
L748R
2D
AIThe SynGAP1 missense variant L748R is listed in ClinVar with an “Uncertain” status and is present in gnomAD (ID 6‑33441708‑T‑G). Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT all predict a pathogenic impact. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as “Likely Benign.” High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized predicts benign, SGM‑Consensus is likely benign, and Foldetta (a protein‑folding stability method combining FoldX‑MD and Rosetta outputs) has no available result for this variant. Overall, the majority of evidence points to a benign effect, and this conclusion does not contradict the current ClinVar “Uncertain” designation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.703578Disordered0.611637Binding0.3390.8630.750Conflicting 26-33441708-T-G31.86e-6-3.331Likely Benign0.245Likely BenignLikely Benign0.055Likely Benign-0.67Neutral0.912Possibly Damaging0.448Possibly Damaging2.73Benign0.02Affected4.3220.13420.0888-3-2-8.343.03
c.2288T>G
L763R
2D
AIThe SynGAP1 missense variant L763R is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, FATHMM, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (2 benign vs 2 pathogenic) and Foldetta results are unavailable. Overall, the balance of evidence leans toward a benign impact, and this conclusion does not contradict the ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.380708Structured0.918636Binding0.3510.8650.125-5.516Likely Benign0.643Likely PathogenicLikely Benign0.163Likely Benign-1.66Neutral0.999Probably Damaging0.977Probably Damaging2.38Pathogenic0.07Tolerated0.11990.0761-3-2-8.343.03
c.2306T>G
L769R
2D
AIThe SynGAP1 missense variant L769R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Only SIFT predicts a pathogenic outcome, while AlphaMissense‑Default remains uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM‑Consensus as likely benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) is unavailable for this variant. Based on the preponderance of evidence, the variant is most likely benign, and this assessment does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.411940Structured0.928432Binding0.3670.8830.250-6.245Likely Benign0.493AmbiguousLikely Benign0.206Likely Benign-1.66Neutral0.003Benign0.006Benign3.91Benign0.00Affected0.12860.0702-3-2-8.343.03
c.2330T>G
L777R
2D
AIThe SynGAP1 missense variant L777R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as Likely Benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact. This conclusion is consistent with the lack of ClinVar annotation, so there is no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.408655Structured0.876129Binding0.3360.8820.250-6.084Likely Benign0.650Likely PathogenicLikely Benign0.227Likely Benign-2.20Neutral0.991Probably Damaging0.985Probably Damaging3.97Benign0.00Affected0.12490.0846-3-2-8.343.03
c.2357T>G
L786R
2D
AIThe SynGAP1 missense variant L786R is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL and ESM1b, whereas the majority of tools predict a pathogenic impact: PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus score. AlphaMissense‑Optimized is uncertain, and no Foldetta stability assessment is available. The high‑accuracy consensus from SGM (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) favors pathogenicity, and the lack of a Foldetta result does not alter this conclusion. Overall, the preponderance of evidence indicates that the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because the variant has not yet been catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicSH3-binding motif0.882776Disordered0.655253Binding0.3410.8950.750-4.989Likely Benign0.842Likely PathogenicAmbiguous0.169Likely Benign-3.07Deleterious0.999Probably Damaging0.998Probably Damaging1.79Pathogenic0.00Affected0.14030.1288-3-2-8.343.03
c.2414T>G
L805R
2D
AIThe SynGAP1 missense variant L805R is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include REVEL, ESM1b, and AlphaMissense‑Optimized. In contrast, the majority of tools predict a pathogenic impact: SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Default all indicate pathogenicity. High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as benign, whereas the SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) labels it as likely pathogenic; Foldetta results are unavailable. Overall, the balance of evidence from the broader set of predictors leans toward pathogenicity, and this conclusion does not contradict any existing ClinVar annotation, as none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicSH3-binding motif0.775545Disordered0.827669Binding0.3410.9030.625-6.640Likely Benign0.569Likely PathogenicLikely Benign0.196Likely Benign-3.00Deleterious0.927Possibly Damaging0.617Possibly Damaging2.37Pathogenic0.00Affected0.13720.0908-3-2-8.343.03
c.242T>G
L81R
2D
AIThe SynGAP1 missense variant L81R is not reported in ClinVar and has no entries in gnomAD. Consensus from multiple in silico predictors shows a split: benign calls from REVEL, PROVEAN, polyPhen2_HumVar, ESM1b, FATHMM, and AlphaMissense‑Optimized, whereas pathogenic calls come from polyPhen2_HumDiv, SIFT, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy tools further support a benign interpretation: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus (majority vote) also indicates benign. No Foldetta stability assessment is available for this variant. Overall, the majority of evidence points to a benign effect, and this conclusion is consistent with the absence of a ClinVar pathogenic annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.632174Disordered0.502033Binding0.2910.8780.250-4.451Likely Benign0.639Likely PathogenicLikely Benign0.053Likely Benign-1.22Neutral0.919Possibly Damaging0.226Benign3.94Benign0.00Affected0.11790.0688-3-2-8.343.03
c.2438T>G
L813R
2D
AIThe SynGAP1 missense variant L813R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, and FATHMM, while polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default predict a pathogenic outcome. The SGM‑Consensus, which aggregates the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as “Likely Benign.” High‑accuracy assessments show AlphaMissense‑Optimized as “Uncertain” and Foldetta results are unavailable. Taken together, the majority of evidence points to a benign impact, and this conclusion does not contradict the ClinVar status, which currently contains no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignSH3-binding motif0.411940Structured0.838481Binding0.2920.9050.250-4.697Likely Benign0.786Likely PathogenicAmbiguous0.160Likely Benign-1.57Neutral0.999Probably Damaging0.985Probably Damaging2.68Benign0.11Tolerated0.12610.0947-3-2-8.343.03
c.245T>G
L82R
2D
AIThe SynGAP1 missense variant L82R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumVar, ESM1b, FATHMM, and the SGM‑Consensus (Likely Benign). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as pathogenic, while the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates a likely benign outcome; Foldetta results are unavailable. Overall, the majority of predictions (six benign vs. four pathogenic) lean toward a benign interpretation, and this is not contradicted by any ClinVar annotation. Thus, based on the current computational evidence, the variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.637480Disordered0.517720Binding0.2840.8900.375-6.345Likely Benign0.974Likely PathogenicLikely Pathogenic0.077Likely Benign-2.18Neutral0.939Possibly Damaging0.114Benign3.67Benign0.00Affected0.13380.0590-3-2-8.343.03
c.2504T>G
L835R
2D
AIThe SynGAP1 missense variant L835R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, and AlphaMissense‑Optimized, while polyPhen‑2 (HumDiv and HumVar) and SIFT all predict a pathogenic outcome. AlphaMissense‑Default remains uncertain. The high‑accuracy consensus from SGM (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) classifies the variant as Likely Benign, and AlphaMissense‑Optimized independently predicts Benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of evidence points to a benign effect, and this assessment does not contradict any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.608892Disordered0.642742Binding0.3190.8630.125-4.749Likely Benign0.381AmbiguousLikely Benign0.126Likely Benign-1.05Neutral0.996Probably Damaging0.955Probably Damaging2.70Benign0.02Affected0.12390.0804-3-2-8.343.03
c.2531T>G
L844R
2D
AIThe SynGAP1 missense variant L844R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL and FATHMM, while the majority of tools predict a pathogenic effect: PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments further support a deleterious outcome: AlphaMissense‑Optimized is uncertain, but the SGM Consensus—derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—classifies the variant as Likely Pathogenic. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, was not available for this variant. Overall, the preponderance of evidence indicates that the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.595080Disordered0.611301Binding0.3040.8350.375-9.355Likely Pathogenic0.904Likely PathogenicAmbiguous0.267Likely Benign-2.77Deleterious0.960Probably Damaging0.697Possibly Damaging2.60Benign0.01Affected0.12300.0947-3-2-8.343.03
c.2564T>G
L855R
2D
AIThe SynGAP1 missense variant L855R is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as benign. Only SIFT predicts a pathogenic outcome. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as “Likely Benign.” High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized is benign, and the SGM‑Consensus is likely benign; Foldetta results are not available. Overall, the preponderance of evidence indicates that the variant is most likely benign, and this conclusion does not contradict any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.724957Disordered0.485558Uncertain0.2850.8230.625-3.703Likely Benign0.229Likely BenignLikely Benign0.086Likely Benign-1.62Neutral0.026Benign0.015Benign4.00Benign0.03Affected0.13030.1187-3-2-8.343.03
c.2588T>G
L863R
2D
AIThe SynGAP1 missense variant L863R is not reported in ClinVar and is absent from gnomAD. Consensus predictions from multiple in silico tools cluster around a benign effect: REVEL, PROVEAN, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized all indicate benign, while the majority of high‑accuracy predictors (AlphaMissense‑Optimized and the SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also support a benign classification. In contrast, polyPhen‑2 (HumDiv and HumVar) predict a pathogenic impact, but these are the only tools in disagreement. The AlphaMissense‑Default score is uncertain, and no Foldetta stability assessment is available. Overall, the preponderance of evidence points to a benign effect for the variant, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.525368Disordered0.594839Binding0.2670.7950.250-6.402Likely Benign0.488AmbiguousLikely Benign0.129Likely Benign-1.36Neutral0.999Probably Damaging0.977Probably Damaging4.02Benign0.09Tolerated0.12340.0947-3-2-8.343.03
c.2606T>G
L869R
2D
AIThe SynGAP1 missense variant L869R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include SGM‑Consensus (Likely Benign), REVEL, PROVEAN, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact. There is no ClinVar entry to contradict this conclusion, so the variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.501700Disordered0.688653Binding0.2720.8390.250-2.546Likely Benign0.567Likely PathogenicLikely Benign0.170Likely Benign-0.79Neutral0.970Probably Damaging0.801Possibly Damaging2.60Benign0.29Tolerated0.11620.0846-3-2-8.343.03
c.2609T>G
L870R
2D
AIThe SynGAP1 missense variant L870R is not reported in ClinVar and has no entries in gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact for this variant, and this conclusion does not contradict the ClinVar status, which currently contains no classification for L870R.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.483068Structured0.688079Binding0.2740.8500.125-4.578Likely Benign0.636Likely PathogenicLikely Benign0.175Likely Benign-1.97Neutral0.999Probably Damaging0.998Probably Damaging2.63Benign0.02Affected0.11470.0846-3-2-8.343.03
c.2630T>G
L877R
2D
AIThe SynGAP1 missense variant L877R is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact for this variant, and this conclusion does not contradict the ClinVar status, which currently contains no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.653063Disordered0.634010Binding0.2650.8750.250-6.678Likely Benign0.673Likely PathogenicLikely Benign0.148Likely Benign-1.82Neutral0.986Probably Damaging0.876Possibly Damaging2.57Benign0.02Affected0.12180.0761-3-2-8.343.03
c.2648T>G
L883R
2D
AIThe SynGAP1 missense variant L883R is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict benign. Only polyPhen‑2 HumDiv indicates a pathogenic effect, while the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) classifies the variant as Likely Benign. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized is benign and the SGM‑Consensus is Likely Benign; Foldetta results are not available. Overall, the preponderance of evidence points to a benign impact for the L883R variant, and this conclusion is consistent with the lack of any ClinVar pathogenic annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.716283Disordered0.641952Binding0.3340.8860.250-3.026Likely Benign0.286Likely BenignLikely Benign0.110Likely Benign-0.83Neutral0.934Possibly Damaging0.435Benign2.73Benign0.11Tolerated0.12370.1147-3-2-8.343.03
c.2672T>G
L891R
2D
AIThe SynGAP1 missense variant L891R is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, PROVEAN, ESM1b, FATHMM, and AlphaMissense‑Optimized, while pathogenic predictions arise from polyPhen‑2 (HumDiv and HumVar) and SIFT. AlphaMissense‑Default remains uncertain. The high‑accuracy consensus methods reinforce the benign assessment: AlphaMissense‑Optimized predicts benign, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates “Likely Benign,” and the protein‑folding stability tool Foldetta has no available result for this variant. Based on the aggregate evidence, the variant is most likely benign, and this conclusion does not contradict any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.712013Disordered0.505861Binding0.3050.9230.750-4.120Likely Benign0.419AmbiguousLikely Benign0.122Likely Benign-1.83Neutral0.970Probably Damaging0.801Possibly Damaging2.65Benign0.01Affected0.12330.0863-3-2-8.343.03
c.2717T>G
L906R
2D
AIThe SynGAP1 missense variant L906R is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, and AlphaMissense‑Optimized. Tools that agree on a pathogenic effect are polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Default. The SGM Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is inconclusive (2 benign vs 2 pathogenic). Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of standard predictors (5 vs 4) lean toward pathogenicity, while the high‑accuracy AlphaMissense‑Optimized predicts benign and the consensus remains unresolved. Thus, the variant is most likely pathogenic based on the current predictions, and this assessment does not contradict any ClinVar status because the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.604312Disordered0.644316Binding0.3150.9200.250-3.440Likely Benign0.769Likely PathogenicLikely Benign0.160Likely Benign-0.26Neutral1.000Probably Damaging0.990Probably Damaging2.18Pathogenic0.04Affected0.12280.0947-3-2-8.343.03
c.2762T>G
L921R
2D
AIThe SynGAP1 missense variant L921R is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, and AlphaMissense‑Optimized. Tools that agree on a pathogenic effect are polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM. AlphaMissense‑Default is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized predicts benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also predicts benign, and Foldetta results are unavailable. Overall, the majority of high‑confidence tools predict a benign impact, and there is no conflict with ClinVar status. Thus, the variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.608892Disordered0.943282Binding0.3110.8450.375-2.205Likely Benign0.563AmbiguousLikely Benign0.217Likely Benign-1.19Neutral0.994Probably Damaging0.912Probably Damaging2.41Pathogenic0.00Affected0.13060.0761-3-2-8.343.03
c.2774T>G
L925R
2D
AIThe SynGAP1 missense variant L925R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include only ESM1b, whereas the remaining tools—REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN)—all predict a pathogenic or likely pathogenic impact. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized reports a pathogenic effect, and the SGM‑Consensus indicates a likely pathogenic classification. Foldetta results are not available for this variant. Based on the preponderance of pathogenic predictions and the lack of benign consensus, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none is reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.483068Structured0.977963Binding0.2900.8520.125-2.340Likely Benign0.984Likely PathogenicLikely Pathogenic0.519Likely Pathogenic-4.54Deleterious1.000Probably Damaging0.999Probably Damaging1.28Pathogenic0.00Affected0.12780.1294-3-2-8.343.03
c.2792T>G
L931R
2D
AIThe SynGAP1 missense variant L931R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include only REVEL, whereas the majority of tools predict a pathogenic impact: PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN). High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, while the SGM‑Consensus remains pathogenic; Foldetta results are not available. Overall, the preponderance of evidence from multiple in‑silico predictors indicates that the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.549308Disordered0.989212Binding0.3350.8560.375-8.606Likely Pathogenic0.933Likely PathogenicAmbiguous0.344Likely Benign-3.48Deleterious1.000Probably Damaging0.999Probably Damaging2.39Pathogenic0.01Affected0.12410.1205-3-2-8.343.03
c.2963T>G
L988R
2D
AIThe SynGAP1 missense variant L988R is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.827927Disordered0.918781Binding0.3600.9130.750-4.412Likely Benign0.681Likely PathogenicLikely Benign0.202Likely Benign-2.39Neutral0.954Possibly Damaging0.867Possibly Damaging2.69Benign0.00Affected0.12570.1088-3-2-8.343.03
c.3002T>G
L1001R
2D
AIThe SynGAP1 missense variant L1001R is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote) which classifies the variant as Likely Benign. In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT all predict a pathogenic impact. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized returns Benign, and the SGM‑Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates Likely Benign. No Foldetta stability prediction is available, so it does not influence the assessment. Overall, the majority of evidence points to a benign effect, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.754692Disordered0.958507Binding0.2690.9020.375-2.285Likely Benign0.320Likely BenignLikely Benign0.091Likely Benign-1.09Neutral0.966Probably Damaging0.708Possibly Damaging2.67Benign0.00Affected0.12990.0832-3-2-8.343.03
c.3065T>G
L1022R
2D
AIThe SynGAP1 missense variant L1022R is not reported in ClinVar and has no entries in gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact for this variant, and this conclusion does not contradict the ClinVar status, which currently contains no classification for L1022R.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.859585Disordered0.986981Binding0.3390.7520.500-2.875Likely Benign0.659Likely PathogenicLikely Benign0.183Likely Benign-1.96Neutral0.986Probably Damaging0.894Possibly Damaging2.51Benign0.01Affected0.12790.1387-3-2-8.343.03
c.3071T>G
L1024R
2D
AIThe SynGAP1 missense variant L1024R is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, and ESM1b, whereas those that agree on a pathogenic effect are polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Default. The high‑accuracy AlphaMissense‑Optimized tool returns an uncertain result, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (2 pathogenic vs. 2 benign). Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of available predictions (5 pathogenic vs. 3 benign) lean toward a pathogenic interpretation. This assessment does not contradict ClinVar status, as the variant is not yet catalogued there. Thus, based on current computational evidence, the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.862302Disordered0.992699Binding0.3270.7530.500-3.434Likely Benign0.841Likely PathogenicAmbiguous0.148Likely Benign-2.41Neutral0.997Probably Damaging0.962Probably Damaging2.40Pathogenic0.02Affected0.13350.1557-3-2-8.343.03
c.3083T>G
L1028R
2D
AIThe SynGAP1 missense variant L1028R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, and FATHMM, while those that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is classified as Likely Benign (three benign votes versus one pathogenic). High‑accuracy assessments show AlphaMissense‑Optimized as Uncertain, and Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact. This conclusion is not contradicted by ClinVar status, as no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.899122Disordered0.995137Binding0.3640.7300.500-2.204Likely Benign0.793Likely PathogenicAmbiguous0.167Likely Benign-0.24Neutral0.960Probably Damaging0.761Possibly Damaging2.75Benign0.84Tolerated0.13280.1603-3-2-8.343.03
c.3095T>G
L1032R
2D
AIThe SynGAP1 missense variant L1032R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; Foldetta results are not available. Overall, the majority of evidence points to a benign impact. This conclusion is consistent with the lack of ClinVar annotation, so there is no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.865454Disordered0.995318Binding0.3650.7350.500-2.658Likely Benign0.707Likely PathogenicLikely Benign0.099Likely Benign-1.03Neutral0.995Probably Damaging0.892Possibly Damaging2.66Benign0.02Affected0.13500.1919-3-2-8.343.03
c.3272T>G
L1091R
2D
AIThe SynGAP1 missense variant L1091R is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, and ESM1b, whereas those that predict a pathogenic effect are polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Default. The high‑accuracy AlphaMissense‑Optimized tool returns an uncertain result, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (2 pathogenic vs. 2 benign). Foldetta, a protein‑folding stability method, has no available result for this variant. Overall, the majority of consensus tools (five pathogenic vs. three benign) suggest a pathogenic impact. Thus, the variant is most likely pathogenic based on current predictions, and this assessment does not contradict any ClinVar status because the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.924947Disordered0.984454Binding0.3760.8891.000-3.662Likely Benign0.896Likely PathogenicAmbiguous0.191Likely Benign-1.51Neutral0.997Probably Damaging0.939Probably Damaging2.47Pathogenic0.02Affected0.12740.1357-3-2-8.343.03
c.3326T>G
L1109R
2D
AIThe SynGAP1 missense variant L1109R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. Only polyPhen‑2 HumDiv predicts a pathogenic outcome, while AlphaMissense‑Default remains uncertain. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized is benign, and the SGM‑Consensus is Likely Benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of evidence points to a benign effect, and this conclusion does not contradict any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.856457Disordered0.948334Binding0.3430.8930.875-5.440Likely Benign0.408AmbiguousLikely Benign0.139Likely Benign-0.70Neutral0.586Possibly Damaging0.225Benign2.68Benign0.34Tolerated0.13520.1919-3-2-8.343.03
c.3386T>G
L1129R
2D
AIThe SynGAP1 missense variant L1129R is not reported in ClinVar and has no entry in gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, and AlphaMissense‑Optimized. Only SIFT predicts a pathogenic outcome, while AlphaMissense‑Default remains uncertain. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized is benign, and the SGM‑Consensus is Likely Benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the preponderance of evidence indicates that the variant is most likely benign, and this conclusion does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.903857Disordered0.876543Binding0.3390.9090.875-2.613Likely Benign0.442AmbiguousLikely Benign0.376Likely Benign-1.68Neutral0.005Benign0.007Benign5.48Benign0.00Affected0.13340.1636-3-2-8.343.03
c.3491T>G
L1164R
2D
AIThe SynGAP1 missense variant L1164R has no ClinVar entry and is absent from gnomAD, so its population frequency is unknown. Functional prediction tools show mixed results: benign calls come from PROVEAN, SIFT, ESM1b, and FATHMM, while pathogenic calls come from REVEL, polyPhen‑2 (HumDiv and HumVar), AlphaMissense‑Default, and AlphaMissense‑Optimized. Grouping by consensus, four tools predict benign and five predict pathogenic. High‑accuracy methods give a more nuanced view: the SGM Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a Likely Benign outcome; AlphaMissense‑Optimized independently predicts Pathogenic; Foldetta’s stability assessment is unavailable. Overall, the majority of standard predictors lean toward pathogenicity, but the SGM Consensus and several benign‑oriented tools counterbalance this. Given the lack of ClinVar annotation, there is no contradiction. The variant is most likely pathogenic based on the preponderance of predictions, though the SGM Consensus suggests a benign interpretation, indicating uncertainty.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.517562Disordered0.853935Binding0.3250.8150.375-4.390Likely Benign0.987Likely PathogenicLikely Pathogenic0.539Likely Pathogenic-1.65Neutral0.999Probably Damaging0.998Probably Damaging5.33Benign0.08Tolerated0.13960.0623-3-2-8.343.03
c.3539T>G
L1180R
2D
AIThe SynGAP1 missense variant L1180R is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, and FATHMM, while those that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as Likely Benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) is not available. Overall, the majority of evidence—including the SGM Consensus and several benign‑predicting tools—suggests a benign impact. This conclusion does not contradict ClinVar status, as the variant has no ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignCoiled-coil0.626927Disordered0.559845Binding0.5910.6720.250-4.238Likely Benign0.920Likely PathogenicAmbiguous0.175Likely Benign-1.58Neutral0.977Probably Damaging0.900Possibly Damaging2.67Benign0.00Affected0.11990.0660-3-2-8.343.03
c.3575T>G
L1192R
2D
AIThe SynGAP1 missense variant L1192R is not reported in ClinVar and has no entries in gnomAD. Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized, while polyPhen‑2 (HumDiv and HumVar) and AlphaMissense‑Default predict a pathogenic outcome. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus also indicates Likely Benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the preponderance of evidence points to the variant being most likely benign, and this conclusion does not contradict any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignCoiled-coil0.575842Disordered0.441757Uncertain0.7620.6090.625-3.221Likely Benign0.695Likely PathogenicLikely Benign0.184Likely Benign-1.33Neutral0.992Probably Damaging0.940Probably Damaging2.75Benign0.35Tolerated0.11480.0558-3-2-8.343.03
c.3614T>G
L1205R
2D
AIThe SynGAP1 missense variant L1205R is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include only REVEL, which scores the variant as benign. All other evaluated algorithms—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the variant as pathogenic. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates a likely pathogenic outcome. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts pathogenic, and the SGM‑Consensus (majority vote) is likely pathogenic. Foldetta results are unavailable. Based on the collective predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status, as no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.595080Disordered0.552471Binding0.8800.5760.375-16.706Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.451Likely Benign-5.08Deleterious1.000Probably Damaging0.999Probably Damaging1.46Pathogenic0.00Affected0.10810.0558-3-2-8.343.03
c.3626T>G
L1209R
2D
AIThe SynGAP1 missense variant L1209R is not reported in ClinVar and is absent from gnomAD, indicating no known population frequency data. Functional prediction tools largely agree on a deleterious effect: REVEL predicts a benign outcome, whereas all other evaluated algorithms—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the change as pathogenic. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also reports a likely pathogenic status. High‑accuracy assessments further support this view: AlphaMissense‑Optimized predicts pathogenicity, and the SGM‑Consensus confirms a likely pathogenic classification. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, did not provide a result for this variant, so its influence is unavailable. Overall, the preponderance of evidence from multiple prediction tools and high‑accuracy methods indicates that the variant is most likely pathogenic, with no conflict from ClinVar status (which is currently unreported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.595080Disordered0.583711Binding0.8990.5740.375-17.481Likely Pathogenic0.995Likely PathogenicLikely Pathogenic0.438Likely Benign-5.12Deleterious1.000Probably Damaging0.999Probably Damaging1.46Pathogenic0.00Affected0.11290.0558-3-2-8.343.03
c.3647T>G
L1216R
2D
AIThe SynGAP1 missense variant L1216R is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include only REVEL, whereas the remaining tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also classifies the variant as Likely Pathogenic. High‑accuracy assessments further support this view: AlphaMissense‑Optimized predicts pathogenicity, and the SGM‑Consensus agrees. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the preponderance of evidence indicates that the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.580690Disordered0.504713Binding0.8630.5630.250-9.700Likely Pathogenic0.986Likely PathogenicLikely Pathogenic0.387Likely Benign-4.39Deleterious1.000Probably Damaging0.999Probably Damaging2.16Pathogenic0.00Affected0.10710.0488-3-2-8.343.03
c.3668T>G
L1223R
2D
AIThe SynGAP1 missense variant L1223R is not reported in ClinVar and is absent from gnomAD, indicating no known population frequency data. Prediction tools that agree on a benign effect include only REVEL, which scores the variant as benign. All other evaluated algorithms—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the variant as pathogenic. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also reports the variant as likely pathogenic. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized predicts pathogenicity, and the SGM‑Consensus confirms a likely pathogenic status. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, was not available for this variant. Overall, the preponderance of computational evidence indicates that the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.608892Disordered0.436267Uncertain0.8680.5400.375-15.396Likely Pathogenic0.966Likely PathogenicLikely Pathogenic0.317Likely Benign-4.14Deleterious0.999Probably Damaging0.986Probably Damaging1.46Pathogenic0.00Affected0.10780.0919-3-2-8.343.03
c.3671T>G
L1224R
2D
AIThe SynGAP1 missense variant L1224R is listed in ClinVar with no assertion (ClinVar status: None) and is present in the gnomAD database (ID 6‑33446663‑T‑G). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. Those that predict a pathogenic outcome are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM; ESM1b remains uncertain. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized is benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also yields benign, while Foldetta results are unavailable. Overall, the majority of evidence points to a benign effect, and this conclusion does not contradict the ClinVar status, which currently contains no pathogenic assertion.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Coiled-coil0.525368Disordered0.441554Uncertain0.8710.5430.5006-33446663-T-G16.20e-7-7.504In-Between0.220Likely BenignLikely Benign0.113Likely Benign-1.85Neutral0.989Probably Damaging0.900Possibly Damaging2.42Pathogenic0.33Tolerated3.7750.11200.0558-2-3-8.343.03
c.3701T>G
L1234R
2D
AIThe SynGAP1 missense change L1234R occurs in a coiled‑coil domain. ClinVar has no entry for this variant, and it is not reported in gnomAD. Prediction tools that agree on a benign effect are limited to REVEL, which scores the variant as benign. All other evaluated predictors—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default—classify the variant as pathogenic, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports it as Likely Pathogenic. High‑accuracy assessments show AlphaMissense‑Optimized as Uncertain, SGM‑Consensus as Likely Pathogenic, and Foldetta results are unavailable. Based on the preponderance of pathogenic predictions and the lack of benign consensus, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.599170Disordered0.575096Binding0.8440.5270.125-15.015Likely Pathogenic0.912Likely PathogenicAmbiguous0.211Likely Benign-4.52Deleterious0.997Probably Damaging0.939Probably Damaging1.46Pathogenic0.00Affected0.10610.0849-3-2-8.343.03
c.3722T>G
L1241R
2D
AIThe SynGAP1 missense variant L1241R is not reported in ClinVar and is absent from gnomAD, indicating no known population frequency data. Functional prediction tools largely agree on a deleterious effect: REVEL predicts a benign outcome, whereas the remaining predictors—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the variant as pathogenic. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also reports a likely pathogenic status. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts pathogenicity, and the SGM‑Consensus confirms a likely pathogenic classification. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the consensus of the majority of prediction tools indicates that the variant is most likely pathogenic, and this conclusion is consistent with the absence of any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.545602Disordered0.488880Uncertain0.8280.5410.375-14.178Likely Pathogenic0.983Likely PathogenicLikely Pathogenic0.366Likely Benign-4.69Deleterious1.000Probably Damaging0.999Probably Damaging1.62Pathogenic0.00Affected0.12040.0488-3-2-8.343.03
c.3743T>G
L1248R
2D
AIThe SynGAP1 missense variant L1248R is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include only REVEL, whereas the remaining tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN)—all predict a pathogenic or likely pathogenic impact. High‑accuracy assessments further support this: AlphaMissense‑Optimized classifies the variant as pathogenic, and the SGM‑Consensus also reports it as likely pathogenic. No Foldetta stability analysis is available for this variant. Based on the preponderance of pathogenic predictions, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation, as none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.834292Disordered0.371716Uncertain0.8800.5620.625-11.285Likely Pathogenic0.984Likely PathogenicLikely Pathogenic0.370Likely Benign-4.69Deleterious1.000Probably Damaging0.999Probably Damaging1.64Pathogenic0.00Affected0.12220.0488-3-2-8.343.03
c.3797T>G
L1266R
2D
AISynGAP1 missense variant L1266R is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include only REVEL, whereas the remaining tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates a likely pathogenic outcome. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized scores the variant as pathogenic, and the SGM‑Consensus confirms a likely pathogenic classification. Foldetta results are unavailable for this variant. Overall, the preponderance of evidence from multiple in silico predictors and high‑accuracy tools points to a pathogenic effect, with no conflict from ClinVar status (which has no entry).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.433034Structured0.802655Binding0.8680.6020.000-16.676Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.391Likely Benign-5.04Deleterious0.996Probably Damaging0.951Probably Damaging2.13Pathogenic0.00Affected0.10630.0891-3-2-8.343.03
c.3803T>G
L1268R
2D
AIThe SynGAP1 missense change L1268R is not reported in ClinVar and is absent from gnomAD. Consensus from multiple in‑silico predictors indicates a benign effect: REVEL, PROVEAN, SIFT, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score (Likely Benign) all support a neutral impact. In contrast, polyPhen‑2 (HumDiv and HumVar) predict a pathogenic outcome, while ESM1b remains uncertain. High‑accuracy tools reinforce the benign assessment: AlphaMissense‑Optimized returns a benign prediction and the SGM‑Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates Likely Benign. Foldetta results are not available, so they do not influence the interpretation. Overall, the preponderance of evidence points to a benign effect for L1268R, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignCoiled-coil0.458154Structured0.804315Binding0.8590.6290.000-7.010In-Between0.293Likely BenignLikely Benign0.076Likely Benign-0.79Neutral0.970Probably Damaging0.637Possibly Damaging2.68Benign0.08Tolerated0.11350.0558-3-2-8.343.03
c.3818T>G
L1273R
2D
AIThe SynGAP1 missense variant L1273R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL and ESM1b, whereas the majority of tools predict a pathogenic impact: PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Default all classify the variant as damaging. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as Likely Pathogenic. High‑accuracy assessments show AlphaMissense‑Optimized as Uncertain, SGM‑Consensus as Likely Pathogenic, and Foldetta results are unavailable. Based on the preponderance of pathogenic predictions and the SGM‑Consensus outcome, the variant is most likely pathogenic; this assessment is not contradicted by any ClinVar status, as none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.599170Disordered0.773625Binding0.7470.6770.500-6.252Likely Benign0.946Likely PathogenicAmbiguous0.431Likely Benign-5.05Deleterious0.997Probably Damaging0.934Probably Damaging2.13Pathogenic0.00Affected0.13690.0761-3-2-8.343.03
c.3851T>G
L1284R
2D
AIThe SynGAP1 missense variant L1284R is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include REVEL, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and FATHMM. The SGM Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is inconclusive (2 benign vs. 2 pathogenic). Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, was not available for this variant. Overall, the majority of predictions (five pathogenic vs. four benign) lean toward a pathogenic impact. This assessment does not contradict ClinVar status, as the variant has not yet been classified in that database.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.812494Disordered0.824557Binding0.4410.7480.875-4.203Likely Benign0.156Likely BenignLikely Benign0.163Likely Benign-3.11Deleterious0.990Probably Damaging0.722Possibly Damaging2.48Pathogenic0.00Affected0.12160.0488-3-2-8.343.03
c.3872T>G
L1291R
2D
AIThe SynGAP1 missense variant L1291R is not reported in ClinVar and is present in gnomAD (ID 6‑33447920‑T‑G). Functional prediction tools cluster into two groups: benign predictions come from REVEL, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized; pathogenic predictions come from PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM. High‑accuracy assessment shows AlphaMissense‑Optimized classifying the variant as benign, while the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive and Foldetta results are unavailable. Overall, the majority of conventional predictors indicate a pathogenic effect, whereas the single high‑accuracy tool suggests benign. No ClinVar annotation contradicts these findings. Thus, based on the collective evidence, the variant is most likely pathogenic, though the high‑accuracy prediction introduces uncertainty.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.827927Disordered0.863458Binding0.5790.7970.6256-33447920-T-G16.44e-7-3.977Likely Benign0.302Likely BenignLikely Benign0.287Likely Benign-4.29Deleterious0.990Probably Damaging0.856Possibly Damaging2.49Pathogenic0.00Affected3.7750.11600.1049-2-3-8.343.03
c.3875T>G
L1292R
2D
AIThe SynGAP1 missense variant L1292R is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM. The SGM Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is inconclusive (2 benign vs 2 pathogenic). Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, five tools predict pathogenicity while four predict benignity, giving a slight tilt toward a pathogenic interpretation. This prediction does not contradict ClinVar status, as the variant has not yet been classified in that database.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.779859Disordered0.882643Binding0.5860.8000.625-4.249Likely Benign0.238Likely BenignLikely Benign0.223Likely Benign-4.34Deleterious0.971Probably Damaging0.773Possibly Damaging2.46Pathogenic0.00Affected0.12860.0849-3-2-8.343.03
c.3896T>G
L1299R
2D
AIThe SynGAP1 missense variant L1299R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (which is “Likely Benign”). Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; Foldetta results are not available. Overall, the majority of evidence points to a benign impact for this variant, and this conclusion does not contradict any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.771762Disordered0.896323Binding0.3980.8320.750-3.080Likely Benign0.260Likely BenignLikely Benign0.293Likely Benign-3.75Deleterious0.971Probably Damaging0.597Possibly Damaging2.68Benign0.01Affected0.13660.1147-3-2-8.343.03
c.3932T>G
L1311R
2D
AIThe SynGAP1 missense variant L1311R is not reported in ClinVar and is absent from gnomAD. Consensus from multiple in‑silico predictors indicates a benign effect: REVEL, PROVEAN, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all score the change as tolerated or benign. Only polyPhen‑2 HumDiv classifies it as pathogenic, but this is the sole discordant call. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a Likely Benign classification. High‑accuracy tools further support a benign outcome: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus (majority vote) also indicates Likely Benign. Foldetta results are unavailable. Overall, the evidence overwhelmingly points to a benign impact, and this conclusion is consistent with the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.816150Disordered0.968153Binding0.3930.9070.750-3.794Likely Benign0.169Likely BenignLikely Benign0.083Likely Benign-0.36Neutral0.579Possibly Damaging0.267Benign2.74Benign0.12Tolerated0.16110.1719-3-2-8.343.03
c.3953T>G
L1318R
2D
AIThe SynGAP1 missense variant L1318R is reported in gnomAD (variant ID 6-33451827‑T‑G) but has no ClinVar entry. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as benign. In contrast, polyPhen‑2 HumDiv and SIFT predict a pathogenic impact. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as “Likely Benign.” High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus (majority vote) also indicates benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the preponderance of evidence from both general and high‑accuracy predictors points to a benign effect, and this conclusion is not contradicted by any ClinVar classification (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.887230Disordered0.968271Binding0.3990.8650.7506-33451827-T-G-3.381Likely Benign0.187Likely BenignLikely Benign0.081Likely Benign-1.58Neutral0.588Possibly Damaging0.212Benign4.01Benign0.01Affected3.7750.14290.1303-2-3-8.343.03
c.3986T>G
L1329R
2D
AIThe SynGAP1 missense variant L1329R is catalogued in gnomAD (ID 6‑33451860‑T‑G) but has no ClinVar submission. Functional prediction tools cluster into two groups: benign predictions from REVEL, ESM1b, and FATHMM; pathogenic predictions from PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and AlphaMissense‑Default. AlphaMissense‑Optimized returns an uncertain result. The SGM Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is inconclusive due to a 2‑to‑2 split. No Foldetta stability assessment is available. Overall, the majority of high‑confidence predictors (five pathogenic vs three benign) lean toward a pathogenic effect. Because ClinVar contains no classification, there is no conflict with existing clinical annotations. Thus, based on current in silico evidence, the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.930790Disordered0.924905Binding0.3360.7480.8756-33451860-T-G-3.636Likely Benign0.923Likely PathogenicAmbiguous0.141Likely Benign-3.16Deleterious0.994Probably Damaging0.990Probably Damaging3.05Benign0.00Affected3.7750.15940.1547-2-3-8.343.03
c.398T>G
L133R
2D
AIThe SynGAP1 missense variant L133R is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. In contrast, tools that predict a pathogenic effect are PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The high‑accuracy consensus, SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates a likely pathogenic outcome (3 pathogenic vs. 1 benign votes). AlphaMissense‑Optimized independently predicts pathogenicity. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of computational evidence supports a pathogenic classification for L133R, and this assessment does not contradict any existing ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.422041Structured0.718429Binding0.3200.8960.250-8.857Likely Pathogenic0.965Likely PathogenicLikely Pathogenic0.389Likely Benign-2.57Deleterious0.002Benign0.005Benign3.55Benign0.00Affected0.15220.0479-3-2-8.343.03
c.410T>G
L137R
2D
AIThe SynGAP1 missense variant L137R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL and FATHMM. All other evaluated tools—PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN)—predict a pathogenic or likely pathogenic impact. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic, and the SGM‑Consensus is labeled Likely Pathogenic. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Based on the collective predictions, the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.553315Disordered0.639549Binding0.3770.8970.375-11.595Likely Pathogenic0.994Likely PathogenicLikely Pathogenic0.334Likely Benign-3.50Deleterious0.998Probably Damaging0.994Probably Damaging3.60Benign0.00Affected0.13000.0691-3-2-8.343.03
c.449T>G
L150R
2D
AIThe SynGAP1 missense variant L150R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL and FATHMM, whereas the majority of tools predict a pathogenic impact: PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) all indicate pathogenicity. High‑accuracy assessments further support this: AlphaMissense‑Optimized classifies the variant as pathogenic, and the SGM‑Consensus also reports it as Likely Pathogenic. The Foldetta protein‑folding stability analysis is unavailable for this variant. Overall, the preponderance of evidence from multiple in silico predictors and high‑accuracy tools points to a pathogenic effect for the SynGAP1 L150R variant, and this conclusion does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.494003Structured0.505752Binding0.2990.8390.625-14.879Likely Pathogenic0.985Likely PathogenicLikely Pathogenic0.290Likely Benign-3.16Deleterious0.998Probably Damaging0.994Probably Damaging3.67Benign0.00Affected0.12750.0719-3-2-8.343.03
c.479T>G
L160R
2D
AIThe SynGAP1 missense variant L160R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL and FATHMM, whereas the majority of tools predict a pathogenic impact: PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic, and the SGM‑Consensus is labeled Likely Pathogenic. The protein‑folding stability method Foldetta did not provide a result, so its status is unavailable. Overall, the preponderance of evidence from both general and high‑accuracy predictors indicates that the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.454136Structured0.526760Binding0.2750.7280.125-14.539Likely Pathogenic0.970Likely PathogenicLikely Pathogenic0.190Likely Benign-2.83Deleterious0.700Possibly Damaging0.483Possibly Damaging3.90Benign0.00Affected0.14820.0702-3-2-8.343.03
c.518T>G
L173R
2D
AIThe SynGAP1 missense variant L173R is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumVar, SIFT, and FATHMM. Those that predict a pathogenic effect are polyPhen‑2 HumDiv, ESM1b, and AlphaMissense‑Default. The high‑accuracy AlphaMissense‑Optimized tool returns an uncertain result, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (2 vs 2). Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of consensus tools lean toward a benign interpretation, and there is no ClinVar evidence to contradict this assessment. Thus, the variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.534167Disordered0.491566Uncertain0.3900.6310.375-9.524Likely Pathogenic0.904Likely PathogenicAmbiguous0.119Likely Benign-1.63Neutral0.561Possibly Damaging0.178Benign3.95Benign0.08Tolerated0.12580.0761-3-2-8.343.03
c.560T>G
L187R
2D
AIThe SynGAP1 missense variant L187R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL and FATHMM, whereas the majority of tools predict a pathogenic impact: PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote). High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts a deleterious effect, and the SGM‑Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) labels the variant as Likely Pathogenic. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the preponderance of evidence from both general and high‑accuracy predictors indicates that the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.465241Structured0.428046Uncertain0.3670.6250.375-14.118Likely Pathogenic0.994Likely PathogenicLikely Pathogenic0.332Likely Benign-4.38Deleterious0.917Possibly Damaging0.467Possibly Damaging3.72Benign0.00Affected0.14810.0702-3-2-8.343.03
c.593T>G
L198R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L198R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL and FATHMM, whereas a majority of tools predict a pathogenic impact: PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Predictions from FoldX, Rosetta, Foldetta, and premPS are uncertain and are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus as likely pathogenic, and Foldetta as uncertain. Overall, the preponderance of evidence from multiple in‑silico predictors indicates that the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status because no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.444081Structured0.431715Uncertain0.5720.4850.125-15.992Likely Pathogenic0.990Likely PathogenicLikely Pathogenic0.74Ambiguous0.21.56Ambiguous1.15Ambiguous0.69Ambiguous0.410Likely Benign-4.98Deleterious0.982Probably Damaging0.648Possibly Damaging3.34Benign0.00Affected0.11800.0719-3-2-8.343.03
c.641T>G
L214R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 L214R missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include only FATHMM, whereas the majority of tools (SGM‑Consensus, REVEL, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) predict a pathogenic impact; FoldX, Rosetta, and Foldetta are uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Pathogenic, and Foldetta as uncertain. Overall, the evidence strongly favors a pathogenic effect for this variant, and this conclusion does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.155435Structured0.372604Uncertain0.8180.3020.125-11.458Likely Pathogenic0.995Likely PathogenicLikely Pathogenic1.35Ambiguous0.60.92Ambiguous1.14Ambiguous1.68Destabilizing0.927Likely Pathogenic-4.98Deleterious0.997Probably Damaging0.916Probably Damaging5.75Benign0.00Affected0.13350.0772-3-2-8.343.03
c.737T>G
L246R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 L246R missense variant is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect are limited to FATHMM, whereas the remaining tools—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized reports pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts pathogenic. No prediction or folding stability result is missing or inconclusive. Based on the collective evidence, the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.472492Structured0.302312Uncertain0.8590.3640.000-13.849Likely Pathogenic0.999Likely PathogenicLikely Pathogenic3.94Destabilizing0.82.77Destabilizing3.36Destabilizing1.72Destabilizing0.925Likely Pathogenic-5.43Deleterious0.997Probably Damaging0.916Probably Damaging4.67Benign0.00Affected0.12660.0600-3-2-8.343.03
c.791T>G
L264R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L264R is not reported in ClinVar and is absent from gnomAD. All available in‑silico predictors classify it as pathogenic: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a benign effect. High‑accuracy assessments are consistent: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. Consequently, the variant is most likely pathogenic, and this prediction does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.185198Structured0.323473Uncertain0.9390.2640.000-16.976Likely Pathogenic0.999Likely PathogenicLikely Pathogenic4.25Destabilizing0.33.37Destabilizing3.81Destabilizing2.28Destabilizing0.742Likely Pathogenic-5.52Deleterious1.000Probably Damaging0.999Probably Damaging0.49Pathogenic0.00Affected0.11320.0558-3-2-8.343.03
c.797T>G
L266R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L266R is not reported in ClinVar and is absent from gnomAD. Prediction tools that assess pathogenicity unanimously classify the variant as deleterious: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool in the dataset predicts a benign effect, so the benign‑prediction group is empty. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. Based on the collective evidence, the variant is most likely pathogenic, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.232838Structured0.297157Uncertain0.9480.2640.000-17.131Likely Pathogenic0.998Likely PathogenicLikely Pathogenic3.97Destabilizing0.22.76Destabilizing3.37Destabilizing2.04Destabilizing0.574Likely Pathogenic-5.32Deleterious1.000Probably Damaging0.999Probably Damaging1.53Pathogenic0.00Affected0.10590.0558-3-2-8.343.03
c.821T>G
L274R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L274R is not reported in ClinVar (ClinVar status: none) and is absent from gnomAD (no gnomAD ID). Prediction tools that assess pathogenicity all agree on a deleterious effect: SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict a pathogenic outcome. No tool in the dataset predicts a benign effect. High‑accuracy methods reinforce this consensus: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. All available predictions and stability analyses are concordant and indicate a likely pathogenic impact. Thus, based on the current computational evidence, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.066181Structured0.377483Uncertain0.8660.1950.250-17.691Likely Pathogenic0.997Likely PathogenicLikely Pathogenic3.61Destabilizing0.83.15Destabilizing3.38Destabilizing1.56Destabilizing0.807Likely Pathogenic-5.45Deleterious1.000Probably Damaging0.999Probably Damaging0.00Pathogenic0.00Affected0.14040.0488-3-2-8.343.03
c.851T>G
L284R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L284R is not reported in ClinVar and is absent from gnomAD. Prediction tools that assess pathogenicity uniformly classify the variant as deleterious: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a benign effect. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts pathogenicity, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts pathogenicity. With all available evidence pointing to a damaging effect and no ClinVar entry to contradict, the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.094817Structured0.371601Uncertain0.9500.2550.000-17.698Likely Pathogenic0.999Likely PathogenicLikely Pathogenic5.05Destabilizing0.54.29Destabilizing4.67Destabilizing2.14Destabilizing0.797Likely Pathogenic-5.38Deleterious1.000Probably Damaging0.999Probably Damaging1.65Pathogenic0.00Affected0.11750.0600-3-2-8.343.03
c.857T>G
L286R
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant L286R is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly indicate a deleterious effect: REVEL, FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as pathogenic, while Rosetta remains uncertain. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also reports a likely pathogenic outcome. High‑accuracy assessments corroborate this: AlphaMissense‑Optimized predicts pathogenicity; the SGM‑Consensus (majority vote) is likely pathogenic; and Foldetta, which integrates FoldX‑MD (pathogenic) and Rosetta (uncertain), reports a pathogenic effect. Consequently, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation, as none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.122885Structured0.385647Uncertain0.9320.2600.000-15.563Likely Pathogenic0.998Likely PathogenicLikely Pathogenic2.90Destabilizing0.31.80Ambiguous2.35Destabilizing1.97Destabilizing0.868Likely Pathogenic-5.52Deleterious1.000Probably Damaging0.999Probably Damaging1.49Pathogenic0.00Affected0.13700.0600-3-2-8.343.03
c.869T>G
L290R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense change L290R is not reported in ClinVar and has no entry in gnomAD. Functional prediction tools largely agree on a deleterious effect: benign predictions are limited to FoldX, whereas the remaining tools—REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN)—all classify the variant as pathogenic. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts pathogenicity, the SGM‑Consensus also indicates likely pathogenic, while Foldetta (combining FoldX‑MD and Rosetta outputs) yields an uncertain result. Overall, the consensus of the majority of evidence points to a pathogenic impact. This conclusion is consistent with the absence of a ClinVar entry, so there is no contradiction with existing clinical annotations.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.127496Structured0.399723Uncertain0.9040.2550.000-13.938Likely Pathogenic0.988Likely PathogenicLikely Pathogenic0.48Likely Benign0.10.88Ambiguous0.68Ambiguous0.89Ambiguous0.705Likely Pathogenic-5.52Deleterious1.000Probably Damaging0.999Probably Damaging2.03Pathogenic0.01Affected0.12150.1056-3-2-8.343.03
c.950T>G
L317R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L317R is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that assess pathogenicity unanimously classify the variant as deleterious: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a benign effect. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts Pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts Pathogenic. Based on the collective evidence, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status because the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.106997Structured0.394031Uncertain0.8740.2400.125-14.185Likely Pathogenic0.998Likely PathogenicLikely Pathogenic3.33Destabilizing0.22.01Destabilizing2.67Destabilizing1.63Destabilizing0.569Likely Pathogenic-5.52Deleterious1.000Probably Damaging0.999Probably Damaging1.75Pathogenic0.00Affected0.15010.0893-3-2-8.343.03
c.968T>G
L323R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L323R is listed in ClinVar (ID 978601.0) as Pathogenic and is not reported in gnomAD. All available in‑silico predictors classify the change as pathogenic: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool reports a benign effect. High‑accuracy assessments reinforce this: AlphaMissense‑Optimized predicts Pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts Pathogenic. Consequently, the variant is most likely pathogenic, and this prediction aligns with its ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.268042Structured0.428564Uncertain0.9560.3690.000Likely Pathogenic 1-14.568Likely Pathogenic0.997Likely PathogenicLikely Pathogenic3.75Destabilizing0.44.47Destabilizing4.11Destabilizing2.15Destabilizing0.692Likely Pathogenic-4.70Deleterious0.999Probably Damaging0.969Probably Damaging0.59Pathogenic0.01Affected3.39220.10660.0600-3-2-8.343.03261.8-61.6-0.40.20.80.2XXXPotentially PathogenicThe iso-butyl side chain of Leu323, located at the beginning of an anti-parallel β sheet strand (res. Ala322-Asp330), packs against multiple hydrophobic leucine residues (e.g., Leu264, Leu266, Leu284, Leu286). In contrast, in the variant simulations, the positively charged guanidinium group of the Arg323 side chain is unsuitable for the hydrophobic niche. Consequently, the side chain either rotates away from the center of the C2 domain or, if it remains within the C2 domain core, it reorients nearby residues to form hydrogen bonds. Regardless, the residue swap extensively disrupts the C2 domain structure.
c.974T>G
L325R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L325R is not reported in ClinVar and is absent from gnomAD. Prediction tools that assess pathogenicity all converge on a deleterious effect: SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict a pathogenic outcome. No tool in the dataset predicts a benign effect. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, is pathogenic. No predictions or stability results are missing or inconclusive. **Based on the collective predictions, the variant is most likely pathogenic, and this assessment does not contradict the ClinVar status (no ClinVar entry).**

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.352862Structured0.424577Uncertain0.9550.4360.000-16.612Likely Pathogenic0.998Likely PathogenicLikely Pathogenic4.34Destabilizing0.34.11Destabilizing4.23Destabilizing1.94Destabilizing0.551Likely Pathogenic-4.39Deleterious0.999Probably Damaging0.969Probably Damaging1.33Pathogenic0.00Affected0.14050.1047-3-2-8.343.03
c.980T>G
L327R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L327R is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that assess pathogenicity all agree that the variant is deleterious: SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify it as pathogenic. No tool predicts a benign effect. High‑accuracy methods reinforce this consensus: AlphaMissense‑Optimized predicts pathogenicity; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also predicts pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, predicts a destabilizing, pathogenic effect. All available predictions are concordant and indicate a likely pathogenic impact. Thus, based on the current computational evidence, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.335645Structured0.409189Uncertain0.9390.4900.000-13.403Likely Pathogenic0.998Likely PathogenicLikely Pathogenic4.46Destabilizing0.34.75Destabilizing4.61Destabilizing1.95Destabilizing0.619Likely Pathogenic-5.28Deleterious1.000Probably Damaging0.999Probably Damaging1.52Pathogenic0.00Affected0.12810.1085-3-2-8.343.03
c.1232T>A
I411N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I411N is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include only FATHMM, whereas all other evaluated algorithms—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized scores the variant as pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates a likely pathogenic outcome; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also predicts pathogenicity. Based on the collective evidence, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.116183Structured0.339366Uncertain0.9270.1980.000-14.426Likely Pathogenic0.996Likely PathogenicLikely Pathogenic3.00Destabilizing0.13.71Destabilizing3.36Destabilizing2.16Destabilizing0.556Likely Pathogenic-6.42Deleterious1.000Probably Damaging1.000Probably Damaging3.29Benign0.00Affected0.07380.0700-2-3-8.00.94
c.1361T>A
I454N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I454N resides in the GAP domain. ClinVar has no entry for this variant, and it is absent from gnomAD. Prediction tools that agree on benign impact are REVEL and FATHMM, whereas the remaining tools—FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict pathogenicity. High‑accuracy methods further support a deleterious effect: AlphaMissense‑Optimized is pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is likely pathogenic, and Foldetta predicts a destabilizing, pathogenic change. Overall, the evidence strongly favors a pathogenic classification, and this assessment does not conflict with the absence of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.254060Structured0.312811Uncertain0.9650.1820.000-14.246Likely Pathogenic0.999Likely PathogenicLikely Pathogenic4.24Destabilizing0.13.56Destabilizing3.90Destabilizing2.44Destabilizing0.497Likely Benign-6.82Deleterious1.000Probably Damaging1.000Probably Damaging3.25Benign0.00Affected0.07500.0412-2-3-8.00.94
c.149T>A
I50N
2D
AIThe SynGAP1 missense variant I50N is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumVar, and FATHMM, while those that predict a pathogenic effect are polyPhen‑2 HumDiv, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized; ESM1b remains uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, whereas the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) resolves as benign. Foldetta results are unavailable. Overall, the predictions are mixed, with an equal split between benign and pathogenic calls, but the most reliable single‑tool prediction (AlphaMissense‑Optimized) and the majority of individual tools lean toward pathogenicity. Thus, the variant is most likely pathogenic based on current computational evidence, and this assessment does not contradict any ClinVar status because no ClinVar claim exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.295083Structured0.449965Uncertain0.5450.7080.000-7.091In-Between0.962Likely PathogenicLikely Pathogenic0.135Likely Benign-2.37Neutral0.842Possibly Damaging0.272Benign3.73Benign0.00Affected0.08240.0412-2-3-8.00.94
c.1502T>A
I501N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I501N is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect are REVEL and FATHMM, while a majority of tools (SGM‑Consensus, FoldX, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default) predict a pathogenic impact. Uncertain results come from AlphaMissense‑Optimized, Foldetta, and Rosetta. High‑accuracy assessments show AlphaMissense‑Optimized as inconclusive, whereas the SGM Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates a likely pathogenic outcome; Foldetta likewise remains inconclusive. Overall, the balance of evidence favors a pathogenic classification, and this conclusion does not contradict any existing ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.079919Structured0.366596Uncertain0.8860.1530.000-11.105Likely Pathogenic0.854Likely PathogenicAmbiguous2.22Destabilizing0.01.70Ambiguous1.96Ambiguous1.90Destabilizing0.445Likely Benign-6.13Deleterious1.000Probably Damaging1.000Probably Damaging3.37Benign0.01Affected0.08250.0270-2-3-8.00.94
c.1529T>A
I510N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I510N is not reported in ClinVar and is absent from gnomAD. Prediction tools that assess pathogenicity all converge on a deleterious effect: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all indicate a pathogenic or likely pathogenic outcome. No tool in the dataset predicts a benign effect. High‑accuracy assessments reinforce this consensus: AlphaMissense‑Optimized classifies the variant as pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports it as likely pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also predicts a pathogenic impact. Based on the uniform predictions, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status, as the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.025762Structured0.250630Uncertain0.9450.2730.000-12.784Likely Pathogenic0.986Likely PathogenicLikely Pathogenic3.09Destabilizing0.13.00Destabilizing3.05Destabilizing2.08Destabilizing0.925Likely Pathogenic-5.62Deleterious1.000Probably Damaging0.999Probably Damaging-1.45Pathogenic0.00Affected0.07610.0270-2-3-8.00.94
c.152T>A
I51N
2D
AIThe SynGAP1 missense variant I51N is not reported in ClinVar (ClinVar status: not reported) and is absent from gnomAD (gnomAD: not present). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumVar, and FATHMM. Those that predict a pathogenic effect are polyPhen‑2 HumDiv, SIFT, ESM1b, and AlphaMissense‑Default. The high‑accuracy AlphaMissense‑Optimized tool returns an uncertain result, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (2 pathogenic vs. 2 benign). Foldetta, a protein‑folding stability method, has no available output for this variant. Consequently, the evidence is split evenly between benign and pathogenic predictions, with no decisive support from the most accurate methods. The variant is therefore inconclusive; it is not contradicted by any ClinVar record.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.291804Structured0.454181Uncertain0.6060.7100.000-9.287Likely Pathogenic0.909Likely PathogenicAmbiguous0.155Likely Benign-1.77Neutral0.704Possibly Damaging0.272Benign4.13Benign0.00Affected0.10050.0769-2-3-8.00.94
c.1541T>A
I514N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I514N is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include only FATHMM, whereas all other evaluated algorithms—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the variant as pathogenic. High‑accuracy methods further support a deleterious impact: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. Based on the overwhelming consensus of pathogenic predictions and the lack of benign evidence, the variant is most likely pathogenic. This assessment does not contradict ClinVar status, as no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.049374Structured0.221408Uncertain0.9480.2660.000-13.869Likely Pathogenic0.994Likely PathogenicLikely Pathogenic3.41Destabilizing0.32.41Destabilizing2.91Destabilizing2.61Destabilizing0.582Likely Pathogenic-6.86Deleterious1.000Probably Damaging1.000Probably Damaging2.82Benign0.00Affected0.07700.0142-2-3-8.00.94
c.1586T>A
I529N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I529N is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign) all predict a neutral impact. In contrast, polyPhen‑2 (HumDiv and HumVar) and FATHMM predict a pathogenic outcome. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized scores the variant as benign; the SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates Likely Benign; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, predicts a benign effect. Taken together, the preponderance of evidence from both general and high‑accuracy predictors indicates that the variant is most likely benign, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.318242Structured0.019545Uncertain0.9010.4030.000-4.478Likely Benign0.283Likely BenignLikely Benign0.12Likely Benign0.2-0.05Likely Benign0.04Likely Benign0.46Likely Benign0.378Likely Benign-0.31Neutral0.997Probably Damaging0.952Probably Damaging-1.24Pathogenic0.20Tolerated0.07220.0700-2-3-8.00.94
c.1751T>A
I584N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I584N is not reported in ClinVar (ClinVar status: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that assess pathogenicity all agree that the variant is deleterious: SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify it as pathogenic. No tool predicts a benign effect. High‑accuracy methods reinforce this consensus: AlphaMissense‑Optimized predicts pathogenicity; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also predicts pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, indicates a pathogenic impact. All available predictions are concordant and supportive. Based on these computational assessments, the variant is most likely pathogenic, and this conclusion does not contradict any existing ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.059222Structured0.046673Uncertain0.8460.2440.000-13.153Likely Pathogenic0.962Likely PathogenicLikely Pathogenic2.70Destabilizing0.12.13Destabilizing2.42Destabilizing2.08Destabilizing0.706Likely Pathogenic-6.57Deleterious1.000Probably Damaging0.999Probably Damaging-1.18Pathogenic0.01Affected0.06930.0470-2-3-8.00.94
c.1766T>A
I589N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I589N is not reported in ClinVar (ClinVar status: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that assess pathogenicity all agree that the variant is deleterious: SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict a pathogenic effect. No tool predicts a benign outcome. High‑accuracy methods reinforce this consensus: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also predicts pathogenicity. All available predictions are consistent and conclusive. Based on the unanimous computational evidence, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.018415Structured0.084536Uncertain0.9270.2140.000-15.539Likely Pathogenic0.999Likely PathogenicLikely Pathogenic3.72Destabilizing0.23.13Destabilizing3.43Destabilizing2.69Destabilizing0.930Likely Pathogenic-6.97Deleterious1.000Probably Damaging1.000Probably Damaging-1.99Pathogenic0.00Affected0.09680.0742-2-3-8.00.94
c.1805T>A
I602N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I602N is not reported in ClinVar and is absent from gnomAD. Prediction tools that assess pathogenicity unanimously classify the variant as deleterious: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a benign effect. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. All available evidence points to a damaging impact. Therefore, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.010221Structured0.186541Uncertain0.9630.1710.000-16.033Likely Pathogenic0.993Likely PathogenicLikely Pathogenic2.94Destabilizing0.23.34Destabilizing3.14Destabilizing2.31Destabilizing0.880Likely Pathogenic-6.89Deleterious1.000Probably Damaging0.999Probably Damaging-2.01Pathogenic0.00Affected0.07180.0700-2-3-8.00.94
c.1877T>A
I626N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I626N is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include only FATHMM, whereas all other evaluated algorithms—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. High‑accuracy methods further support this: AlphaMissense‑Optimized scores the variant as pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates a likely pathogenic outcome; and Foldetta, which integrates FoldX‑MD and Rosetta stability predictions, also classifies the variant as pathogenic. Based on the unanimous agreement of the majority of tools and the corroborating high‑accuracy predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.109221Structured0.040732Uncertain0.9700.2230.000-15.240Likely Pathogenic0.997Likely PathogenicLikely Pathogenic3.49Destabilizing0.13.56Destabilizing3.53Destabilizing2.36Destabilizing0.621Likely Pathogenic-6.41Deleterious1.000Probably Damaging1.000Probably Damaging3.03Benign0.00Affected0.08800.0270-2-3-8.00.94
c.1889T>A
I630N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I630N is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly indicate a deleterious effect. Benign predictions: none. Pathogenic predictions: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, predicts pathogenic. Based on the consensus of all available predictions, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.040537Structured0.036106Uncertain0.9660.2360.000-14.259Likely Pathogenic0.979Likely PathogenicLikely Pathogenic2.96Destabilizing0.02.55Destabilizing2.76Destabilizing2.39Destabilizing0.825Likely Pathogenic-4.86Deleterious1.000Probably Damaging0.994Probably Damaging-1.49Pathogenic0.00Affected0.08530.0270-2-3-8.00.94
c.2000T>A
I667N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I667N is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include only FATHMM, whereas all other evaluated algorithms—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized indicates pathogenicity; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) reports “Likely Pathogenic”; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, also predicts pathogenicity. No prediction or folding stability result is missing or inconclusive. Based on the collective evidence, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status because the variant is not yet catalogued in ClinVar.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.142424Structured0.083597Uncertain0.9270.3790.000-15.730Likely Pathogenic0.993Likely PathogenicLikely Pathogenic2.89Destabilizing0.22.84Destabilizing2.87Destabilizing2.56Destabilizing0.572Likely Pathogenic-6.73Deleterious1.000Probably Damaging0.997Probably Damaging2.95Benign0.00Affected0.08410.0470-2-3-8.00.94
c.2048T>A
I683N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I683N is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a deleterious effect: SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default all predict pathogenicity, whereas only FATHMM predicts a benign outcome. High‑accuracy assessments reinforce the pathogenic signal: AlphaMissense‑Optimized returns a pathogenic score, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is labeled Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta stability outputs) also indicates pathogenicity. No predictions are missing or inconclusive. Consequently, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation (none available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.200174Structured0.143268Uncertain0.8480.3140.000-12.120Likely Pathogenic0.974Likely PathogenicLikely Pathogenic2.18Destabilizing0.12.08Destabilizing2.13Destabilizing1.46Destabilizing0.546Likely Pathogenic-6.87Deleterious1.000Probably Damaging0.992Probably Damaging3.26Benign0.01Affected0.09780.1133-2-3-8.00.94
c.206T>A
I69N
2D
AIThe SynGAP1 missense variant I69N is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). Tools that predict a pathogenic outcome are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as Likely Benign; Foldetta results are not available. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict any ClinVar annotation (none exists). Thus, the variant is most likely benign based on current computational predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.575842Disordered0.466129Uncertain0.4370.7860.375-3.220Likely Benign0.631Likely PathogenicLikely Benign0.110Likely Benign-0.90Neutral0.943Possibly Damaging0.781Possibly Damaging4.10Benign0.00Affected0.08590.0412-2-3-8.00.94
c.2162T>A
I721N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I721N is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Prediction tools that agree on a benign effect include only REVEL, whereas the remaining tools—FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus—consistently predict a pathogenic impact. High‑accuracy assessments further support this: AlphaMissense‑Optimized classifies the variant as pathogenic; the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates a likely pathogenic outcome; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also predicts pathogenicity. Based on the collective evidence, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.394753Structured0.454550Uncertain0.9570.4370.125-14.905Likely Pathogenic0.998Likely PathogenicLikely Pathogenic2.82Destabilizing0.03.21Destabilizing3.02Destabilizing2.10Destabilizing0.425Likely Benign-6.30Deleterious1.000Probably Damaging1.000Probably Damaging2.19Pathogenic0.00Affected0.07370.0340-2-3-8.00.94
c.2189T>A
I730N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I730N is not reported in ClinVar (ClinVar status: none) and is absent from gnomAD (gnomAD ID: none). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, PROVEAN, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are polyPhen‑2 (HumDiv and HumVar) and SIFT. The remaining tools—premPS, ESM1b, and AlphaMissense‑Default—return uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑to‑2 split, and Foldetta, which integrates FoldX‑MD and Rosetta outputs, also predicts benign. Overall, the majority of evidence points to a benign impact. This conclusion does not contradict ClinVar status, as no ClinVar classification exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.733139Disordered0.420109Uncertain0.5910.6190.750-7.987In-Between0.369AmbiguousLikely Benign0.09Likely Benign0.20.04Likely Benign0.07Likely Benign0.70Ambiguous0.080Likely Benign-1.60Neutral1.000Probably Damaging0.986Probably Damaging3.46Benign0.02Affected0.09690.0533-2-3-8.00.94
c.2300T>A
I767N
2D
AIThe SynGAP1 missense variant I767N is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized, while polyPhen‑2 (HumDiv and HumVar) predict a pathogenic outcome. AlphaMissense‑Default is uncertain, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates a likely benign classification. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict any ClinVar status because no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.321458Structured0.927771Binding0.3690.8720.125-5.117Likely Benign0.541AmbiguousLikely Benign0.122Likely Benign-0.16Neutral0.977Probably Damaging0.632Possibly Damaging4.04Benign0.06Tolerated0.10390.1012-2-3-8.00.94
c.23T>A
I8N
2D
AIThe SynGAP1 missense variant I8N is not reported in ClinVar and has no entry in gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict benign. Only two tools (polyPhen‑2 HumDiv and SIFT) predict pathogenicity, while the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates a likely benign outcome. High‑accuracy assessments confirm this: AlphaMissense‑Optimized is benign and the SGM‑Consensus is likely benign; Foldetta results are unavailable. Overall, the consensus of the majority of predictors, including the high‑accuracy methods, points to a benign impact. This conclusion is consistent with the absence of any ClinVar classification, so there is no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.490133Structured0.543080Binding0.3410.9160.625-3.979Likely Benign0.163Likely BenignLikely Benign0.120Likely Benign0.05Neutral0.561Possibly Damaging0.032Benign3.99Benign0.00Affected0.08030.0540-2-3-8.00.94
c.2480T>A
I827N
2D
AIThe SynGAP1 missense variant I827N is not reported in ClinVar and has no entry in gnomAD. Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, and FATHMM, while those that predict a pathogenic outcome are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is classified as Likely Benign. High‑accuracy assessments show AlphaMissense‑Optimized as Uncertain, whereas the SGM‑Consensus (majority vote) supports a benign prediction. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, is not available for this variant. Overall, the preponderance of evidence points to a benign effect; this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.590140Disordered0.636272Binding0.3830.8840.625-4.860Likely Benign0.804Likely PathogenicAmbiguous0.114Likely Benign-1.69Neutral0.999Probably Damaging0.998Probably Damaging2.66Benign0.11Tolerated0.08760.0342-2-3-8.00.94
c.2696T>A
I899N
2D
AIThe SynGAP1 missense variant I899N is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions include REVEL, PROVEAN, polyPhen‑2 HumVar, ESM1b, FATHMM, and AlphaMissense‑Optimized; pathogenic predictions come from polyPhen‑2 HumDiv and SIFT. AlphaMissense‑Default is uncertain, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates a likely benign outcome. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized predicts benign, SGM‑Consensus is likely benign, and Foldetta results are unavailable. Overall, the preponderance of evidence points to a benign effect for I899N, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.675549Disordered0.443727Uncertain0.2920.9280.375-3.328Likely Benign0.469AmbiguousLikely Benign0.058Likely Benign-0.68Neutral0.611Possibly Damaging0.140Benign2.76Benign0.00Affected0.09330.0470-2-3-8.00.94
c.2768T>A
I923N
2D
AIThe SynGAP1 missense variant I923N (ClinVar ID 647043.0) is listed as “Uncertain” and is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is “Likely Benign” because the majority of its constituent tools (three benign, one pathogenic) favor a benign outcome. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus as benign, and the Foldetta stability analysis is unavailable. Overall, the collective predictions point to a benign impact, which does not contradict the ClinVar “Uncertain” status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.562014Disordered0.964857Binding0.2920.8520.250Uncertain 1-0.733Likely Benign0.712Likely PathogenicLikely Benign0.108Likely Benign-1.16Neutral0.991Probably Damaging0.793Possibly Damaging2.70Benign0.13Tolerated3.7750.11640.1073-2-3-8.00.94
c.2999T>A
I1000N
2D
AIThe SynGAP1 missense variant I1000N is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Tools that predict a pathogenic outcome are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict any ClinVar annotation (none is present). Thus, the variant is most likely benign based on current predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.745909Disordered0.957020Binding0.2930.9040.625-5.246Likely Benign0.677Likely PathogenicLikely Benign0.145Likely Benign-0.82Neutral0.995Probably Damaging0.913Probably Damaging2.72Benign0.16Tolerated0.10010.0900-2-3-8.00.94
c.3110T>A
I1037N
2D
AIThe SynGAP1 missense variant I1037N is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumVar, SIFT, ESM1b, and FATHMM. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and AlphaMissense‑Default. The high‑accuracy consensus from SGM (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields a Likely Benign classification, while AlphaMissense‑Optimized remains uncertain. Foldetta stability analysis is unavailable. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict any ClinVar annotation (none exists). Thus, the variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.939629Disordered0.986140Binding0.3090.7740.625-3.955Likely Benign0.832Likely PathogenicAmbiguous0.131Likely Benign1.56Neutral0.666Possibly Damaging0.211Benign2.81Benign0.34Tolerated0.10220.1140-2-3-8.00.94
c.3116T>A
I1039N
2D
AIThe SynGAP1 missense variant I1039N has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and FATHMM. Tools that predict a pathogenic effect are SIFT and AlphaMissense‑Default. AlphaMissense‑Optimized is uncertain. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely benign classification. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of evidence points to a benign impact, and this assessment does not contradict any ClinVar status (none is present). Thus, the variant is most likely benign based on current predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.969315Disordered0.979204Binding0.2920.8060.625-3.469Likely Benign0.951Likely PathogenicAmbiguous0.155Likely Benign-1.24Neutral0.011Benign0.010Benign2.67Benign0.02Affected0.11510.1311-2-3-8.00.94
c.3344T>A
I1115N
2D
AIThe SynGAP1 missense variant I1115N is not reported in ClinVar and is absent from gnomAD. In silico prediction tools uniformly indicate a benign effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as benign. The SGM‑Consensus, which aggregates the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also reports a likely benign outcome. No pathogenic predictions are present among the evaluated tools. High‑accuracy assessments confirm this: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus likewise indicates likely benign; Foldetta results are unavailable. Consequently, the variant is most likely benign based on current predictions, and this assessment does not contradict any ClinVar status, as no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.889439Disordered0.892339Binding0.3080.9120.750-4.018Likely Benign0.118Likely BenignLikely Benign0.095Likely Benign-0.60Neutral0.009Benign0.011Benign2.77Benign0.08Tolerated0.12990.1270-2-3-8.00.94
c.3398T>A
I1133N
2D
AIThe SynGAP1 missense variant I1133N is not reported in ClinVar and is absent from gnomAD. Consensus predictions from multiple in‑silico tools cluster around a benign effect: REVEL, PROVEAN, polyPhen‑2 HumVar, ESM1b, FATHMM, and AlphaMissense‑Optimized all indicate benign. Pathogenicity is suggested only by polyPhen‑2 HumDiv and SIFT, while AlphaMissense‑Default remains uncertain. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus likewise indicates Likely Benign; Foldetta stability analysis is unavailable. Overall, the preponderance of evidence points to a benign effect for I1133N, and this conclusion does not conflict with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.919029Disordered0.832785Binding0.3160.8920.750-5.887Likely Benign0.520AmbiguousLikely Benign0.290Likely Benign-1.07Neutral0.453Possibly Damaging0.162Benign5.51Benign0.02Affected0.09610.1140-2-3-8.00.94
c.3503T>A
I1168N
2D
AIThe SynGAP1 missense variant I1168N is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, and the SGM‑Consensus (majority vote) which labels the variant as Likely Benign. In contrast, tools that predict a pathogenic effect are PolyPhen‑2 (HumDiv and HumVar), SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments further show AlphaMissense‑Optimized as Pathogenic, while the SGM‑Consensus remains Likely Benign; Foldetta results are unavailable. Overall, the evidence is split evenly between benign and pathogenic predictions, with no consensus from the most accurate methods. Consequently, the variant’s pathogenicity is uncertain and does not contradict any ClinVar status, as none is currently assigned.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.642678Disordered0.763262Binding0.4230.7960.500-4.269Likely Benign0.971Likely PathogenicLikely Pathogenic0.455Likely Benign-1.79Neutral0.998Probably Damaging0.987Probably Damaging5.53Benign0.01Affected0.09430.0969-2-3-8.00.94
c.3518T>A
I1173N
2D
AIThe SynGAP1 missense variant I1173N is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, PROVEAN, ESM1b, FATHMM, and AlphaMissense‑Optimized, while pathogenic predictions arise from polyPhen‑2 (HumDiv and HumVar), SIFT, and AlphaMissense‑Default. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, indicates a likely benign effect. High‑accuracy assessments further support this: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus also leans benign. Foldetta, a protein‑folding stability method that integrates FoldX‑MD and Rosetta outputs, has no available result for this variant. Taken together, the preponderance of evidence points to a benign impact for I1173N, and this conclusion does not conflict with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignCoiled-coil0.501700Disordered0.653145Binding0.5210.7560.375-4.130Likely Benign0.691Likely PathogenicLikely Benign0.443Likely Benign-1.46Neutral0.925Possibly Damaging0.611Possibly Damaging5.34Benign0.02Affected0.09200.0142-2-3-8.00.94
c.3605T>A
I1202N
2D
AIThe SynGAP1 missense variant I1202N is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Functional prediction tools that agree on a benign effect include only REVEL, which scores the variant as benign. All other evaluated predictors—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the variant as pathogenic. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates a likely pathogenic outcome. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts pathogenic, and the SGM‑Consensus (majority vote) is likely pathogenic. Foldetta results are unavailable. Based on the preponderance of pathogenic predictions and the lack of benign consensus, the variant is most likely pathogenic, with no ClinVar status to contradict this assessment.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.529623Disordered0.510422Binding0.8740.5930.250-10.922Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.303Likely Benign-5.65Deleterious0.999Probably Damaging0.998Probably Damaging1.79Pathogenic0.00Affected0.10140.0270-2-3-8.00.94
c.3698T>A
I1233N
2D
AIThe SynGAP1 I1233N missense variant is not reported in ClinVar (ClinVar ID None) and has no entries in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect are REVEL and FATHMM. All other evaluated tools—PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus—predict a pathogenic impact. High‑accuracy assessments confirm this: AlphaMissense‑Optimized predicts pathogenic, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates pathogenic. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of evidence points to a pathogenic effect, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.525368Disordered0.564054Binding0.8810.5310.125-9.586Likely Pathogenic0.987Likely PathogenicLikely Pathogenic0.193Likely Benign-4.36Deleterious0.995Probably Damaging0.913Probably Damaging2.52Benign0.00Affected0.08790.0340-2-3-8.00.94
c.3776T>A
I1259N
2D
AIThe SynGAP1 missense variant I1259N is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL and FATHMM, whereas the majority of tools predict a pathogenic impact: PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) all indicate likely pathogenicity. High‑accuracy assessments further support this: AlphaMissense‑Optimized predicts pathogenic, and the SGM‑Consensus also reports a likely pathogenic classification. The Foldetta protein‑folding stability analysis is unavailable for this variant. Overall, the preponderance of evidence from multiple in silico predictors points to a pathogenic effect for I1259N. This conclusion is consistent with the lack of ClinVar annotation, so there is no contradiction with existing clinical database status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.494003Structured0.576405Binding0.8850.5740.250-10.979Likely Pathogenic0.996Likely PathogenicLikely Pathogenic0.459Likely Benign-3.55Deleterious0.999Probably Damaging0.998Probably Damaging2.51Benign0.00Affected0.07990.0340-2-3-8.00.94
c.3785T>A
I1262N
2D
AIThe SynGAP1 missense variant I1262N is not reported in ClinVar and is absent from gnomAD, indicating no known population frequency data. Functional prediction tools largely agree on a deleterious effect: REVEL predicts a benign outcome, whereas all other evaluated algorithms—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the change as pathogenic. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also reports a likely pathogenic status. High‑accuracy assessments further support this view: AlphaMissense‑Optimized predicts pathogenicity, and the SGM‑Consensus confirms a likely pathogenic classification. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, did not provide a result for this variant. Overall, the preponderance of computational evidence indicates that I1262N is most likely pathogenic, and this conclusion is consistent with the absence of any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.497853Structured0.707863Binding0.8860.5760.125-14.512Likely Pathogenic1.000Likely PathogenicLikely Pathogenic0.463Likely Benign-5.81Deleterious0.999Probably Damaging0.998Probably Damaging1.79Pathogenic0.00Affected0.09400.0340-2-3-8.00.94
c.3788T>A
I1263N
2D
AIThe SynGAP1 missense variant I1263N is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include only REVEL, whereas the remaining tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is “Likely Pathogenic.” Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the preponderance of evidence indicates that the variant is most likely pathogenic, and this conclusion does not contradict the ClinVar status, which currently has no classification for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.425610Structured0.740957Binding0.8670.5740.000-9.158Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.379Likely Benign-5.80Deleterious0.995Probably Damaging0.913Probably Damaging1.79Pathogenic0.00Affected0.10410.0340-2-3-8.00.94
c.38T>A
I13N
2D
AIThe SynGAP1 missense variant I13N is reported in gnomAD (ID 6‑33420302‑T‑A) but has no ClinVar entry. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as benign. Only SIFT predicts it to be pathogenic, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) labels it “Likely Benign.” High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized is benign, and the SGM‑Consensus is also likely benign; Foldetta results are not available. Overall, the consensus of the majority of tools, including the high‑accuracy methods, indicates that the variant is most likely benign, and this conclusion does not contradict any ClinVar status (none is reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.486429Structured0.482657Uncertain0.3180.9160.3756-33420302-T-A-3.725Likely Benign0.237Likely BenignLikely Benign0.096Likely Benign-0.16Neutral0.056Benign0.005Benign4.02Benign0.00Affected4.3210.12200.1100-3-2-8.00.94
c.3992T>A
I1331N
2D
AIThe SynGAP1 missense variant I1331N is not reported in ClinVar (ClinVar status: none) but is present in gnomAD (ID 6‑33451866‑T‑A). Prediction tools that agree on a benign effect include REVEL, ESM1b, and FATHMM, whereas those that predict a pathogenic effect are PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is inconclusive (2 vs 2), and Foldetta results are unavailable. Overall, the majority of evaluated tools predict a pathogenic impact, and there is no conflict with ClinVar status. Thus, the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.921076Disordered0.941705Binding0.3590.7520.8756-33451866-T-A-3.788Likely Benign0.994Likely PathogenicLikely Pathogenic0.237Likely Benign-4.09Deleterious0.984Probably Damaging0.979Probably Damaging3.29Benign0.00Affected3.7750.10120.0666-3-2-8.00.94
c.422T>A
I141N
2D
AIThe SynGAP1 missense variant I141N is not reported in ClinVar and is absent from gnomAD. Consensus from standard prediction algorithms shows a split: benign predictions come from REVEL, polyPhen‑2 HumVar, and FATHMM, whereas pathogenic predictions arise from PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, AlphaMissense‑Default, and the SGM‑Consensus (Likely Pathogenic). High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized predicts pathogenic, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates Likely Pathogenic. Foldetta stability analysis is unavailable. Overall, the majority of evidence points toward a pathogenic impact for I141N. This conclusion is consistent with the lack of ClinVar annotation and does not contradict any existing database status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.465241Structured0.577021Binding0.3670.8770.500-12.417Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.258Likely Benign-3.90Deleterious0.799Possibly Damaging0.424Benign3.54Benign0.00Affected0.10470.0270-2-3-8.00.94
c.476T>A
I159N
2D
AIThe SynGAP1 missense variant I159N is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, and FATHMM, whereas polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default all predict a pathogenic impact. The high‑accuracy AlphaMissense‑Optimized result is uncertain, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive because it yields a 2‑vs‑2 split. Foldetta, which would assess protein‑folding stability, has no available output for this variant. Overall, the majority of tools (five out of eight) predict pathogenicity, while three predict benign and one is uncertain. Thus, the variant is most likely pathogenic based on current computational predictions, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.454136Structured0.529953Binding0.2780.7310.125-14.684Likely Pathogenic0.891Likely PathogenicAmbiguous0.218Likely Benign-1.93Neutral0.995Probably Damaging0.986Probably Damaging3.82Benign0.00Affected0.09190.0342-2-3-8.00.94
c.614T>A
I205N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 I205N missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Functional prediction tools cluster into two groups: benign predictions come from REVEL, SIFT, FATHMM, and AlphaMissense‑Optimized; pathogenic predictions come from premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), and ESM1b. Four tools (FoldX, Rosetta, Foldetta, AlphaMissense‑Default) give uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as uncertain. No evidence from these tools contradicts the lack of ClinVar annotation. Overall, the majority of predictions (five pathogenic vs. four benign) and the pathogenic SGM Consensus suggest the variant is most likely pathogenic, with no ClinVar status to conflict this assessment.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
PH0.264545Structured0.409933Uncertain0.8210.4140.125-10.928Likely Pathogenic0.552AmbiguousLikely Benign0.66Ambiguous0.11.16Ambiguous0.91Ambiguous1.57Destabilizing0.138Likely Benign-3.56Deleterious0.940Possibly Damaging0.641Possibly Damaging4.06Benign0.07Tolerated0.08020.0212-2-3-8.00.94
c.617T>A
I206N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I206N is not reported in ClinVar (ClinVar status: not listed) and is absent from gnomAD (gnomAD ID: none). Prediction tools that agree on a benign effect include REVEL and FATHMM, while the remaining tools—FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. High‑accuracy assessments further support a deleterious outcome: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is “Likely Pathogenic”; and Foldetta, which integrates FoldX‑MD and Rosetta stability predictions, is pathogenic. No prediction or folding result is missing or inconclusive. Based on the overwhelming majority of pathogenic predictions, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status because the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.298791Structured0.405123Uncertain0.8630.3910.125-15.211Likely Pathogenic0.998Likely PathogenicLikely Pathogenic2.98Destabilizing0.22.57Destabilizing2.78Destabilizing2.04Destabilizing0.334Likely Benign-5.55Deleterious0.940Possibly Damaging0.641Possibly Damaging3.62Benign0.00Affected0.06890.0340-2-3-8.00.94
c.638T>A
I213N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I213N is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include only FATHMM, whereas the remaining evaluated algorithms—SGM‑Consensus, REVEL, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact; FoldX is uncertain and is treated as unavailable. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized reports pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts pathogenic. Based on the collective predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.158265Structured0.372201Uncertain0.8500.2950.125-15.069Likely Pathogenic0.999Likely PathogenicLikely Pathogenic1.71Ambiguous0.82.81Destabilizing2.26Destabilizing1.85Destabilizing0.862Likely Pathogenic-5.81Deleterious0.995Probably Damaging0.880Possibly Damaging5.83Benign0.00Affected0.07500.0412-2-3-8.00.94
c.728T>A
I243N
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant I243N is not reported in ClinVar and is absent from gnomAD. Prediction tools cluster into three groups: benign (FATHMM), pathogenic (SGM‑Consensus, REVEL, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized), and uncertain (FoldX, Rosetta, Foldetta). High‑accuracy methods give a consistent pathogenic signal: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, while Foldetta remains uncertain. Overall, the majority of evidence points to a pathogenic effect, and this assessment does not contradict any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.363090Structured0.344471Uncertain0.8420.3470.000-14.784Likely Pathogenic0.988Likely PathogenicLikely Pathogenic1.90Ambiguous0.21.43Ambiguous1.67Ambiguous1.76Destabilizing0.811Likely Pathogenic-4.46Deleterious0.995Probably Damaging0.854Possibly Damaging5.49Benign0.00Affected0.08990.0212-2-3-8.00.94
c.803T>A
I268N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I268N is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that assess pathogenicity all agree that the variant is deleterious: SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify it as pathogenic. No tool predicts a benign effect. High‑accuracy methods reinforce this consensus: AlphaMissense‑Optimized predicts pathogenicity; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also predicts pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, indicates a destabilizing, pathogenic effect. All available predictions are concordant and supportive. Based on these computational assessments, the variant is most likely pathogenic, and this conclusion does not contradict any existing ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.216401Structured0.314336Uncertain0.9510.2640.000-13.664Likely Pathogenic0.998Likely PathogenicLikely Pathogenic3.48Destabilizing0.13.17Destabilizing3.33Destabilizing2.21Destabilizing0.812Likely Pathogenic-6.26Deleterious0.999Probably Damaging0.998Probably Damaging1.51Pathogenic0.00Affected0.07080.0142-2-3-8.00.94
c.1028T>A
V343D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V343D is not reported in ClinVar and is absent from gnomAD. Prediction tools that assess pathogenicity uniformly indicate a deleterious effect: REVEL, polyPhen‑2 (HumDiv and HumVar), SIFT, PROVEAN, ESM1b, FATHMM, premPS, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as pathogenic. Rosetta and Foldetta, which evaluate protein‑folding stability, also predict a pathogenic outcome, while FoldX remains uncertain. No tool in the dataset predicts a benign effect. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta is pathogenic. Consequently, the variant is most likely pathogenic based on the available predictions, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.291804Structured0.383911Uncertain0.8820.4970.250-15.523Likely Pathogenic0.997Likely PathogenicLikely Pathogenic1.57Ambiguous0.23.40Destabilizing2.49Destabilizing1.73Destabilizing0.530Likely Pathogenic-5.62Deleterious0.996Probably Damaging0.930Probably Damaging1.59Pathogenic0.00Affected0.17810.2261-2-3-7.715.96
c.1037T>A
V346E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V346E is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). All evaluated in silico predictors classify the change as pathogenic: SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a benign effect. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts a pathogenic outcome; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates a likely pathogenic effect; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also predicts a pathogenic impact. **Conclusion:** The variant is most likely pathogenic based on the unanimous computational evidence, and this assessment is not contradicted by the absence of a ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.260850Structured0.350921Uncertain0.9490.4610.000-14.004Likely Pathogenic0.999Likely PathogenicLikely Pathogenic3.30Destabilizing0.44.79Destabilizing4.05Destabilizing2.13Destabilizing0.720Likely Pathogenic-5.52Deleterious0.999Probably Damaging0.991Probably Damaging1.47Pathogenic0.00Affected0.10880.1568-2-2-7.729.98
c.1043T>A
V348E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V348E is not reported in ClinVar and is absent from gnomAD. Prediction tools cluster into two groups: the single benign prediction comes from REVEL, while all other evaluated algorithms (FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized) indicate pathogenicity. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is “Likely Pathogenic”; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, also predicts pathogenic. No prediction or stability result is missing or inconclusive. Based on the overwhelming agreement among the majority of tools, the variant is most likely pathogenic, and this conclusion does not contradict the ClinVar status, which currently has no entry for V348E.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.170161Structured0.346556Uncertain0.9510.4140.000-11.135Likely Pathogenic0.993Likely PathogenicLikely Pathogenic2.41Destabilizing0.12.20Destabilizing2.31Destabilizing2.14Destabilizing0.470Likely Benign-5.26Deleterious0.989Probably Damaging0.637Possibly Damaging1.56Pathogenic0.01Affected0.10890.1922-2-2-7.729.98
c.1049T>A
V350E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V350E is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on benign effect include REVEL and SIFT, whereas a majority of tools predict pathogenicity: premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, Foldetta, and Rosetta. Two tools give inconclusive results: FoldX (Uncertain) and AlphaMissense‑Optimized (Uncertain). High‑accuracy assessments show AlphaMissense‑Optimized as Uncertain, SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as Pathogenic. Overall, the preponderance of evidence points to a pathogenic effect for V350E. This conclusion is not contradicted by ClinVar, which contains no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.179055Structured0.353227Uncertain0.9310.3710.000-15.975Likely Pathogenic0.941Likely PathogenicAmbiguous1.73Ambiguous0.22.61Destabilizing2.17Destabilizing1.93Destabilizing0.304Likely Benign-4.67Deleterious0.976Probably Damaging0.559Possibly Damaging1.61Pathogenic0.08Tolerated0.10780.1568-2-2-7.729.98
c.104T>A
V35D
2D
AIThe SynGAP1 missense variant V35D is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote) which classifies the variant as Likely Benign. In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT all predict a pathogenic impact. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized predicts Benign, and the SGM‑Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates Likely Benign. No Foldetta stability analysis is available, so it does not influence the overall assessment. Overall, the majority of evidence points to the variant being most likely benign, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.613573Disordered0.434838Uncertain0.3600.8510.375-4.232Likely Benign0.321Likely BenignLikely Benign0.125Likely Benign-0.42Neutral0.824Possibly Damaging0.828Possibly Damaging4.18Benign0.00Affected0.15400.1547-2-3-7.715.96
c.1094T>A
V365E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V365E is not reported in ClinVar and is absent from gnomAD. Prediction tools uniformly indicate a deleterious effect: SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the variant as pathogenic. No tool predicts a benign outcome. High‑accuracy assessments corroborate this: AlphaMissense‑Optimized predicts pathogenicity; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also predicts pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, predicts pathogenic. With all available evidence pointing to a damaging effect and no ClinVar annotation to contradict, the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.414856Structured0.441505Uncertain0.9230.6080.250-16.263Likely Pathogenic0.994Likely PathogenicLikely Pathogenic3.99Destabilizing0.33.81Destabilizing3.90Destabilizing2.20Destabilizing0.613Likely Pathogenic-5.02Deleterious0.989Probably Damaging0.688Possibly Damaging1.66Pathogenic0.00Affected0.08490.2083-2-2-7.729.98
c.1199T>A
V400E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V400E is listed in ClinVar with an “Uncertain” status and is not reported in gnomAD. Prediction tools that indicate a benign effect are polyPhen‑2 HumVar and FATHMM; all other evaluated algorithms (REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, AlphaMissense‑Default, and the SGM‑Consensus) predict a pathogenic impact. High‑accuracy assessments further support a deleterious outcome: AlphaMissense‑Optimized scores the variant as pathogenic, the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) labels it “Likely Pathogenic,” and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts a pathogenic effect. Based on the preponderance of pathogenic predictions, the variant is most likely pathogenic, which does not contradict its current ClinVar “Uncertain” classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.398279Structured0.415488Uncertain0.9510.4510.000Uncertain 1-13.686Likely Pathogenic0.998Likely PathogenicLikely Pathogenic3.70Destabilizing0.22.46Destabilizing3.08Destabilizing2.29Destabilizing0.810Likely Pathogenic-4.88Deleterious0.920Possibly Damaging0.335Benign5.31Benign0.00Affected3.38270.10440.1922-2-2-7.729.98249.1-38.8-0.10.11.00.0XXXPotentially PathogenicThe iso-propyl side chain of Val400, located in an anti-parallel β sheet strand (res. Ala399-Ile411), hydrophobically packs against hydrophobic residues within the anti-parallel β sheet of the C2 domain (e.g., Ile268, Ala404, Leu325, Leu402). In the variant simulations, the negatively charged carboxylate group of the Glu400 side chain is not suitable for occupying the hydrophobic niche. Consequently, the side chain escapes the center of the C2 domain and interacts with the backbone amide groups of Leu402 in the same β strand and/or Ile269 and Glu270 in a neighboring β strand (res. Arg259-Arg272). This residue swap disrupts the hydrophobic packing and generally has extensive negative effects on the C2 domain structure. At a minimum, the residue swap could affect the C2 domain stability and membrane association.
c.1271T>A
V424D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V424D is not reported in ClinVar and is absent from gnomAD. Consensus from multiple in silico predictors indicates a pathogenic effect: SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict pathogenicity, whereas only FATHMM predicts a benign outcome. High‑accuracy tools reinforce this view: AlphaMissense‑Optimized scores the variant as pathogenic; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, labels it likely pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also predicts pathogenicity. No prediction is missing or inconclusive. Consequently, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.050641Structured0.411431Uncertain0.9730.2480.000-15.531Likely Pathogenic0.999Likely PathogenicLikely Pathogenic3.60Destabilizing0.13.50Destabilizing3.55Destabilizing2.13Destabilizing0.615Likely Pathogenic-5.87Deleterious1.000Probably Damaging0.992Probably Damaging3.33Benign0.00Affected0.15360.0845-2-3-7.715.96
c.1301T>A
V434D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V434D is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that classify the variant as benign are SIFT and FATHMM; all other evaluated algorithms—including REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), AlphaMissense‑Default, and ESM1b—predict it to be pathogenic. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized returns a pathogenic score; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is “Likely Pathogenic”; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also predicts pathogenicity. No prediction or folding stability result is missing or inconclusive. Based on the overwhelming agreement among pathogenic predictors and the corroborating high‑accuracy tools, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.158265Structured0.342846Uncertain0.9540.3060.000-14.765Likely Pathogenic0.983Likely PathogenicLikely Pathogenic3.26Destabilizing0.03.33Destabilizing3.30Destabilizing1.78Destabilizing0.592Likely Pathogenic-5.18Deleterious1.000Probably Damaging1.000Probably Damaging3.38Benign0.13Tolerated0.13070.0741-2-3-7.715.96
c.1322T>A
V441D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V441D is not reported in ClinVar and has no entry in gnomAD. Prediction tools that agree on a benign effect include REVEL, SIFT, FATHMM, and Foldetta, whereas a majority of tools (SGM Consensus, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default) predict a pathogenic impact. FoldX and Rosetta are inconclusive, and AlphaMissense‑Optimized is uncertain. High‑accuracy assessments show that the SGM Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) predicts pathogenicity, while Foldetta predicts benign stability. Overall, the balance of evidence leans toward pathogenicity, and this conclusion does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.161087Structured0.259875Uncertain0.9180.2490.000-15.392Likely Pathogenic0.934Likely PathogenicAmbiguous-0.57Ambiguous0.10.56Ambiguous-0.01Likely Benign1.15Destabilizing0.308Likely Benign-6.07Deleterious1.000Probably Damaging0.959Probably Damaging3.38Benign0.10Tolerated0.12320.0698-2-3-7.715.96
c.1340T>A
V447D
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant V447D lies in the GAP domain. ClinVar has no entry for this change, and it is absent from gnomAD. Prediction tools that agree on benign impact are REVEL and FATHMM, whereas the remaining predictors—FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently classify the variant as pathogenic. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized predicts pathogenicity, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates likely pathogenic, and Foldetta also reports a pathogenic effect. Overall, the evidence points to a pathogenic effect for V447D, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.250310Structured0.283801Uncertain0.9700.2430.000-16.643Likely Pathogenic0.998Likely PathogenicLikely Pathogenic4.34Destabilizing0.13.59Destabilizing3.97Destabilizing2.29Destabilizing0.491Likely Benign-5.33Deleterious1.000Probably Damaging1.000Probably Damaging3.30Benign0.01Affected0.14240.0541-2-3-7.715.96
c.1355T>A
V452D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V452D is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools largely agree on a deleterious effect: benign predictions are limited to FATHMM, while all other evaluated algorithms—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the variant as pathogenic. High‑accuracy methods reinforce this consensus: AlphaMissense‑Optimized predicts pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts pathogenic. No prediction or folding stability result is missing or inconclusive. Based on the overwhelming agreement among both general and high‑accuracy predictors, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.335645Structured0.315167Uncertain0.9700.2290.000-15.793Likely Pathogenic0.999Likely PathogenicLikely Pathogenic3.92Destabilizing0.13.37Destabilizing3.65Destabilizing2.52Destabilizing0.630Likely Pathogenic-6.92Deleterious1.000Probably Damaging1.000Probably Damaging3.16Benign0.00Affected0.13200.0610-2-3-7.715.96
c.1418T>A
V473E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V473E is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools largely agree on a deleterious effect: all evaluated algorithms except FATHMM predict pathogenicity, while FATHMM alone predicts benign. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized classifies the variant as pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates a likely pathogenic outcome; and Foldetta, which integrates FoldX‑MD and Rosetta stability predictions, also reports a pathogenic effect. No predictions or stability results are missing or inconclusive. Based on the consensus of the majority of tools and the high‑accuracy methods, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.191378Structured0.362529Uncertain0.8840.2390.000-15.296Likely Pathogenic0.992Likely PathogenicLikely Pathogenic3.20Destabilizing0.22.24Destabilizing2.72Destabilizing2.22Destabilizing0.664Likely Pathogenic-5.92Deleterious1.000Probably Damaging1.000Probably Damaging3.13Benign0.00Affected0.09030.1396-2-2-7.729.98
c.1577T>A
V526E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V526E is not listed in ClinVar and has no reported allele in gnomAD. In silico prediction tools uniformly indicate a deleterious effect: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as pathogenic. No tool predicts a benign outcome. High‑accuracy assessments corroborate this: AlphaMissense‑Optimized predicts pathogenicity; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) reports “Likely Pathogenic”; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also predicts pathogenicity. Because all available evidence points to a damaging effect and there is no conflicting ClinVar annotation or population frequency data, the variant is most likely pathogenic. This conclusion aligns with the absence of ClinVar status and gnomAD entries, indicating no contradiction.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.139895Structured0.023118Uncertain0.9430.4030.000-16.080Likely Pathogenic0.993Likely PathogenicLikely Pathogenic5.19Destabilizing0.35.12Destabilizing5.16Destabilizing2.32Destabilizing0.962Likely Pathogenic-5.94Deleterious1.000Probably Damaging1.000Probably Damaging-1.46Pathogenic0.00Affected0.07660.1326-2-2-7.729.98
c.1661T>A
V554E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V554E is not reported in ClinVar and is absent from gnomAD. Prediction tools largely agree on a deleterious effect: all evaluated algorithms except FATHMM classify the variant as pathogenic (REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default). FATHMM is the sole benign prediction. High‑accuracy assessments reinforce the pathogenic signal: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts pathogenic. No predictions are missing or inconclusive. Based on the overwhelming consensus of pathogenic predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.020522Structured0.007349Uncertain0.9550.2260.000-12.813Likely Pathogenic0.992Likely PathogenicLikely Pathogenic2.51Destabilizing0.12.05Destabilizing2.28Destabilizing2.42Destabilizing0.590Likely Pathogenic-5.96Deleterious1.000Probably Damaging0.994Probably Damaging3.21Benign0.00Affected0.08620.1180-2-2-7.729.98
c.1664T>A
V555D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V555D is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect are none, while a majority of algorithms predict a pathogenic impact: REVEL, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. FoldX, Rosetta, and Foldetta provide uncertain results. High‑accuracy methods reinforce the pathogenic prediction: AlphaMissense‑Optimized is pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is pathogenic, and Foldetta remains uncertain. Overall, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.013265Structured0.008218Uncertain0.9430.2250.000-16.413Likely Pathogenic0.994Likely PathogenicLikely Pathogenic1.84Ambiguous0.11.70Ambiguous1.77Ambiguous1.25Destabilizing0.896Likely Pathogenic-5.71Deleterious1.000Probably Damaging0.987Probably Damaging-1.39Pathogenic0.00Affected0.14110.0541-2-3-7.715.96
c.1679T>A
V560E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V560E is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include only SIFT, whereas the remaining tools—REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and the SGM Consensus—predict a pathogenic impact. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. With the majority of evidence pointing to pathogenicity and no ClinVar annotation to contradict this, the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.021381Structured0.013872Uncertain0.8530.2040.000-13.331Likely Pathogenic0.932Likely PathogenicAmbiguous1.12Ambiguous0.11.41Ambiguous1.27Ambiguous1.61Destabilizing0.711Likely Pathogenic-4.98Deleterious1.000Probably Damaging0.990Probably Damaging-1.16Pathogenic0.18Tolerated0.11000.1667-2-2-7.729.98
c.1703T>A
V568E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V568E is not reported in ClinVar and is absent from gnomAD. Prediction tools that assess pathogenicity are unanimous: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as pathogenic. No tool in the dataset predicts a benign effect, so the benign‑prediction group is empty. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized indicates pathogenicity; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also reports Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts a destabilizing, pathogenic effect. Based on the collective evidence, the variant is most likely pathogenic, and this assessment does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.024826Structured0.053503Uncertain0.9370.2570.000-13.835Likely Pathogenic0.992Likely PathogenicLikely Pathogenic2.48Destabilizing0.14.62Destabilizing3.55Destabilizing2.03Destabilizing0.940Likely Pathogenic-5.88Deleterious1.000Probably Damaging0.998Probably Damaging-1.46Pathogenic0.00Affected0.08910.1495-2-2-7.729.98
c.1886T>A
V629D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V629D is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a deleterious effect: SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized all return pathogenic or likely pathogenic calls, whereas only FATHMM predicts a benign outcome. High‑accuracy assessments reinforce this trend: AlphaMissense‑Optimized indicates pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta) predicts pathogenic. No predictions are missing or inconclusive. Consequently, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.040537Structured0.034796Uncertain0.9700.2360.000-17.143Likely Pathogenic0.996Likely PathogenicLikely Pathogenic3.85Destabilizing0.13.82Destabilizing3.84Destabilizing2.17Destabilizing0.713Likely Pathogenic-6.37Deleterious1.000Probably Damaging1.000Probably Damaging3.06Benign0.00Affected0.12840.0541-2-3-7.715.96
c.2096T>A
V699E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 V699E missense variant is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify it as benign include REVEL and FATHMM, whereas the majority of other in‑silico predictors (FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, and the SGM‑Consensus score) indicate a pathogenic effect. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as Pathogenic. Based on the preponderance of pathogenic predictions and the high‑accuracy tools’ results, the variant is most likely pathogenic, and this assessment does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.069024Structured0.432975Uncertain0.9350.3150.000-12.647Likely Pathogenic0.813Likely PathogenicAmbiguous2.41Destabilizing0.12.08Destabilizing2.25Destabilizing1.82Destabilizing0.468Likely Benign-4.56Deleterious1.000Probably Damaging0.986Probably Damaging3.42Benign0.02Affected0.10920.1326-2-2-7.729.98
c.2237T>A
V746E
2D
AIThe SynGAP1 missense variant V746E is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict benign. Only two tools—polyPhen‑2 HumDiv and SIFT—suggest a pathogenic impact. The high‑accuracy consensus from SGM (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) classifies the variant as Likely Benign, and AlphaMissense‑Optimized also predicts benign. No Foldetta stability data are available. Overall, the majority of evidence points to a benign effect, and this assessment does not conflict with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.808535Disordered0.576597Binding0.3360.8670.875-4.136Likely Benign0.315Likely BenignLikely Benign0.067Likely Benign-0.94Neutral0.642Possibly Damaging0.316Benign2.85Benign0.05Affected0.09280.1813-2-2-7.729.98
c.2240T>A
V747E
2D
AIThe SynGAP1 missense variant V747E is evaluated by multiple in silico tools. ClinVar has no entry for this change, and it is not reported in gnomAD. Consensus from the SGM‑Consensus algorithm classifies the variant as Likely Benign. When grouping predictions by agreement, benign calls come from REVEL, PROVEAN, ESM1b, FATHMM, and AlphaMissense‑Optimized, while pathogenic calls arise from polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. AlphaMissense‑Default remains uncertain. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized predicts Benign, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates Likely Benign, and no Foldetta stability data are available. Overall, the majority of evidence points to a benign effect, and this conclusion does not conflict with the absence of a ClinVar classification. Based on the aggregate predictions, the variant is most likely benign, and this assessment does not contradict the ClinVar status, which currently has no entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.816150Disordered0.594069Binding0.3430.8730.750-4.124Likely Benign0.464AmbiguousLikely Benign0.096Likely Benign-1.31Neutral0.917Possibly Damaging0.666Possibly Damaging2.56Benign0.00Affected0.09650.1559-2-2-7.729.98
c.2423T>A
V808E
2D
AIThe SynGAP1 missense variant V808E is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: the single benign prediction comes from REVEL, while the remaining tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus—indicate pathogenicity. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized returns an uncertain result, SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) labels the variant as Likely Pathogenic, and Foldetta data are not available. Based on the preponderance of pathogenic predictions and the SGM‑Consensus outcome, the variant is most likely pathogenic; this assessment does not contradict any ClinVar status, as none exists for this change.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicSH3-binding motif0.699094Disordered0.856438Binding0.2890.9030.500-9.078Likely Pathogenic0.888Likely PathogenicAmbiguous0.307Likely Benign-2.84Deleterious0.999Probably Damaging0.958Probably Damaging2.28Pathogenic0.00Affected0.11290.2787-2-2-7.729.98
c.2510T>A
V837D
2D
AIThe SynGAP1 missense variant V837D is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, and FATHMM, while those that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is classified as Likely Benign (three benign votes versus one pathogenic). High‑accuracy assessments show AlphaMissense‑Optimized as Uncertain, SGM‑Consensus as Likely Benign, and Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact. This conclusion is not contradicted by ClinVar, as no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.525368Disordered0.626284Binding0.3180.8710.125-5.712Likely Benign0.785Likely PathogenicAmbiguous0.127Likely Benign-0.51Neutral0.999Probably Damaging0.998Probably Damaging2.61Benign0.85Tolerated0.14150.0902-2-3-7.715.96
c.2522T>A
V841E
2D
AIThe SynGAP1 missense variant V841E is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect are REVEL and FATHMM. All other evaluated algorithms—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—predict a pathogenic impact. The SGM‑Consensus, which aggregates the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Pathogenic. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts pathogenic, and the SGM‑Consensus also indicates Likely Pathogenic. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the preponderance of evidence from multiple prediction tools and high‑accuracy methods indicates that V841E is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.622677Disordered0.616495Binding0.2610.8730.125-13.750Likely Pathogenic0.976Likely PathogenicLikely Pathogenic0.292Likely Benign-3.13Deleterious0.999Probably Damaging0.997Probably Damaging2.52Benign0.00Affected0.09390.1656-2-2-7.729.98
c.2579T>A
V860D
2D
AIThe SynGAP1 missense variant V860D is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). Tools that predict a pathogenic outcome are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; Foldetta results are not available. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict the ClinVar status, which currently contains no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.545602Disordered0.518121Binding0.2690.8030.250-4.310Likely Benign0.590Likely PathogenicLikely Benign0.164Likely Benign-1.98Neutral0.971Probably Damaging0.690Possibly Damaging4.08Benign0.00Affected0.13820.1047-2-3-7.715.96
c.257T>A
V86D
2D
AIThe SynGAP1 missense variant V86D is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on benign impact include REVEL, PROVEAN, and FATHMM, whereas those that agree on pathogenic impact are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized; ESM1b is uncertain. High‑accuracy assessment shows AlphaMissense‑Optimized predicts pathogenic, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) leans benign (two benign, one pathogenic, one uncertain). Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of conventional tools predict pathogenicity, whereas the high‑accuracy consensus suggests benign. Based on the aggregate predictions, the variant is most likely pathogenic, and this assessment does not contradict ClinVar status, which currently has no entry for V86D.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.685117Disordered0.552911Binding0.2950.8870.500-7.141In-Between0.999Likely PathogenicLikely Pathogenic0.147Likely Benign-2.38Neutral0.824Possibly Damaging0.485Possibly Damaging3.73Benign0.00Affected0.15900.1047-2-3-7.715.96
c.2597T>A
V866E
2D
AIThe SynGAP1 missense variant V866E is not reported in ClinVar and has no entries in gnomAD, indicating it is not catalogued in these databases. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, and AlphaMissense‑Optimized, while polyPhen‑2 (HumDiv and HumVar) and SIFT uniformly predict a pathogenic impact. AlphaMissense‑Default remains uncertain. The high‑accuracy consensus from SGM (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) classifies the variant as Likely Benign, and AlphaMissense‑Optimized also predicts Benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of evidence—including the SGM consensus and AlphaMissense‑Optimized—points to a benign effect, and this assessment does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.599170Disordered0.638070Binding0.2660.7880.250-3.917Likely Benign0.422AmbiguousLikely Benign0.157Likely Benign-2.09Neutral0.998Probably Damaging0.939Probably Damaging2.72Benign0.05Affected0.09960.1629-2-2-7.729.98
c.263T>A
V88E
2D
AIThe SynGAP1 missense variant V88E is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. Tools that predict a pathogenic effect are SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. ESM1b is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) favors a benign outcome. Foldetta, a protein‑folding stability method, has no available result for this variant. Overall, the majority of predictions (five benign vs. three pathogenic) and the SGM Consensus support a benign classification, whereas AlphaMissense‑Optimized alone suggests pathogenicity. Based on the collective evidence, the variant is most likely benign, and this assessment does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.703578Disordered0.552910Binding0.3230.8700.500-7.978In-Between0.993Likely PathogenicLikely Pathogenic0.095Likely Benign-1.95Neutral0.001Benign0.000Benign3.68Benign0.00Affected0.14440.1725-2-2-7.729.98
c.269T>A
V90E
2D
AIThe SynGAP1 missense variant V90E is listed in ClinVar (ID 971665.0) with an uncertain significance status and is not reported in gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, and AlphaMissense‑Optimized all predict benign. Only two tools—SIFT and AlphaMissense‑Default—suggest a pathogenic outcome. When the high‑accuracy consensus is considered, AlphaMissense‑Optimized remains benign, and the SGM Consensus (derived from the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates a likely benign effect. No Foldetta stability assessment is available for this variant. Overall, the preponderance of evidence points to a benign impact, which does not contradict the ClinVar uncertain classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.570702Disordered0.542047Binding0.3430.8730.500Uncertain 1-4.079Likely Benign0.703Likely PathogenicLikely Benign0.108Likely Benign-0.38Neutral0.001Benign0.000Benign4.00Benign0.00Affected4.3210.13230.2233-2-2-7.729.98
c.2732T>A
V911D
2D
AIThe SynGAP1 missense variant V911D is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumVar, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, SIFT, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a “Likely Benign” classification. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; Foldetta results are unavailable. Overall, the majority of high‑confidence predictors indicate a benign impact, and this is consistent with the lack of ClinVar evidence. Therefore, the variant is most likely benign and does not contradict any existing ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.685117Disordered0.724137Binding0.3270.9140.375-4.422Likely Benign0.624Likely PathogenicLikely Benign0.114Likely Benign-0.41Neutral0.500Possibly Damaging0.157Benign2.71Benign0.05Affected0.14160.1289-2-3-7.715.96
c.2747T>A
V916D
2D
AIThe SynGAP1 missense variant V916D is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, and AlphaMissense‑Optimized, while polyPhen‑2 (HumDiv and HumVar) and SIFT uniformly predict a pathogenic outcome. AlphaMissense‑Default remains uncertain. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized predicts Benign, SGM‑Consensus indicates Likely Benign, and Foldetta (which integrates FoldX‑MD and Rosetta outputs) is not available for this variant. Based on the collective evidence, the variant is most likely benign, and this assessment does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.642678Disordered0.835395Binding0.3080.8790.250-2.653Likely Benign0.392AmbiguousLikely Benign0.139Likely Benign-1.48Neutral0.975Probably Damaging0.767Possibly Damaging2.69Benign0.01Affected0.15800.1113-2-3-7.715.96
c.2975T>A
V992D
2D
AIThe SynGAP1 missense variant V992D is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict benign, while only SIFT predicts pathogenic. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely benign classification. High‑accuracy assessments confirm this: AlphaMissense‑Optimized is benign and the SGM‑Consensus is likely benign; Foldetta results are unavailable. Overall, the consensus of the majority of tools, including the high‑accuracy methods, indicates that V992D is most likely benign, and this assessment does not contradict any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.754692Disordered0.921728Binding0.3310.9170.750-3.976Likely Benign0.306Likely BenignLikely Benign0.029Likely Benign-1.24Neutral0.302Benign0.158Benign4.21Benign0.05Affected0.16450.1056-2-3-7.715.96
c.3233T>A
V1078D
2D
AIThe SynGAP1 missense variant V1078D is listed in ClinVar (ID 2993122.0) with an “Uncertain” status and is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, and FATHMM. Tools that predict a pathogenic effect are AlphaMissense‑Default, AlphaMissense‑Optimized, and SIFT. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a “Likely Benign” classification. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, SGM‑Consensus as likely benign, and Foldetta (a protein‑folding stability method combining FoldX‑MD and Rosetta) has no available result for this variant. Overall, the majority of predictions lean toward a benign impact, and this is consistent with the ClinVar “Uncertain” designation; there is no contradiction with the existing ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.882776Disordered0.986989Binding0.2940.8980.750Uncertain 1-5.155Likely Benign0.979Likely PathogenicLikely Pathogenic0.158Likely Benign-1.45Neutral0.003Benign0.008Benign3.84Benign0.00Affected3.7750.15700.1173-3-2-7.715.96
c.329T>A
V110D
2D
AIThe SynGAP1 missense variant V110D is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, ESM1b, and FATHMM. Tools that agree on a pathogenic effect include PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized predicts pathogenic. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is inconclusive (two pathogenic vs. two benign). Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of evaluated tools (seven pathogenic vs. three benign) indicate a pathogenic effect. This prediction is consistent with the lack of ClinVar reporting and does not contradict any existing ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.622677Disordered0.665934Binding0.3470.8600.750-4.536Likely Benign0.970Likely PathogenicLikely Pathogenic0.189Likely Benign-2.84Deleterious0.978Probably Damaging0.500Possibly Damaging4.04Benign0.00Affected0.18490.1115-2-3-7.715.96
c.3464T>A
V1155E
2D
AIThe SynGAP1 missense variant V1155E is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show mixed results: benign predictions come from REVEL, PROVEAN, ESM1b, FATHMM, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Pathogenic predictions arise from polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments highlight a discrepancy: AlphaMissense‑Optimized predicts pathogenic, whereas the SGM‑Consensus indicates likely benign; Foldetta stability analysis is unavailable. Consequently, the evidence is evenly split between benign and pathogenic interpretations, and no ClinVar entry contradicts these findings. The variant’s clinical significance remains uncertain, with no definitive leaning toward benign or pathogenic based on current predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.750527Disordered0.855718Binding0.3350.8570.500-3.175Likely Benign0.993Likely PathogenicLikely Pathogenic0.204Likely Benign-2.01Neutral0.999Probably Damaging0.997Probably Damaging2.58Benign0.02Affected0.09730.1727-2-2-7.729.98
c.3473T>A
V1158D
2D
AIThe SynGAP1 missense variant V1158D is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL and ESM1b, whereas the remaining tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized classifies the variant as pathogenic, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports it as Likely Pathogenic. No Foldetta stability prediction is available for this variant. Overall, the majority of computational evidence indicates that V1158D is most likely pathogenic, and this conclusion does not contradict any ClinVar status, as none is currently assigned.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.599170Disordered0.877504Binding0.3690.8470.250-4.076Likely Benign0.999Likely PathogenicLikely Pathogenic0.486Likely Benign-4.56Deleterious0.999Probably Damaging0.998Probably Damaging2.29Pathogenic0.00Affected0.15020.1820-2-3-7.715.96
c.3584T>A
V1195E
2D
AIThe SynGAP1 missense variant V1195E is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, and FATHMM, while those that predict a pathogenic outcome are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely benign classification. AlphaMissense‑Optimized yields an uncertain result, and Foldetta (a protein‑folding stability method combining FoldX‑MD and Rosetta outputs) has no available prediction for this variant. Overall, the balance of evidence leans toward a benign impact, with no conflict with ClinVar status (which has no entry). Thus, the variant is most likely benign based on current computational predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignCoiled-coil0.604312Disordered0.434133Uncertain0.8420.6030.250-1.722Likely Benign0.946Likely PathogenicAmbiguous0.499Likely Benign-2.19Neutral1.000Probably Damaging0.998Probably Damaging5.64Benign0.02Affected0.08700.1268-2-2-7.729.98
c.3806T>A
V1269E
2D
AIThe SynGAP1 missense change V1269E is listed in ClinVar with an “Uncertain” status and is not reported in gnomAD. Prediction tools that flag the variant as benign include only REVEL, whereas the remaining predictors—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently classify it as pathogenic. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also reports a “Likely Pathogenic” outcome. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic and the SGM‑Consensus as likely pathogenic; the Foldetta stability analysis is unavailable. Overall, the preponderance of evidence points to a pathogenic effect, which does not contradict the ClinVar designation of uncertainty.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.433034Structured0.787464Binding0.8430.6470.125Uncertain 1-11.418Likely Pathogenic0.989Likely PathogenicLikely Pathogenic0.403Likely Benign-5.05Deleterious0.999Probably Damaging0.995Probably Damaging2.09Pathogenic0.00Affected3.7750.08990.1557-2-2-7.729.98
c.3926T>A
V1309E
2D
AIThe SynGAP1 missense variant V1309E is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and FATHMM. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments show AlphaMissense‑Optimized as Benign and the SGM‑Consensus as Likely Benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict any ClinVar annotation because no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.712013Disordered0.948596Binding0.4020.9070.750-3.393Likely Benign0.333Likely BenignLikely Benign0.294Likely Benign-2.40Neutral0.767Possibly Damaging0.473Possibly Damaging2.40Pathogenic0.00Affected0.10980.1727-2-2-7.729.98
c.626T>A
V209E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V209E is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include REVEL and FATHMM, whereas the remaining 13 tools (FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM Consensus) all predict a pathogenic outcome. High‑accuracy methods further support a deleterious impact: AlphaMissense‑Optimized is pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is pathogenic, and Foldetta (combining FoldX‑MD and Rosetta) is pathogenic. No prediction or stability result is missing or inconclusive. Based on the overwhelming majority of pathogenic predictions, V209E is most likely pathogenic, and this assessment does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.247041Structured0.397624Uncertain0.8740.3310.125-14.366Likely Pathogenic0.997Likely PathogenicLikely Pathogenic3.53Destabilizing1.32.35Destabilizing2.94Destabilizing1.52Destabilizing0.403Likely Benign-4.54Deleterious0.995Probably Damaging0.829Possibly Damaging3.65Benign0.00Affected0.08260.1652-2-2-7.729.98
c.665T>A
V222E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V222E is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools largely agree on a deleterious effect: pathogenic calls come from REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Only FATHMM predicts a benign outcome. High‑accuracy assessments reinforce the pathogenic prediction: AlphaMissense‑Optimized is pathogenic, the SGM‑Consensus is likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. No predictions are missing or inconclusive. Based on the overwhelming consensus of pathogenic predictions, the variant is most likely pathogenic, and this conclusion is consistent with the lack of ClinVar reporting (i.e., no contradictory evidence).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.116183Structured0.402706Uncertain0.8850.3100.125-18.017Likely Pathogenic0.999Likely PathogenicLikely Pathogenic4.04Destabilizing0.23.46Destabilizing3.75Destabilizing1.64Destabilizing0.960Likely Pathogenic-5.20Deleterious0.998Probably Damaging0.987Probably Damaging5.20Benign0.00Affected0.08330.1495-2-2-7.729.98
c.71T>A
V24E
2D
AIThe SynGAP1 missense variant V24E is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, and AlphaMissense‑Optimized. Only SIFT predicts a pathogenic outcome, while AlphaMissense‑Default remains uncertain. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized predicts Benign, the SGM‑Consensus also indicates Likely Benign, and Foldetta results are unavailable. Based on the collective evidence, the variant is most likely benign, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.541878Disordered0.438970Uncertain0.3820.8900.500-3.397Likely Benign0.517AmbiguousLikely Benign0.171Likely Benign-1.73Neutral0.198Benign0.074Benign3.77Benign0.00Affected0.11330.2415-2-2-7.729.98
c.749T>A
V250E
2D
3DClick to see structure in 3D Viewer
AISynGAP1 variant V250E is not reported in ClinVar and is absent from gnomAD. Prediction tools largely agree on a deleterious effect: benign predictions are limited to FATHMM, whereas the remaining 12 tools (SGM‑Consensus, REVEL, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) all classify the change as pathogenic. The high‑accuracy methods reinforce this view: AlphaMissense‑Optimized predicts pathogenicity, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) reports likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also indicates pathogenic. No prediction or stability result is inconclusive. Consequently, the variant is most likely pathogenic, and this assessment is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.447574Structured0.244075Uncertain0.7780.3240.125-15.723Likely Pathogenic0.983Likely PathogenicLikely Pathogenic1.85Ambiguous0.13.34Destabilizing2.60Destabilizing2.01Destabilizing0.906Likely Pathogenic-5.13Deleterious0.997Probably Damaging0.916Probably Damaging5.74Benign0.00Affected0.07870.1564-2-2-7.729.98
c.779T>A
V260E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V260E is not reported in ClinVar and has no entries in gnomAD. Prediction tools that indicate a benign effect include FoldX, Rosetta, Foldetta, SIFT, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect comprise SGM‑Consensus, REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as benign, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) labeling it likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicting a benign impact on protein stability. Overall, the majority of computational evidence points toward a pathogenic interpretation, and this conclusion is not contradicted by the ClinVar status. Thus, the variant is most likely pathogenic, and this conclusion is not contradicted by the ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.254060Structured0.382651Uncertain0.8880.2590.250-9.516Likely Pathogenic0.667Likely PathogenicLikely Benign-0.02Likely Benign0.10.32Likely Benign0.15Likely Benign1.10Destabilizing0.848Likely Pathogenic-3.66Deleterious0.999Probably Damaging0.991Probably Damaging5.79Benign0.09Tolerated0.08460.1636-2-2-7.729.98
c.788T>A
V263E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 V263E missense variant is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools largely agree on a deleterious effect: FATHMM predicts the variant as benign, while the remaining twelve tools—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default—classify it as pathogenic. AlphaMissense‑Optimized is uncertain. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized remains uncertain, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates “Likely Pathogenic,” and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts a destabilizing, pathogenic effect. Overall, the preponderance of evidence points to a pathogenic impact for V263E, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.268042Structured0.356141Uncertain0.9180.2570.000-13.498Likely Pathogenic0.809Likely PathogenicAmbiguous2.04Destabilizing0.32.18Destabilizing2.11Destabilizing1.99Destabilizing0.862Likely Pathogenic-3.84Deleterious0.999Probably Damaging0.991Probably Damaging5.96Benign0.01Affected0.08860.1436-2-2-7.729.98
c.917T>A
V306D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V306D is listed in ClinVar with an “Uncertain” status and is not reported in gnomAD. All available in‑silico predictors that were evaluated return a pathogenic or likely‑pathogenic assessment: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool in the dataset predicts a benign effect. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is “Likely Pathogenic”; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, is pathogenic. Based on the unanimous pathogenic predictions, the variant is most likely pathogenic, and this conclusion does not contradict the current ClinVar status of uncertainty.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.363090Structured0.315026Uncertain0.8960.2870.125Uncertain 1-18.289Likely Pathogenic0.986Likely PathogenicLikely Pathogenic4.40Destabilizing0.34.29Destabilizing4.35Destabilizing2.44Destabilizing0.530Likely Pathogenic-5.44Deleterious1.000Probably Damaging0.999Probably Damaging1.74Pathogenic0.00Affected3.38190.13170.0768-2-3-7.715.96212.3-18.3-0.20.40.00.2XXXPotentially PathogenicThe isopropyl group of Val396, located at the beginning of an anti-parallel β sheet strand (res. Thr305-Asn315), packs against multiple hydrophobic residues (e.g., Leu274, Trp308, Ala271) in the WT simulations. However, in the variant simulations, the negatively charged carboxylate group of the Asp306 side chain is not suitable for this hydrophobic niche. Consequently, the side chain moves out to interact with Ser300 in the β strand (res. Met289-Arg299) and the guanidinium group of Arg299 in the β hairpin loop.In the third simulation, the residue swap disrupts the C2 domain secondary structure and tertiary assembly to a large degree when the amino group of the Lys297 side chain rotates to form a salt bridge with Asp306. This drastic effect could potentially reflect the challenge presented by the residue swap during the C2 domain folding. Because the residue swap affects the C2 domain structure, the SynGAP-membrane association could also be impacted. However, this is beyond the scope of the solvent-only simulations to unravel.
c.959T>A
V320D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V320D is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions from REVEL and SIFT; pathogenic predictions from premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score (Likely Pathogenic). Stability‑based methods FoldX and Rosetta returned uncertain results, and Foldetta, which integrates FoldX‑MD and Rosetta outputs, also yielded an uncertain prediction. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus as Likely Pathogenic, and Foldetta as uncertain. Overall, the majority of evidence points toward a pathogenic effect, which is consistent with the lack of ClinVar annotation and gnomAD absence. Thus, the variant is most likely pathogenic, and this prediction does not contradict ClinVar status because ClinVar has no entry for it.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.185198Structured0.419626Uncertain0.9050.2660.125-11.269Likely Pathogenic0.996Likely PathogenicLikely Pathogenic1.99Ambiguous1.01.67Ambiguous1.83Ambiguous1.50Destabilizing0.405Likely Benign-5.58Deleterious0.999Probably Damaging0.972Probably Damaging1.93Pathogenic0.07Tolerated0.11010.0482-2-3-7.715.96
c.1034T>A
L345Q
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant L345Q is not reported in ClinVar and is absent from gnomAD. Prediction tools cluster into benign (REVEL, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) and pathogenic (premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, FATHMM). FoldX, Rosetta, and Foldetta give uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive, and Foldetta is unavailable. Overall, the majority of predictions lean toward pathogenicity, while the single high‑accuracy tool that is definitive is benign. Thus, the variant is most likely pathogenic based on the collective evidence, and this assessment does not contradict the absence of a ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.260850Structured0.354989Uncertain0.9360.4780.125-6.034Likely Benign0.213Likely BenignLikely Benign1.32Ambiguous0.10.86Ambiguous1.09Ambiguous1.26Destabilizing0.218Likely Benign-3.67Deleterious0.993Probably Damaging0.844Possibly Damaging1.82Pathogenic0.03Affected0.09370.0842-2-2-7.314.97
c.1058T>A
L353Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 L353Q missense variant has no ClinVar entry and is absent from gnomAD. Among in‑silico predictors, only REVEL classifies it as benign, whereas the majority—FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus—label it pathogenic. Predictions marked uncertain include Rosetta, Foldetta, ESM1b, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. Overall, the preponderance of pathogenic predictions outweighs the single benign call, and no ClinVar record contradicts this assessment. Thus, the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.137348Structured0.373584Uncertain0.9260.3150.000-7.074In-Between0.884Likely PathogenicAmbiguous2.38Destabilizing0.21.41Ambiguous1.90Ambiguous2.00Destabilizing0.388Likely Benign-3.56Deleterious0.947Possibly Damaging0.556Possibly Damaging1.30Pathogenic0.01Affected0.10980.1303-2-2-7.314.97
c.1100T>A
L367Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L367Q is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include REVEL, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, AlphaMissense‑Default, AlphaMissense‑Optimized, and ESM1b. Tools that predict a pathogenic effect are SIFT and FATHMM. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as “Likely Benign.” High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM‑Consensus also as benign, while Foldetta (combining FoldX‑MD and Rosetta outputs) yields an uncertain result. Overall, the majority of evidence points to a benign impact. This conclusion is consistent with the lack of ClinVar annotation; there is no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.370445Structured0.441805Uncertain0.7900.6570.250-3.432Likely Benign0.150Likely BenignLikely Benign1.09Ambiguous0.31.63Ambiguous1.36Ambiguous0.31Likely Benign0.061Likely Benign0.38Neutral0.002Benign0.002Benign1.65Pathogenic0.02Affected0.16150.0973-2-2-7.314.97
c.1205T>A
L402Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L402Q is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect are limited to FATHMM, whereas the remaining 13 tools (SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) uniformly predict a pathogenic impact. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized scores the variant as pathogenic; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, labels it Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also predicts pathogenicity. No prediction or stability result is missing or inconclusive. Consequently, the variant is most likely pathogenic based on the collective computational evidence, and this assessment does not contradict any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.243554Structured0.431978Uncertain0.9610.3830.000-13.403Likely Pathogenic0.996Likely PathogenicLikely Pathogenic2.93Destabilizing0.02.55Destabilizing2.74Destabilizing2.09Destabilizing0.523Likely Pathogenic-4.52Deleterious0.999Probably Damaging0.957Probably Damaging3.69Benign0.00Affected0.13840.1173-2-2-7.314.97
c.1247T>A
L416Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L416Q is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) all predict benign. Only two tools, polyPhen‑2 (HumDiv and HumVar), predict a pathogenic outcome. Stability‑based methods (FoldX, Rosetta, Foldetta, premPS) are inconclusive. High‑accuracy assessments reinforce the benign prediction: AlphaMissense‑Optimized is benign, the SGM‑Consensus is benign, and Foldetta remains uncertain. Overall, the evidence strongly supports a benign classification for this variant, and this conclusion is consistent with the absence of any ClinVar pathogenic annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.104810Structured0.336105Uncertain0.9350.2270.000-6.445Likely Benign0.234Likely BenignLikely Benign1.17Ambiguous0.10.54Ambiguous0.86Ambiguous0.88Ambiguous0.187Likely Benign-1.07Neutral1.000Probably Damaging1.000Probably Damaging3.39Benign0.46Tolerated0.12810.0860-2-2-7.314.97
c.1292T>A
L431Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L431Q resides in the GAP domain. ClinVar has no entry for this variant, and it is not present in gnomAD. Prediction tools that agree on a benign effect are REVEL and FATHMM; all other evaluated algorithms—including FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. No predictions or stability results are missing or inconclusive. Based on the overwhelming agreement among pathogenic predictions and the high‑accuracy tools, the variant is most likely pathogenic; this conclusion is not contradicted by ClinVar status, which is currently absent.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.094817Structured0.374755Uncertain0.9590.3000.000-12.399Likely Pathogenic0.986Likely PathogenicLikely Pathogenic2.69Destabilizing0.02.37Destabilizing2.53Destabilizing1.99Destabilizing0.493Likely Benign-5.40Deleterious1.000Probably Damaging0.992Probably Damaging2.92Benign0.01Affected0.10360.1088-2-2-7.314.97
c.1316T>A
L439Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L439Q is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include only FATHMM, whereas all other evaluated algorithms—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the variant as pathogenic. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. No prediction or folding stability result is missing or inconclusive. Based on the overwhelming consensus of pathogenic predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.222385Structured0.281542Uncertain0.9420.2650.000-11.162Likely Pathogenic0.972Likely PathogenicLikely Pathogenic2.50Destabilizing0.12.06Destabilizing2.28Destabilizing1.35Destabilizing0.575Likely Pathogenic-5.15Deleterious1.000Probably Damaging1.000Probably Damaging3.21Benign0.01Affected0.10650.0488-2-2-7.314.97
c.1352T>A
L451Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L451Q is not reported in ClinVar and is absent from gnomAD. Prediction tools uniformly indicate a deleterious effect: pathogenic predictions are returned by REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a benign outcome. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized classifies the change as pathogenic; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, labels it likely pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also reports a pathogenic effect. Consequently, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.281712Structured0.314017Uncertain0.9780.2320.000-15.426Likely Pathogenic0.998Likely PathogenicLikely Pathogenic2.91Destabilizing0.02.48Destabilizing2.70Destabilizing2.30Destabilizing0.708Likely Pathogenic-5.79Deleterious1.000Probably Damaging1.000Probably Damaging2.43Pathogenic0.00Affected0.08690.0558-2-2-7.314.97
c.1364T>A
L455Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L455Q is not reported in ClinVar (ClinVar status: none) and is absent from gnomAD (gnomAD ID: none). Prediction tools that agree on a benign effect include only FATHMM, whereas all other evaluated algorithms—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic or likely pathogenic impact. High‑accuracy assessments further support this: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts pathogenic. No predictions are missing or inconclusive. Based on the overwhelming agreement among these tools, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation, as none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.188120Structured0.310377Uncertain0.9630.1680.000-13.075Likely Pathogenic0.997Likely PathogenicLikely Pathogenic2.84Destabilizing0.03.42Destabilizing3.13Destabilizing2.24Destabilizing0.655Likely Pathogenic-5.66Deleterious1.000Probably Damaging1.000Probably Damaging3.23Benign0.00Affected0.08710.0958-2-2-7.314.97
c.1499T>A
L500Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L500Q has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect include only AlphaMissense‑Optimized. All other evaluated predictors—SGM‑Consensus, REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default—consistently classify the variant as pathogenic. FoldX, Rosetta, and Foldetta provide uncertain or inconclusive stability results and are treated as unavailable. High‑accuracy assessments further clarify the picture: AlphaMissense‑Optimized (benign) stands alone, whereas the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, predicts pathogenic. Foldetta remains uncertain. Overall, the preponderance of evidence from multiple independent pathogenic predictors indicates that the variant is most likely pathogenic, and this conclusion does not contradict ClinVar status, which currently has no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.066181Structured0.382942Uncertain0.8930.1500.000-13.431Likely Pathogenic0.649Likely PathogenicLikely Benign1.92Ambiguous0.11.78Ambiguous1.85Ambiguous1.49Destabilizing0.878Likely Pathogenic-5.97Deleterious1.000Probably Damaging1.000Probably Damaging-1.35Pathogenic0.00Affected0.09500.0488-2-2-7.314.97
c.1550T>A
L517Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L517Q is not reported in ClinVar and is absent from gnomAD, indicating no known population frequency data. Prediction tools that assess pathogenicity unanimously classify the variant as deleterious: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a benign effect, so the benign group is empty. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. All available evidence points to a pathogenic impact. Thus, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status because the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.118441Structured0.147645Uncertain0.9380.2960.000-11.660Likely Pathogenic0.995Likely PathogenicLikely Pathogenic2.17Destabilizing0.12.07Destabilizing2.12Destabilizing1.87Destabilizing0.946Likely Pathogenic-5.71Deleterious1.000Probably Damaging1.000Probably Damaging-1.50Pathogenic0.00Affected0.10310.0888-2-2-7.314.97
c.1628T>A
L543Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L543Q is not reported in ClinVar (ClinVar status: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that assess pathogenicity all agree on a deleterious effect: SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the variant as pathogenic. No tool predicts a benign outcome. High‑accuracy methods reinforce this consensus: AlphaMissense‑Optimized predicts pathogenicity; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also predicts pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, indicates a destabilizing, pathogenic effect. All available predictions are concordant and supportive. Therefore, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.048328Structured0.020918Uncertain0.9630.3140.000-14.851Likely Pathogenic0.999Likely PathogenicLikely Pathogenic3.03Destabilizing0.23.48Destabilizing3.26Destabilizing2.25Destabilizing0.746Likely Pathogenic-5.97Deleterious1.000Probably Damaging1.000Probably Damaging1.89Pathogenic0.00Affected0.09830.0488-2-2-7.314.97
c.1652T>A
L551Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L551Q is not reported in ClinVar and is present in gnomAD (allele ID 6‑33438895‑T‑A). In silico prediction tools uniformly indicate a deleterious effect: benign‑predicting tools: none; pathogenic‑predicting tools: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. No predictions are inconclusive or missing. **Thus, the variant is most likely pathogenic based on the available predictions, and this conclusion does not contradict the ClinVar status (no entry).**

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.009977Structured0.006653Uncertain0.9600.2540.0006-33438895-T-A16.20e-7-13.632Likely Pathogenic0.990Likely PathogenicLikely Pathogenic2.48Destabilizing0.12.19Destabilizing2.34Destabilizing2.37Destabilizing0.936Likely Pathogenic-3.68Deleterious1.000Probably Damaging1.000Probably Damaging-1.60Pathogenic0.01Affected3.37350.09830.0688-2-2-7.314.97
c.167T>A
L56Q
2D
AIThe SynGAP1 missense variant L56Q is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, and FATHMM. Tools that agree on a pathogenic effect include polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments are mixed: AlphaMissense‑Optimized is uncertain; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (2 pathogenic vs 2 benign), and Foldetta results are unavailable. Overall, the majority of available predictions (5 pathogenic vs 3 benign) indicate a pathogenic impact. There is no ClinVar entry to contradict this assessment, so the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.342579Structured0.476218Uncertain0.4950.6570.000-11.064Likely Pathogenic0.926Likely PathogenicAmbiguous0.293Likely Benign-2.03Neutral0.943Possibly Damaging0.944Probably Damaging3.79Benign0.00Affected0.10830.0842-2-2-7.314.97
c.1694T>A
L565Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L565Q is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include only FATHMM, whereas the remaining tools—SGM‑Consensus, REVEL, FoldX, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic or likely pathogenic impact; Rosetta is uncertain. High‑accuracy methods give the following results: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates likely pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. No prediction or stability result is missing or inconclusive. Based on the overwhelming agreement among pathogenic predictors and the high‑accuracy tools, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.034884Structured0.045819Uncertain0.9220.2050.000-13.912Likely Pathogenic0.996Likely PathogenicLikely Pathogenic2.86Destabilizing0.11.95Ambiguous2.41Destabilizing2.39Destabilizing0.545Likely Pathogenic-5.97Deleterious1.000Probably Damaging1.000Probably Damaging2.76Benign0.00Affected0.11490.0972-2-2-7.314.97
c.1721T>A
L574Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L574Q resides in the GAP domain. ClinVar contains no entry for this variant, and it is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, Foldetta, premPS, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). Tools that predict a pathogenic outcome are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM; Rosetta’s assessment is uncertain. High‑accuracy methods give a consistent benign signal: AlphaMissense‑Optimized predicts benign, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts benign. Based on the preponderance of evidence, the variant is most likely benign, and this assessment does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.083462Structured0.026427Uncertain0.9270.2460.000-3.015Likely Benign0.196Likely BenignLikely Benign0.26Likely Benign0.20.52Ambiguous0.39Likely Benign-0.18Likely Benign0.327Likely Benign2.53Neutral0.998Probably Damaging0.937Probably Damaging-1.17Pathogenic0.65Tolerated0.11070.0888-2-2-7.314.97
c.176T>A
L59Q
2D
AIThe SynGAP1 missense variant L59Q is not reported in ClinVar and is absent from gnomAD. Consensus predictions from multiple in‑silico tools are mixed: benign calls come from SGM‑Consensus (Likely Benign), REVEL, PROVEAN, ESM1b, and FATHMM, whereas pathogenic calls are made by polyPhen‑2 (HumDiv and HumVar), SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments further highlight this discordance: AlphaMissense‑Optimized predicts a pathogenic effect, while the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates a likely benign outcome. No Foldetta stability analysis is available for this residue. Overall, the majority of high‑confidence tools lean toward a pathogenic interpretation, but the presence of several strong benign predictions and the lack of ClinVar evidence suggest uncertainty. The variant is most likely pathogenic based on the prevailing predictions, and this does not contradict any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.212910Structured0.484882Uncertain0.5100.6680.000-3.841Likely Benign0.977Likely PathogenicLikely Pathogenic0.287Likely Benign-2.21Neutral0.943Possibly Damaging0.944Probably Damaging3.26Benign0.00Affected0.11030.0758-2-2-7.314.97
c.1784T>A
L595Q
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant L595Q is listed in ClinVar with an uncertain significance and is not reported in gnomAD. Prediction tools that classify the variant as benign include only FATHMM. All other evaluated algorithms—REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized—predict a pathogenic effect, and the SGM‑Consensus score indicates a likely pathogenic outcome. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized returns a pathogenic prediction, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also yields a likely pathogenic result, while Foldetta’s stability analysis is inconclusive. Overall, the majority of computational evidence points to a pathogenic effect, which does not contradict the ClinVar designation of uncertain significance but suggests a higher likelihood of pathogenicity.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.015344Structured0.128444Uncertain0.9200.1500.000Uncertain 1-15.101Likely Pathogenic0.984Likely PathogenicLikely Pathogenic0.79Ambiguous0.11.40Ambiguous1.10Ambiguous1.99Destabilizing0.733Likely Pathogenic-5.97Deleterious1.000Probably Damaging1.000Probably Damaging2.75Benign0.00Affected3.37350.10740.1563-2-2-7.314.97
c.1898T>A
L633Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L633Q is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include only FATHMM, whereas all other evaluated algorithms—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the variant as pathogenic. High‑accuracy methods further support a deleterious impact: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. No prediction or folding stability result is missing or inconclusive. Based on the overwhelming consensus of pathogenic predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because the variant is not yet catalogued in ClinVar.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.045352Structured0.045407Uncertain0.9520.2520.000-14.303Likely Pathogenic0.993Likely PathogenicLikely Pathogenic2.98Destabilizing0.12.97Destabilizing2.98Destabilizing2.23Destabilizing0.712Likely Pathogenic-5.98Deleterious1.000Probably Damaging1.000Probably Damaging2.69Benign0.00Affected0.13330.0876-2-2-7.314.97
c.1937T>A
L646Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense change L646Q lies in the GAP domain. ClinVar has no entry for this variant, and it is not present in gnomAD. Prediction tools that agree on a benign effect are REVEL, FATHMM, and AlphaMissense‑Optimized. All other evaluated algorithms—FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and the SGM‑Consensus—classify the variant as pathogenic. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized predicts benign, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. Taken together, the overwhelming majority of evidence indicates that the variant is most likely pathogenic, and this conclusion does not contradict the ClinVar status, which is currently unreported.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.048328Structured0.303751Uncertain0.9410.3440.000-12.735Likely Pathogenic0.752Likely PathogenicLikely Benign3.23Destabilizing0.13.04Destabilizing3.14Destabilizing2.12Destabilizing0.462Likely Benign-2.78Deleterious0.994Probably Damaging0.790Possibly Damaging3.17Benign0.00Affected0.20900.1963-2-2-7.314.97
c.1958T>A
L653Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L653Q is not reported in ClinVar and is absent from gnomAD. Prediction tools that assess pathogenicity largely agree: SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (both HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict a deleterious effect. Only FATHMM predicts a benign outcome. High‑accuracy methods reinforce the pathogenic signal: AlphaMissense‑Optimized is pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta) is pathogenic. No predictions are missing or inconclusive. Based on the consensus of these tools, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.049374Structured0.335213Uncertain0.9630.3320.000-14.347Likely Pathogenic0.993Likely PathogenicLikely Pathogenic2.71Destabilizing0.13.26Destabilizing2.99Destabilizing1.98Destabilizing0.614Likely Pathogenic-5.65Deleterious1.000Probably Damaging0.993Probably Damaging3.09Benign0.01Affected0.11950.1363-2-2-7.314.97
c.1964T>A
L655Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L655Q is listed in ClinVar with an uncertain significance and is not reported in gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, FoldX, Foldetta, premPS, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) all indicate benign or likely benign. Only the two polyPhen‑2 implementations (HumDiv and HumVar) predict pathogenicity, while Rosetta remains inconclusive. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized scores benign, the SGM‑Consensus is likely benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts benign stability. Overall, the majority of evidence supports a benign impact for L655Q, which does not contradict the ClinVar uncertain status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.015344Structured0.268808Uncertain0.9610.2740.000Uncertain 1-5.278Likely Benign0.144Likely BenignLikely Benign-0.01Likely Benign0.00.69Ambiguous0.34Likely Benign-0.15Likely Benign0.139Likely Benign0.61Neutral0.955Possibly Damaging0.602Possibly Damaging3.59Benign0.65Tolerated3.39240.12480.0972-2-2-7.314.97229.9-8.60.00.00.40.0XPotentially BenignThe iso-butyl side chain of Leu655, located on the surface of an α helix (res. Ser641-Glu666), is not involved in any interactions in the WT simulations. In the variant simulations, the carboxamide side chain of Gln655 dynamically interacts with neighboring residues (e.g., Glu651, Glu656, Arg544) on the protein surface, with no negative structural effects.
c.2009T>A
L670Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L670Q is not reported in ClinVar and has no entry in gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b. Predictions that are inconclusive (FoldX, Rosetta, Foldetta, premPS) are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM‑Consensus also as Likely Benign, while Foldetta remains uncertain. Overall, the majority of available evidence points to a benign impact. This conclusion is not contradicted by ClinVar, which contains no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.161087Structured0.090855Uncertain0.8120.3850.000-8.217Likely Pathogenic0.306Likely BenignLikely Benign1.02Ambiguous0.11.21Ambiguous1.12Ambiguous0.96Ambiguous0.152Likely Benign-1.12Neutral1.000Probably Damaging0.988Probably Damaging3.40Benign0.36Tolerated0.10880.1303-2-2-7.314.97
c.200T>A
L67Q
2D
AIThe SynGAP1 missense variant L67Q is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as Likely Benign; Foldetta results are not available. Overall, the majority of evidence points to a benign impact. This conclusion is consistent with the lack of ClinVar annotation, so there is no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.458154Structured0.473668Uncertain0.4280.7610.125-3.948Likely Benign0.687Likely PathogenicLikely Benign0.115Likely Benign-0.66Neutral0.943Possibly Damaging0.766Possibly Damaging4.10Benign0.00Affected0.08610.0719-2-2-7.314.97
c.2018T>A
L673Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L673Q is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FATHMM, and AlphaMissense‑Optimized. Tools that agree on a pathogenic effect include Rosetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and ESM1b. FoldX and Foldetta, as well as AlphaMissense‑Default, are inconclusive and are treated as unavailable evidence. High‑accuracy assessments show AlphaMissense‑Optimized predicting benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts pathogenic. Foldetta remains uncertain. Overall, the majority of available predictions (seven pathogenic vs. three benign) indicate that the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation because no ClinVar claim exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.060549Structured0.104692Uncertain0.5450.3690.000-11.963Likely Pathogenic0.445AmbiguousLikely Benign1.56Ambiguous0.22.32Destabilizing1.94Ambiguous1.02Destabilizing0.190Likely Benign-3.40Deleterious1.000Probably Damaging0.968Probably Damaging3.32Benign0.03Affected0.10450.1172-2-2-7.314.97
c.203T>A
L68Q
2D
AIThe SynGAP1 missense variant L68Q is listed in gnomAD (6‑33425811‑T‑A) but has no ClinVar entry. Functional prediction tools cluster into two groups: benign predictions from REVEL, PROVEAN, ESM1b, and FATHMM; pathogenic predictions from polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely benign outcome, reflecting the majority of benign calls. High‑accuracy assessments are limited: AlphaMissense‑Optimized is uncertain, and Foldetta results are not available. Based on the available evidence, the variant is most likely benign, and this assessment does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.534167Disordered0.470567Uncertain0.4050.7680.2506-33425811-T-A53.10e-6-3.436Likely Benign0.826Likely PathogenicAmbiguous0.119Likely Benign-0.14Neutral0.943Possibly Damaging0.766Possibly Damaging4.15Benign0.00Affected4.3210.08640.0919-2-2-7.314.97
c.2075T>A
L692Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L692Q is listed in ClinVar as Pathogenic (ClinVar ID 2714634.0) and is not reported in gnomAD. Prediction tools that classify the variant as benign include only FATHMM. All other evaluated algorithms—REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—predict a pathogenic effect. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, is pathogenic. No prediction or stability result is missing or inconclusive. Based on the consensus of these tools, the variant is most likely pathogenic, and this conclusion aligns with its ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.064632Structured0.295225Uncertain0.9660.2430.000Pathogenic 1-13.873Likely Pathogenic0.998Likely PathogenicLikely Pathogenic3.24Destabilizing0.13.27Destabilizing3.26Destabilizing2.76Destabilizing0.596Likely Pathogenic-5.98Deleterious1.000Probably Damaging0.998Probably Damaging3.06Benign0.00Affected3.42170.10790.0488-2-2-7.314.97
c.2084T>A
L695Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L695Q is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic impact comprise REVEL, Rosetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, AlphaMissense‑Default, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). FoldX and Foldetta provide uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM‑Consensus, derived from a majority of high‑confidence predictors, indicates pathogenicity; Foldetta remains inconclusive. Overall, the majority of reliable tools predict a pathogenic effect, and this is consistent with the lack of ClinVar annotation (no contradiction). Thus, the variant is most likely pathogenic based on current computational predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.118441Structured0.373419Uncertain0.9420.2580.000-12.192Likely Pathogenic0.706Likely PathogenicLikely Benign1.88Ambiguous0.12.03Destabilizing1.96Ambiguous1.71Destabilizing0.554Likely Pathogenic-5.92Deleterious1.000Probably Damaging0.993Probably Damaging3.17Benign0.08Tolerated0.08690.0688-2-2-7.314.97
c.2099T>A
L700Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L700Q is not reported in ClinVar and has no entry in gnomAD. Prediction tools that agree on a benign effect include REVEL, FATHMM, and AlphaMissense‑Optimized. All other evaluated tools—SGM‑Consensus, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default—predict a pathogenic impact. High‑accuracy methods give a mixed picture: AlphaMissense‑Optimized indicates a benign change, whereas the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) and Foldetta (combining FoldX‑MD and Rosetta outputs) both predict pathogenicity. No predictions are missing or inconclusive. Overall, the preponderance of evidence from the majority of tools points to a pathogenic effect, and this assessment does not contradict any ClinVar status because none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.113710Structured0.416255Uncertain0.9270.3310.000-10.522Likely Pathogenic0.783Likely PathogenicLikely Benign2.41Destabilizing0.14.02Destabilizing3.22Destabilizing1.35Destabilizing0.321Likely Benign-3.79Deleterious0.994Probably Damaging0.896Possibly Damaging3.34Benign0.01Affected0.10740.0488-2-2-7.314.97
c.2126T>A
L709Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L709Q is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote) all indicate benign or likely benign. Only two tools, polyPhen‑2 HumDiv and HumVar, predict a pathogenic outcome. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized scores benign, the SGM‑Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts benign stability. Thus, the variant is most likely benign, and this conclusion is consistent with the absence of a ClinVar pathogenic classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.243554Structured0.365830Uncertain0.9340.3790.000-5.758Likely Benign0.179Likely BenignLikely Benign0.13Likely Benign0.00.40Likely Benign0.27Likely Benign0.18Likely Benign0.033Likely Benign-0.78Neutral0.998Probably Damaging0.923Probably Damaging3.52Benign0.48Tolerated0.08380.0488-2-2-7.314.97
c.2132T>A
L711Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L711Q is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect are REVEL and FATHMM. Tools that predict a pathogenic effect include FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, SGM Consensus, and Foldetta; Rosetta is uncertain. High‑accuracy methods give a consistent pathogenic signal: AlphaMissense‑Optimized predicts Pathogenic, SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts Pathogenic. No predictions are missing or inconclusive. Based on the preponderance of pathogenic predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.308712Structured0.377436Uncertain0.9500.3640.000-11.792Likely Pathogenic0.994Likely PathogenicLikely Pathogenic2.93Destabilizing0.01.68Ambiguous2.31Destabilizing1.63Destabilizing0.388Likely Benign-5.67Deleterious1.000Probably Damaging1.000Probably Damaging3.31Benign0.00Affected0.10410.0488-2-2-7.314.97
c.2141T>A
L714Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L714Q is not reported in ClinVar (ClinVar: not reported) and is absent from gnomAD (gnomAD: not found). Prediction tools that agree on a benign effect are REVEL and FATHMM. All other evaluated tools—including FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—predict a pathogenic impact. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. No predictions are missing or inconclusive. Overall, the preponderance of evidence indicates that the variant is most likely pathogenic, and this conclusion is not contradicted by the current ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.314870Structured0.402311Uncertain0.9610.3690.000-12.145Likely Pathogenic0.999Likely PathogenicLikely Pathogenic2.91Destabilizing0.05.23Destabilizing4.07Destabilizing2.13Destabilizing0.378Likely Benign-5.56Deleterious1.000Probably Damaging1.000Probably Damaging3.11Benign0.00Affected0.10960.0558-2-2-7.314.97
c.2174T>A
L725Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L725Q is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect are limited to REVEL, which scores the variant as benign. The majority of tools predict a pathogenic impact: premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, Rosetta, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Uncertain or inconclusive results come from FoldX, Foldetta, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as likely pathogenic, and Foldetta as uncertain. Taken together, the preponderance of evidence indicates that the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation because none exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.557691Disordered0.455613Uncertain0.9110.4910.625-13.952Likely Pathogenic0.888Likely PathogenicAmbiguous1.55Ambiguous0.12.09Destabilizing1.82Ambiguous1.88Destabilizing0.319Likely Benign-5.43Deleterious1.000Probably Damaging1.000Probably Damaging1.28Pathogenic0.00Affected0.11980.1203-2-2-7.314.97
c.2243T>A
L748Q
2D
AIThe SynGAP1 missense variant L748Q is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (which is “Likely Benign”). In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT all predict a pathogenic impact. High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates a likely benign outcome. No Foldetta stability result is available, so it does not influence the assessment. Overall, the majority of evidence points to a benign effect for L748Q, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.703578Disordered0.611637Binding0.3390.8630.750-3.177Likely Benign0.119Likely BenignLikely Benign0.060Likely Benign-0.46Neutral0.912Possibly Damaging0.611Possibly Damaging2.74Benign0.01Affected0.12350.1246-2-2-7.314.97
c.2414T>A
L805Q
2D
AIThe SynGAP1 missense variant L805Q is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools cluster into two groups: benign predictions come from REVEL, ESM1b, and AlphaMissense‑Optimized, while pathogenic predictions arise from PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM. AlphaMissense‑Default remains uncertain. High‑accuracy assessments further clarify the picture: AlphaMissense‑Optimized predicts a benign effect, whereas the SGM Consensus—derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—leans pathogenic (2 pathogenic vs. 1 benign, 1 uncertain). Foldetta, a protein‑folding stability method, has no available result for this variant. Overall, the balance of evidence (five pathogenic vs. three benign predictions, with a pathogenic SGM Consensus) indicates that the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
SH3-binding motif0.775545Disordered0.827669Binding0.3410.9030.625-6.244Likely Benign0.427AmbiguousLikely Benign0.152Likely Benign-2.66Deleterious0.927Possibly Damaging0.690Possibly Damaging2.37Pathogenic0.00Affected0.12150.1265-2-2-7.314.97
c.242T>A
L81Q
2D
AIThe SynGAP1 missense variant L81Q is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumVar, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and SIFT. AlphaMissense‑Default is uncertain. The high‑accuracy consensus from SGM (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) classifies the variant as Likely Benign, and AlphaMissense‑Optimized also predicts Benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of evidence points to a benign impact, and this assessment does not contradict any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.632174Disordered0.502033Binding0.2910.8780.250-5.055Likely Benign0.517AmbiguousLikely Benign0.052Likely Benign-1.22Neutral0.919Possibly Damaging0.226Benign3.93Benign0.00Affected0.10460.0888-2-2-7.314.97
c.2438T>A
L813Q
2D
AIThe SynGAP1 missense variant L813Q is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized, while polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default predict a pathogenic outcome. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments show AlphaMissense‑Optimized as Benign and the SGM‑Consensus as Likely Benign; Foldetta results are unavailable. Overall, the balance of evidence points to a benign impact for the variant, and this conclusion does not contradict any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignSH3-binding motif0.411940Structured0.838481Binding0.2920.9050.250-5.380Likely Benign0.660Likely PathogenicLikely Benign0.137Likely Benign-1.30Neutral0.999Probably Damaging0.985Probably Damaging2.67Benign0.10Tolerated0.11220.1105-2-2-7.314.97
c.245T>A
L82Q
2D
AIThe SynGAP1 missense variant L82Q is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumVar, and FATHMM, while those that predict a pathogenic effect are polyPhen‑2 HumDiv, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized; ESM1b remains uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, whereas the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields a benign prediction. Foldetta results are unavailable. Overall, the majority of conventional tools lean toward benign, and the SGM Consensus supports this, but the AlphaMissense‑Optimized prediction introduces a pathogenic signal. Consequently, the variant is most likely benign based on the prevailing evidence, and this assessment does not contradict any ClinVar status because no ClinVar claim exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.637480Disordered0.517720Binding0.2840.8900.375-7.576In-Between0.987Likely PathogenicLikely Pathogenic0.079Likely Benign-2.16Neutral0.939Possibly Damaging0.114Benign3.71Benign0.00Affected0.11500.0790-2-2-7.314.97
c.2504T>A
L835Q
2D
AIThe SynGAP1 missense variant L835Q is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (which is “Likely Benign”). In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT all predict a pathogenic impact. High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates a likely benign effect. Foldetta results are not available, so they do not influence the overall assessment. Based on the majority of predictions, the variant is most likely benign, and this conclusion does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.608892Disordered0.642742Binding0.3190.8630.125-4.788Likely Benign0.162Likely BenignLikely Benign0.093Likely Benign-0.84Neutral0.996Probably Damaging0.967Probably Damaging2.70Benign0.02Affected0.10330.1162-2-2-7.314.97
c.2531T>A
L844Q
2D
AIThe SynGAP1 missense variant L844Q is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, and FATHMM, while those that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments show AlphaMissense‑Optimized as Uncertain, SGM‑Consensus as Likely Benign, and Foldetta results are unavailable. Overall, the balance of evidence leans toward a benign interpretation, with no conflict with ClinVar status because no ClinVar assertion exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.595080Disordered0.611301Binding0.3040.8350.375-3.989Likely Benign0.856Likely PathogenicAmbiguous0.172Likely Benign-2.17Neutral0.960Probably Damaging0.827Possibly Damaging2.60Benign0.01Affected0.11460.1105-2-2-7.314.97
c.2588T>A
L863Q
2D
AIThe SynGAP1 missense variant L863Q is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict benign, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates a likely benign outcome. In contrast, polyPhen‑2 (both HumDiv and HumVar models) predict a pathogenic effect. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized is benign, and the SGM‑Consensus is likely benign; Foldetta results are not available. Overall, the preponderance of evidence from multiple independent predictors points to a benign classification for L863Q, and this conclusion does not contradict any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.525368Disordered0.594839Binding0.2670.7950.250-6.334Likely Benign0.279Likely BenignLikely Benign0.135Likely Benign-0.68Neutral0.999Probably Damaging0.977Probably Damaging4.02Benign0.23Tolerated0.11000.1305-2-2-7.314.97
c.2606T>A
L869Q
2D
AIThe SynGAP1 missense variant L869Q is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and polyPhen‑2 HumVar. AlphaMissense‑Default remains uncertain, while the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates a likely benign outcome. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; Foldetta results are unavailable. Based on the collective predictions, the variant is most likely benign, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.501700Disordered0.688653Binding0.2720.8390.250-2.925Likely Benign0.368AmbiguousLikely Benign0.160Likely Benign-0.57Neutral0.970Probably Damaging0.801Possibly Damaging2.60Benign0.06Tolerated0.09770.1203-2-2-7.314.97
c.2609T>A
L870Q
2D
AIThe SynGAP1 missense variant L870Q is not reported in ClinVar and is absent from gnomAD. Consensus predictions from multiple in‑silico tools cluster into two groups: benign predictions include REVEL, PROVEAN, ESM1b, FATHMM, and AlphaMissense‑Optimized, while pathogenic predictions come from polyPhen‑2 (HumDiv and HumVar) and SIFT. AlphaMissense‑Default remains uncertain. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, indicates a likely benign effect. High‑accuracy assessments further support this view: AlphaMissense‑Optimized classifies the variant as benign, and the SGM‑Consensus itself is labeled likely benign. No output is available from the Foldetta stability analysis, so it does not influence the overall assessment. Based on the aggregate predictions, the variant is most likely benign, and this conclusion does not contradict the ClinVar status, which contains no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.483068Structured0.688079Binding0.2740.8500.125-4.029Likely Benign0.417AmbiguousLikely Benign0.185Likely Benign-1.90Neutral0.999Probably Damaging0.999Probably Damaging2.63Benign0.02Affected0.10270.1003-2-2-7.314.97
c.2630T>A
L877Q
2D
AIThe SynGAP1 missense variant L877Q is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, and AlphaMissense‑Optimized, while polyPhen‑2 (HumDiv and HumVar) and SIFT uniformly predict a pathogenic impact. AlphaMissense‑Default remains uncertain. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized predicts benign, SGM‑Consensus is Likely Benign, and Foldetta (which integrates FoldX‑MD and Rosetta outputs) is not available for this variant. Based on the collective evidence, the variant is most likely benign, and this assessment does not contradict any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.653063Disordered0.634010Binding0.2650.8750.250-5.919Likely Benign0.460AmbiguousLikely Benign0.152Likely Benign-1.58Neutral0.986Probably Damaging0.876Possibly Damaging2.57Benign0.03Affected0.12080.0919-2-2-7.314.97
c.2648T>A
L883Q
2D
AIThe SynGAP1 missense variant L883Q is reported in gnomAD (6‑33443200‑T‑A) but has no ClinVar entry. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict benign. Only the two polyPhen‑2 implementations (HumDiv and HumVar) predict pathogenicity. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely benign classification. High‑accuracy assessments reinforce this: AlphaMissense‑Optimized is benign, and the SGM‑Consensus is likely benign; Foldetta results are not available. Overall, the majority of evidence points to a benign impact. The variant is therefore most likely benign, and this conclusion does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.716283Disordered0.641952Binding0.3340.8860.2506-33443200-T-A31.86e-6-3.559Likely Benign0.123Likely BenignLikely Benign0.129Likely Benign-0.51Neutral0.934Possibly Damaging0.637Possibly Damaging2.66Benign0.11Tolerated4.3240.11190.1505-2-2-7.314.97
c.2762T>A
L921Q
2D
AIThe SynGAP1 missense variant L921Q is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include SGM‑Consensus (Likely Benign), REVEL, PROVEAN, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and FATHMM. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also as benign; Foldetta results are unavailable. Overall, the majority of predictions (six benign vs. four pathogenic) lean toward a benign interpretation. Thus, the variant is most likely benign, and this conclusion does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.608892Disordered0.943282Binding0.3110.8450.375-2.389Likely Benign0.311Likely BenignLikely Benign0.132Likely Benign-0.62Neutral0.994Probably Damaging0.940Probably Damaging2.41Pathogenic0.00Affected0.10970.1119-2-2-7.314.97
c.3083T>A
L1028Q
2D
AIThe SynGAP1 missense variant L1028Q is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely benign classification. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; Foldetta results are not available. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict any ClinVar annotation because no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.899122Disordered0.995137Binding0.3640.7300.500-2.718Likely Benign0.612Likely PathogenicLikely Benign0.179Likely Benign-0.19Neutral0.986Probably Damaging0.825Possibly Damaging2.80Benign0.38Tolerated0.11100.1403-2-2-7.314.97
c.3095T>A
L1032Q
2D
AIThe SynGAP1 missense variant L1032Q is not reported in ClinVar and has no entry in gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, PROVEAN, ESM1b, FATHMM, and AlphaMissense‑Optimized, while pathogenic predictions arise from polyPhen‑2 (HumDiv and HumVar) and SIFT. AlphaMissense‑Default remains uncertain. The high‑accuracy consensus, SGM‑Consensus, classifies the variant as Likely Benign, and AlphaMissense‑Optimized also predicts Benign. Foldetta, a protein‑folding stability method that integrates FoldX‑MD and Rosetta outputs, has no available result for this variant. Based on the aggregate evidence, the variant is most likely benign, and this assessment does not contradict any ClinVar status (none is assigned).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.865454Disordered0.995318Binding0.3650.7350.500-2.992Likely Benign0.467AmbiguousLikely Benign0.134Likely Benign-0.78Neutral0.995Probably Damaging0.892Possibly Damaging2.66Benign0.03Affected0.12170.1677-2-2-7.314.97
c.3272T>A
L1091Q
2D
AIThe SynGAP1 missense variant L1091Q is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, and ESM1b, whereas those that agree on a pathogenic effect are polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Default. High‑accuracy assessments are less definitive: AlphaMissense‑Optimized is uncertain; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (2 pathogenic vs 2 benign), and Foldetta results are unavailable. Overall, the majority of available predictions (five pathogenic vs three benign) lean toward a pathogenic impact. Thus, the variant is most likely pathogenic based on current computational evidence, and this assessment does not contradict any ClinVar status because the variant has not yet been reported there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.924947Disordered0.984454Binding0.3760.8891.000-4.381Likely Benign0.854Likely PathogenicAmbiguous0.155Likely Benign-1.32Neutral0.997Probably Damaging0.939Probably Damaging2.47Pathogenic0.02Affected0.11920.1514-2-2-7.314.97
c.3386T>A
L1129Q
2D
AIThe SynGAP1 missense variant L1129Q is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote) which classifies the variant as Likely Benign. In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT all predict a pathogenic impact. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized predicts Benign, and the SGM‑Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates Likely Benign. No Foldetta stability analysis is available for this variant. Overall, the majority of computational evidence points to a benign effect, and this conclusion does not contradict any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.903857Disordered0.876543Binding0.3390.9090.875-3.684Likely Benign0.149Likely BenignLikely Benign0.453Likely Benign-1.63Neutral0.846Possibly Damaging0.525Possibly Damaging5.49Benign0.00Affected0.12780.1436-2-2-7.314.97
c.3491T>A
L1164Q
2D
AIThe SynGAP1 missense variant L1164Q has no ClinVar record and is not present in gnomAD. Functional prediction tools cluster into two groups: benign predictions include REVEL, PROVEAN, SIFT, ESM1b, and FATHMM, while pathogenic predictions come from polyPhen‑2 HumDiv, polyPhen‑2 HumVar, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely benign status. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, whereas the SGM‑Consensus remains benign; Foldetta results are unavailable. Overall, the balance of evidence favors a benign interpretation, and this conclusion does not conflict with ClinVar, which contains no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.517562Disordered0.853935Binding0.3250.8150.375-5.374Likely Benign0.990Likely PathogenicLikely Pathogenic0.497Likely Benign-0.95Neutral0.999Probably Damaging0.999Probably Damaging5.32Benign0.18Tolerated0.11710.1181-2-2-7.314.97
c.3575T>A
L1192Q
2D
AIThe SynGAP1 missense variant L1192Q is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized, while polyPhen‑2 (both HumDiv and HumVar) predict a pathogenic outcome. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized predicts Benign, and the SGM‑Consensus also indicates Likely Benign; Foldetta results are unavailable. Overall, the preponderance of evidence from multiple prediction algorithms and consensus methods points to a benign impact for this variant, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignCoiled-coil0.575842Disordered0.441757Uncertain0.7620.6090.625-3.804Likely Benign0.535AmbiguousLikely Benign0.224Likely Benign-1.09Neutral0.992Probably Damaging0.940Probably Damaging2.70Benign0.10Tolerated0.10320.0558-2-2-7.314.97
c.3614T>A
L1205Q
2D
AIThe SynGAP1 missense variant L1205Q is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include only REVEL, whereas the remaining tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also classifies the variant as Likely Pathogenic. High‑accuracy assessments further support this view: AlphaMissense‑Optimized predicts pathogenicity, and the SGM‑Consensus agrees. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the preponderance of evidence indicates that the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.595080Disordered0.552471Binding0.8800.5760.375-14.466Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.453Likely Benign-5.02Deleterious1.000Probably Damaging0.999Probably Damaging1.46Pathogenic0.00Affected0.10320.0558-2-2-7.314.97
c.3626T>A
L1209Q
2D
AIThe SynGAP1 missense variant L1209Q is not listed in ClinVar and has no entry in gnomAD, indicating it is not a common population variant. Functional prediction tools largely agree on a deleterious effect: REVEL predicts a benign outcome, whereas the remaining predictors—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the change as pathogenic. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also reports a likely pathogenic status. High‑accuracy assessments further support this view: AlphaMissense‑Optimized predicts pathogenicity, and the SGM‑Consensus confirms a likely pathogenic classification. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, is not available for this variant. Overall, the preponderance of evidence indicates that the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.595080Disordered0.583711Binding0.8990.5740.375-12.820Likely Pathogenic0.997Likely PathogenicLikely Pathogenic0.379Likely Benign-5.09Deleterious1.000Probably Damaging0.999Probably Damaging1.46Pathogenic0.00Affected0.10420.0558-2-2-7.314.97
c.3647T>A
L1216Q
2D
AIThe SynGAP1 missense variant L1216Q is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include only REVEL, whereas the remaining tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus—predict a pathogenic impact. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates pathogenicity. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic and the SGM‑Consensus as pathogenic; Foldetta results are not available. Based on the collective evidence, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.580690Disordered0.504713Binding0.8630.5630.250-8.731Likely Pathogenic0.990Likely PathogenicLikely Pathogenic0.404Likely Benign-4.12Deleterious1.000Probably Damaging0.999Probably Damaging2.23Pathogenic0.00Affected0.09390.0488-2-2-7.314.97
c.3668T>A
L1223Q
2D
AIThe SynGAP1 missense variant L1223Q is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include only REVEL, which scores the variant as benign. All other evaluated algorithms—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default—predict a pathogenic impact, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) labels it “Likely Pathogenic.” High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as likely pathogenic, and Foldetta results are unavailable. Based on the preponderance of pathogenic predictions and the lack of any benign consensus, the variant is most likely pathogenic; this conclusion is not contradicted by ClinVar status, which is currently unreported.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.608892Disordered0.436267Uncertain0.8680.5400.375-13.700Likely Pathogenic0.934Likely PathogenicAmbiguous0.380Likely Benign-4.13Deleterious1.000Probably Damaging0.986Probably Damaging1.46Pathogenic0.01Affected0.10100.1119-2-2-7.314.97
c.3671T>A
L1224Q
2D
AIThe SynGAP1 missense variant L1224Q is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote) all indicate a benign or likely benign outcome. In contrast, polyPhen‑2 (HumDiv and HumVar) and FATHMM predict a pathogenic impact. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized scores benign, and the SGM‑Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also reports likely benign. No Foldetta stability prediction is available. Overall, the majority of evidence points to a benign effect for L1224Q, and this conclusion is consistent with the absence of a ClinVar pathogenic classification. Thus, the variant is most likely benign, and this is not contradictory to ClinVar.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignCoiled-coil0.525368Disordered0.441554Uncertain0.8710.5430.500-6.254Likely Benign0.100Likely BenignLikely Benign0.125Likely Benign-1.87Neutral0.994Probably Damaging0.900Possibly Damaging2.40Pathogenic0.13Tolerated0.10180.0558-2-2-7.314.97
c.3701T>A
L1234Q
2D
AIThe SynGAP1 missense variant L1234Q is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include only REVEL, which scores the variant as benign. All other evaluated predictors—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default—classify the variant as pathogenic, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also reports it as likely pathogenic. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as likely pathogenic, and Foldetta results are unavailable. Based on the predominance of pathogenic predictions and the lack of supporting benign evidence, the variant is most likely pathogenic; this conclusion is not contradicted by any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.599170Disordered0.575096Binding0.8440.5270.125-12.969Likely Pathogenic0.858Likely PathogenicAmbiguous0.272Likely Benign-4.34Deleterious0.997Probably Damaging0.955Probably Damaging1.46Pathogenic0.01Affected0.09620.1049-2-2-7.314.97
c.3722T>A
L1241Q
2D
AIThe SynGAP1 missense variant L1241Q is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: the single benign prediction comes from REVEL, while all other evaluated algorithms (PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized) predict a pathogenic effect. High‑accuracy assessments further support a deleterious outcome: AlphaMissense‑Optimized classifies the variant as pathogenic, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports it as Likely Pathogenic. No Foldetta stability prediction is available for this variant. Based on the preponderance of pathogenic predictions and the high‑accuracy consensus, the variant is most likely pathogenic, and this conclusion is consistent with the absence of any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.545602Disordered0.488880Uncertain0.8280.5410.375-10.429Likely Pathogenic0.986Likely PathogenicLikely Pathogenic0.386Likely Benign-4.65Deleterious1.000Probably Damaging0.999Probably Damaging1.61Pathogenic0.00Affected0.12170.0488-2-2-7.314.97
c.3743T>A
L1248Q
2D
AIThe SynGAP1 missense variant L1248Q is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL and ESM1b, whereas the remaining tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—predict a pathogenic impact. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates a likely pathogenic outcome. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts pathogenic, and the SGM‑Consensus (majority vote) confirms this prediction; the Foldetta stability analysis is unavailable. Overall, the preponderance of evidence points to a pathogenic effect for this variant, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.834292Disordered0.371716Uncertain0.8800.5620.625-6.471Likely Benign0.981Likely PathogenicLikely Pathogenic0.364Likely Benign-4.65Deleterious1.000Probably Damaging0.999Probably Damaging1.64Pathogenic0.00Affected0.10670.0688-2-2-7.314.97
c.3797T>A
L1266Q
2D
AIThe SynGAP1 missense variant L1266Q is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include only REVEL, which scores the variant as benign. All other evaluated predictors—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN)—classify the variant as pathogenic or likely pathogenic. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized predicts pathogenicity, and the SGM‑Consensus also indicates likely pathogenic. The Foldetta protein‑folding stability analysis is unavailable for this variant. Overall, the preponderance of evidence points to a pathogenic effect for L1266Q, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.433034Structured0.802655Binding0.8680.6020.000-16.101Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.374Likely Benign-5.02Deleterious0.999Probably Damaging0.977Probably Damaging2.12Pathogenic0.00Affected0.09060.1249-2-2-7.314.97
c.3803T>A
L1268Q
2D
AIThe SynGAP1 missense variant L1268Q is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict benign. Only the two PolyPhen‑2 implementations (HumDiv and HumVar) predict a pathogenic outcome. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as “Likely Benign.” High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized is benign, and the SGM‑Consensus also indicates benign. Foldetta results are not available, so they do not influence the assessment. Overall, the preponderance of evidence points to a benign impact for this variant, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignCoiled-coil0.458154Structured0.804315Binding0.8590.6290.000-5.707Likely Benign0.143Likely BenignLikely Benign0.062Likely Benign-0.50Neutral0.990Probably Damaging0.637Possibly Damaging2.68Benign0.08Tolerated0.09880.0558-2-2-7.314.97
c.3818T>A
L1273Q
2D
AIThe SynGAP1 missense variant L1273Q is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL and ESM1b, whereas the majority of tools predict a pathogenic impact: PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic and the SGM‑Consensus is labeled Likely Pathogenic; Foldetta results are unavailable. Based on the preponderance of evidence, the variant is most likely pathogenic, and this conclusion does not contradict any existing ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.599170Disordered0.773625Binding0.7470.6770.500-6.813Likely Benign0.957Likely PathogenicLikely Pathogenic0.423Likely Benign-5.05Deleterious0.997Probably Damaging0.950Probably Damaging2.13Pathogenic0.00Affected0.11390.1119-2-2-7.314.97
c.3851T>A
L1284Q
2D
AIThe SynGAP1 missense variant L1284Q is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include REVEL, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and FATHMM. The SGM Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is inconclusive (two benign vs. two pathogenic votes). Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. High‑accuracy tools specifically show AlphaMissense‑Optimized as benign, while SGM Consensus and Foldetta remain unavailable. Overall, the majority of predictions (five pathogenic vs. four benign) indicate that the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.812494Disordered0.824557Binding0.4410.7480.875-4.730Likely Benign0.094Likely BenignLikely Benign0.138Likely Benign-2.80Deleterious0.990Probably Damaging0.796Possibly Damaging2.48Pathogenic0.01Affected0.10650.0488-2-2-7.314.97
c.3872T>A
L1291Q
2D
AISynGAP1 missense variant L1291Q is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that classify the variant as benign include REVEL, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict pathogenicity are PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM. The SGM Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is equivocal (two benign, two pathogenic votes). Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the computational evidence is split, with an equal number of benign and pathogenic calls and no decisive high‑accuracy consensus. Consequently, the variant’s likely effect remains uncertain; it is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.827927Disordered0.863458Binding0.5790.7970.625-4.450Likely Benign0.207Likely BenignLikely Benign0.290Likely Benign-4.18Deleterious0.990Probably Damaging0.856Possibly Damaging2.49Pathogenic0.01Affected0.10520.1049-2-2-7.314.97
c.3932T>A
L1311Q
2D
AIThe SynGAP1 missense variant L1311Q is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only polyPhen‑2 HumDiv predicts a pathogenic outcome. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as Likely Benign; the Foldetta protein‑folding stability analysis is unavailable. Overall, the preponderance of evidence indicates that the variant is most likely benign, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.816150Disordered0.968153Binding0.3930.9070.750-4.009Likely Benign0.100Likely BenignLikely Benign0.074Likely Benign-0.03Neutral0.579Possibly Damaging0.413Benign2.74Benign0.12Tolerated0.14760.1677-2-2-7.314.97
c.3953T>A
L1318Q
2D
AIThe SynGAP1 missense variant L1318Q is reported in gnomAD (variant ID 6‑33451827‑T‑A) but has no ClinVar entry. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as benign. In contrast, polyPhen‑2 HumDiv and SIFT predict a pathogenic impact. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, yields a “Likely Benign” verdict. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus also indicates benign. No Foldetta stability analysis is available, so it does not influence the conclusion. Overall, the majority of evidence points to a benign effect, and this assessment does not contradict any ClinVar status (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.887230Disordered0.968271Binding0.3990.8650.7506-33451827-T-A16.32e-7-3.445Likely Benign0.120Likely BenignLikely Benign0.077Likely Benign-2.06Neutral0.834Possibly Damaging0.307Benign4.04Benign0.00Affected3.7750.14100.0903-2-2-7.314.97
c.3986T>A
L1329Q
2D
AIThe SynGAP1 missense variant L1329Q is reported in gnomAD (ID 6‑33451860‑T‑A) but has no ClinVar entry. Functional prediction tools cluster into two groups: benign predictions come from REVEL, ESM1b, and FATHMM, whereas pathogenic predictions are made by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive, and Foldetta stability analysis is unavailable. Overall, the majority of evidence points to a deleterious effect, indicating that the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.930790Disordered0.924905Binding0.3360.7480.8756-33451860-T-A-4.106Likely Benign0.956Likely PathogenicLikely Pathogenic0.157Likely Benign-3.31Deleterious0.994Probably Damaging0.993Probably Damaging3.05Benign0.00Affected3.7750.13820.1505-2-2-7.314.97
c.398T>A
L133Q
2D
AIThe SynGAP1 missense variant L133Q is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that indicate a benign effect include REVEL, polyPhen‑2 HumVar, and FATHMM, whereas those that predict a pathogenic effect comprise PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Pathogenic. High‑accuracy assessments show AlphaMissense‑Optimized as Pathogenic and the SGM‑Consensus as Likely Pathogenic; the Foldetta protein‑folding stability analysis is unavailable. Based on the preponderance of pathogenic predictions and the high‑accuracy consensus, the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.422041Structured0.718429Binding0.3200.8960.250-9.054Likely Pathogenic0.985Likely PathogenicLikely Pathogenic0.317Likely Benign-2.65Deleterious0.535Possibly Damaging0.259Benign3.53Benign0.01Affected0.13160.0879-2-2-7.314.97
c.410T>A
L137Q
2D
AIThe SynGAP1 missense variant L137Q is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect are REVEL and FATHMM. All other evaluated algorithms—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN)—predict a pathogenic or likely pathogenic impact. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic, and the SGM‑Consensus is labeled “Likely Pathogenic.” The Foldetta protein‑folding stability analysis is unavailable for this variant. Overall, the majority of evidence points to a pathogenic effect, and this conclusion does not contradict any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.553315Disordered0.639549Binding0.3770.8970.375-12.246Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.356Likely Benign-3.43Deleterious0.998Probably Damaging0.995Probably Damaging3.60Benign0.00Affected0.11370.1049-2-2-7.314.97
c.479T>A
L160Q
2D
AIThe SynGAP1 missense variant L160Q is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL and FATHMM, whereas the majority of tools predict a pathogenic impact: PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic, and the SGM‑Consensus is labeled Likely Pathogenic. The Foldetta protein‑folding stability analysis is unavailable for this variant. Overall, the preponderance of evidence from both general and high‑accuracy predictors indicates that the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status because no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.454136Structured0.526760Binding0.2750.7280.125-16.626Likely Pathogenic0.973Likely PathogenicLikely Pathogenic0.227Likely Benign-2.83Deleterious0.700Possibly Damaging0.483Possibly Damaging3.87Benign0.00Affected0.12480.1060-2-2-7.314.97
c.518T>A
L173Q
2D
AIThe SynGAP1 missense variant L173Q is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and FATHMM. Only AlphaMissense‑Default predicts a pathogenic outcome, while AlphaMissense‑Optimized is uncertain. The SGM‑Consensus, which aggregates the majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the preponderance of evidence from multiple in silico predictors and the SGM‑Consensus indicates that the variant is most likely benign, and this assessment does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.534167Disordered0.491566Uncertain0.3900.6310.375-5.605Likely Benign0.850Likely PathogenicAmbiguous0.133Likely Benign-1.72Neutral0.022Benign0.022Benign3.94Benign0.08Tolerated0.10280.0919-2-2-7.314.97
c.560T>A
L187Q
2D
AIThe SynGAP1 missense variant L187Q is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL and FATHMM, whereas the majority of tools predict a pathogenic impact: PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) all indicate likely pathogenicity. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized classifies the variant as pathogenic, and the SGM‑Consensus also reports it as likely pathogenic. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, was not available for this variant. Overall, the preponderance of evidence from multiple in silico predictors points to a pathogenic effect for the SynGAP1 L187Q variant, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.465241Structured0.428046Uncertain0.3670.6250.375-13.063Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.322Likely Benign-4.31Deleterious0.917Possibly Damaging0.548Possibly Damaging3.72Benign0.00Affected0.12510.1060-2-2-7.314.97
c.641T>A
L214Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense change at residue 214 (Leu→Gln) is not reported in ClinVar and is absent from gnomAD. Across the available in‑silico predictors, the majority (SGM‑Consensus, REVEL, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) predict a pathogenic effect, while only FATHMM predicts a benign outcome. Three tools (FoldX, Rosetta, Foldetta) return uncertain results. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta is uncertain. Taken together, the overwhelming consensus of pathogenic predictions indicates that the variant is most likely pathogenic, with no ClinVar evidence contradicting this assessment.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.155435Structured0.372604Uncertain0.8180.3020.125-10.119Likely Pathogenic0.998Likely PathogenicLikely Pathogenic1.60Ambiguous0.61.71Ambiguous1.66Ambiguous1.73Destabilizing0.912Likely Pathogenic-5.12Deleterious0.997Probably Damaging0.936Probably Damaging5.74Benign0.00Affected0.11400.0930-2-2-7.314.97
c.737T>A
L246Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 L246Q missense variant is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Prediction tools that agree on a benign effect are limited to FATHMM, while the remaining tools—SGM‑Consensus, REVEL, FoldX, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact; Rosetta is uncertain and is not grouped. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. Taken together, the overwhelming majority of evidence indicates that the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status, as none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.472492Structured0.302312Uncertain0.8590.3640.000-15.420Likely Pathogenic1.000Likely PathogenicLikely Pathogenic2.82Destabilizing0.31.79Ambiguous2.31Destabilizing1.69Destabilizing0.921Likely Pathogenic-5.43Deleterious0.997Probably Damaging0.916Probably Damaging4.67Benign0.00Affected0.10920.0758-2-2-7.314.97
c.791T>A
L264Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L264Q is listed in ClinVar with an “Uncertain” status and is not reported in gnomAD. Prediction tools that assess pathogenicity all converge on a deleterious effect: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict pathogenicity. No tool in the dataset predicts a benign outcome. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is “Likely Pathogenic”; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, is pathogenic. Based on the unanimous computational evidence, the variant is most likely pathogenic, a conclusion that contradicts the current ClinVar “Uncertain” classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.185198Structured0.323473Uncertain0.9390.2640.000Uncertain 1-15.729Likely Pathogenic0.999Likely PathogenicLikely Pathogenic3.43Destabilizing0.12.41Destabilizing2.92Destabilizing2.48Destabilizing0.678Likely Pathogenic-5.52Deleterious1.000Probably Damaging0.999Probably Damaging0.49Pathogenic0.00Affected3.38180.09420.0558-2-2-7.314.97254.7-7.60.00.00.00.3XXXPotentially PathogenicThe iso-butyl branched hydrocarbon side chain of Leu264, located at the end of an anti-parallel β sheet strand (res. Arg259-Arg272), packs against multiple hydrophobic residues such as Leu266, Phe314, Leu317, and Leu323 in the WT simulations. In the variant simulations, the hydrophilic carboxamide group of the Gln264 side chain is not suitable for the hydrophobic niche, causing the hydrophobic residues to make room for the swapped residue. Additionally, the carboxamide group of Gln264 forms hydrogen bonds with the backbone amide groups of Arg405 and Lys256 in the β sheet and the carbonyl group of Val350 in an α helical section of a nearby loop (res. Pro359-Phe358). The residue swap disrupts the packing of the C2 domain, which could adversely affect the C2 domain structure during folding. This disruption could potentially weaken the stability of the SynGAP-membrane association.
c.797T>A
L266Q
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant L266Q is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect: none. Tools that agree on a pathogenic effect: REVEL, FoldX, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). The only tool with an uncertain outcome is Rosetta. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts pathogenic; the SGM‑Consensus (majority vote) also predicts pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, predicts pathogenic. Based on the overwhelming agreement among these predictions, the variant is most likely pathogenic, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.232838Structured0.297157Uncertain0.9480.2640.000-16.672Likely Pathogenic0.994Likely PathogenicLikely Pathogenic2.92Destabilizing0.11.49Ambiguous2.21Destabilizing2.21Destabilizing0.563Likely Pathogenic-5.25Deleterious1.000Probably Damaging0.999Probably Damaging1.53Pathogenic0.00Affected0.08150.0558-2-2-7.314.97
c.821T>A
L274Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L274Q is reported in ClinVar with an uncertain significance (ClinVar ID 1810279.0) and is not found in gnomAD. Functional prediction tools uniformly indicate a deleterious effect: REVEL, FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as pathogenic, while Rosetta remains inconclusive. No tool predicts a benign outcome. High‑accuracy assessments corroborate this trend: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, is pathogenic. Consequently, the variant is most likely pathogenic, and this assessment does not contradict the current ClinVar status of uncertain significance.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.066181Structured0.377483Uncertain0.8660.1950.250Uncertain 1-15.518Likely Pathogenic0.995Likely PathogenicLikely Pathogenic2.54Destabilizing0.31.74Ambiguous2.14Destabilizing1.97Destabilizing0.774Likely Pathogenic-5.42Deleterious1.000Probably Damaging0.999Probably Damaging0.00Pathogenic0.00Affected3.38190.11280.0688-2-2-7.314.97245.91.80.00.00.10.2XXXPotentially PathogenicThe aliphatic side chain of Leu274, located in a β hairpin loop (res. Glu273-Lys278) connecting two anti-parallel β sheet strands, packs against multiple hydrophobic residues facing the β sheet (e.g., Ala271, Leu327, Tyr280, Val306). The hydrophilic carboxamide group of the Gln274 side chain is not suitable for this hydrophobic niche, causing nearby residues to adjust to make room for the hydrophilic glutamine. Additionally, a new hydrogen bond forms with the backbone carboxyl group of Arg272 in another β strand (res. Glu273-Arg259).As a result, the backbone amide group of Ala399 and the carbonyl group of Arg272, which connect two β strands at the β sheet end, form fewer hydrogen bonds in the variant than in the WT simulations. Although no major secondary structure disruption is observed in the variant simulations, the residue swap could profoundly affect the C2 domain folding, as the hydrophobic packing of Leu274 is crucial for maintaining the loop's contact with the rest of the C2 domain. Lastly, because the Leu274-containing loop faces the membrane surface, the residue swap could also negatively impact the SynGAP-membrane association.
c.857T>A
L286Q
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant L286Q is not reported in ClinVar and is absent from gnomAD. Prediction tools that assess pathogenicity are unanimous: SGM‑Consensus, REVEL, FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict a deleterious effect. No tool predicts a benign outcome. Two tools, Rosetta and Foldetta, return uncertain results. High‑accuracy methods give the following: AlphaMissense‑Optimized predicts pathogenic; SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely pathogenic; Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, is inconclusive. Overall, the preponderance of evidence indicates that the variant is most likely pathogenic, and this assessment does not contradict the ClinVar status, which simply lacks an entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.122885Structured0.385647Uncertain0.9320.2600.000-13.056Likely Pathogenic0.998Likely PathogenicLikely Pathogenic2.37Destabilizing0.31.42Ambiguous1.90Ambiguous2.06Destabilizing0.852Likely Pathogenic-5.52Deleterious1.000Probably Damaging0.999Probably Damaging1.48Pathogenic0.00Affected0.11230.0958-2-2-7.314.97
c.869T>A
L290Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L290Q is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include only SIFT, whereas the majority of tools predict a pathogenic impact: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (which itself is “Likely Pathogenic”). Uncertain or inconclusive results come from FoldX, Rosetta, Foldetta, and premPS. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic, the SGM‑Consensus is likely pathogenic, and Foldetta’s stability prediction is unavailable. Overall, the preponderance of evidence indicates that the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.127496Structured0.399723Uncertain0.9040.2550.000-12.776Likely Pathogenic0.993Likely PathogenicLikely Pathogenic1.12Ambiguous0.11.38Ambiguous1.25Ambiguous0.68Ambiguous0.697Likely Pathogenic-5.52Deleterious1.000Probably Damaging0.999Probably Damaging1.97Pathogenic0.06Tolerated0.10790.1014-2-2-7.314.97
c.950T>A
L317Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L317Q is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly indicate a deleterious effect. Benign predictions: none. Pathogenic predictions: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. Based on these predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.106997Structured0.394031Uncertain0.8740.2400.125-13.424Likely Pathogenic0.995Likely PathogenicLikely Pathogenic2.87Destabilizing0.22.47Destabilizing2.67Destabilizing1.61Destabilizing0.607Likely Pathogenic-5.52Deleterious1.000Probably Damaging0.999Probably Damaging1.75Pathogenic0.00Affected0.12520.1251-2-2-7.314.97
c.968T>A
L323Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L323Q is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly classify it as pathogenic. Benign predictions are absent; all evaluated algorithms—REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—return pathogenic or likely pathogenic calls. High‑accuracy assessments corroborate this: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also reports pathogenic. Consequently, the variant is most likely pathogenic, with no conflict with ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.268042Structured0.428564Uncertain0.9560.3690.000-14.487Likely Pathogenic0.996Likely PathogenicLikely Pathogenic3.19Destabilizing0.23.28Destabilizing3.24Destabilizing1.85Destabilizing0.728Likely Pathogenic-4.54Deleterious0.999Probably Damaging0.977Probably Damaging0.59Pathogenic0.00Affected0.09150.0758-2-2-7.314.97
c.974T>A
L325Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L325Q is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly classify it as pathogenic. Benign predictions are absent; all evaluated algorithms—REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—return pathogenic or likely pathogenic calls. High‑accuracy assessments corroborate this: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also reports pathogenic. Consequently, the variant is most likely pathogenic, with no conflict with ClinVar status because no ClinVar assertion exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.352862Structured0.424577Uncertain0.9550.4360.000-17.005Likely Pathogenic0.997Likely PathogenicLikely Pathogenic3.23Destabilizing0.02.68Destabilizing2.96Destabilizing2.02Destabilizing0.547Likely Pathogenic-3.97Deleterious0.999Probably Damaging0.977Probably Damaging1.33Pathogenic0.00Affected0.12350.1405-2-2-7.314.97
c.980T>A
L327Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L327Q is not reported in ClinVar and is absent from gnomAD. Prediction tools that assess pathogenicity all converge on a deleterious effect: SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all indicate a pathogenic or likely pathogenic outcome. No tool in the dataset predicts a benign effect. High‑accuracy methods reinforce this consensus: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, is pathogenic. With all available evidence pointing to a harmful impact and no ClinVar entry to contradict this, the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.335645Structured0.409189Uncertain0.9390.4900.000-14.243Likely Pathogenic0.999Likely PathogenicLikely Pathogenic3.03Destabilizing0.12.17Destabilizing2.60Destabilizing2.11Destabilizing0.605Likely Pathogenic-5.26Deleterious1.000Probably Damaging0.999Probably Damaging1.52Pathogenic0.00Affected0.11310.1042-2-2-7.314.97
c.1189T>C
C397R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant C397R is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include Rosetta, PROVEAN, SIFT, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are REVEL, polyPhen‑2 HumDiv, and AlphaMissense‑Default. The remaining tools (FoldX, premPS, ESM1b) are uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) resolves to benign (2 benign vs. 1 pathogenic, 1 uncertain), and Foldetta predicts a benign impact on protein folding stability. Overall, the majority of evidence points to a benign effect. This conclusion is consistent with the lack of ClinVar annotation and does not contradict any existing clinical classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.429200Structured0.395774Uncertain0.7780.5510.250-7.094In-Between0.708Likely PathogenicLikely Benign0.55Ambiguous0.80.40Likely Benign0.48Likely Benign0.96Ambiguous0.514Likely Pathogenic-1.46Neutral0.480Possibly Damaging0.226Benign4.65Benign0.11Tolerated0.17800.1853-4-3-7.053.05
c.1294T>C
C432R
2D
3DClick to see structure in 3D Viewer
AIClinVar has no entry for this SynGAP1 missense variant, and it is absent from gnomAD. Prediction tools that agree on a benign effect include only FATHMM. The majority of algorithms predict a pathogenic impact: REVEL, Rosetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score (Likely Pathogenic). FoldX and Foldetta report uncertain results. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized is pathogenic, the SGM‑Consensus is likely pathogenic, while Foldetta remains inconclusive. Overall, the consensus of the available predictions indicates that the variant is most likely pathogenic, and this assessment does not contradict the ClinVar status, which currently has no classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.111485Structured0.362533Uncertain0.9600.2850.000-13.858Likely Pathogenic0.996Likely PathogenicLikely Pathogenic1.03Ambiguous0.22.05Destabilizing1.54Ambiguous1.73Destabilizing0.690Likely Pathogenic-11.46Deleterious0.999Probably Damaging0.993Probably Damaging3.45Benign0.01Affected0.13590.1766-4-3-7.053.05
c.1394T>A
L465H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L465H is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly indicate a deleterious effect. Benign predictions: none. Pathogenic predictions: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, predicts pathogenic. Based on the consensus of all available predictions, the variant is most likely pathogenic, and this conclusion is not contradicted by ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.346032Structured0.319240Uncertain0.9560.2020.000-16.751Likely Pathogenic0.999Likely PathogenicLikely Pathogenic3.15Destabilizing0.42.29Destabilizing2.72Destabilizing2.54Destabilizing0.764Likely Pathogenic-6.96Deleterious1.000Probably Damaging1.000Probably Damaging2.29Pathogenic0.00Affected0.12890.1089-2-3-7.023.98
c.1445T>A
L482H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L482H is not reported in ClinVar (ClinVar status: None) and has no entries in gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect are absent; all available pathogenic predictors (REVEL, premPS, PROVEAN, polyPhen‑2 HumDiv/HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized) and the SGM‑Consensus vote (Likely Pathogenic) uniformly indicate a deleterious impact. Uncertain predictions come from FoldX, Rosetta, and Foldetta. High‑accuracy assessments show AlphaMissense‑Optimized as Pathogenic, SGM‑Consensus as Likely Pathogenic, and Foldetta as Uncertain. No evidence suggests a benign outcome. Consequently, the variant is most likely pathogenic based on the consensus of pathogenic predictions, and this assessment does not contradict the ClinVar status, which currently has no classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.254060Structured0.426236Uncertain0.7950.2480.000-13.825Likely Pathogenic0.987Likely PathogenicLikely Pathogenic1.49Ambiguous0.01.44Ambiguous1.47Ambiguous1.64Destabilizing0.886Likely Pathogenic-6.91Deleterious1.000Probably Damaging1.000Probably Damaging-1.28Pathogenic0.00Affected0.10000.0879-2-3-7.023.98
c.145T>C
C49R
2D
AIThe SynGAP1 missense variant C49R has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect are REVEL and FATHMM, whereas the majority of tools (PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default) predict a pathogenic impact. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as Likely Pathogenic. High‑accuracy assessments show AlphaMissense‑Optimized as Uncertain and no Foldetta (FoldX‑MD/Rosetta) result is available. Taken together, the preponderance of evidence points to a pathogenic effect, and this conclusion does not contradict ClinVar status, as no ClinVar classification exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.209395Structured0.445316Uncertain0.5410.7040.000-10.000Likely Pathogenic0.948Likely PathogenicAmbiguous0.320Likely Benign-3.53Deleterious0.676Possibly Damaging0.761Possibly Damaging3.95Benign0.00Affected0.16050.2120-4-3-7.053.05
c.1466T>A
L489H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L489H is not reported in ClinVar (ClinVar status: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that assess pathogenicity all agree that the variant is deleterious: SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify it as pathogenic. No tool predicts a benign effect. High‑accuracy methods reinforce this consensus: AlphaMissense‑Optimized predicts pathogenicity; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also predicts pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, indicates a destabilizing, pathogenic effect. All available predictions are concordant and supportive. Therefore, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.191378Structured0.326126Uncertain0.9490.2340.125-15.946Likely Pathogenic1.000Likely PathogenicLikely Pathogenic3.12Destabilizing0.22.13Destabilizing2.63Destabilizing1.99Destabilizing0.919Likely Pathogenic-6.74Deleterious1.000Probably Damaging1.000Probably Damaging-1.60Pathogenic0.00Affected0.11320.0871-2-3-7.023.98
c.1517T>A
L506H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L506H is not reported in ClinVar and is absent from gnomAD. Prediction tools that assess pathogenicity unanimously classify the variant as deleterious: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a benign effect. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts Pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts Pathogenic. Based on the collective evidence, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.034884Structured0.279180Uncertain0.9240.1960.000-12.999Likely Pathogenic0.987Likely PathogenicLikely Pathogenic4.45Destabilizing0.33.47Destabilizing3.96Destabilizing2.18Destabilizing0.758Likely Pathogenic-6.96Deleterious1.000Probably Damaging1.000Probably Damaging1.54Pathogenic0.00Affected0.09190.0488-2-3-7.023.98
c.1570T>C
C524R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant C524R is not reported in ClinVar (ClinVar ID None) and has no entries in gnomAD (gnomAD ID None). Across the evaluated in‑silico tools, all pathogenic‑predicating algorithms—REVEL, SGM‑Consensus, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—return a pathogenic or likely pathogenic verdict. The only tool with an inconclusive result is FoldX, which is treated as unavailable. High‑accuracy predictors reinforce this assessment: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates likely pathogenic; and Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, also predicts pathogenic. Based on the collective evidence, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.134866Structured0.024729Uncertain0.9160.3850.125-14.337Likely Pathogenic1.000Likely PathogenicLikely Pathogenic-0.53Ambiguous0.59.04Destabilizing4.26Destabilizing1.62Destabilizing0.917Likely Pathogenic-11.93Deleterious0.999Probably Damaging0.998Probably Damaging-1.40Pathogenic0.00Affected0.20310.1463-4-3-7.053.05
c.1591T>C
C531R
2D
AIThe SynGAP1 missense variant C531R is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify the variant as benign include FoldX, Rosetta, Foldetta, and polyPhen‑2 HumVar, whereas the remaining tools—REVEL, premPS, PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—predict it to be pathogenic. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Overall, the majority of evidence points to a pathogenic effect, and this conclusion does not contradict any ClinVar classification because the variant is currently unreported in that database.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.281712Structured0.017941Uncertain0.8780.4010.000-12.600Likely Pathogenic0.966Likely PathogenicLikely Pathogenic0.31Likely Benign2.0-0.27Likely Benign0.02Likely Benign1.40Destabilizing0.619Likely Pathogenic-9.85Deleterious0.929Possibly Damaging0.385Benign-1.24Pathogenic0.00Affected0.13220.1566-4-3-7.053.05
c.1636T>C
C546R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant C546R is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include only SIFT, whereas the majority of tools predict a pathogenic impact: SGM‑Consensus (Likely Pathogenic), REVEL, Rosetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. FoldX and Foldetta return uncertain results and are therefore not considered evidence for either side. High‑accuracy assessments show AlphaMissense‑Optimized as Pathogenic, SGM‑Consensus as Likely Pathogenic, and Foldetta as Uncertain. Based on the preponderance of pathogenic predictions, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status because no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.027463Structured0.009041Uncertain0.9600.2880.000-15.237Likely Pathogenic0.999Likely PathogenicLikely Pathogenic-0.70Ambiguous0.32.04Destabilizing0.67Ambiguous1.70Destabilizing0.894Likely Pathogenic-9.73Deleterious1.000Probably Damaging0.998Probably Damaging-1.26Pathogenic0.06Tolerated0.18080.1685-4-3-7.053.05
c.1639T>C
C547R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant C547R is listed in ClinVar with an “Uncertain” status and is not reported in gnomAD. Prediction tools that assess pathogenicity all converge on a deleterious effect: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict pathogenicity, while no tool in the dataset predicts a benign outcome. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is “Likely Pathogenic”; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also predicts pathogenicity. Based on the unanimous computational evidence, the variant is most likely pathogenic, a conclusion that contradicts the current ClinVar “Uncertain” classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.045352Structured0.007912Uncertain0.9710.2750.000Uncertain 1-16.967Likely Pathogenic0.999Likely PathogenicLikely Pathogenic7.76Destabilizing0.85.83Destabilizing6.80Destabilizing1.69Destabilizing0.900Likely Pathogenic-11.60Deleterious1.000Probably Damaging0.998Probably Damaging-1.33Pathogenic0.02Affected3.37350.18020.1408-4-3-7.053.05267.4-90.30.00.0-0.10.1XXXXPotentially PathogenicCys547 is located in an α-helix (res. Ala533-Val560). The thiol side chain of Cys is situated in a hydrophobic inter-helix space, where it packs hydrophobically with other residues such as Ile626, Leu551, and Phe652. Additionally, the thiol side chain of Cys547 weakly hydrogen bonds with the carbonyl group of Leu543 in the same α-helix. In the variant simulations, the bulkier, positively charged guanidinium group of Arg547 must rotate out of the hydrophobic space. Consequently, it forms ionic interactions with the carboxylate groups of Glu548 in the same helix and Glu656 in the neighboring α-helix (res. Glu666-Asp644). This causes the two helices to slightly separate, significantly affecting the secondary structure integrity of the latter helix. These negative structural effects could be more pronounced during protein folding and are likely to be undermined in the MD simulations.
c.1654T>C
C552R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant C552R is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include only SIFT, whereas the remaining tools (REVEL, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized) uniformly predict a pathogenic impact. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates a likely pathogenic outcome. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, SGM‑Consensus as likely pathogenic, and Foldetta (a protein‑folding stability method combining FoldX‑MD and Rosetta outputs) yields an uncertain result, which is treated as unavailable evidence. Overall, the preponderance of predictions supports a pathogenic classification, and this conclusion does not contradict the ClinVar status, which is currently unreported.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.013265Structured0.005714Uncertain0.9550.2560.000-14.315Likely Pathogenic0.997Likely PathogenicLikely Pathogenic-1.18Ambiguous0.1-0.51Ambiguous-0.85Ambiguous1.10Destabilizing0.809Likely Pathogenic-9.93Deleterious1.000Probably Damaging0.998Probably Damaging-1.19Pathogenic0.48Tolerated0.14490.1366-4-3-7.053.05
c.1675T>C
C559R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant C559R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, SIFT, FATHMM, Rosetta, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. Uncertain or inconclusive results come from FoldX, Foldetta, and premPS. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as uncertain. Overall, the majority of tools (six pathogenic vs five benign) lean toward a pathogenic interpretation, and this does not contradict any ClinVar status because the variant is not yet classified in ClinVar. Thus, the variant is most likely pathogenic based on current predictive evidence.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.016021Structured0.010460Uncertain0.8420.2040.000-9.509Likely Pathogenic0.779Likely PathogenicLikely Benign-1.03Ambiguous0.1-0.38Likely Benign-0.71Ambiguous0.79Ambiguous0.498Likely Benign-8.58Deleterious0.999Probably Damaging0.996Probably Damaging3.48Benign0.46Tolerated0.24980.1720-4-3-7.053.05
c.170T>A
L57H
2D
AIThe SynGAP1 missense variant L57H is not reported in ClinVar and has no entry in gnomAD. Prediction tools show a split: benign calls come from REVEL, PROVEAN, ESM1b, and FATHMM, whereas pathogenic calls come from polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a Likely Benign classification. High‑accuracy assessments further indicate that AlphaMissense‑Optimized is Uncertain, whereas the SGM‑Consensus remains Likely Benign; Foldetta stability analysis is unavailable. Overall, the majority of high‑confidence tools and the consensus score favor a benign effect, and this conclusion does not conflict with the absence of a ClinVar assertion.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.254060Structured0.481044Uncertain0.5540.6420.000-6.251Likely Benign0.796Likely PathogenicAmbiguous0.173Likely Benign-1.58Neutral0.984Probably Damaging0.971Probably Damaging3.90Benign0.00Affected0.10450.0611-2-3-7.023.98
c.1726T>C
C576R
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant C576R is listed in ClinVar with an uncertain significance (ClinVar ID 2780076.0) and is not reported in gnomAD. Prediction tools that classify the variant as benign include only FATHMM. All other evaluated algorithms—REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN)—predict it to be pathogenic. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized scores it pathogenic, the SGM‑Consensus (derived from the majority of high‑confidence predictors) is pathogenic, and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also predicts pathogenicity. Taken together, the overwhelming majority of computational evidence indicates that C576R is likely pathogenic, a conclusion that is consistent with, but not in conflict with, the current ClinVar uncertain status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.113710Structured0.017684Uncertain0.9130.2450.000Conflicting 2-14.886Likely Pathogenic1.000Likely PathogenicLikely Pathogenic7.20Destabilizing1.04.09Destabilizing5.65Destabilizing1.64Destabilizing0.579Likely Pathogenic-10.88Deleterious0.999Probably Damaging0.996Probably Damaging3.38Benign0.00Affected3.37350.18870.1279-3-4-7.053.05
c.1763T>A
L588H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L588H is listed in ClinVar (ID 422233.0) as Pathogenic and is not reported in gnomAD. All available in silico predictors classify the change as pathogenic: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a benign effect. High‑accuracy assessments confirm this: AlphaMissense‑Optimized predicts Pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts Pathogenic. Thus, the variant is most likely pathogenic, and this prediction aligns with its ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.038042Structured0.082229Uncertain0.8870.2140.000Likely Pathogenic 1-16.947Likely Pathogenic0.999Likely PathogenicLikely Pathogenic4.20Destabilizing0.23.69Destabilizing3.95Destabilizing2.26Destabilizing0.939Likely Pathogenic-6.97Deleterious1.000Probably Damaging1.000Probably Damaging-1.42Pathogenic0.00Affected3.38340.09800.0456-2-3-7.023.98214.320.90.00.00.00.2XXXPotentially PathogenicThe isobutyl group of the Leu588 side chain, located in an α helix (res. Glu582-Met603), packs against hydrophobic residues in the inter-helix hydrophobic space (e.g., Ile584, Trp572, Phe484, Met470, Val473, Ile483).In the variant simulations, the imidazole ring of His588 is aromatic but contains polar delta and epsilon nitrogen atoms that are not suited for the hydrophobic niche. The protonated epsilon nitrogen forms a hydrogen bond with the backbone carbonyl group of Ala469, which can disrupt the continuity of the opposing α helix (res. Phe476-Lys460).While the residue swap could affect the tertiary assembly and the underlying protein folding process, it is difficult to determine if the mutation would be tolerated based solely on the variant simulations.
c.1778T>A
L593H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L593H is listed in ClinVar with an uncertain significance and is not present in gnomAD. In silico predictors that classify the variant as benign include only FATHMM. All other evaluated tools—REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—predict a pathogenic effect. High‑accuracy methods further support pathogenicity: AlphaMissense‑Optimized is pathogenic; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, is pathogenic. No prediction or stability result is missing or inconclusive. Overall, the variant is most likely pathogenic based on the consensus of predictions, and this assessment does not contradict the ClinVar uncertain status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.009728Structured0.110534Uncertain0.9410.1510.000Uncertain 1-16.504Likely Pathogenic0.998Likely PathogenicLikely Pathogenic2.52Destabilizing0.22.32Destabilizing2.42Destabilizing2.75Destabilizing0.812Likely Pathogenic-6.77Deleterious1.000Probably Damaging1.000Probably Damaging2.77Benign0.00Affected3.37350.11010.0541-2-3-7.023.98222.020.70.00.00.20.0XXPotentially PathogenicThe iso-propyl side chain of Leu593, located in an α helix (res. Glu582-Met603), packs favourably with multiple hydrophobic residues in the inter-helix space (e.g., Leu598, Ile589, Phe594, Phe561).In the variant simulations, His593 retains a similar packing arrangement via its aromatic imidazole ring. However, the polar nitrogen atoms introduce hydrogen bond donors and acceptors into the previously hydrophobic space. The epsilon protonated nitrogen of His593 forms a stable hydrogen bond with the phenol group of the Tyr505 side chain in an α helix (res. Gln503-Tyr518).While the residue swap could affect the tertiary assembly and the underlying protein folding process, it is difficult to determine if the mutation would be tolerated based solely on the variant simulations.
c.1793T>A
L598H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L598H is not reported in ClinVar and is absent from gnomAD. Prediction tools largely agree on a deleterious effect: FATHMM is the sole benign predictor, while all other evaluated algorithms (REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) predict pathogenicity. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized returns a pathogenic score; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also predicts pathogenicity. No predictions are missing or inconclusive. Based on the overwhelming consensus of pathogenic predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.007259Structured0.147872Uncertain0.9530.1540.000-17.210Likely Pathogenic0.990Likely PathogenicLikely Pathogenic2.52Destabilizing0.22.37Destabilizing2.45Destabilizing2.24Destabilizing0.648Likely Pathogenic-6.87Deleterious1.000Probably Damaging0.999Probably Damaging3.10Benign0.00Affected0.10600.0879-2-3-7.023.98
c.1795T>C
C599R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant C599R is not reported in ClinVar and is absent from gnomAD. In silico prediction tools uniformly indicate a deleterious effect: REVEL, polyPhen‑2 (HumDiv and HumVar), SIFT, PROVEAN, ESM1b, FATHMM, premPS, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify it as pathogenic, while FoldX reports an uncertain outcome. No tool predicts a benign effect. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts pathogenicity; the SGM Consensus, derived from the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely pathogenic status; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, also predicts pathogenicity. Consequently, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation, as none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.009865Structured0.151725Uncertain0.9600.1510.000-15.968Likely Pathogenic0.999Likely PathogenicLikely Pathogenic1.00Ambiguous0.33.29Destabilizing2.15Destabilizing1.54Destabilizing0.909Likely Pathogenic-11.95Deleterious1.000Probably Damaging0.998Probably Damaging-1.50Pathogenic0.00Affected0.15190.1566-4-3-7.053.05
c.1820T>A
L607H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L607H is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on pathogenicity include REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized; no tool predicts a benign effect. Uncertain predictions come from FoldX, Rosetta, and Foldetta. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized is pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, while Foldetta’s stability analysis is inconclusive. Taken together, the overwhelming majority of evidence indicates that the variant is most likely pathogenic, and this conclusion does not contradict any existing ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.048328Structured0.194229Uncertain0.8690.2500.000-14.775Likely Pathogenic0.981Likely PathogenicLikely Pathogenic0.76Ambiguous0.11.88Ambiguous1.32Ambiguous1.38Destabilizing0.906Likely Pathogenic-6.97Deleterious1.000Probably Damaging1.000Probably Damaging-1.48Pathogenic0.01Affected0.11990.0541-2-3-7.023.98
c.1829T>A
L610H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L610H is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that assess pathogenicity all agree that the variant is deleterious: SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify it as pathogenic. No tool predicts a benign effect. High‑accuracy methods reinforce this consensus: AlphaMissense‑Optimized predicts pathogenicity; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also predicts pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, indicates a destabilizing, pathogenic effect. All available predictions are concordant and supportive. Based on these computational assessments, the variant is most likely pathogenic, and this conclusion does not contradict any existing ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.271506Structured0.209504Uncertain0.8880.2530.000-14.573Likely Pathogenic0.960Likely PathogenicLikely Pathogenic4.83Destabilizing0.54.98Destabilizing4.91Destabilizing2.03Destabilizing0.927Likely Pathogenic-6.91Deleterious1.000Probably Damaging1.000Probably Damaging-1.59Pathogenic0.00Affected0.10670.0741-2-3-7.023.98
c.1868T>A
L623H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L623H is not reported in ClinVar and is absent from gnomAD. Prediction tools that assess pathogenicity all converge on a deleterious effect: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict pathogenicity, while no tool predicts a benign outcome. High‑accuracy methods reinforce this consensus: AlphaMissense‑Optimized indicates pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) reports “Likely Pathogenic,” and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts pathogenic. No contradictory evidence is present. Based on the unanimous computational predictions, the variant is most likely pathogenic, and this assessment does not conflict with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.175930Structured0.060667Uncertain0.9620.2110.000-14.631Likely Pathogenic0.999Likely PathogenicLikely Pathogenic2.76Destabilizing0.32.22Destabilizing2.49Destabilizing2.40Destabilizing0.793Likely Pathogenic-6.97Deleterious1.000Probably Damaging1.000Probably Damaging1.55Pathogenic0.00Affected0.10990.0541-2-3-7.023.98
c.1874T>A
L625H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L625H is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include only FATHMM, whereas all other evaluated algorithms—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the variant as pathogenic. High‑accuracy methods further support a deleterious impact: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. No prediction or folding stability result is missing or inconclusive. Based on the overwhelming consensus of pathogenic predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.229226Structured0.045896Uncertain0.9660.2150.000-14.264Likely Pathogenic0.994Likely PathogenicLikely Pathogenic2.85Destabilizing0.32.96Destabilizing2.91Destabilizing2.02Destabilizing0.738Likely Pathogenic-6.87Deleterious1.000Probably Damaging1.000Probably Damaging2.98Benign0.00Affected0.09540.0541-2-3-7.023.98
c.2066T>A
L689H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L689H is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include only FATHMM, whereas all other evaluated algorithms—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. High‑accuracy methods further support this: AlphaMissense‑Optimized is pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. No prediction or folding stability result is missing or inconclusive. Based on the overwhelming agreement among these tools, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.042364Structured0.227227Uncertain0.9630.2480.000-14.659Likely Pathogenic0.999Likely PathogenicLikely Pathogenic3.40Destabilizing0.12.50Destabilizing2.95Destabilizing2.21Destabilizing0.532Likely Pathogenic-6.97Deleterious1.000Probably Damaging0.999Probably Damaging3.14Benign0.00Affected0.10130.0456-2-3-7.023.98
c.2087T>A
L696H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L696H is not reported in ClinVar and is absent from gnomAD. Prediction tools largely agree on a deleterious effect: all available predictors except FATHMM classify the variant as pathogenic (SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized). Only FATHMM predicts a benign outcome. High‑accuracy assessments reinforce the pathogenic prediction: AlphaMissense‑Optimized scores the variant as pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also predicts pathogenicity. Taken together, the overwhelming majority of computational evidence supports a pathogenic classification, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.200174Structured0.390093Uncertain0.9620.2670.000-17.042Likely Pathogenic0.998Likely PathogenicLikely Pathogenic2.56Destabilizing0.02.55Destabilizing2.56Destabilizing2.07Destabilizing0.569Likely Pathogenic-6.58Deleterious1.000Probably Damaging1.000Probably Damaging3.00Benign0.00Affected0.10090.0488-2-3-7.023.98
c.2108T>A
L703H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L703H is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a deleterious effect: benign predictions come from REVEL and FATHMM, whereas pathogenic predictions are made by FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Pathogenic. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts Pathogenic; the SGM‑Consensus itself is Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, also predicts Pathogenic. Taken together, the overwhelming majority of evidence indicates that the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.144935Structured0.388282Uncertain0.9290.3530.000-12.886Likely Pathogenic0.957Likely PathogenicLikely Pathogenic2.52Destabilizing0.02.29Destabilizing2.41Destabilizing1.75Destabilizing0.420Likely Benign-5.71Deleterious1.000Probably Damaging0.993Probably Damaging3.09Benign0.00Affected0.10380.0288-2-3-7.023.98
c.2123T>A
L708H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L708H is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include REVEL, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect comprise premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default; the SGM Consensus score is also labeled Likely Pathogenic. Stability‑based methods FoldX and Rosetta return uncertain results, and Foldetta likewise is inconclusive. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus as Likely Pathogenic, and Foldetta as uncertain. Overall, the majority of conventional predictors lean toward pathogenicity, whereas a few high‑accuracy tools suggest benign or are inconclusive. Thus, the variant is most likely pathogenic based on the prevailing predictions, and this assessment does not contradict any ClinVar annotation because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.250310Structured0.365875Uncertain0.9310.3780.000-8.059Likely Pathogenic0.677Likely PathogenicLikely Benign1.84Ambiguous0.11.55Ambiguous1.70Ambiguous1.44Destabilizing0.243Likely Benign-4.68Deleterious1.000Probably Damaging0.981Probably Damaging3.25Benign0.02Affected0.08240.0288-2-3-7.023.98
c.2150T>A
L717H
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant L717H occurs in the GAP domain. ClinVar has no entry for this variant, and it is not present in gnomAD. Prediction tools that agree on a benign effect are REVEL and FATHMM; all other evaluated algorithms (FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) predict a pathogenic impact, and the SGM‑Consensus score is “Likely Pathogenic.” High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. No predictions or stability results are missing or inconclusive. Based on the overwhelming majority of computational evidence, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.239899Structured0.429342Uncertain0.9690.3970.000-11.107Likely Pathogenic0.977Likely PathogenicLikely Pathogenic2.27Destabilizing0.12.04Destabilizing2.16Destabilizing1.05Destabilizing0.317Likely Benign-5.23Deleterious1.000Probably Damaging1.000Probably Damaging3.29Benign0.00Affected0.09180.0558-2-3-7.023.98
c.2153T>A
L718H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L718H is not reported in ClinVar (ClinVar ID None) and has no entry in gnomAD (gnomAD ID None). Prediction tools cluster into two groups: the single benign predictor REVEL, and a consensus of pathogenic predictions from FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts pathogenic. No predictions are inconclusive or missing. Based on the overwhelming agreement among these tools, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status, as none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.298791Structured0.438417Uncertain0.9660.3850.000-14.923Likely Pathogenic0.999Likely PathogenicLikely Pathogenic3.84Destabilizing0.12.68Destabilizing3.26Destabilizing2.69Destabilizing0.460Likely Benign-6.64Deleterious1.000Probably Damaging1.000Probably Damaging1.28Pathogenic0.00Affected0.10200.0526-2-3-7.023.98
c.2288T>A
L763H
2D
AIThe SynGAP1 missense variant L763H is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on benign include REVEL, PROVEAN, ESM1b, and AlphaMissense‑Optimized, while pathogenic predictions come from polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is inconclusive (2 pathogenic vs. 2 benign), and Foldetta results are unavailable. Overall, the predictions are mixed, with a slight tilt toward pathogenicity (5 pathogenic vs. 4 benign). Thus, the variant is most likely pathogenic according to the aggregate predictions, and this assessment does not contradict ClinVar, which currently has no entry for it.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.380708Structured0.918636Binding0.3510.8650.125-6.681Likely Benign0.640Likely PathogenicLikely Benign0.180Likely Benign-0.79Neutral1.000Probably Damaging0.992Probably Damaging2.36Pathogenic0.03Affected0.10210.0887-2-3-7.023.98
c.2306T>A
L769H
2D
AIThe SynGAP1 missense variant L769H is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, and AlphaMissense‑Optimized, all of which classify the variant as benign. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT, all of which report the variant as pathogenic. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, indicates a likely benign outcome. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; Foldetta results are unavailable. Based on the preponderance of evidence, the variant is most likely benign, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.411940Structured0.928432Binding0.3670.8830.250-6.038Likely Benign0.422AmbiguousLikely Benign0.235Likely Benign-1.96Neutral0.977Probably Damaging0.721Possibly Damaging3.90Benign0.00Affected0.10160.0828-2-3-7.023.98
c.2330T>A
L777H
2D
AIThe SynGAP1 missense variant L777H has no ClinVar record and is not present in gnomAD. Prediction tools that agree on a benign effect include REVEL, ESM1b, FATHMM, and AlphaMissense‑Optimized, while those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT; AlphaMissense‑Default is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also favors a benign outcome. Foldetta, a protein‑folding stability method, has no available result for this variant. Overall, the balance of evidence—including the consensus of high‑accuracy tools—suggests that the variant is most likely benign, and this assessment does not contradict the ClinVar status, which currently contains no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.408655Structured0.876129Binding0.3360.8820.250-6.719Likely Benign0.492AmbiguousLikely Benign0.230Likely Benign-2.51Deleterious0.997Probably Damaging0.993Probably Damaging3.95Benign0.00Affected0.10520.0972-2-3-7.023.98
c.2357T>A
L786H
2D
AIThe SynGAP1 missense variant L786H is not reported in ClinVar and has no entries in gnomAD. Functional prediction tools show a split: benign calls come from REVEL and ESM1b, while pathogenic calls are made by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus score. Grouping by agreement, two tools predict benign, seven predict pathogenic, and AlphaMissense‑Optimized remains uncertain. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized is inconclusive, but the SGM‑Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is pathogenic. Foldetta, a protein‑folding stability method that integrates FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of evidence points to a pathogenic impact, and this conclusion does not conflict with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicSH3-binding motif0.882776Disordered0.655253Binding0.3410.8950.750-5.892Likely Benign0.836Likely PathogenicAmbiguous0.168Likely Benign-3.72Deleterious1.000Probably Damaging0.999Probably Damaging1.79Pathogenic0.00Affected0.13090.1214-2-3-7.023.98
c.2461T>C
C821R
2D
AIThe SynGAP1 missense variant C821R is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, ESM1b, and FATHMM. Tools that agree on a pathogenic effect include PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is inconclusive (2 pathogenic vs. 2 benign votes). Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of high‑accuracy predictors (six out of nine) indicate a pathogenic impact, while three suggest benign. Thus, the variant is most likely pathogenic based on current computational evidence, and this assessment does not contradict any ClinVar status because the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.745909Disordered0.672821Binding0.3510.8830.750-3.997Likely Benign0.993Likely PathogenicLikely Pathogenic0.183Likely Benign-2.93Deleterious0.999Probably Damaging0.998Probably Damaging2.69Benign0.03Affected0.19440.1746-4-3-7.053.05
c.2564T>A
L855H
2D
AIThe SynGAP1 missense variant L855H is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote) which classifies the variant as Likely Benign. In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT all predict a pathogenic impact. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized predicts Benign, and the SGM‑Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates Likely Benign. No Foldetta stability analysis is available for this variant. Overall, the majority of evidence points to a benign effect, and this conclusion does not contradict any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.724957Disordered0.485558Uncertain0.2850.8230.625-3.224Likely Benign0.148Likely BenignLikely Benign0.114Likely Benign-2.07Neutral0.938Possibly Damaging0.690Possibly Damaging3.96Benign0.01Affected0.11370.1313-2-3-7.023.98
c.2672T>A
L891H
2D
AIThe SynGAP1 missense variant L891H is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as benign, while the single pathogenic prediction comes from SIFT. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as “Likely Benign.” High‑accuracy assessments confirm this: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus also indicates a benign outcome. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta, has no available result for this variant. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.712013Disordered0.505861Binding0.3050.9230.750-4.604Likely Benign0.320Likely BenignLikely Benign0.111Likely Benign-1.79Neutral0.122Benign0.134Benign2.69Benign0.00Affected0.10990.1189-2-3-7.023.98
c.2717T>A
L906H
2D
AIThe SynGAP1 missense variant L906H is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (two benign vs. two pathogenic votes) and Foldetta results are unavailable. Overall, the majority of standard predictors lean toward pathogenicity, but the most reliable high‑accuracy tool suggests a benign outcome and the consensus is unresolved. Thus, the variant is most likely pathogenic based on the prevailing predictions, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.604312Disordered0.644316Binding0.3150.9200.250-4.367Likely Benign0.732Likely PathogenicLikely Benign0.124Likely Benign-1.01Neutral1.000Probably Damaging0.997Probably Damaging2.18Pathogenic0.02Affected0.11250.1073-2-3-7.023.98
c.2774T>A
L925H
2D
AIThe SynGAP1 missense variant L925H is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL and ESM1b, whereas the remaining tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—predict a pathogenic impact. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is “Likely Pathogenic.” No Foldetta stability result is available. Overall, the majority of evidence points to a pathogenic effect for L925H, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.483068Structured0.977963Binding0.2900.8520.125-3.369Likely Benign0.997Likely PathogenicLikely Pathogenic0.475Likely Benign-5.24Deleterious1.000Probably Damaging0.999Probably Damaging1.28Pathogenic0.00Affected0.12190.1494-2-3-7.023.98
c.2792T>A
L931H
2D
AIThe SynGAP1 missense variant L931H has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect include only REVEL, whereas the majority of tools (PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, FATHMM, AlphaMissense‑Default) predict a pathogenic impact. ESM1b and AlphaMissense‑Optimized are uncertain. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Pathogenic. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as Likely Pathogenic, and Foldetta results are unavailable. Based on the preponderance of pathogenic predictions and the SGM‑Consensus outcome, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.549308Disordered0.989212Binding0.3350.8560.375-7.495In-Between0.954Likely PathogenicAmbiguous0.301Likely Benign-3.76Deleterious1.000Probably Damaging0.999Probably Damaging2.38Pathogenic0.00Affected0.11980.1205-2-3-7.023.98
c.2963T>A
L988H
2D
AIThe SynGAP1 missense variant L988H is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (2 vs 2). Foldetta results are unavailable. Overall, the majority of predictions (five pathogenic vs four benign) lean toward pathogenicity. Thus, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.827927Disordered0.918781Binding0.3600.9130.750-4.779Likely Benign0.733Likely PathogenicLikely Benign0.179Likely Benign-2.70Deleterious0.998Probably Damaging0.947Probably Damaging2.62Benign0.00Affected0.11790.1414-2-3-7.023.98
c.3002T>A
L1001H
2D
AIThe SynGAP1 missense variant L1001H is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote) which classifies the variant as Likely Benign. In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT all predict a pathogenic impact. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized predicts Benign, and the SGM‑Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates Likely Benign. No Foldetta stability analysis is available for this variant. Overall, the majority of evidence points to a benign effect, and this conclusion does not contradict any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.754692Disordered0.958507Binding0.2690.9020.375-3.119Likely Benign0.258Likely BenignLikely Benign0.109Likely Benign-1.02Neutral0.997Probably Damaging0.870Possibly Damaging2.64Benign0.00Affected0.11410.0958-2-3-7.023.98
c.3065T>A
L1022H
2D
AIThe SynGAP1 missense variant L1022H is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, and AlphaMissense‑Optimized. Tools that agree on a pathogenic effect are polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized predicts a benign outcome, while the SGM Consensus—derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—yields a tie (2 pathogenic, 2 benign) and is therefore inconclusive. Foldetta, which would provide a protein‑folding stability estimate, has no available result for this variant. Overall, the majority of conventional predictors lean toward pathogenicity, whereas the single high‑accuracy tool predicts benign and the consensus is unresolved. Thus, the variant is most likely pathogenic based on the current predictions, and this assessment does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.859585Disordered0.986981Binding0.3390.7520.500-2.473Likely Benign0.589Likely PathogenicLikely Benign0.140Likely Benign-2.21Neutral0.999Probably Damaging0.944Probably Damaging2.49Pathogenic0.00Affected0.11650.1313-2-3-7.023.98
c.3071T>A
L1024H
2D
AIThe SynGAP1 missense variant L1024H is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split: benign predictions come from REVEL and ESM1b, whereas pathogenic predictions are made by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Pathogenic. High‑accuracy assessments are mixed: AlphaMissense‑Optimized returns an Uncertain result, SGM‑Consensus indicates Likely Pathogenic, and Foldetta data are unavailable. Overall, the majority of evidence points toward a deleterious effect, suggesting the variant is most likely pathogenic. This conclusion is not contradicted by ClinVar, which contains no entry for this change.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.862302Disordered0.992699Binding0.3270.7530.500-3.271Likely Benign0.868Likely PathogenicAmbiguous0.123Likely Benign-3.09Deleterious1.000Probably Damaging0.981Probably Damaging2.38Pathogenic0.01Affected0.11980.1483-2-3-7.023.98
c.3326T>A
L1109H
2D
AIThe SynGAP1 missense variant L1109H is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote) which classifies the variant as Likely Benign. In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT all predict a pathogenic impact. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized predicts Benign, and the SGM‑Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates Likely Benign. No Foldetta stability analysis is available for this variant. Overall, the majority of computational evidence points to a benign effect, and this conclusion does not contradict any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.856457Disordered0.948334Binding0.3430.8930.875-4.353Likely Benign0.237Likely BenignLikely Benign0.134Likely Benign-0.56Neutral0.832Possibly Damaging0.499Possibly Damaging2.70Benign0.04Affected0.12500.1845-2-3-7.023.98
c.3539T>A
L1180H
2D
AIThe SynGAP1 missense variant L1180H is not reported in ClinVar and has no gnomAD allele, so its population frequency is unknown. Functional prediction tools show a split: benign calls come from REVEL, PROVEAN, ESM1b, and FATHMM, whereas pathogenic calls come from polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely benign outcome. High‑accuracy assessments highlight AlphaMissense‑Optimized as pathogenic, while the SGM‑Consensus leans benign; Foldetta results are not available. Overall, five of nine individual predictors favor pathogenicity, four favor benign, and the consensus tool suggests benign. Thus, the variant is most likely pathogenic based on the preponderance of high‑confidence predictions, and this assessment is not contradicted by ClinVar, which contains no entry for this change.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignCoiled-coil0.626927Disordered0.559845Binding0.5910.6720.250-5.621Likely Benign0.976Likely PathogenicLikely Pathogenic0.213Likely Benign-0.22Neutral0.987Probably Damaging0.865Possibly Damaging2.65Benign0.00Affected0.09910.0860-2-3-7.023.98
c.3875T>A
L1292H
2D
AIThe SynGAP1 missense variant L1292H is not reported in ClinVar (ClinVar status: None) but is present in gnomAD (ID 6‑33447923‑T‑A). Prediction tools that agree on a benign effect include REVEL, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and FATHMM. The SGM Consensus, which takes a majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is inconclusive (2 benign vs. 2 pathogenic). Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the predictions are split, with a slight tilt toward pathogenicity (five pathogenic vs. four benign). Thus, the variant is most likely pathogenic based on the current computational evidence, and this assessment does not contradict any ClinVar status because no ClinVar claim exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.779859Disordered0.882643Binding0.5860.8000.6256-33447923-T-A-5.692Likely Benign0.335Likely BenignLikely Benign0.202Likely Benign-4.42Deleterious0.992Probably Damaging0.820Possibly Damaging2.46Pathogenic0.00Affected3.7750.12710.0649-3-2-7.023.98
c.3896T>A
L1299H
2D
AIThe SynGAP1 missense variant L1299H is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as Likely Benign. High‑accuracy assessments show AlphaMissense‑Optimized as Benign and the SGM‑Consensus as Likely Benign; Foldetta results are unavailable. Based on the collective predictions, the variant is most likely benign, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.771762Disordered0.896323Binding0.3980.8320.750-4.586Likely Benign0.300Likely BenignLikely Benign0.317Likely Benign-3.83Deleterious0.992Probably Damaging0.750Possibly Damaging2.67Benign0.00Affected0.12930.1273-2-3-7.023.98
c.449T>A
L150H
2D
AIThe SynGAP1 missense variant L150H is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL and FATHMM, whereas the majority of tools predict a pathogenic impact: PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The high‑accuracy consensus, SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is classified as Likely Pathogenic (3 pathogenic vs. 1 benign). AlphaMissense‑Optimized alone also predicts Pathogenic. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the preponderance of evidence from multiple independent predictors indicates that the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status, as none is currently assigned.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.494003Structured0.505752Binding0.2990.8390.625-14.892Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.303Likely Benign-4.09Deleterious0.999Probably Damaging0.995Probably Damaging3.64Benign0.00Affected0.10110.0519-2-3-7.023.98
c.593T>A
L198H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L198H is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL and FATHMM, whereas a majority of tools predict pathogenicity: PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score (Likely Pathogenic). Predictions from FoldX, Rosetta, Foldetta, and premPS are uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus as Likely Pathogenic, and Foldetta as uncertain. Overall, the preponderance of evidence points to a pathogenic effect for L198H. This conclusion is not contradicted by ClinVar, which contains no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.444081Structured0.431715Uncertain0.5720.4850.125-15.650Likely Pathogenic0.995Likely PathogenicLikely Pathogenic1.09Ambiguous0.21.04Ambiguous1.07Ambiguous0.74Ambiguous0.419Likely Benign-5.91Deleterious0.999Probably Damaging0.936Probably Damaging3.33Benign0.00Affected0.10570.0519-2-3-7.023.98
c.655T>C
C219R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant C219R is not reported in ClinVar (ClinVar ID None) and has no entries in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include only FATHMM, while the remaining 13 tools—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic or likely pathogenic impact. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized reports Pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts Pathogenic. No prediction or folding stability result is missing or inconclusive. Based on the collective evidence, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.254060Structured0.426845Uncertain0.9030.2790.000-15.727Likely Pathogenic1.000Likely PathogenicLikely Pathogenic3.00Destabilizing1.52.20Destabilizing2.60Destabilizing1.33Destabilizing0.904Likely Pathogenic-9.90Deleterious0.969Probably Damaging0.680Possibly Damaging5.80Benign0.00Affected0.13810.1837-4-3-7.053.05
c.688T>C
C230R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant C230R is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a deleterious effect: benign predictions come from FoldX and FATHMM, while pathogenic predictions are made by REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Uncertain results are reported by Rosetta and Foldetta. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts a pathogenic effect; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates likely pathogenic; Foldetta remains inconclusive. Overall, the preponderance of evidence points to a pathogenic impact for C230R, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.268042Structured0.308076Uncertain0.8700.3080.000-12.478Likely Pathogenic1.000Likely PathogenicLikely Pathogenic-0.48Likely Benign0.0-1.61Ambiguous-1.05Ambiguous1.12Destabilizing0.905Likely Pathogenic-9.88Deleterious0.838Possibly Damaging0.548Possibly Damaging5.91Benign0.01Affected0.17440.1637-4-3-7.053.05
c.697T>C
C233R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant C233R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. In contrast, the majority of tools predict a pathogenic impact: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy methods reinforce the pathogenic prediction: AlphaMissense‑Optimized is pathogenic, SGM‑Consensus is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. No predictions are missing or inconclusive. Based on the overall consensus of the majority of tools and the high‑accuracy methods, the variant is most likely pathogenic, which is consistent with the lack of ClinVar annotation and gnomAD presence.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.239899Structured0.306787Uncertain0.8680.3220.000-16.789Likely Pathogenic1.000Likely PathogenicLikely Pathogenic3.79Destabilizing3.42.17Destabilizing2.98Destabilizing1.75Destabilizing0.830Likely Pathogenic-10.68Deleterious0.002Benign0.002Benign5.71Benign0.01Affected0.17330.2212-4-3-7.053.05
c.844T>C
C282R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant C282R is listed in ClinVar as Pathogenic (ClinVar ID 635755.0) and is not reported in gnomAD. Prediction tools that agree on a benign effect are limited to REVEL, which scores the variant as benign. All other evaluated algorithms predict a pathogenic outcome: FoldX, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Rosetta’s output is uncertain and is therefore not counted as evidence. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts pathogenic, the SGM‑Consensus indicates Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta) also predicts pathogenic. Based on the overwhelming agreement among these predictions, the variant is most likely pathogenic, which aligns with its ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.098513Structured0.348535Uncertain0.9420.2500.000Pathogenic 2-16.378Likely Pathogenic0.999Likely PathogenicLikely Pathogenic3.13Destabilizing0.61.58Ambiguous2.36Destabilizing1.70Destabilizing0.466Likely Benign-11.03Deleterious0.999Probably Damaging0.998Probably Damaging1.63Pathogenic0.00Affected3.39180.16960.1557-4-3-7.053.05297.4-98.2-0.10.10.50.0XXXPotentially PathogenicThe thiol-containing side chain of Cys282, located at the beginning of an anti-parallel β sheet strand (res. Arg279-Leu286), is packed against multiple hydrophobic residues (e.g., Ile268, Leu284, Trp308, Leu327). In the variant simulations, the bulky side chain of Arg282 with its positively charged guanidinium group is not suitable for this hydrophobic niche. Consequently, the hydrophobic residues must either make room to accommodate Arg282 or it must escape the hydrophobic C2 domain core.As a result, new hydrogen bonds are formed with the backbone carbonyl groups of the surrounding β sheet residues Ala399, Leu325, and His326, which decreases the unity of the secondary structure elements. Notably, it is likely that the residue swap causes major problems during the C2 domain folding that are not visible in the variant simulations. In fact, even increased lability in the C2 domain could adversely affect the establishment of a stable SynGAP-membrane association.
c.851T>A
L284H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L284H is not reported in ClinVar and is absent from gnomAD. Prediction tools that assess pathogenicity uniformly classify the variant as deleterious: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a benign effect. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts pathogenicity, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts a pathogenic impact. Based on the unanimous computational evidence, the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.094817Structured0.371601Uncertain0.9500.2550.000-16.581Likely Pathogenic1.000Likely PathogenicLikely Pathogenic3.26Destabilizing0.13.06Destabilizing3.16Destabilizing2.57Destabilizing0.772Likely Pathogenic-6.22Deleterious1.000Probably Damaging0.999Probably Damaging1.65Pathogenic0.00Affected0.09540.0726-2-3-7.023.98
c.853T>C
C285R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant C285R is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include only FoldX, which scores the variant as benign. All other evaluated predictors—REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the variant as pathogenic. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates a likely pathogenic outcome. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts pathogenic, SGM‑Consensus confirms a likely pathogenic status, while Foldetta (combining FoldX‑MD and Rosetta outputs) remains uncertain. Consequently, the preponderance of evidence points to a pathogenic effect for C285R, and this conclusion does not contradict any existing ClinVar annotation, as none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.144935Structured0.375400Uncertain0.9460.2500.000-9.127Likely Pathogenic0.981Likely PathogenicLikely Pathogenic-0.47Likely Benign0.2-0.63Ambiguous-0.55Ambiguous1.53Destabilizing0.583Likely Pathogenic-9.66Deleterious0.999Probably Damaging0.998Probably Damaging1.83Pathogenic0.04Affected0.19470.1453-4-3-7.053.05
c.1130T>G
M377R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M377R is present in gnomAD (6‑33438035‑T‑G) and has no ClinVar entry. Prediction tools that report a benign effect include REVEL, FoldX, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are Rosetta and Foldetta. The high‑accuracy consensus (SGM‑Consensus) is “Likely Benign,” derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—all of which are benign. AlphaMissense‑Optimized also predicts benign, whereas Foldetta predicts pathogenic. Overall, the majority of evidence points to a benign impact, and this assessment does not contradict the ClinVar status (which is currently absent).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.675549Disordered0.431183Uncertain0.3240.8840.6256-33438035-T-G-3.150Likely Benign0.219Likely BenignLikely Benign0.49Likely Benign0.44.81Destabilizing2.65Destabilizing0.69Ambiguous0.471Likely Benign-0.64Neutral0.004Benign0.009Benign5.46Benign0.18Tolerated4.32120.23690.1918-10-6.424.99
c.1226T>G
M409R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M409R is not reported in ClinVar and is present in gnomAD (ID 6‑33438131‑T‑G). Functional prediction tools cluster into two groups: benign (REVEL, SIFT, FATHMM, Rosetta) and pathogenic (premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default). Three tools give uncertain results (FoldX, Foldetta, AlphaMissense‑Optimized). The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as likely pathogenic. High‑accuracy assessments are mixed: AlphaMissense‑Optimized is inconclusive, SGM‑Consensus predicts pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is uncertain. Overall, the balance of evidence favors a pathogenic effect, and this conclusion does not conflict with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.150080Structured0.360643Uncertain0.8840.2190.0006-33438131-T-G-12.795Likely Pathogenic0.911Likely PathogenicAmbiguous1.47Ambiguous0.40.44Likely Benign0.96Ambiguous1.30Destabilizing0.485Likely Benign-4.39Deleterious0.877Possibly Damaging0.807Possibly Damaging4.15Benign0.27Tolerated3.38280.15370.0957-10-6.424.99
c.1241T>G
M414R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M414R has no ClinVar entry and is not reported in gnomAD. Functional prediction tools largely agree on a deleterious effect: FATHMM is the sole benign predictor, while REVEL, Rosetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict pathogenicity. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as “Likely Pathogenic.” High‑accuracy assessments further support a damaging outcome: AlphaMissense‑Optimized is pathogenic, SGM‑Consensus remains likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is inconclusive. Overall, the preponderance of evidence indicates that M414R is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.081712Structured0.329108Uncertain0.9140.2170.000-13.404Likely Pathogenic0.996Likely PathogenicLikely Pathogenic1.17Ambiguous0.12.58Destabilizing1.88Ambiguous1.45Destabilizing0.525Likely Pathogenic-5.20Deleterious0.972Probably Damaging0.895Possibly Damaging3.38Benign0.03Affected0.15090.10370-1-6.424.99
c.1289T>G
M430R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M430R is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, Rosetta, polyPhen‑2 HumVar, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, and ESM1b. The remaining tools—FoldX, Foldetta, premPS, and AlphaMissense‑Default—return uncertain or inconclusive results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as uncertain. Overall, the majority of consensus tools lean toward a benign classification, while a subset of high‑accuracy methods suggest pathogenicity, leaving the variant’s impact ambiguous. Based on the aggregate predictions, the variant is most likely benign, and this assessment does not contradict the absence of a ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.071867Structured0.385298Uncertain0.9520.3060.000-10.636Likely Pathogenic0.558AmbiguousLikely Benign0.98Ambiguous0.10.47Likely Benign0.73Ambiguous0.83Ambiguous0.153Likely Benign-2.87Deleterious0.620Possibly Damaging0.046Benign3.48Benign0.38Tolerated0.17750.16520-1-6.424.99
c.1403T>G
M468R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M468R is not reported in ClinVar and is absent from gnomAD. All evaluated in‑silico predictors classify the substitution as pathogenic: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a benign effect. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized indicates pathogenicity; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) reports “Likely Pathogenic”; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also predicts pathogenicity. Consequently, the variant is most likely pathogenic based on the consensus of predictive tools, and this assessment does not contradict any ClinVar status (none available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.284882Structured0.339253Uncertain0.9320.2570.000-16.180Likely Pathogenic0.984Likely PathogenicLikely Pathogenic2.66Destabilizing0.22.23Destabilizing2.45Destabilizing2.43Destabilizing0.837Likely Pathogenic-4.64Deleterious0.939Possibly Damaging0.943Probably Damaging-1.34Pathogenic0.00Affected0.17170.06370-1-6.424.99
c.1409T>G
M470R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M470R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include only SIFT, whereas all other evaluated algorithms—REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—predict a pathogenic impact. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. No prediction or folding stability result is missing or inconclusive. Based on the overwhelming consensus of pathogenic predictions, the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.298791Structured0.351497Uncertain0.9080.2720.000-13.161Likely Pathogenic0.995Likely PathogenicLikely Pathogenic2.75Destabilizing0.12.75Destabilizing2.75Destabilizing1.57Destabilizing0.823Likely Pathogenic-5.47Deleterious0.963Probably Damaging0.943Probably Damaging-1.19Pathogenic0.17Tolerated0.13990.07570-1-6.424.99
c.1430T>G
M477R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M477R is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, PROVEAN, SIFT, ESM1b, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are premPS, polyPhen‑2 HumDiv, and FATHMM. Tools with uncertain or inconclusive results are Rosetta, Foldetta, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also yields a benign prediction, while Foldetta remains uncertain and is not taken as evidence. Overall, the majority of reliable predictors indicate a benign impact. This conclusion does not contradict ClinVar status, as no ClinVar assertion exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.268042Structured0.408680Uncertain0.7610.2500.000-6.786Likely Benign0.552AmbiguousLikely Benign0.48Likely Benign0.20.77Ambiguous0.63Ambiguous1.24Destabilizing0.442Likely Benign-1.12Neutral0.720Possibly Damaging0.242Benign-1.22Pathogenic0.11Tolerated0.19010.08280-1-6.424.99
c.1493T>G
M498R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M498R is listed in ClinVar as Pathogenic (ClinVar ID 3907767.0) and is not reported in gnomAD. Prediction tools that agree on a benign effect include only polyPhen‑2 HumVar; all other evaluated algorithms (REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized) predict a pathogenic impact. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, is pathogenic. No predictions or stability results are missing or inconclusive. Based on the overwhelming consensus of pathogenic predictions, the variant is most likely pathogenic, and this conclusion aligns with its ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.092881Structured0.399612Uncertain0.9320.1580.000Likely Pathogenic 1-8.812Likely Pathogenic0.988Likely PathogenicLikely Pathogenic3.85Destabilizing0.22.35Destabilizing3.10Destabilizing1.76Destabilizing0.869Likely Pathogenic-4.53Deleterious0.464Possibly Damaging0.120Benign-1.36Pathogenic0.00Affected0.14820.07570-1-6.424.99
c.1634T>G
M545R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M545R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Prediction tools that classify the variant as benign include SIFT, FoldX, and Foldetta, whereas the majority of tools predict it to be pathogenic: SGM‑Consensus, REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Rosetta’s assessment is uncertain. High‑accuracy methods give a mixed picture: AlphaMissense‑Optimized predicts pathogenicity; the SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates likely pathogenic; Foldetta, which integrates FoldX‑MD and Rosetta outputs, predicts benign. Overall, the preponderance of evidence from both general and high‑accuracy predictors points to a pathogenic effect. This conclusion does not contradict ClinVar status, as no ClinVar classification exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.025762Structured0.012875Uncertain0.9550.3110.000-9.223Likely Pathogenic0.994Likely PathogenicLikely Pathogenic-0.27Likely Benign0.10.95Ambiguous0.34Likely Benign1.07Destabilizing0.773Likely Pathogenic-4.76Deleterious0.987Probably Damaging0.971Probably Damaging-1.23Pathogenic0.36Tolerated0.13450.08370-1-6.424.99
c.173T>G
M58R
2D
AIThe SynGAP1 missense variant M58R is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and FATHMM. Tools that predict a pathogenic effect are SIFT and AlphaMissense‑Default. AlphaMissense‑Optimized is uncertain, and no Foldetta stability assessment is available. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as Likely Benign. High‑accuracy assessments therefore indicate a benign likelihood: AlphaMissense‑Optimized is inconclusive, SGM‑Consensus is benign, and Foldetta data are missing. Based on the collective predictions, the variant is most likely benign, and this conclusion does not contradict the ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.188120Structured0.484415Uncertain0.5150.6650.000-5.035Likely Benign0.940Likely PathogenicAmbiguous0.237Likely Benign-1.78Neutral0.042Benign0.184Benign4.07Benign0.00Affected0.17450.11130-1-6.424.99
c.1808T>G
M603R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M603R is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include only FoldX, which scores the variant as benign. All other evaluated predictors—REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN)—classify the variant as pathogenic. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized predicts pathogenicity, the SGM‑Consensus also indicates likely pathogenic, while Foldetta (combining FoldX‑MD and Rosetta outputs) yields an uncertain result. No other tools provide conflicting evidence. Based on the preponderance of pathogenic predictions and the absence of benign consensus, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.011342Structured0.197847Uncertain0.9420.1760.000-14.968Likely Pathogenic0.993Likely PathogenicLikely Pathogenic0.08Likely Benign0.01.13Ambiguous0.61Ambiguous0.65Ambiguous0.935Likely Pathogenic-5.64Deleterious0.963Probably Damaging0.943Probably Damaging-1.35Pathogenic0.00Affected0.15160.08370-1-6.424.99
c.1832T>G
M611R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M611R is not reported in ClinVar (ClinVar ID None) and has no entries in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect are AlphaMissense‑Optimized, polyPhen2_HumVar, and SIFT. Tools that agree on a pathogenic effect include SGM‑Consensus, REVEL, Rosetta, premPS, PROVEAN, polyPhen2_HumDiv, ESM1b, FATHMM, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized predicts a benign outcome, whereas the SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) predicts pathogenic. Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, is reported as uncertain. No prediction or folding result is missing; all available data are considered. Based on the overall distribution of predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.236433Structured0.210791Uncertain0.8700.2530.000-11.050Likely Pathogenic0.642Likely PathogenicLikely Benign1.80Ambiguous0.82.00Destabilizing1.90Ambiguous1.58Destabilizing0.644Likely Pathogenic-4.10Deleterious0.779Possibly Damaging0.159Benign-1.21Pathogenic0.21Tolerated0.13990.08370-1-6.424.99
c.1946T>G
M649R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M649R is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include only FATHMM, whereas all other evaluated algorithms—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. High‑accuracy assessments further support this: AlphaMissense‑Optimized classifies the variant as pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates a likely pathogenic outcome; and Foldetta, which integrates FoldX‑MD and Rosetta stability predictions, also reports a pathogenic effect. Based on the collective evidence, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.051831Structured0.360413Uncertain0.9620.3450.000-14.827Likely Pathogenic0.996Likely PathogenicLikely Pathogenic5.02Destabilizing0.15.97Destabilizing5.50Destabilizing2.09Destabilizing0.595Likely Pathogenic-5.98Deleterious0.985Probably Damaging0.464Possibly Damaging3.33Benign0.00Affected0.16350.12280-1-6.424.99
c.1979T>G
M660R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M660R is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely converge on a deleterious effect: SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict pathogenicity, whereas only FATHMM predicts a benign outcome. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized indicates pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts pathogenic. No prediction is inconclusive. Consequently, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.047319Structured0.134270Uncertain0.9440.2890.000-15.985Likely Pathogenic0.996Likely PathogenicLikely Pathogenic2.95Destabilizing0.23.52Destabilizing3.24Destabilizing1.96Destabilizing0.588Likely Pathogenic-5.99Deleterious0.976Probably Damaging0.464Possibly Damaging3.34Benign0.00Affected0.16120.09570-1-6.424.99
c.2264T>G
M755R
2D
AIThe SynGAP1 missense variant M755R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. Only polyPhen‑2 HumDiv predicts a pathogenic outcome. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized predicts Benign, and the SGM‑Consensus also indicates Likely Benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the preponderance of evidence from multiple prediction algorithms and high‑accuracy tools indicates that the M755R variant is most likely benign, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.490133Structured0.783855Binding0.3360.8730.375-4.247Likely Benign0.453AmbiguousLikely Benign0.104Likely Benign-2.06Neutral0.468Possibly Damaging0.206Benign2.63Benign0.18Tolerated0.14070.08370-1-6.424.99
c.2276T>G
M759R
2D
AIThe SynGAP1 missense variant M759R is not reported in ClinVar and is absent from gnomAD. Consensus predictions from multiple in silico tools cluster around a benign effect: REVEL, PROVEAN, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized all indicate benign, while the majority of high‑accuracy predictors—AlphaMissense‑Optimized and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN)—also support a benign classification. In contrast, polyPhen‑2 (HumDiv and HumVar) predict a pathogenic impact, but these are the only tools in disagreement. No Foldetta stability analysis is available, so it does not influence the assessment. Overall, the preponderance of evidence points to a benign effect for M759R, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.525368Disordered0.879389Binding0.2990.8640.375-4.507Likely Benign0.531AmbiguousLikely Benign0.244Likely Benign-1.82Neutral0.891Possibly Damaging0.575Possibly Damaging2.55Benign0.06Tolerated0.15090.06370-1-6.424.99
c.2279T>G
M760R
2D
AIThe SynGAP1 missense variant M760R is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates the majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus likewise indicates Likely Benign. No Foldetta stability prediction is available for this variant. Overall, the majority of computational evidence points to a benign impact, and this conclusion is consistent with the absence of any ClinVar pathogenic annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.541878Disordered0.893402Binding0.3460.8650.375-2.794Likely Benign0.594Likely PathogenicLikely Benign0.125Likely Benign-1.61Neutral0.975Probably Damaging0.690Possibly Damaging2.71Benign0.09Tolerated0.18040.13180-1-6.424.99
c.2318T>G
M773R
2D
AIThe SynGAP1 missense variant M773R is listed in gnomAD (ID 6‑33442476‑T‑G) but has no ClinVar entry. Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, ESM1b, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic outcome are polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as “Likely Benign.” High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus likewise indicates benign. No Foldetta (FoldX‑MD/Rosetta stability) result is available, so it does not influence the assessment. Overall, the majority of evidence points to a benign effect, and this conclusion is not contradicted by ClinVar status, which is currently absent.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.408655Structured0.916222Binding0.3250.8930.2506-33442476-T-G11.28e-6-4.340Likely Benign0.597Likely PathogenicLikely Benign0.183Likely Benign-1.87Neutral0.220Benign0.471Possibly Damaging4.18Benign0.02Affected3.6460.17780.0800-10-6.424.99
c.2342T>G
M781R
2D
AIThe SynGAP1 missense variant M781R is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. Only AlphaMissense‑Default predicts a pathogenic outcome. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely benign classification. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; Foldetta results are not available. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.580690Disordered0.792850Binding0.3420.8890.625-4.990Likely Benign0.697Likely PathogenicLikely Benign0.265Likely Benign-1.72Neutral0.327Benign0.206Benign2.71Benign0.14Tolerated0.16850.08370-1-6.424.99
c.2348T>G
M783R
2D
AIThe SynGAP1 missense variant M783R is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is inconclusive (2 benign vs 2 pathogenic). Foldetta results are unavailable. Overall, the majority of predictions (five pathogenic vs four benign) lean toward a pathogenic impact. Thus, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.736850Disordered0.738119Binding0.3310.8890.625-3.849Likely Benign0.655Likely PathogenicLikely Benign0.208Likely Benign-2.69Deleterious0.925Possibly Damaging0.529Possibly Damaging2.66Benign0.01Affected0.18150.08930-1-6.424.99
c.2501T>G
M834R
2D
AIThe SynGAP1 missense variant M834R is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are polyPhen‑2 HumDiv, SIFT, and FATHMM. AlphaMissense‑Default remains uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) leans toward benign (2 benign vs. 1 pathogenic votes). Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of computational evidence indicates a benign impact, and this conclusion does not contradict any ClinVar annotation, as none exists for M834R.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.585406Disordered0.640801Binding0.2580.8630.375-2.621Likely Benign0.449AmbiguousLikely Benign0.148Likely Benign-2.44Neutral0.812Possibly Damaging0.284Benign2.43Pathogenic0.00Affected0.13100.08370-1-6.424.99
c.2528T>G
M843R
2D
AIThe SynGAP1 missense variant M843R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL and FATHMM, whereas the majority of tools predict a pathogenic impact: PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Pathogenic). High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic, and the SGM‑Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is also pathogenic. Foldetta results are unavailable. Overall, the preponderance of evidence from both general and high‑accuracy predictors indicates that M843R is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.585406Disordered0.617934Binding0.3270.8540.375-12.044Likely Pathogenic0.989Likely PathogenicLikely Pathogenic0.430Likely Benign-3.78Deleterious0.968Probably Damaging0.978Probably Damaging2.59Benign0.00Affected0.18190.09220-1-6.424.99
c.2711T>G
M904R
2D
AIThe SynGAP1 missense variant M904R is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely benign classification. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact for M904R, and this conclusion does not contradict any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.671169Disordered0.589073Binding0.3500.9200.250-1.238Likely Benign0.693Likely PathogenicLikely Benign0.078Likely Benign-0.81Neutral0.468Possibly Damaging0.206Benign2.76Benign0.82Tolerated0.17420.13180-1-6.424.99
c.2726T>G
M909R
2D
AIThe SynGAP1 missense variant M909R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include SGM‑Consensus (Likely Benign), REVEL, PROVEAN, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also as benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact. There is no ClinVar entry to contradict this conclusion, so the variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.642678Disordered0.696196Binding0.3140.9140.250-3.064Likely Benign0.699Likely PathogenicLikely Benign0.127Likely Benign-1.23Neutral0.965Probably Damaging0.703Possibly Damaging2.70Benign0.12Tolerated0.17450.08090-1-6.424.99
c.2801T>G
M934R
2D
AISynGAP1 missense variant M934R is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify the variant as benign include REVEL, SIFT, ESM1b, and AlphaMissense‑Optimized, whereas pathogenic predictions come from PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, FATHMM, and AlphaMissense‑Default. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as Likely Pathogenic. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus as Likely Pathogenic, and Foldetta results are unavailable. Overall, the balance of evidence leans toward pathogenicity, with no ClinVar entry to contradict this assessment.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.762850Disordered0.984677Binding0.2900.8670.625-1.854Likely Benign0.771Likely PathogenicLikely Benign0.322Likely Benign-3.54Deleterious0.969Probably Damaging0.624Possibly Damaging2.37Pathogenic0.11Tolerated0.19020.12430-1-6.424.99
c.3092T>G
M1031R
2D
AIThe SynGAP1 missense variant M1031R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN). Only AlphaMissense‑Default predicts a pathogenic outcome. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; the Foldetta protein‑folding stability analysis is unavailable. Taken together, the majority of evidence points to a benign impact for M1031R, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.865454Disordered0.995959Binding0.3400.7360.500-1.365Likely Benign0.673Likely PathogenicLikely Benign0.117Likely Benign-0.85Neutral0.325Benign0.129Benign2.64Benign0.12Tolerated0.13680.12120-1-6.424.99
c.3443T>G
M1148R
2D
AIThe SynGAP1 missense variant M1148R is not reported in ClinVar and has no entry in gnomAD. Prediction tools that agree on a benign effect include SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are SIFT and AlphaMissense‑Default. High‑accuracy assessments reinforce the benign prediction: AlphaMissense‑Optimized scores the variant as benign, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates a likely benign outcome. No Foldetta stability analysis is available for this variant. Overall, the majority of computational evidence points to a benign impact, and this conclusion does not contradict any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.762850Disordered0.774279Binding0.3430.8350.875-2.303Likely Benign0.669Likely PathogenicLikely Benign0.129Likely Benign-1.77Neutral0.255Benign0.113Benign2.54Benign0.00Affected0.16240.08880-1-6.424.99
c.3482T>G
M1161R
2D
AIThe SynGAP1 missense variant M1161R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that indicate a benign effect include REVEL, SIFT, and ESM1b, whereas the remaining tools—PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (a majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN)—predict a pathogenic outcome. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic and the SGM‑Consensus as likely pathogenic; Foldetta results are unavailable. Based on the overall distribution of predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.580690Disordered0.864109Binding0.3720.8300.375-2.653Likely Benign0.995Likely PathogenicLikely Pathogenic0.220Likely Benign-2.97Deleterious0.968Probably Damaging0.978Probably Damaging2.18Pathogenic0.13Tolerated0.16890.08090-1-6.424.99
c.353T>G
M118R
2D
AIThe SynGAP1 missense variant M118R is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include REVEL, polyPhen‑2 HumVar, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, SIFT, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑vs‑2 split, and Foldetta results are unavailable. Overall, the balance of evidence leans toward a benign impact for M118R. This conclusion does not contradict any ClinVar annotation, as no ClinVar status is currently assigned.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.694846Disordered0.676867Binding0.3300.8830.500-3.318Likely Benign0.698Likely PathogenicLikely Benign0.286Likely Benign-3.17Deleterious0.697Possibly Damaging0.202Benign3.83Benign0.00Affected0.20270.09130-1-6.424.99
c.3560T>G
M1187R
2D
AIThe SynGAP1 missense variant M1187R is not reported in ClinVar and has no entry in gnomAD. Prediction tools that agree on a benign effect include PROVEAN, ESM1b, and FATHMM, while those that predict a pathogenic effect are REVEL, polyPhen‑2 (HumDiv and HumVar), SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a “Likely Benign” outcome. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, SGM‑Consensus as benign, and Foldetta results are unavailable. Overall, the majority of individual predictors (seven) indicate pathogenicity, whereas only three suggest benignity. Consequently, the variant is most likely pathogenic based on the available computational evidence, and this assessment does not contradict any ClinVar status, as no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignCoiled-coil0.562014Disordered0.499801Uncertain0.5970.6360.625-3.350Likely Benign0.967Likely PathogenicLikely Pathogenic0.557Likely Pathogenic-0.73Neutral0.968Probably Damaging0.978Probably Damaging5.52Benign0.02Affected0.19340.10000-1-6.424.99
c.3632T>G
M1211R
2D
AIThe SynGAP1 missense variant M1211R is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect are FATHMM and AlphaMissense‑Optimized, whereas the remaining tools—REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and the SGM‑Consensus—predict a pathogenic outcome. High‑accuracy assessments further support this: AlphaMissense‑Optimized classifies the variant as benign, whereas the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) yields a pathogenic verdict. Foldetta results are unavailable, so they do not influence the overall assessment. Based on the preponderance of pathogenic predictions, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.585406Disordered0.578388Binding0.8760.5650.500-8.196Likely Pathogenic0.713Likely PathogenicLikely Benign0.587Likely Pathogenic-3.18Deleterious0.987Probably Damaging0.985Probably Damaging5.47Benign0.01Affected0.16440.08280-1-6.424.99
c.3704T>G
M1235R
2D
AIThe SynGAP1 missense variant M1235R is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as benign. Only SIFT predicts a pathogenic outcome. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as “Likely Benign.” High‑accuracy assessments confirm this: AlphaMissense‑Optimized is benign, and the SGM‑Consensus is also benign; Foldetta results are not available. Overall, the preponderance of evidence indicates that the variant is most likely benign, and this conclusion does not contradict any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignCoiled-coil0.690604Disordered0.577958Binding0.8720.5320.125-5.410Likely Benign0.246Likely BenignLikely Benign0.114Likely Benign-2.37Neutral0.270Benign0.089Benign2.64Benign0.00Affected0.15050.07570-1-6.424.99
c.3800T>G
M1267R
2D
AIThe SynGAP1 missense variant M1267R is not reported in ClinVar and has no entries in gnomAD. Functional prediction tools show a split: benign calls come from REVEL and ESM1b, while pathogenic calls are made by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Default. Grouping by consensus, two tools predict benign and six predict pathogenic. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized is uncertain, but the SGM‑Consensus—derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—classifies the variant as likely pathogenic. Foldetta, a protein‑folding stability method that integrates FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the preponderance of evidence points to a pathogenic impact, and this assessment does not conflict with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.429200Structured0.812047Binding0.8470.6140.000-4.990Likely Benign0.899Likely PathogenicAmbiguous0.366Likely Benign-5.03Deleterious0.982Probably Damaging0.757Possibly Damaging2.30Pathogenic0.00Affected0.15550.08370-1-6.424.99
c.3839T>G
M1280R
2D
AIThe SynGAP1 missense variant M1280R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are SIFT and FATHMM. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a Likely Benign classification. High‑accuracy assessments show AlphaMissense‑Optimized as Benign and the SGM‑Consensus as Likely Benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact for M1280R, and this conclusion does not contradict any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.882776Disordered0.822030Binding0.5100.7260.875-2.347Likely Benign0.209Likely BenignLikely Benign0.272Likely Benign-1.97Neutral0.001Benign0.001Benign2.44Pathogenic0.00Affected0.13390.08370-1-6.424.99
c.47T>G
M16R
2D
AIThe SynGAP1 missense variant M16R is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, and AlphaMissense‑Optimized all classify the change as benign, while the only pathogenic call comes from SIFT. AlphaMissense‑Default is uncertain, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports the variant as likely benign. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts benign, the SGM‑Consensus also indicates likely benign, and no Foldetta stability data are available. Taken together, the preponderance of evidence supports a benign classification for M16R, and this conclusion does not conflict with the absence of a ClinVar assertion.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.440853Structured0.459925Uncertain0.3460.9080.375-1.475Likely Benign0.485AmbiguousLikely Benign0.191Likely Benign-0.25Neutral0.014Benign0.003Benign4.21Benign0.00Affected0.19920.10930-1-6.424.99
c.521T>G
M174R
2D
AIThe SynGAP1 missense variant M174R is not reported in ClinVar and is absent from gnomAD. Computational assessment shows a split in predictions: benign calls come from REVEL, polyPhen‑2 (HumDiv and HumVar), and FATHMM, whereas pathogenic calls arise from PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as Likely Pathogenic. High‑accuracy tools further support a deleterious effect: AlphaMissense‑Optimized predicts pathogenicity, and the SGM‑Consensus (majority vote) also indicates Likely Pathogenic. Foldetta results are unavailable, so no additional stability evidence is provided. Overall, the preponderance of evidence points to a pathogenic effect; this conclusion is not contradicted by any ClinVar annotation, as none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.661982Disordered0.485854Uncertain0.3730.6200.375-9.114Likely Pathogenic0.970Likely PathogenicLikely Pathogenic0.308Likely Benign-3.15Deleterious0.139Benign0.039Benign4.05Benign0.01Affected0.15450.10370-1-6.424.99
c.866T>G
M289R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M289R has no ClinVar entry and is not reported in gnomAD. Prediction tools that classify the variant as benign include REVEL, FoldX, Rosetta, Foldetta, SIFT, and AlphaMissense‑Optimized. Those that predict pathogenicity are SGM‑Consensus, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. No predictions or stability results are missing or inconclusive. Overall, the majority of tools lean toward a pathogenic effect, and this conclusion does not contradict the absence of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.127496Structured0.403499Uncertain0.8860.2760.000-11.090Likely Pathogenic0.719Likely PathogenicLikely Benign0.04Likely Benign0.10.28Likely Benign0.16Likely Benign1.01Destabilizing0.228Likely Benign-2.84Deleterious0.989Probably Damaging0.767Possibly Damaging1.84Pathogenic0.08Tolerated0.14820.08280-1-6.424.99
c.86T>G
M29R
2D
AIThe SynGAP1 missense variant M29R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only SIFT predicts a pathogenic outcome. The high‑accuracy consensus from SGM (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) classifies the variant as Likely Benign, and AlphaMissense‑Optimized also predicts Benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of evidence points to a benign effect, and this conclusion does not contradict any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.541878Disordered0.438540Uncertain0.3410.8830.250-1.708Likely Benign0.241Likely BenignLikely Benign0.211Likely Benign-0.92Neutral0.042Benign0.184Benign4.23Benign0.00Affected0.20760.12930-1-6.424.99
c.1130T>A
M377K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M377K is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are Rosetta and Foldetta. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates a likely benign outcome, while premPS remains uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus as likely benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) as pathogenic. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict the absence of a ClinVar classification. Thus, the variant is most likely benign based on current predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.675549Disordered0.431183Uncertain0.3240.8840.625-3.718Likely Benign0.226Likely BenignLikely Benign0.20Likely Benign0.24.44Destabilizing2.32Destabilizing0.62Ambiguous0.440Likely Benign-0.26Neutral0.002Benign0.003Benign5.46Benign0.07Tolerated0.24230.16710-1-5.8-3.02
c.1226T>A
M409K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M409K has no ClinVar record and is absent from gnomAD. Functional prediction tools show a split: benign calls come from REVEL, Rosetta, SIFT, and FATHMM, while pathogenic calls arise from premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, and AlphaMissense‑Default. Uncertain results are reported by FoldX, Foldetta, and AlphaMissense‑Optimized. High‑accuracy assessments further clarify the picture: AlphaMissense‑Optimized is inconclusive; the SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, predicts pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, is also inconclusive. Overall, the majority of evidence points toward a pathogenic effect, and this conclusion does not conflict with the ClinVar status, which currently has no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.150080Structured0.360643Uncertain0.8840.2190.000-13.618Likely Pathogenic0.927Likely PathogenicAmbiguous0.93Ambiguous0.30.29Likely Benign0.61Ambiguous1.45Destabilizing0.490Likely Benign-4.26Deleterious0.769Possibly Damaging0.750Possibly Damaging4.18Benign0.40Tolerated0.13180.06560-1-5.8-3.02
c.1241T>A
M414K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M414K is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect are limited to FATHMM, whereas the remaining tools—SGM‑Consensus, REVEL, Rosetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. FoldX and Foldetta provide uncertain or inconclusive results and are treated as unavailable. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic, SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is pathogenic, and Foldetta is unavailable. Based on the overwhelming agreement among the majority of prediction tools and the high‑accuracy methods, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.081712Structured0.329108Uncertain0.9140.2170.000-13.537Likely Pathogenic0.996Likely PathogenicLikely Pathogenic1.18Ambiguous0.12.39Destabilizing1.79Ambiguous1.50Destabilizing0.503Likely Pathogenic-5.03Deleterious0.942Possibly Damaging0.860Possibly Damaging3.40Benign0.04Affected0.12990.08880-1-5.8-3.02
c.1289T>A
M430K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M430K is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, Rosetta, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are PROVEAN and ESM1b. The remaining tools—FoldX, Foldetta, premPS, and AlphaMissense‑Default—return uncertain or inconclusive results. High‑accuracy methods give a mixed picture: AlphaMissense‑Optimized classifies the variant as benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) favors a pathogenic outcome; Foldetta remains uncertain. Overall, the majority of individual predictors lean toward a benign interpretation, whereas the SGM Consensus suggests pathogenicity. Given the lack of ClinVar evidence, there is no contradiction with existing clinical annotations. Based on the aggregate predictions, the variant is most likely benign, and this assessment does not conflict with the current ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.071867Structured0.385298Uncertain0.9520.3060.000-10.816Likely Pathogenic0.494AmbiguousLikely Benign0.78Ambiguous0.10.44Likely Benign0.61Ambiguous0.86Ambiguous0.149Likely Benign-2.66Deleterious0.134Benign0.033Benign3.47Benign0.32Tolerated0.16600.12710-1-5.8-3.02
c.1403T>A
M468K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M468K is listed in ClinVar (ID 642691.0) as Pathogenic and is not reported in gnomAD. All available in silico predictors classify the variant as pathogenic: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a benign effect. High‑accuracy assessments confirm this: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. Thus, the variant is most likely pathogenic, and this prediction aligns with its ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.284882Structured0.339253Uncertain0.9320.2570.000Likely Pathogenic 1-16.982Likely Pathogenic0.978Likely PathogenicLikely Pathogenic3.21Destabilizing0.13.30Destabilizing3.26Destabilizing2.57Destabilizing0.828Likely Pathogenic-4.61Deleterious0.878Possibly Damaging0.922Probably Damaging-1.34Pathogenic0.04Affected3.37310.15760.04560-1-5.8-3.02188.769.30.00.0-0.10.2XXPotentially PathogenicThe thioether group of Met468, located in the middle of an α helix (res. Ala461–Phe476), interacts with hydrophobic residues (e.g., Phe464, Leu465, Leu489) in an inter-helix space formed by two other α helices (res. Ala461–Phe476, res. Thr488–Gly502). In the variant simulations, the positively charged side chain of Lys468 rotates outward to escape the hydrophobic niche, forming an H-bond with the hydroxyl group of the Ser471 side chain and a salt bridge with the carboxylate group of the Glu472 side chain. This residue swap also disrupts the methionine-aromatic stacking with the phenyl ring of the Phe464 side chain. Although no large-scale structural changes are observed during the variant simulations, the importance of hydrophobic packing suggests that the effects could be more pronounced during protein folding.
c.1409T>A
M470K
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant M470K is not reported in ClinVar (status: None) and is absent from gnomAD. Prediction tools cluster into two groups: the single benign call comes from SIFT, while all other evaluated algorithms—REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus—label the change as pathogenic or likely pathogenic. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized predicts pathogenic; the SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates likely pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also reports pathogenic. Thus, the variant is most likely pathogenic based on the consensus of available predictions, and this assessment does not contradict any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.298791Structured0.351497Uncertain0.9080.2720.000-14.327Likely Pathogenic0.996Likely PathogenicLikely Pathogenic2.77Destabilizing0.12.67Destabilizing2.72Destabilizing1.55Destabilizing0.823Likely Pathogenic-5.42Deleterious0.923Possibly Damaging0.922Probably Damaging-1.06Pathogenic0.20Tolerated0.11570.06560-1-5.8-3.02
c.1430T>A
M477K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M477K is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are premPS and FATHMM. Predictions that are uncertain or inconclusive are FoldX, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as benign, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is unavailable due to mixed or uncertain inputs. Overall, the majority of evidence points to a benign impact. Thus, the variant is most likely benign, and this conclusion does not contradict the current ClinVar status, which contains no report of pathogenicity.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.268042Structured0.408680Uncertain0.7610.2500.000-7.519In-Between0.553AmbiguousLikely Benign0.54Ambiguous0.10.37Likely Benign0.46Likely Benign1.12Destabilizing0.371Likely Benign-1.32Neutral0.254Benign0.122Benign-1.15Pathogenic0.14Tolerated0.18170.08470-1-5.8-3.02
c.1493T>A
M498K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M498K is not reported in ClinVar and is absent from gnomAD. Prediction tools largely agree on a deleterious effect: benign calls come only from polyPhen‑2 HumDiv and HumVar, whereas the remaining 15 tools (REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus) all predict pathogenicity. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized scores the variant as pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) labels it likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts a destabilizing, pathogenic effect. Taken together, the overwhelming majority of evidence indicates that M498K is most likely pathogenic, and this conclusion is consistent with the absence of a ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.092881Structured0.399612Uncertain0.9320.1580.000-11.622Likely Pathogenic0.983Likely PathogenicLikely Pathogenic2.82Destabilizing0.12.86Destabilizing2.84Destabilizing1.79Destabilizing0.867Likely Pathogenic-4.53Deleterious0.287Benign0.120Benign-1.37Pathogenic0.00Affected0.12810.06560-1-5.8-3.02
c.1634T>A
M545K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M545K is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from SIFT, FoldX, and Rosetta, while pathogenic predictions are made by REVEL, premPS, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and PROVEAN. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, labels the variant as Likely Pathogenic. High‑accuracy assessments further show AlphaMissense‑Optimized as Pathogenic, SGM Consensus as Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as Benign. Overall, the majority of evidence points toward a pathogenic effect, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.025762Structured0.012875Uncertain0.9550.3110.000-11.723Likely Pathogenic0.996Likely PathogenicLikely Pathogenic0.02Likely Benign0.10.46Likely Benign0.24Likely Benign1.07Destabilizing0.809Likely Pathogenic-4.80Deleterious0.972Probably Damaging0.960Probably Damaging-1.17Pathogenic0.43Tolerated0.11440.04880-1-5.8-3.02
c.173T>A
M58K
2D
AIThe SynGAP1 missense variant M58K is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and FATHMM. Tools that predict a pathogenic effect are SIFT and AlphaMissense‑Default. AlphaMissense‑Optimized is uncertain. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely benign classification. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of evidence points to a benign impact. There is no ClinVar entry to contradict this assessment, so the variant is most likely benign based on current predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.188120Structured0.484415Uncertain0.5150.6650.000-6.059Likely Benign0.939Likely PathogenicAmbiguous0.199Likely Benign-1.52Neutral0.018Benign0.184Benign4.08Benign0.00Affected0.16150.11630-1-5.8-3.02
c.1808T>A
M603K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M603K is not reported in ClinVar and has no entries in gnomAD. Prediction tools largely agree on a deleterious effect: pathogenic calls come from REVEL, SGM Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized, while only FoldX reports a benign outcome. High‑accuracy assessments reinforce this trend: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic, and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, is inconclusive. No other tools provide a clear benign signal. Consequently, the variant is most likely pathogenic, and this assessment does not conflict with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.011342Structured0.197847Uncertain0.9420.1760.000-15.561Likely Pathogenic0.994Likely PathogenicLikely Pathogenic0.17Likely Benign0.01.19Ambiguous0.68Ambiguous0.67Ambiguous0.933Likely Pathogenic-5.64Deleterious0.923Possibly Damaging0.922Probably Damaging-1.35Pathogenic0.00Affected0.12680.04880-1-5.8-3.02
c.1832T>A
M611K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 M611K variant has no ClinVar entry and is not reported in gnomAD. Prediction tools that classify it as benign include polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Optimized. The majority of other in silico predictors (SGM‑Consensus, REVEL, Rosetta, Foldetta, premPS, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default) indicate a pathogenic effect; FoldX is uncertain and therefore not considered evidence. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM Consensus (derived from the unanimous pathogenic vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) and Foldetta (combining FoldX‑MD and Rosetta outputs) both predict pathogenicity. Based on the preponderance of pathogenic predictions and the high‑accuracy consensus, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.236433Structured0.210791Uncertain0.8700.2530.000-13.021Likely Pathogenic0.630Likely PathogenicLikely Benign1.86Ambiguous0.62.65Destabilizing2.26Destabilizing1.65Destabilizing0.665Likely Pathogenic-4.10Deleterious0.250Benign0.120Benign-1.26Pathogenic0.03Affected0.11930.06880-1-5.8-3.02
c.1946T>A
M649K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M649K is not reported in ClinVar and is absent from gnomAD. Prediction tools largely agree on a deleterious effect: pathogenic predictions come from REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Benign calls are limited to polyPhen‑2 (HumVar) and FATHMM. High‑accuracy methods reinforce the pathogenic consensus: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also predicts pathogenic. No prediction or stability result is missing or inconclusive. Based on the overwhelming agreement among these tools, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.051831Structured0.360413Uncertain0.9620.3450.000-14.533Likely Pathogenic0.995Likely PathogenicLikely Pathogenic3.42Destabilizing0.06.19Destabilizing4.81Destabilizing1.79Destabilizing0.614Likely Pathogenic-5.98Deleterious0.968Probably Damaging0.382Benign3.34Benign0.01Affected0.14380.10790-1-5.8-3.02
c.1979T>A
M660K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M660K is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect are polyPhen‑2 HumVar and FATHMM. All other evaluated predictors—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the variant as pathogenic. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized predicts pathogenicity; the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates pathogenicity; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, reports a pathogenic effect. Based on the overwhelming consensus of pathogenic predictions and the corroborating high‑accuracy tools, the variant is most likely pathogenic, and this conclusion does not contradict the current ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.047319Structured0.134270Uncertain0.9440.2890.000-14.123Likely Pathogenic0.995Likely PathogenicLikely Pathogenic3.13Destabilizing0.14.46Destabilizing3.80Destabilizing2.36Destabilizing0.604Likely Pathogenic-5.99Deleterious0.862Possibly Damaging0.216Benign3.34Benign0.00Affected0.13890.08560-1-5.8-3.02
c.2264T>A
M755K
2D
AIThe SynGAP1 missense variant M755K is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. Only polyPhen‑2 HumDiv predicts a pathogenic outcome, while AlphaMissense‑Default remains uncertain. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized predicts Benign, SGM‑Consensus indicates Likely Benign, and Foldetta results are unavailable. Based on the collective evidence, the variant is most likely benign, and this conclusion does not contradict the ClinVar status, which contains no conflicting report.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.490133Structured0.783855Binding0.3360.8730.375-5.642Likely Benign0.531AmbiguousLikely Benign0.101Likely Benign-1.88Neutral0.468Possibly Damaging0.206Benign2.63Benign0.28Tolerated0.11830.06880-1-5.8-3.02
c.2276T>A
M759K
2D
AIThe SynGAP1 missense variant M759K (ClinVar ID 4178662) is listed as ClinVar status Uncertain and is not present in gnomAD. Prediction tools that agree on a benign effect include SGM‑Consensus (Likely Benign), REVEL, PROVEAN, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as Likely Benign; the Foldetta protein‑folding stability analysis is unavailable. Overall, the majority of evidence points to a benign impact, which does not contradict the ClinVar Uncertain designation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.525368Disordered0.879389Binding0.2990.8640.375Uncertain 1-5.670Likely Benign0.616Likely PathogenicLikely Benign0.288Likely Benign-1.86Neutral0.891Possibly Damaging0.492Possibly Damaging2.55Benign0.06Tolerated0.13380.06880-1-5.8-3.02
c.2279T>A
M760K
2D
AIThe SynGAP1 missense variant M760K is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; Foldetta results are not available. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict the ClinVar status, which currently contains no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.541878Disordered0.893402Binding0.3460.8650.375-4.069Likely Benign0.654Likely PathogenicLikely Benign0.108Likely Benign-1.18Neutral0.784Possibly Damaging0.492Possibly Damaging2.75Benign0.12Tolerated0.17510.10710-1-5.8-3.02
c.2318T>A
M773K
2D
AIThe SynGAP1 missense variant M773K is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is classified as Likely Benign (three benign votes versus one pathogenic). High‑accuracy assessments show AlphaMissense‑Optimized as Benign and the SGM‑Consensus as Likely Benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.408655Structured0.916222Binding0.3250.8930.250-5.117Likely Benign0.641Likely PathogenicLikely Benign0.178Likely Benign-1.80Neutral0.106Benign0.471Possibly Damaging4.19Benign0.02Affected0.16460.08510-1-5.8-3.02
c.2342T>A
M781K
2D
AIThe SynGAP1 missense variant M781K is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Only AlphaMissense‑Default predicts a pathogenic outcome. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; the Foldetta protein‑folding stability analysis is unavailable for this variant. Overall, the majority of evidence points to a benign impact, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.580690Disordered0.792850Binding0.3420.8890.625-6.321Likely Benign0.734Likely PathogenicLikely Benign0.258Likely Benign-1.47Neutral0.138Benign0.150Benign2.72Benign0.20Tolerated0.15500.06880-1-5.8-3.02
c.2348T>A
M783K
2D
AIThe SynGAP1 missense variant M783K is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, polyPhen‑2 HumVar, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, SIFT, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is inconclusive due to a 2‑vs‑2 split, and Foldetta results are unavailable. Overall, the majority of evidence points toward a benign impact. This conclusion does not contradict ClinVar status, as the variant has no ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.736850Disordered0.738119Binding0.3310.8890.625-4.923Likely Benign0.693Likely PathogenicLikely Benign0.206Likely Benign-2.70Deleterious0.925Possibly Damaging0.424Benign2.66Benign0.01Affected0.17300.09120-1-5.8-3.02
c.2501T>A
M834K
2D
AIThe SynGAP1 missense variant M834K is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are SIFT and FATHMM, while AlphaMissense‑Default remains uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also predicts benign. Foldetta, a protein‑folding stability method, has no available result for this variant. Overall, the majority of evidence points to a benign impact. This conclusion is consistent with the lack of ClinVar annotation and does not contradict any existing clinical database status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.585406Disordered0.640801Binding0.2580.8630.375-3.154Likely Benign0.453AmbiguousLikely Benign0.154Likely Benign-2.21Neutral0.369Benign0.150Benign2.43Pathogenic0.00Affected0.11310.06880-1-5.8-3.02
c.2528T>A
M843K
2D
AIThe SynGAP1 missense variant M843K is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect are REVEL and FATHMM, whereas the remaining tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN)—all predict a pathogenic or likely pathogenic impact. High‑accuracy assessments further support a deleterious outcome: AlphaMissense‑Optimized classifies the variant as pathogenic, and the SGM‑Consensus indicates it is likely pathogenic. The Foldetta protein‑folding stability analysis is unavailable for this variant. Overall, the preponderance of evidence from both general and high‑accuracy predictors indicates that M843K is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation because no ClinVar status exists for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.585406Disordered0.617934Binding0.3270.8540.375-13.256Likely Pathogenic0.992Likely PathogenicLikely Pathogenic0.442Likely Benign-3.60Deleterious0.968Probably Damaging0.969Probably Damaging2.60Benign0.00Affected0.17630.09400-1-5.8-3.02
c.2711T>A
M904K
2D
AIThe SynGAP1 missense variant M904K is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). Only AlphaMissense‑Default predicts a pathogenic outcome. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; Foldetta results are not available for this variant. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.671169Disordered0.589073Binding0.3500.9200.250-2.333Likely Benign0.744Likely PathogenicLikely Benign0.033Likely Benign-1.08Neutral0.277Benign0.137Benign2.80Benign1.00Tolerated0.16960.08710-1-5.8-3.02
c.2726T>A
M909K
2D
AIThe SynGAP1 missense variant M909K is not reported in ClinVar and is absent from gnomAD. Consensus predictions from multiple in silico tools cluster into two groups: benign (SGM‑Consensus, REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Optimized) and pathogenic (polyPhen‑2 HumDiv, polyPhen‑2 HumVar, AlphaMissense‑Default). High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates likely benign. Foldetta, a protein‑folding stability method, was not available for this variant. Overall, the preponderance of evidence points to a benign effect, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.642678Disordered0.696196Binding0.3140.9140.250-5.024Likely Benign0.748Likely PathogenicLikely Benign0.126Likely Benign-1.17Neutral0.965Probably Damaging0.629Possibly Damaging2.71Benign0.18Tolerated0.15850.06280-1-5.8-3.02
c.2801T>A
M934K
2D
AIThe SynGAP1 missense variant M934K is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, SIFT, and ESM1b, whereas those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, FATHMM, and AlphaMissense‑Default. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as Likely Pathogenic. High‑accuracy assessments show AlphaMissense‑Optimized as Uncertain, SGM‑Consensus as Likely Pathogenic, and Foldetta (a protein‑folding stability method combining FoldX‑MD and Rosetta outputs) is unavailable for this variant. Overall, the balance of evidence from the majority of tools points to a pathogenic impact. This conclusion is not contradicted by ClinVar status, which currently contains no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.762850Disordered0.984677Binding0.2900.8670.625-2.457Likely Benign0.816Likely PathogenicAmbiguous0.333Likely Benign-3.66Deleterious0.929Possibly Damaging0.521Possibly Damaging2.38Pathogenic0.13Tolerated0.18280.12620-1-5.8-3.02
c.3092T>A
M1031K
2D
AIThe SynGAP1 missense variant M1031K is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Only AlphaMissense‑Default predicts a pathogenic outcome. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; Foldetta results are not available. Based on the collective evidence, the variant is most likely benign, and this conclusion does not contradict any ClinVar status because no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.865454Disordered0.995959Binding0.3400.7360.500-1.940Likely Benign0.709Likely PathogenicLikely Benign0.114Likely Benign-0.80Neutral0.325Benign0.098Benign2.66Benign0.18Tolerated0.12240.14120-1-5.8-3.02
c.3443T>A
M1148K
2D
AIThe SynGAP1 missense variant M1148K is not reported in ClinVar and has no entry in gnomAD. Prediction tools that agree on a benign effect include SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are SIFT and AlphaMissense‑Default. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized predicts benign, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) yields a “Likely Benign” outcome. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of evidence points to a benign impact, and this is consistent with the absence of a ClinVar pathogenic classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.762850Disordered0.774279Binding0.3430.8350.875-2.527Likely Benign0.624Likely PathogenicLikely Benign0.105Likely Benign-1.58Neutral0.144Benign0.085Benign2.55Benign0.00Affected0.15390.10560-1-5.8-3.02
c.3482T>A
M1161K
2D
AIThe SynGAP1 missense variant M1161K is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that indicate a benign effect include REVEL, SIFT, and ESM1b, whereas tools that predict a pathogenic effect include PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote). High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as pathogenic and the SGM‑Consensus labeling it as Likely Pathogenic; Foldetta results are unavailable. Overall, the majority of computational predictions support a pathogenic impact, and this conclusion is not contradicted by any ClinVar annotation. Thus, the variant is most likely pathogenic based on the available predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.580690Disordered0.864109Binding0.3720.8300.375-3.005Likely Benign0.994Likely PathogenicLikely Pathogenic0.236Likely Benign-2.91Deleterious0.968Probably Damaging0.969Probably Damaging2.19Pathogenic0.17Tolerated0.16290.08280-1-5.8-3.02
c.353T>A
M118K
2D
AIThe SynGAP1 missense variant M118K is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include REVEL, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, SIFT, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM Consensus (a majority vote among AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is inconclusive (two pathogenic vs. two benign votes). Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict any ClinVar annotation, as none exists for M118K.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.694846Disordered0.676867Binding0.3300.8830.500-3.979Likely Benign0.767Likely PathogenicLikely Benign0.276Likely Benign-2.98Deleterious0.396Benign0.099Benign3.84Benign0.01Affected0.20100.11310-1-5.8-3.02
c.3560T>A
M1187K
2D
AIThe SynGAP1 missense variant M1187K is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include PROVEAN, ESM1b, and FATHMM, while those that predict a pathogenic effect are REVEL, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as Likely Benign. High‑accuracy assessments show AlphaMissense‑Optimized as Pathogenic and the SGM‑Consensus as Likely Benign; Foldetta results are unavailable. Overall, the majority of evidence points to a pathogenic impact, and this conclusion does not contradict any ClinVar annotation (none is present). Thus, the variant is most likely pathogenic based on current predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignCoiled-coil0.562014Disordered0.499801Uncertain0.5970.6360.625-3.712Likely Benign0.972Likely PathogenicLikely Pathogenic0.594Likely Pathogenic-0.71Neutral0.968Probably Damaging0.969Probably Damaging5.54Benign0.03Affected0.17580.08510-1-5.8-3.02
c.3632T>A
M1211K
2D
AIThe SynGAP1 missense variant M1211K is listed in ClinVar (ID 834052.0) as benign and is not reported in gnomAD. Functional prediction tools cluster into two groups: benign predictions come from FATHMM and AlphaMissense‑Optimized, while the remaining seven tools—REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default—classify the change as pathogenic. High‑accuracy assessments further clarify the picture: AlphaMissense‑Optimized predicts a benign effect, whereas the SGM Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates a likely pathogenic outcome; Foldetta data are unavailable. Overall, the preponderance of evidence from standard predictors and the SGM Consensus supports a pathogenic interpretation, which contradicts the benign classification reported in ClinVar.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.585406Disordered0.578388Binding0.8760.5650.500Likely Benign 1-9.013Likely Pathogenic0.662Likely PathogenicLikely Benign0.595Likely Pathogenic-2.95Deleterious0.987Probably Damaging0.979Probably Damaging5.59Benign0.01Affected3.7750.14620.08790-1-5.8-3.02
c.3704T>A
M1235K
2D
AIThe SynGAP1 missense variant M1235K is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the substitution as benign. Only SIFT predicts a pathogenic outcome. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates a likely benign effect. High‑accuracy assessments confirm this: AlphaMissense‑Optimized is benign, and the SGM‑Consensus is likely benign; Foldetta results are not available. Overall, the consensus of the majority of tools, including the high‑accuracy methods, supports a benign classification. This prediction is consistent with the lack of ClinVar evidence and does not contradict any existing database status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignCoiled-coil0.690604Disordered0.577958Binding0.8720.5320.125-6.348Likely Benign0.269Likely BenignLikely Benign0.109Likely Benign-2.37Neutral0.270Benign0.089Benign2.66Benign0.00Affected0.12820.06560-1-5.8-3.02
c.3800T>A
M1267K
2D
AIThe SynGAP1 missense variant M1267K is not reported in ClinVar and has no entries in gnomAD. Functional prediction tools show a split: benign calls come from REVEL and ESM1b, while pathogenic calls are made by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Default. The high‑accuracy consensus, SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, favors a pathogenic outcome (3/4 pathogenic). AlphaMissense‑Optimized is uncertain, and no Foldetta stability assessment is available. Overall, the majority of evidence points to a deleterious effect, classifying the variant as most likely pathogenic. This assessment does not conflict with ClinVar, which contains no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.429200Structured0.812047Binding0.8470.6140.000-6.415Likely Benign0.917Likely PathogenicAmbiguous0.366Likely Benign-5.01Deleterious0.884Possibly Damaging0.581Possibly Damaging2.31Pathogenic0.00Affected0.13730.04880-1-5.8-3.02
c.3839T>A
M1280K
2D
AIThe SynGAP1 missense variant M1280K is not reported in ClinVar and has no entry in gnomAD, indicating it is not catalogued in these databases. Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), AlphaMissense‑Default, AlphaMissense‑Optimized, and ESM1b. Tools that predict a pathogenic effect are SIFT and FATHMM. The SGM‑Consensus, which aggregates the majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus (majority vote) also indicates benign. The Foldetta protein‑folding stability analysis is unavailable for this variant. Overall, the preponderance of evidence from multiple prediction algorithms and consensus methods points to a benign impact for M1280K, and this conclusion does not contradict any ClinVar status, as none is assigned.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.882776Disordered0.822030Binding0.5100.7260.875-2.963Likely Benign0.223Likely BenignLikely Benign0.213Likely Benign-1.42Neutral0.126Benign0.041Benign2.37Pathogenic0.00Affected0.10960.04880-1-5.8-3.02
c.47T>A
M16K
2D
AIThe SynGAP1 missense variant M16K is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are SIFT and AlphaMissense‑Default. The SGM‑Consensus, which aggregates the majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized predicts Benign, and the SGM‑Consensus also indicates Likely Benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of computational predictions and the high‑accuracy consensus suggest that M16K is most likely benign, and this assessment does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.440853Structured0.459925Uncertain0.3460.9080.375-2.567Likely Benign0.635Likely PathogenicLikely Benign0.185Likely Benign-0.37Neutral0.003Benign0.001Benign4.23Benign0.00Affected0.19840.11120-1-5.8-3.02
c.521T>A
M174K
2D
AIThe SynGAP1 missense variant M174K has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. Tools that predict a pathogenic effect are PROVEAN, SIFT, ESM1b, and AlphaMissense‑Default. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as Likely Pathogenic, and AlphaMissense‑Optimized independently predicts it as Pathogenic. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the balance of evidence from high‑accuracy predictors and the consensus score points to a pathogenic classification. This assessment is not contradicted by ClinVar, which currently contains no entry for M174K.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.661982Disordered0.485854Uncertain0.3730.6200.375-9.542Likely Pathogenic0.978Likely PathogenicLikely Pathogenic0.325Likely Benign-3.21Deleterious0.002Benign0.002Benign4.06Benign0.01Affected0.13730.06880-1-5.8-3.02
c.866T>A
M289K
2D
3DClick to see structure in 3D Viewer
AISynGAP1 M289K is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, FoldX, SIFT, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely pathogenic classification. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Because the majority of consensus and individual predictors lean toward pathogenicity, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status since none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.127496Structured0.403499Uncertain0.8860.2760.000-12.192Likely Pathogenic0.738Likely PathogenicLikely Benign0.36Likely Benign0.20.60Ambiguous0.48Likely Benign0.94Ambiguous0.229Likely Benign-2.52Deleterious0.891Possibly Damaging0.492Possibly Damaging1.94Pathogenic0.12Tolerated0.12710.08790-1-5.8-3.02
c.86T>A
M29K
2D
AIThe SynGAP1 missense variant M29K is not reported in ClinVar and is absent from gnomAD, indicating no known population frequency or clinical annotation. Prediction tools that converge on a benign outcome include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only SIFT predicts a pathogenic effect. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus likewise indicates Likely Benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the collective predictions point to a benign effect, and this conclusion does not contradict the absence of a ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.541878Disordered0.438540Uncertain0.3410.8830.250-2.514Likely Benign0.287Likely BenignLikely Benign0.197Likely Benign-0.88Neutral0.018Benign0.184Benign4.27Benign0.00Affected0.20190.13120-1-5.8-3.02
c.2635_2636delinsAA
A879K
2D
AIThe SynGAP1 missense variant A879K is listed in ClinVar (ID 575856.0) as benign and is not reported in gnomAD. Prediction tools that agree on a benign effect include PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; a Foldetta stability analysis is unavailable. Overall, the majority of evidence points to a benign impact, and this consensus aligns with the ClinVar designation, with no contradiction.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.608892Disordered0.622695Binding0.2770.8740.250Likely Benign 1-5.877Likely Benign0.757Likely PathogenicLikely Benign-0.71Neutral0.969Probably Damaging0.593Possibly Damaging2.69Benign0.21Tolerated3.7750.09300.2569-1-1-5.757.10
c.1034T>C
L345P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L345P is not reported in ClinVar (ClinVar status: not listed) and is absent from gnomAD (gnomAD ID: none). Prediction tools that agree on a benign effect include only REVEL, which scores the variant as benign. All other evaluated algorithms—FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the variant as pathogenic. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates a likely pathogenic outcome. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts pathogenic, the SGM‑Consensus (majority vote) is likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. Based on the collective predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.260850Structured0.354989Uncertain0.9360.4780.125-10.994Likely Pathogenic0.994Likely PathogenicLikely Pathogenic3.33Destabilizing0.23.26Destabilizing3.30Destabilizing1.27Destabilizing0.335Likely Benign-4.80Deleterious0.998Probably Damaging0.889Possibly Damaging1.70Pathogenic0.02Affected0.35810.1342-3-3-5.4-16.04
c.1058T>C
L353P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L353P is listed in ClinVar with an uncertain significance and is not reported in gnomAD. Functional prediction tools show a strong bias toward pathogenicity: REVEL predicts benign, whereas FoldX, Rosetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Default all predict pathogenic. Two tools report uncertainty: ESM1b and AlphaMissense‑Optimized. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized is inconclusive, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts pathogenic. Overall, the majority of evidence points to a pathogenic impact, which is consistent with the ClinVar designation of uncertain significance but leans toward pathogenicity rather than benign. Thus, the variant is most likely pathogenic, and this prediction does not contradict the ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.137348Structured0.373584Uncertain0.9260.3150.000Uncertain 1-7.913In-Between0.936Likely PathogenicAmbiguous4.63Destabilizing0.110.19Destabilizing7.41Destabilizing2.17Destabilizing0.464Likely Benign-3.70Deleterious0.947Possibly Damaging0.454Possibly Damaging1.29Pathogenic0.02Affected3.37250.35820.1645-3-3-5.4-16.04
c.1100T>C
L367P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L367P is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Functional prediction tools that agree on benign impact include REVEL, PROVEAN, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote). Tools that predict pathogenicity are FoldX, Rosetta, Foldetta, polyPhen‑2 HumDiv, SIFT, and FATHMM; premPS remains uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM‑Consensus as likely benign, while Foldetta (combining FoldX‑MD and Rosetta outputs) predicts a pathogenic effect. Overall, the majority of predictions lean toward a benign effect, and this conclusion does not contradict any ClinVar annotation because no ClinVar status exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.370445Structured0.441805Uncertain0.7900.6570.250-2.418Likely Benign0.160Likely BenignLikely Benign2.13Destabilizing0.44.05Destabilizing3.09Destabilizing0.72Ambiguous0.212Likely Benign-0.50Neutral0.627Possibly Damaging0.196Benign1.72Pathogenic0.02Affected0.39460.1874-3-3-5.4-16.04
c.1205T>C
L402P
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant L402P is not reported in ClinVar and is absent from gnomAD. Consensus among in‑silico predictors is overwhelmingly pathogenic: SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict a deleterious effect, whereas only FATHMM predicts a benign outcome. High‑accuracy tools reinforce this view: AlphaMissense‑Optimized scores the variant as pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates a likely pathogenic effect; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also predicts pathogenicity. Taken together, the evidence strongly supports a pathogenic classification, and this assessment does not conflict with the absence of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.243554Structured0.431978Uncertain0.9610.3830.000-12.030Likely Pathogenic0.999Likely PathogenicLikely Pathogenic7.40Destabilizing0.15.82Destabilizing6.61Destabilizing2.22Destabilizing0.616Likely Pathogenic-4.80Deleterious1.000Probably Damaging0.980Probably Damaging3.68Benign0.01Affected0.36280.1874-3-3-5.4-16.04
c.1247T>C
L416P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L416P is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split: benign predictions from REVEL, SIFT, and FATHMM; pathogenic predictions from the remaining 13 tools (FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen2_HumDiv, polyPhen2_HumVar, AlphaMissense‑Default, AlphaMissense‑Optimized, ESM1b, and the SGM Consensus). High‑accuracy methods specifically indicate pathogenicity: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. No predictions are inconclusive. Based on the overall consensus of the majority of tools and the high‑accuracy methods, the variant is most likely pathogenic, which is consistent with the lack of ClinVar reporting and gnomAD absence.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.104810Structured0.336105Uncertain0.9350.2270.000-8.859Likely Pathogenic0.975Likely PathogenicLikely Pathogenic2.59Destabilizing0.16.23Destabilizing4.41Destabilizing1.27Destabilizing0.284Likely Benign-3.56Deleterious1.000Probably Damaging1.000Probably Damaging3.35Benign0.21Tolerated0.35890.1353-3-3-5.4-16.04
c.1292T>C
L431P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L431P (ClinVar ID 661045.0) is reported as Pathogenic and is not present in gnomAD. Prediction tools that classify the variant as benign include only FATHMM. All other evaluated tools—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—predict it to be pathogenic. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized predicts Pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts Pathogenic. Based on the overwhelming consensus of pathogenic predictions and the ClinVar designation, the variant is most likely pathogenic, with no contradiction to its ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.094817Structured0.374755Uncertain0.9590.3000.000Likely Pathogenic 1-14.222Likely Pathogenic0.996Likely PathogenicLikely Pathogenic6.78Destabilizing0.311.59Destabilizing9.19Destabilizing2.29Destabilizing0.659Likely Pathogenic-6.39Deleterious1.000Probably Damaging0.998Probably Damaging2.91Benign0.05Affected3.37290.34840.2163-3-3-5.4-16.04222.462.80.10.00.10.0XPotentially PathogenicThe iso-butyl side chain of Leu431, located in an α helix (res. Met414-Glu436), packs against other hydrophobic residues in an interhelix space (e.g., Val434, Leu435, Leu696, Leu711) in the WT simulations. While the backbone amide group of Leu431 forms an H-bond with the carbonyl group of His427, the cyclic five-membered pyrrolidine ring of Pro431, lacking the necessary amide group, cannot do the same. Thus, although the cyclic five-membered pyrrolidine ring of Pro431 packs almost as favorably as the side chain of Leu431 in the hydrophobic niche, the residue swap causes the α helix to partially unfold in the variant simulations.
c.1316T>C
L439P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L439P is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools largely agree on a deleterious effect: pathogenic predictions come from SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only FATHMM predicts a benign outcome. High‑accuracy methods reinforce the pathogenic view: AlphaMissense‑Optimized is pathogenic, SGM‑Consensus is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. No predictions are missing or inconclusive. Based on the overwhelming consensus of pathogenic predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.222385Structured0.281542Uncertain0.9420.2650.000-9.929Likely Pathogenic0.995Likely PathogenicLikely Pathogenic6.30Destabilizing0.27.62Destabilizing6.96Destabilizing1.28Destabilizing0.539Likely Pathogenic-5.72Deleterious1.000Probably Damaging1.000Probably Damaging3.21Benign0.02Affected0.34260.1192-3-3-5.4-16.04
c.1352T>C
L451P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L451P is reported in ClinVar as Pathogenic (ClinVar ID 3064222.0) and is not found in gnomAD. Prediction tools that assess functional impact uniformly classify the variant as pathogenic: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a benign effect. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. Based on these predictions, the variant is most likely pathogenic, and this conclusion aligns with its ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.281712Structured0.314017Uncertain0.9780.2320.000Likely Pathogenic 1-14.549Likely Pathogenic1.000Likely PathogenicLikely Pathogenic6.92Destabilizing0.28.57Destabilizing7.75Destabilizing2.58Destabilizing0.750Likely Pathogenic-6.81Deleterious1.000Probably Damaging1.000Probably Damaging2.43Pathogenic0.00Affected3.37340.28230.1221-3-3-5.4-16.04
c.1364T>C
L455P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L455P is not reported in ClinVar (ClinVar status: none) and is absent from gnomAD (gnomAD ID: none). Prediction tools that agree on a benign effect include only FATHMM, whereas all other evaluated algorithms—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. High‑accuracy assessments further support this: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is “Likely Pathogenic”; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, is pathogenic. No predictions are missing or inconclusive. Based on the overwhelming agreement among these tools, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.188120Structured0.310377Uncertain0.9630.1680.000-14.150Likely Pathogenic1.000Likely PathogenicLikely Pathogenic7.45Destabilizing0.211.99Destabilizing9.72Destabilizing2.19Destabilizing0.695Likely Pathogenic-6.72Deleterious1.000Probably Damaging1.000Probably Damaging3.23Benign0.00Affected0.32110.1221-3-3-5.4-16.04
c.1394T>C
L465P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L465P is listed in ClinVar as Pathogenic (ClinVar ID 1067821.0) and is not reported in gnomAD. Prediction tools that assess functional impact uniformly classify the variant as pathogenic: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a benign effect. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts pathogenicity; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts pathogenicity. Based on the unanimous computational evidence, the variant is most likely pathogenic, and this conclusion aligns with its ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.346032Structured0.319240Uncertain0.9560.2020.000Likely Pathogenic 1-14.824Likely Pathogenic1.000Likely PathogenicLikely Pathogenic7.18Destabilizing0.310.85Destabilizing9.02Destabilizing2.73Destabilizing0.778Likely Pathogenic-6.96Deleterious1.000Probably Damaging1.000Probably Damaging2.29Pathogenic0.00Affected3.37340.33870.1582-3-3-5.4-16.04211.165.90.10.0-0.20.0XPotentially PathogenicThe iso-butyl side chain of Leu465, located in the middle of an α helix (res. Ala461–Phe476), packs with hydrophobic residues (e.g., Phe464, Met468, Tyr497, Ile494) in an inter-helix space formed with two other α helices (res. Ala461–Phe476 and res. Thr488-Gly502). In the variant simulations, the cyclic five-membered pyrrolidine ring of Pro465 is not as optimal as the side chain of Leu465 for filling the three α helix hydrophobic niche. Although the residue swap does not cause a large-scale conformational shift during the simulations, the H-bond between the backbone amide group of Leu465 and the backbone carbonyl group of Ala461 is lost. This, in turn, breaks the continuity of the α helix secondary structure element.
c.1445T>C
L482P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L482P is not reported in ClinVar and is absent from gnomAD. All available in‑silico predictors classify the substitution as pathogenic: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a benign effect. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized indicates pathogenicity; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also reports Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, predicts a pathogenic impact. Based on the unanimous computational evidence, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status, as none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.254060Structured0.426236Uncertain0.7950.2480.000-12.866Likely Pathogenic0.994Likely PathogenicLikely Pathogenic3.59Destabilizing0.110.87Destabilizing7.23Destabilizing1.55Destabilizing0.896Likely Pathogenic-6.91Deleterious1.000Probably Damaging1.000Probably Damaging-1.30Pathogenic0.01Affected0.27560.0825-3-3-5.4-16.04
c.1466T>C
L489P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L489P is listed in ClinVar with an “Uncertain” status and is not reported in gnomAD. All evaluated in‑silico predictors classify the change as pathogenic: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a benign effect. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) reports “Likely Pathogenic”; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also predicts pathogenic. Overall, the variant is most likely pathogenic based on the consensus of predictive tools, a conclusion that contradicts the current ClinVar “Uncertain” classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.191378Structured0.326126Uncertain0.9490.2340.125Conflicting 2-13.520Likely Pathogenic0.997Likely PathogenicLikely Pathogenic2.50Destabilizing0.14.69Destabilizing3.60Destabilizing1.73Destabilizing0.939Likely Pathogenic-6.74Deleterious1.000Probably Damaging1.000Probably Damaging-1.56Pathogenic0.00Affected3.37350.36730.1474-3-3-5.4-16.04209.961.90.10.00.60.1XPotentially PathogenicThe iso-butyl side chain of Leu489, located in the α-helix (res. Leu489-Glu519) within an inter-helix space of four helices (res. Ala461-Phe476, res. Val441-Ser457, and res. Met414-Glu436), packs with hydrophobic residues (e.g., Cys432, Ala448, Lys444, Ala493, Val447, Met468). In the variant simulations, Pro489 is located near the beginning of the α-helix, so the residue swap with Leu489 does not affect the continuity of the secondary structure element. However, the side chain of proline is not as optimal as that of leucine for maintaining hydrophobic packing with nearby residues (e.g., Ala448, Lys444). Additionally, the consistently maintained hydrogen bond interaction between the backbone amide group of Leu489 and the carbonyl of Glu436 is lost due to the residue swap, potentially affecting the tertiary structure integrity.
c.1499T>C
L500P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L500P is listed in ClinVar (ID 2708686.0) as Pathogenic and is not reported in gnomAD. All available in‑silico predictors classify the variant as pathogenic: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a benign effect. High‑accuracy assessments confirm this: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. Thus, the variant is most likely pathogenic, and this prediction aligns with its ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.066181Structured0.382942Uncertain0.8930.1500.000Pathogenic 1-15.898Likely Pathogenic0.996Likely PathogenicLikely Pathogenic5.91Destabilizing0.38.90Destabilizing7.41Destabilizing1.92Destabilizing0.894Likely Pathogenic-6.96Deleterious1.000Probably Damaging1.000Probably Damaging-1.37Pathogenic0.01Affected3.37350.31030.0625-3-3-5.4-16.04
c.1517T>C
L506P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L506P is listed in ClinVar (ID 975474.0) as Pathogenic and is not reported in gnomAD. All available in‑silico predictors classify the variant as pathogenic: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a benign effect. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized is Pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) is Pathogenic. Based on the unanimous computational evidence, the variant is most likely pathogenic, which aligns with its ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.034884Structured0.279180Uncertain0.9240.1960.000Likely Pathogenic1-12.088Likely Pathogenic0.998Likely PathogenicLikely Pathogenic5.48Destabilizing0.710.19Destabilizing7.84Destabilizing2.50Destabilizing0.737Likely Pathogenic-6.96Deleterious1.000Probably Damaging1.000Probably Damaging1.55Pathogenic0.00Affected3.37350.30470.0625-3-3-5.4-16.04182.664.90.10.00.20.1XPotentially PathogenicLeu506 is located in the middle of an α-helix (res. Gly502-Tyr518) within the inter-helix space of two helices (res. Gly502-Tyr518 and res. Glu582-Met603). In the WT simulations, the iso-butyl side chain of Leu506 hydrophobically packs with residues in the inter-helix space (e.g., Ile510, Phe597, Leu598, Ala601). In the variant simulations, the cyclic five-membered pyrrolidine ring of Pro506 is not as optimal as Leu506 for hydrophobic packing with nearby residues. Additionally, Pro506 cannot maintain the hydrogen bond with the backbone oxygen of Gly502 as Leu506 does in the WT, which disrupts the secondary structure element.
c.1550T>C
L517P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L517P is not reported in ClinVar and is absent from gnomAD. Prediction tools uniformly indicate a deleterious effect: pathogenic predictions are returned by REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a benign outcome. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized classifies the change as pathogenic; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, labels it likely pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also reports a pathogenic effect. Consequently, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.118441Structured0.147645Uncertain0.9380.2960.000-15.546Likely Pathogenic1.000Likely PathogenicLikely Pathogenic5.88Destabilizing0.87.96Destabilizing6.92Destabilizing1.92Destabilizing0.937Likely Pathogenic-6.70Deleterious1.000Probably Damaging1.000Probably Damaging-1.50Pathogenic0.00Affected0.35700.1963-3-3-5.4-16.04
c.1628T>C
L543P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L543P (ClinVar ID 4540554) is classified as Pathogenic in ClinVar and is not reported in gnomAD. Prediction tools that assess functional impact uniformly indicate a deleterious effect: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict pathogenicity. No tool in the dataset predicts a benign outcome. High‑accuracy assessments corroborate this: AlphaMissense‑Optimized is Pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) is Pathogenic. All available predictions and stability analyses support a pathogenic effect. Therefore, the variant is most likely pathogenic, and this conclusion is consistent with its ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.048328Structured0.020918Uncertain0.9630.3140.000Likely Pathogenic 1-15.958Likely Pathogenic1.000Likely PathogenicLikely Pathogenic8.56Destabilizing0.613.44Destabilizing11.00Destabilizing1.54Destabilizing0.770Likely Pathogenic-6.97Deleterious1.000Probably Damaging1.000Probably Damaging1.89Pathogenic0.00Affected0.34570.0992-3-3-5.4-16.04
c.1652T>C
L551P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L551P (ClinVar ID 547942.0) is classified as Pathogenic in ClinVar and is not reported in gnomAD. Prediction tools that assess functional impact uniformly indicate a deleterious effect: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict pathogenicity. No tool in the dataset predicts a benign outcome. High‑accuracy assessments further support this: AlphaMissense‑Optimized is Pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability predictions, is Pathogenic. Based on the collective predictions, the variant is most likely pathogenic, and this conclusion aligns with its ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.009977Structured0.006653Uncertain0.9600.2540.000Likely Pathogenic 1-14.620Likely Pathogenic0.999Likely PathogenicLikely Pathogenic6.66Destabilizing0.16.58Destabilizing6.62Destabilizing2.66Destabilizing0.953Likely Pathogenic-4.70Deleterious1.000Probably Damaging1.000Probably Damaging-1.60Pathogenic0.01Affected3.37350.33770.1353-3-3-5.4-16.04208.660.90.10.0-0.30.0XPotentially PathogenicL551 is located on an α-helix (res. Ala533-Val560). The iso-butyl side chain of Leu551 hydrophobically packs with nearby hydrophobic residues such as Cys547, Phe652, Leu633, and Ile630 in the inter-helix space. In the variant simulations, the pyrrolidine side chain of Pro551 is not as optimal as leucine for hydrophobic packing with the nearby residues. Moreover, Pro551 lacks the amide group, and thus, it cannot form a hydrogen bond with the backbone carbonyl group of Cys547, which disrupts the continuity of the secondary structure element.
c.167T>C
L56P
2D
AIThe SynGAP1 missense variant L56P is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL and FATHMM, whereas the majority of tools predict a pathogenic impact: PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score (Likely Pathogenic). High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized classifies the variant as pathogenic, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates Likely Pathogenic. No Foldetta stability prediction is available for this variant. Overall, the preponderance of computational evidence points to a pathogenic effect, and this conclusion is not contradicted by any ClinVar annotation, which is currently absent.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.342579Structured0.476218Uncertain0.4950.6570.000-9.991Likely Pathogenic0.971Likely PathogenicLikely Pathogenic0.307Likely Benign-2.62Deleterious0.943Possibly Damaging0.944Probably Damaging3.77Benign0.00Affected0.38060.1342-3-3-5.4-16.04
c.1694T>C
L565P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L565P is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that assess pathogenicity largely agree: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict a pathogenic effect, while only FATHMM predicts a benign outcome. High‑accuracy assessments reinforce this consensus: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is likely pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, is pathogenic. No prediction or folding‑stability result is missing or inconclusive. Based on the overwhelming agreement among these tools, the variant is most likely pathogenic, and this conclusion does not contradict any existing ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.034884Structured0.045819Uncertain0.9220.2050.000-13.369Likely Pathogenic1.000Likely PathogenicLikely Pathogenic3.59Destabilizing0.46.82Destabilizing5.21Destabilizing2.33Destabilizing0.546Likely Pathogenic-6.97Deleterious1.000Probably Damaging1.000Probably Damaging2.74Benign0.00Affected0.38250.0877-3-3-5.4-16.04
c.170T>C
L57P
2D
AIThe SynGAP1 missense variant L57P is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, and FATHMM. Tools that agree on a pathogenic effect include polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized predicts pathogenicity. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is inconclusive (2 pathogenic vs. 2 benign). Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of predictions (six pathogenic vs. three benign) indicate that the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status, as none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.254060Structured0.481044Uncertain0.5540.6420.000-10.724Likely Pathogenic0.993Likely PathogenicLikely Pathogenic0.242Likely Benign-1.77Neutral0.943Possibly Damaging0.944Probably Damaging3.90Benign0.00Affected0.36510.1703-3-3-5.4-16.04
c.1721T>C
L574P
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant L574P is not reported in ClinVar and is present in gnomAD (6-33440773‑T‑C). Prediction tools that indicate a benign effect include REVEL, PROVEAN, and SIFT, whereas the majority of tools predict a pathogenic impact: FoldX, Rosetta, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, Foldetta, and the SGM Consensus score (likely pathogenic). High‑accuracy methods specifically give a pathogenic verdict: AlphaMissense‑Optimized is pathogenic, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. Based on the collective evidence, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.083462Structured0.026427Uncertain0.9270.2460.0006-33440773-T-C-13.394Likely Pathogenic0.989Likely PathogenicLikely Pathogenic2.95Destabilizing0.59.19Destabilizing6.07Destabilizing0.59Ambiguous0.442Likely Benign-1.05Neutral1.000Probably Damaging0.971Probably Damaging-1.29Pathogenic0.26Tolerated3.38320.38110.0953-3-3-5.4-16.04
c.1763T>C
L588P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L588P is listed in ClinVar with an “Uncertain” status and is not reported in gnomAD. All available in silico predictors classify the change as pathogenic: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a benign effect. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts pathogenicity; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates “Likely Pathogenic”; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, also predicts pathogenicity. Consequently, the variant is most likely pathogenic based on the collective predictions, and this assessment does not contradict the ClinVar status, which remains uncertain.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.038042Structured0.082229Uncertain0.8870.2140.000Uncertain 2-14.771Likely Pathogenic1.000Likely PathogenicLikely Pathogenic5.61Destabilizing0.512.91Destabilizing9.26Destabilizing2.33Destabilizing0.932Likely Pathogenic-6.97Deleterious1.000Probably Damaging1.000Probably Damaging-1.42Pathogenic0.00Affected3.38340.35330.0992-3-3-5.4-16.04
c.176T>C
L59P
2D
AIThe SynGAP1 missense variant L59P is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect are REVEL and FATHMM, whereas the majority of tools predict a pathogenic impact: PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. ESM1b is uncertain. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) yields a pathogenic verdict (2 pathogenic vs. 1 benign). Foldetta, a protein‑folding stability method, has no available result for this variant. Overall, the preponderance of evidence indicates that the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.212910Structured0.484882Uncertain0.5100.6680.000-7.076In-Between0.993Likely PathogenicLikely Pathogenic0.362Likely Benign-2.74Deleterious0.943Possibly Damaging0.944Probably Damaging3.25Benign0.00Affected0.37870.1382-3-3-5.4-16.04
c.1778T>C
L593P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L593P is listed in ClinVar with an “Uncertain” status and is not reported in gnomAD. Prediction tools that agree on a benign effect include only FATHMM, whereas all other evaluated algorithms (SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default) predict a pathogenic outcome. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized scores the variant as pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates “Likely Pathogenic”; and Foldetta, which integrates FoldX‑MD and Rosetta stability predictions, also classifies the variant as pathogenic. Based on the overwhelming consensus of pathogenic predictions, the variant is most likely pathogenic, a conclusion that contradicts its current ClinVar “Uncertain” status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.009728Structured0.110534Uncertain0.9410.1510.000Uncertain 1-13.961Likely Pathogenic0.999Likely PathogenicLikely Pathogenic5.75Destabilizing0.910.77Destabilizing8.26Destabilizing2.43Destabilizing0.777Likely Pathogenic-6.77Deleterious1.000Probably Damaging1.000Probably Damaging2.77Benign0.00Affected0.37830.1274-3-3-5.4-16.04
c.1784T>C
L595P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L595P is listed in ClinVar with an “Uncertain” status (ClinVar ID 3172762.0) and is not reported in gnomAD. Prediction tools that agree on a benign effect include only FATHMM, whereas all other evaluated algorithms (REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus) predict a pathogenic outcome. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. No prediction or folding stability result is missing or inconclusive. Based on the collective evidence, the variant is most likely pathogenic, which does not contradict the current ClinVar “Uncertain” classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.015344Structured0.128444Uncertain0.9200.1500.000Uncertain 1-11.856Likely Pathogenic0.999Likely PathogenicLikely Pathogenic2.09Destabilizing0.85.88Destabilizing3.99Destabilizing1.78Destabilizing0.747Likely Pathogenic-6.97Deleterious1.000Probably Damaging1.000Probably Damaging2.72Benign0.00Affected3.37350.33360.1713-3-3-5.4-16.04
c.1793T>C
L598P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L598P is not reported in ClinVar and is absent from gnomAD. Prediction tools largely agree on a deleterious effect: pathogenic predictions come from SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only FATHMM predicts a benign outcome. High‑accuracy methods reinforce the pathogenic view: AlphaMissense‑Optimized scores the variant as pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates it is likely pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also classifies it as pathogenic. No prediction or stability result is missing or inconclusive. Based on the consensus of these tools, the variant is most likely pathogenic, and this assessment is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.007259Structured0.147872Uncertain0.9530.1540.000-12.621Likely Pathogenic0.997Likely PathogenicLikely Pathogenic8.31Destabilizing0.512.04Destabilizing10.18Destabilizing2.02Destabilizing0.705Likely Pathogenic-6.87Deleterious1.000Probably Damaging1.000Probably Damaging3.10Benign0.00Affected0.27420.1192-3-3-5.4-16.04
c.1820T>C
L607P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L607P is not reported in ClinVar and is absent from gnomAD. Prediction tools that assess pathogenicity uniformly indicate a deleterious effect: REVEL, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as pathogenic, while the SGM‑Consensus score is “Likely Pathogenic.” No tool in the dataset predicts a benign outcome; the only inconclusive result is FoldX, which is listed as uncertain and therefore does not influence the overall assessment. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized predicts pathogenicity, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts pathogenicity. Consequently, the variant is most likely pathogenic based on the available predictions, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.048328Structured0.194229Uncertain0.8690.2500.000-14.059Likely Pathogenic0.994Likely PathogenicLikely Pathogenic1.11Ambiguous0.76.93Destabilizing4.02Destabilizing1.29Destabilizing0.922Likely Pathogenic-6.97Deleterious1.000Probably Damaging1.000Probably Damaging-1.54Pathogenic0.00Affected0.37100.1274-3-3-5.4-16.04
c.1829T>C
L610P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L610P is not reported in ClinVar and is absent from gnomAD. Across the available in‑silico predictors, every tool examined (REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized) classifies the substitution as pathogenic; no tool predicts a benign effect. High‑accuracy methods reinforce this consensus: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also reports a pathogenic effect. Because all evidence points to a deleterious impact and there is no ClinVar entry to contradict this, the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.271506Structured0.209504Uncertain0.8880.2530.000-14.863Likely Pathogenic0.990Likely PathogenicLikely Pathogenic6.02Destabilizing0.28.15Destabilizing7.09Destabilizing1.99Destabilizing0.934Likely Pathogenic-6.91Deleterious1.000Probably Damaging1.000Probably Damaging-1.59Pathogenic0.00Affected0.35990.1113-3-3-5.4-16.04
c.1868T>C
L623P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L623P is not reported in ClinVar and is absent from gnomAD. Prediction tools uniformly indicate a deleterious effect: pathogenic predictions are returned by REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a benign outcome. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized classifies the change as pathogenic; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, labels it likely pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also reports a pathogenic effect. Consequently, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.175930Structured0.060667Uncertain0.9620.2110.000-12.385Likely Pathogenic1.000Likely PathogenicLikely Pathogenic6.70Destabilizing0.211.18Destabilizing8.94Destabilizing2.26Destabilizing0.788Likely Pathogenic-6.97Deleterious1.000Probably Damaging1.000Probably Damaging1.56Pathogenic0.00Affected0.39610.1474-3-3-5.4-16.04
c.1874T>C
L625P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L625P is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include only FATHMM, whereas the remaining 13 tools (SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) uniformly predict a pathogenic impact. High‑accuracy methods give consistent results: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, also predicts pathogenic. No prediction or stability result is missing or inconclusive. Based on the collective evidence, the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.229226Structured0.045896Uncertain0.9660.2150.000-14.819Likely Pathogenic1.000Likely PathogenicLikely Pathogenic5.47Destabilizing0.612.49Destabilizing8.98Destabilizing1.98Destabilizing0.746Likely Pathogenic-6.92Deleterious1.000Probably Damaging1.000Probably Damaging2.98Benign0.00Affected0.32940.1313-3-3-5.4-16.04
c.1898T>C
L633P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L633P (ClinVar ID 858973.0) is listed as Pathogenic and is not reported in gnomAD. Prediction tools that classify the variant as benign include only FATHMM. All other evaluated tools—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—predict it to be pathogenic. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized scores it as Pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, predicts Pathogenic. Based on the overwhelming consensus of pathogenic predictions and the ClinVar designation, the variant is most likely pathogenic, with no contradiction to its ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.045352Structured0.045407Uncertain0.9520.2520.000Pathogenic/Likely path. 2-15.669Likely Pathogenic1.000Likely PathogenicLikely Pathogenic6.60Destabilizing0.210.15Destabilizing8.38Destabilizing2.42Destabilizing0.693Likely Pathogenic-6.97Deleterious1.000Probably Damaging1.000Probably Damaging2.70Benign0.00Affected3.37340.35280.0953-3-3-5.4-16.04193.265.10.00.00.10.0XPotentially PathogenicThe iso-butyl side chain of Leu633, located in the middle of an α helix (res. Glu617-Asn635), packs hydrophobically with nearby residues (e.g., Leu653, Val629, Leu551) in the WT simulations.In the variant simulations, the pyrrolidine side chain of Pro633 is not as optimal for hydrophobic packing as Leu633 in the WT. Additionally, proline lacks a free backbone amide group, so Pro633 cannot form a hydrogen bond with the backbone carbonyl group of Val629, which disrupts the continuity of the secondary structure element.
c.1937T>C
L646P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L646P is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include only FATHMM, whereas all other evaluated algorithms—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the variant as pathogenic. High‑accuracy methods further support a deleterious impact: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. No prediction or folding stability result is missing or inconclusive. Based on the overwhelming consensus of pathogenic predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because the variant is not yet catalogued in ClinVar.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.048328Structured0.303751Uncertain0.9410.3440.000-12.956Likely Pathogenic0.970Likely PathogenicLikely Pathogenic7.34Destabilizing0.512.08Destabilizing9.71Destabilizing2.72Destabilizing0.604Likely Pathogenic-4.55Deleterious0.999Probably Damaging0.926Probably Damaging3.17Benign0.00Affected0.34810.1874-3-3-5.4-16.04
c.1958T>C
L653P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L653P is not reported in ClinVar (ClinVar status: none) and is absent from gnomAD (gnomAD ID: none). Prediction tools that agree on a benign effect include only FATHMM, whereas the remaining tools—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. High‑accuracy methods give the following results: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates likely pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. Based on the overwhelming agreement among these tools, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.049374Structured0.335213Uncertain0.9630.3320.000-17.675Likely Pathogenic0.999Likely PathogenicLikely Pathogenic6.02Destabilizing0.89.20Destabilizing7.61Destabilizing2.56Destabilizing0.700Likely Pathogenic-6.51Deleterious1.000Probably Damaging0.996Probably Damaging3.09Benign0.00Affected0.32510.1874-3-3-5.4-16.04
c.1964T>C
L655P
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant L655P is catalogued in gnomAD (ID 6‑33441223‑T‑C) but has no ClinVar entry. Functional prediction tools show a split: benign calls come from REVEL, PROVEAN, SIFT, and FATHMM, whereas pathogenic calls are made by Rosetta, Foldetta, both polyPhen‑2 versions, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized; FoldX and premPS are uncertain. High‑accuracy assessments give AlphaMissense‑Optimized as pathogenic, Foldetta as pathogenic, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive. Overall, the majority of evidence points to a pathogenic effect. This conclusion is consistent with the absence of a ClinVar classification, so there is no contradiction with ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.015344Structured0.268808Uncertain0.9610.2740.0006-33441223-T-C16.20e-7-9.771Likely Pathogenic0.982Likely PathogenicLikely Pathogenic1.33Ambiguous0.56.52Destabilizing3.93Destabilizing0.57Ambiguous0.126Likely Benign-1.36Neutral0.981Probably Damaging0.772Possibly Damaging3.47Benign0.32Tolerated3.39240.35980.1274-3-3-5.4-16.04
c.2009T>C
L670P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L670P is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, premPS, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) all indicate benign. In contrast, polyPhen‑2 (HumDiv and HumVar) predict a pathogenic impact. Stability‑based methods are inconclusive: FoldX, Rosetta, and the combined Foldetta output are uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus as likely benign, and Foldetta as uncertain. Overall, the majority of evidence supports a benign classification, and this is consistent with the absence of a ClinVar assertion; there is no contradiction with ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.161087Structured0.090855Uncertain0.8120.3850.000-4.916Likely Benign0.237Likely BenignLikely Benign0.56Ambiguous0.31.83Ambiguous1.20Ambiguous-0.25Likely Benign0.211Likely Benign2.42Neutral1.000Probably Damaging0.996Probably Damaging3.41Benign0.26Tolerated0.35900.1474-3-3-5.4-16.04
c.200T>C
L67P
2D
AIThe SynGAP1 missense variant L67P is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, and FATHMM, while those that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a “Likely Benign” classification. High‑accuracy assessments show AlphaMissense‑Optimized as “Uncertain” and the SGM‑Consensus as “Likely Benign”; Foldetta results are unavailable. Overall, the majority of evidence points toward a benign impact. The variant’s predicted benign status does not contradict any ClinVar annotation, as none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.458154Structured0.473668Uncertain0.4280.7610.125-2.852Likely Benign0.945Likely PathogenicAmbiguous0.150Likely Benign-0.80Neutral0.943Possibly Damaging0.766Possibly Damaging4.07Benign0.00Affected0.30520.1382-3-3-5.4-16.04
c.2018T>C
L673P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L673P is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include REVEL, FATHMM, and AlphaMissense‑Optimized. All other evaluated tools—SGM‑Consensus, FoldX, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default—predict a pathogenic impact. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized indicates benign, but the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) resolves as Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts Pathogenic. Taken together, the overwhelming majority of predictions, including the high‑accuracy tools, classify the variant as pathogenic. This conclusion is not contradicted by ClinVar, which contains no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.060549Structured0.104692Uncertain0.5450.3690.000-12.160Likely Pathogenic0.622Likely PathogenicLikely Benign2.41Destabilizing0.31.63Ambiguous2.02Destabilizing1.17Destabilizing0.207Likely Benign-4.10Deleterious1.000Probably Damaging0.978Probably Damaging3.37Benign0.02Affected0.35520.1474-3-3-5.4-16.04
c.203T>C
L68P
2D
AIThe SynGAP1 missense variant L68P is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify the variant as benign include REVEL, PROVEAN, ESM1b, FATHMM, and the SGM‑Consensus (Likely Benign). Tools that predict pathogenicity are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, while the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of predictions lean toward pathogenic, but the consensus from SGM and the high‑accuracy AlphaMissense‑Optimized are contradictory, leaving the variant’s clinical significance uncertain. No conflict exists with ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.534167Disordered0.470567Uncertain0.4050.7680.250-2.122Likely Benign0.956Likely PathogenicLikely Pathogenic0.143Likely Benign-0.57Neutral0.943Possibly Damaging0.766Possibly Damaging4.09Benign0.00Affected0.28270.1382-3-3-5.4-16.04
c.2066T>C
L689P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L689P is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include only FATHMM, whereas all other evaluated algorithms—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the variant as pathogenic. High‑accuracy methods further support a deleterious impact: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. No prediction or folding stability result is missing or inconclusive. Based on the overwhelming consensus of pathogenic predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.042364Structured0.227227Uncertain0.9630.2480.000-17.900Likely Pathogenic1.000Likely PathogenicLikely Pathogenic6.76Destabilizing0.213.35Destabilizing10.06Destabilizing2.29Destabilizing0.631Likely Pathogenic-6.97Deleterious1.000Probably Damaging0.999Probably Damaging3.17Benign0.00Affected0.36680.1353-3-3-5.4-16.04
c.2075T>C
L692P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L692P is listed in ClinVar with an “Uncertain” status (ClinVar ID 847082.0) and is not reported in gnomAD. Prediction tools that agree on a benign effect are limited to FATHMM, while the remaining tools (REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) uniformly predict a pathogenic impact. High‑accuracy assessments further support this: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates “Likely Pathogenic”; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, also predicts pathogenic. Based on the overwhelming consensus of pathogenic predictions, the variant is most likely pathogenic, which does not contradict its current ClinVar “Uncertain” classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.064632Structured0.295225Uncertain0.9660.2430.000Uncertain 1-16.447Likely Pathogenic1.000Likely PathogenicLikely Pathogenic9.19Destabilizing0.113.20Destabilizing11.20Destabilizing1.69Destabilizing0.668Likely Pathogenic-6.98Deleterious1.000Probably Damaging0.999Probably Damaging3.06Benign0.00Affected3.42170.36420.1025-3-3-5.4-16.04186.262.8-0.20.1-0.70.3XPotentially PathogenicThe isobutyl side chain of Leu692, located in the middle of an α-helix (res. Leu685-Gln702), engages in hydrophobic packing with nearby residues (e.g., Leu441, Leu431, Leu696) in the inter-helix space. Prolines lack a free amide group necessary for hydrogen bonding with the carbonyl group of Glu688 in the same manner as Leu692 in the WT. Consequently, the residue swap with proline disrupts the continuity of the secondary structure element in the variant simulations. Additionally, the side chain of Pro692 is not as optimal as Leu692 for hydrophobic packing in the inter-helix space.
c.2084T>C
L695P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L695P is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include only FATHMM, whereas the remaining tools—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. High‑accuracy methods give the following results: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates likely pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts pathogenic. Based on the overwhelming agreement among these tools, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.118441Structured0.373419Uncertain0.9420.2580.000-17.496Likely Pathogenic0.998Likely PathogenicLikely Pathogenic4.63Destabilizing0.24.73Destabilizing4.68Destabilizing2.11Destabilizing0.612Likely Pathogenic-6.85Deleterious1.000Probably Damaging0.998Probably Damaging3.16Benign0.00Affected0.30440.0992-3-3-5.4-16.04
c.2087T>C
L696P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L696P is listed in ClinVar as Pathogenic (ClinVar ID 1699350.0) and is not reported in gnomAD. Prediction tools that classify the variant as benign include only FATHMM; all other evaluated algorithms—REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—report it as pathogenic. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates a pathogenic effect. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote) is pathogenic, and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, predicts a destabilizing, pathogenic outcome. Taken together, the overwhelming majority of predictions and the high‑accuracy tools classify the variant as pathogenic, fully consistent with its ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.200174Structured0.390093Uncertain0.9620.2670.000Likely Pathogenic 1-16.926Likely Pathogenic1.000Likely PathogenicLikely Pathogenic6.66Destabilizing0.210.84Destabilizing8.75Destabilizing2.13Destabilizing0.678Likely Pathogenic-6.58Deleterious1.000Probably Damaging1.000Probably Damaging3.00Benign0.00Affected3.46130.30650.1995-3-3-5.4-16.04180.665.90.10.0-0.60.1XPotentially PathogenicThe isobutyl side chain of Leu696, located in the middle of an α-helix (res. Leu685-Gln702), engages in hydrophobic packing with nearby residues (e.g., Leu441, Leu431, Leu692, Leu714) in the inter-helix space. Prolines lack a free amide group necessary for hydrogen bonding with the carbonyl group of Leu692 in the same manner as Leu696 in the WT. Consequently, the residue swap with proline disrupts the continuity of the secondary structure element in the variant simulations. Additionally, the side chain of Pro696 is not as optimal as Leu696 for hydrophobic packing in the inter-helix space.
c.2099T>C
L700P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L700P is not reported in ClinVar and is absent from gnomAD. Prediction tools largely agree on a deleterious effect: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as pathogenic, while only FATHMM predicts it benign. The SGM‑Consensus, which is a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, yields a “Likely Pathogenic” verdict (3 pathogenic vs. 1 benign). High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized is pathogenic, SGM‑Consensus is likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. No prediction or stability result is missing or inconclusive. Based on the overwhelming consensus of pathogenic predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.113710Structured0.416255Uncertain0.9270.3310.000-13.092Likely Pathogenic0.982Likely PathogenicLikely Pathogenic7.29Destabilizing0.512.85Destabilizing10.07Destabilizing1.84Destabilizing0.541Likely Pathogenic-4.31Deleterious0.999Probably Damaging0.966Probably Damaging3.30Benign0.01Affected0.36030.1025-3-3-5.4-16.04
c.2108T>C
L703P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L703P is not reported in ClinVar and is absent from gnomAD. Prediction tools largely agree on a deleterious effect: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the variant as pathogenic, while only FATHMM predicts it benign. The SGM‑Consensus, which is a majority vote among AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, yields a “Likely Pathogenic” result (3 pathogenic vs. 1 benign). High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized is pathogenic; SGM‑Consensus is likely pathogenic; and Foldetta, integrating FoldX‑MD and Rosetta outputs, is pathogenic. No prediction or stability result is missing or inconclusive. Based on the overwhelming consensus of pathogenic predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.144935Structured0.388282Uncertain0.9290.3530.000-13.766Likely Pathogenic0.990Likely PathogenicLikely Pathogenic4.44Destabilizing0.19.38Destabilizing6.91Destabilizing1.54Destabilizing0.559Likely Pathogenic-5.70Deleterious1.000Probably Damaging0.996Probably Damaging3.11Benign0.00Affected0.36980.1186-3-3-5.4-16.04
c.2123T>C
L708P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L708P is not reported in ClinVar and is absent from gnomAD. Consensus among most in‑silico predictors is strongly pathogenic: FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) all indicate a deleterious effect. Only REVEL and FATHMM predict a benign outcome, while AlphaMissense‑Optimized is uncertain. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is inconclusive, SGM Consensus reports “Likely Pathogenic,” and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts a destabilizing, pathogenic change. Taken together, the preponderance of evidence points to a pathogenic impact for L708P, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.250310Structured0.365875Uncertain0.9310.3780.000-10.268Likely Pathogenic0.932Likely PathogenicAmbiguous4.29Destabilizing0.16.43Destabilizing5.36Destabilizing1.62Destabilizing0.298Likely Benign-4.47Deleterious1.000Probably Damaging0.989Probably Damaging3.39Benign0.04Affected0.28000.0825-3-3-5.4-16.04
c.2126T>C
L709P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L709P is not reported in ClinVar and is absent from gnomAD. Benign predictions come from REVEL, premPS, PROVEAN, SIFT, FATHMM, and AlphaMissense‑Optimized, while pathogenic predictions arise from FoldX, Rosetta, Foldetta, polyPhen2_HumDiv, polyPhen2_HumVar, and AlphaMissense‑Default. High‑accuracy tools give mixed results: AlphaMissense‑Optimized predicts benign; the SGM Consensus (majority vote of AlphaMissense‑Default, FATHMM, PROVEAN) also predicts benign; Foldetta predicts pathogenic. Because the majority of standard predictors and the SGM Consensus favor benign, the variant is most likely benign, and this is consistent with the lack of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.243554Structured0.365830Uncertain0.9340.3790.000-7.517In-Between0.767Likely PathogenicLikely Benign2.81Destabilizing0.05.65Destabilizing4.23Destabilizing0.31Likely Benign0.167Likely Benign-1.93Neutral1.000Probably Damaging0.975Probably Damaging3.47Benign0.37Tolerated0.30040.0825-3-3-5.4-16.04
c.2132T>C
L711P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense change L711P is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect are REVEL and FATHMM; all other evaluated algorithms—including FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized scores the variant as pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates a likely pathogenic outcome; and Foldetta, which integrates FoldX‑MD and Rosetta stability predictions, also classifies the variant as pathogenic. Based on the overwhelming agreement among these tools, the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.308712Structured0.377436Uncertain0.9500.3640.000-12.128Likely Pathogenic0.997Likely PathogenicLikely Pathogenic5.70Destabilizing0.18.15Destabilizing6.93Destabilizing2.09Destabilizing0.375Likely Benign-6.59Deleterious1.000Probably Damaging1.000Probably Damaging3.28Benign0.00Affected0.33000.0986-3-3-5.4-16.04
c.2141T>C
L714P
2D
AIThe SynGAP1 missense variant L714P is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect are REVEL and FATHMM, whereas the remaining tools—FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized scores the variant as pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates a likely pathogenic outcome; and Foldetta, which integrates FoldX‑MD and Rosetta stability predictions, also classifies the variant as pathogenic. Based on the preponderance of evidence from these tools, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.314870Structured0.402311Uncertain0.9610.3690.000-12.562Likely Pathogenic0.999Likely PathogenicLikely Pathogenic7.48Destabilizing1.913.54Destabilizing10.51Destabilizing2.26Destabilizing0.441Likely Benign-6.44Deleterious1.000Probably Damaging1.000Probably Damaging3.08Benign0.00Affected0.35720.1253-3-3-5.4-16.04
c.2150T>C
L717P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L717P is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a deleterious effect: benign predictions come from REVEL and FATHMM, while the remaining 13 tools (FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM Consensus) all classify the variant as pathogenic. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts pathogenicity; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates “Likely Pathogenic”; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also predicts a pathogenic effect. No predictions are missing or inconclusive. Based on the preponderance of evidence, the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.239899Structured0.429342Uncertain0.9690.3970.000-10.214Likely Pathogenic0.998Likely PathogenicLikely Pathogenic3.96Destabilizing0.26.56Destabilizing5.26Destabilizing1.66Destabilizing0.447Likely Benign-5.32Deleterious1.000Probably Damaging1.000Probably Damaging3.28Benign0.00Affected0.30650.1053-3-3-5.4-16.04
c.2153T>C
L718P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L718P is not reported in ClinVar and is absent from gnomAD. Prediction tools that assess pathogenicity are unanimous: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as pathogenic. No tool in the dataset predicts a benign effect, so the benign‑prediction group is empty. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts pathogenic. Consequently, the variant is most likely pathogenic based on the available predictions, and this assessment does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.298791Structured0.438417Uncertain0.9660.3850.000-15.643Likely Pathogenic1.000Likely PathogenicLikely Pathogenic6.56Destabilizing0.19.69Destabilizing8.13Destabilizing2.35Destabilizing0.660Likely Pathogenic-6.64Deleterious1.000Probably Damaging1.000Probably Damaging1.28Pathogenic0.00Affected0.38540.1221-3-3-5.4-16.04
c.2174T>C
L725P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L725P is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include only REVEL, which scores the variant as benign. All other evaluated tools—FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN)—classify the variant as pathogenic or likely pathogenic. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized predicts pathogenic, the SGM‑Consensus (majority vote) indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. No prediction or folding stability result is missing or inconclusive. **Based on the collective predictions, the variant is most likely pathogenic, and this conclusion does not contradict the ClinVar status, which is currently unreported.**

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.557691Disordered0.455613Uncertain0.9110.4910.625-15.390Likely Pathogenic0.997Likely PathogenicLikely Pathogenic4.91Destabilizing0.19.02Destabilizing6.97Destabilizing1.82Destabilizing0.396Likely Benign-6.08Deleterious1.000Probably Damaging1.000Probably Damaging1.28Pathogenic0.00Affected0.37960.1664-3-3-5.4-16.04
c.2243T>C
L748P
2D
AIThe SynGAP1 missense variant L748P is reported in gnomAD (ID 6‑33441708‑T‑C) but has no ClinVar entry. Functional prediction tools cluster into two groups: benign predictions come from REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). Pathogenic predictions are made by polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. High‑accuracy assessments reinforce the benign view: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also yields benign. Foldetta, a protein‑folding stability method, has no available result for this variant. Overall, the preponderance of evidence from both general and high‑accuracy tools indicates that the variant is most likely benign, and this conclusion does not contradict any ClinVar status (none is assigned).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.703578Disordered0.611637Binding0.3390.8630.7506-33441708-T-C16.20e-7-2.732Likely Benign0.129Likely BenignLikely Benign0.075Likely Benign-0.69Neutral0.912Possibly Damaging0.611Possibly Damaging2.69Benign0.02Affected4.3220.35030.1399-3-3-5.4-16.04
c.2288T>C
L763P
2D
AIThe SynGAP1 missense variant L763P is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. AlphaMissense‑Default is uncertain. For high‑accuracy assessment, AlphaMissense‑Optimized predicts benign. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also yields a benign prediction (2 benign vs. 1 pathogenic, with one uncertain). Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict the ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.380708Structured0.918636Binding0.3510.8650.125-5.802Likely Benign0.550AmbiguousLikely Benign0.158Likely Benign-0.89Neutral0.999Probably Damaging0.977Probably Damaging2.36Pathogenic0.12Tolerated0.39200.1182-3-3-5.4-16.04
c.2306T>C
L769P
2D
AIThe SynGAP1 missense variant L769P is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and SIFT. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as Likely Benign. No Foldetta stability result is available, so it does not influence the assessment. Overall, the majority of evidence points to a benign impact for this variant, and this conclusion does not contradict any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.411940Structured0.928432Binding0.3670.8830.250-6.261Likely Benign0.338Likely BenignLikely Benign0.200Likely Benign-1.75Neutral0.925Possibly Damaging0.427Benign3.90Benign0.00Affected0.35730.1323-3-3-5.4-16.04
c.2330T>C
L777P
2D
AIThe SynGAP1 missense variant L777P is catalogued in gnomAD (6‑33442488‑T‑C) but has no ClinVar entry. Functional prediction tools cluster into two groups: benign predictions come from REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Pathogenic predictions are reported by polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT, while AlphaMissense‑Default remains uncertain. High‑accuracy assessments reinforce the benign trend: AlphaMissense‑Optimized scores the variant as benign, and the SGM‑Consensus also indicates a likely benign outcome. No Foldetta stability analysis is available, so it does not influence the assessment. Overall, the preponderance of evidence points to a benign effect for the variant, and this conclusion is not contradicted by any ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.408655Structured0.876129Binding0.3360.8820.2506-33442488-T-C-5.807Likely Benign0.361AmbiguousLikely Benign0.255Likely Benign-2.13Neutral0.991Probably Damaging0.985Probably Damaging3.94Benign0.00Affected3.6460.37320.1664-3-3-5.4-16.04
c.2357T>C
L786P
2D
AISynGAP1 missense variant L786P is reported in gnomAD (ID 6‑33442909‑T‑C) but has no ClinVar entry. Functional prediction tools show discordant results: benign predictions come from REVEL, ESM1b, and AlphaMissense‑Optimized, whereas pathogenic predictions are made by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Default. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Pathogenic. High‑accuracy assessments further highlight this split: AlphaMissense‑Optimized reports a benign effect, SGM‑Consensus confirms a likely pathogenic outcome, and Foldetta results are unavailable. Overall, the majority of conventional tools and the SGM‑Consensus support a pathogenic interpretation, while one high‑accuracy tool suggests benign. No ClinVar status is present, so there is no contradiction with existing clinical annotations.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicSH3-binding motif0.882776Disordered0.655253Binding0.3410.8950.7506-33442909-T-C-3.217Likely Benign0.656Likely PathogenicLikely Benign0.219Likely Benign-4.06Deleterious0.999Probably Damaging0.999Probably Damaging1.79Pathogenic0.00Affected3.7750.33430.1814-3-3-5.4-16.04
c.2414T>C
L805P
2D
AIThe SynGAP1 missense variant L805P is listed in ClinVar with an uncertain significance and is not reported in gnomAD. Functional prediction tools show a split: benign calls come from REVEL, ESM1b, and AlphaMissense‑Optimized, while pathogenic calls are made by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM; AlphaMissense‑Default remains uncertain. High‑accuracy assessments give a benign result from AlphaMissense‑Optimized, a pathogenic outcome from the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), and no Foldetta data are available. Overall, the majority of predictions lean toward pathogenicity, and this conclusion does not conflict with the ClinVar uncertain status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
SH3-binding motif0.775545Disordered0.827669Binding0.3410.9030.625Uncertain 1-4.661Likely Benign0.444AmbiguousLikely Benign0.272Likely Benign-3.40Deleterious0.975Probably Damaging0.767Possibly Damaging2.36Pathogenic0.00Affected3.7750.31280.1650-3-3-5.4-16.04
c.242T>C
L81P
2D
AIThe SynGAP1 missense variant L81P is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumVar, ESM1b, and FATHMM, while those that predict a pathogenic effect are polyPhen‑2 HumDiv, SIFT, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely benign classification. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as likely benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) is not available for this variant. Overall, the majority of evidence points to a benign impact. This conclusion is consistent with the lack of ClinVar annotation, so there is no contradiction with ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.632174Disordered0.502033Binding0.2910.8780.250-4.413Likely Benign0.827Likely PathogenicAmbiguous0.095Likely Benign-1.51Neutral0.919Possibly Damaging0.226Benign3.92Benign0.00Affected0.30620.1818-3-3-5.4-16.04
c.2438T>C
L813P
2D
AIThe SynGAP1 missense variant L813P is not reported in ClinVar and is absent from gnomAD. Consensus predictions from multiple in silico tools cluster around a benign effect: REVEL, PROVEAN, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized all indicate benign, while the majority of high‑accuracy predictors (AlphaMissense‑Optimized and the SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also support a benign classification. In contrast, polyPhen‑2 (HumDiv and HumVar) predict a pathogenic impact, and AlphaMissense‑Default remains uncertain. No Foldetta stability assessment is available, so it does not influence the overall interpretation. Overall, the preponderance of evidence points to a benign effect for the variant, and this conclusion is not contradicted by any ClinVar annotation, as none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignSH3-binding motif0.411940Structured0.838481Binding0.2920.9050.250-2.572Likely Benign0.554AmbiguousLikely Benign0.122Likely Benign-1.96Neutral0.999Probably Damaging0.985Probably Damaging2.58Benign0.21Tolerated0.35640.1458-3-3-5.4-16.04
c.245T>C
L82P
2D
AIThe SynGAP1 missense variant L82P is not reported in ClinVar (ClinVar status: none) but is present in gnomAD (ID 6‑33425853‑T‑C). Prediction tools that agree on a benign effect include REVEL, polyPhen‑2 HumVar, and FATHMM, whereas those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized; ESM1b remains uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic and the SGM Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also favors pathogenicity. Foldetta, a protein‑folding stability method, did not provide a result for this variant. Overall, the majority of evidence points to a pathogenic impact. This conclusion is not contradicted by ClinVar status, which has no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.637480Disordered0.517720Binding0.2840.8900.3756-33425853-T-C16.20e-7-7.667In-Between0.991Likely PathogenicLikely Pathogenic0.125Likely Benign-2.73Deleterious0.939Possibly Damaging0.162Benign3.64Benign0.00Affected4.3210.34770.1118-3-3-5.4-16.04
c.2504T>C
L835P
2D
AIThe SynGAP1 missense variant L835P is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote) which classifies the variant as Likely Benign. In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT all predict a pathogenic impact. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized predicts Benign, and the SGM‑Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates Likely Benign. No Foldetta stability result is available, so it does not influence the overall assessment. Overall, the majority of evidence points to the variant being most likely benign, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.608892Disordered0.642742Binding0.3190.8630.125-3.024Likely Benign0.139Likely BenignLikely Benign0.144Likely Benign0.03Neutral0.999Probably Damaging0.977Probably Damaging2.78Benign0.04Affected0.34550.1079-3-3-5.4-16.04
c.2531T>C
L844P
2D
AIThe SynGAP1 missense variant L844P is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Consensus from standard in‑silico predictors shows a split: benign calls come from REVEL and FATHMM, whereas pathogenic calls are made by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized; ESM1b remains uncertain. High‑accuracy assessment further supports a deleterious effect: AlphaMissense‑Optimized predicts pathogenic, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) resolves to pathogenic. Foldetta, a protein‑folding stability method, has no available result for this variant. Overall, the preponderance of evidence from both conventional and high‑accuracy tools indicates that the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.595080Disordered0.611301Binding0.3040.8350.375-7.425In-Between0.962Likely PathogenicLikely Pathogenic0.319Likely Benign-3.18Deleterious0.986Probably Damaging0.876Possibly Damaging2.58Benign0.01Affected0.35280.1458-3-3-5.4-16.04
c.2564T>C
L855P
2D
AIThe SynGAP1 missense variant L855P is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict benign. Only polyPhen‑2 HumDiv indicates a pathogenic effect. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments confirm this: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus also predicts benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the consensus of the majority of prediction tools and the high‑accuracy methods indicates that the variant is most likely benign, and this assessment does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.724957Disordered0.485558Uncertain0.2850.8230.625-2.434Likely Benign0.092Likely BenignLikely Benign0.116Likely Benign-1.19Neutral0.586Possibly Damaging0.377Benign3.97Benign0.14Tolerated0.36330.1805-3-3-5.4-16.04
c.2588T>C
L863P
2D
AIThe SynGAP1 missense variant L863P is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as benign. In contrast, polyPhen‑2 (both HumDiv and HumVar models) predict it to be pathogenic. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as “Likely Benign.” High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized is benign, and the SGM‑Consensus is likely benign; Foldetta results are not available. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.525368Disordered0.594839Binding0.2670.7950.250-4.760Likely Benign0.234Likely BenignLikely Benign0.202Likely Benign-0.78Neutral0.999Probably Damaging0.977Probably Damaging4.01Benign0.12Tolerated0.35200.1458-3-3-5.4-16.04
c.2606T>C
L869P
2D
AIThe SynGAP1 missense variant L869P is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, and AlphaMissense‑Optimized, while polyPhen‑2 (HumDiv and HumVar) and SIFT all predict a pathogenic impact. AlphaMissense‑Default remains uncertain. The high‑accuracy consensus from SGM (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) yields a “Likely Benign” classification, and AlphaMissense‑Optimized independently predicts benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of evidence—including the high‑accuracy tools—supports a benign interpretation. This conclusion does not contradict ClinVar status, as no ClinVar assertion exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.501700Disordered0.688653Binding0.2720.8390.250-2.394Likely Benign0.523AmbiguousLikely Benign0.174Likely Benign-0.99Neutral0.990Probably Damaging0.900Possibly Damaging2.58Benign0.04Affected0.36870.1503-3-3-5.4-16.04
c.2609T>C
L870P
2D
AIThe SynGAP1 missense variant L870P is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are polyPhen‑2 HumDiv and polyPhen‑2 HumVar. AlphaMissense‑Default is uncertain, while the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates a likely benign outcome. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; Foldetta results are unavailable. Based on the collective predictions, the variant is most likely benign, and this assessment does not contradict any ClinVar status because no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.483068Structured0.688079Binding0.2740.8500.125-4.462Likely Benign0.402AmbiguousLikely Benign0.194Likely Benign-1.92Neutral0.999Probably Damaging0.999Probably Damaging2.59Benign0.13Tolerated0.37950.1864-3-3-5.4-16.04
c.2630T>C
L877P
2D
AIThe SynGAP1 missense variant L877P is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote) which classifies the variant as Likely Benign. In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT all predict a pathogenic impact. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized predicts Benign, and the SGM‑Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates Likely Benign. No Foldetta stability analysis is available for this variant. Overall, the majority of computational evidence points to a benign effect, and this conclusion does not contradict any ClinVar annotation, as none exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.653063Disordered0.634010Binding0.2650.8750.250-4.960Likely Benign0.312Likely BenignLikely Benign0.154Likely Benign-1.57Neutral0.986Probably Damaging0.876Possibly Damaging2.59Benign0.03Affected0.38990.1543-3-3-5.4-16.04
c.2648T>C
L883P
2D
AIThe SynGAP1 missense variant L883P is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict benign, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates a likely benign outcome. In contrast, polyPhen‑2 (both HumDiv and HumVar models) predict a pathogenic effect. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized is benign, and the SGM‑Consensus is likely benign; Foldetta results are unavailable. Overall, the preponderance of evidence supports a benign classification for this variant, and this conclusion does not contradict any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.716283Disordered0.641952Binding0.3340.8860.250-2.572Likely Benign0.105Likely BenignLikely Benign0.074Likely Benign-0.58Neutral0.934Possibly Damaging0.516Possibly Damaging2.62Benign0.21Tolerated0.34620.1658-3-3-5.4-16.04
c.2672T>C
L891P
2D
AIThe SynGAP1 missense variant L891P is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (which is “Likely Benign”). In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT all predict a pathogenic impact. High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates a likely benign outcome. No Foldetta stability result is available, so it does not influence the assessment. Overall, the majority of evidence points to a benign effect for L891P, and this conclusion is not contradicted by any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.712013Disordered0.505861Binding0.3050.9230.750-3.835Likely Benign0.169Likely BenignLikely Benign0.126Likely Benign-1.61Neutral0.990Probably Damaging0.900Possibly Damaging2.67Benign0.01Affected0.35940.1138-3-3-5.4-16.04
c.2717T>C
L906P
2D
AIThe SynGAP1 missense variant L906P is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. AlphaMissense‑Default is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also favors a benign outcome. Foldetta, which would provide a protein‑folding stability estimate, is unavailable for this variant. Overall, the preponderance of evidence points to a benign impact. This conclusion is not contradicted by ClinVar, which contains no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.604312Disordered0.644316Binding0.3150.9200.250-3.662Likely Benign0.478AmbiguousLikely Benign0.150Likely Benign0.08Neutral1.000Probably Damaging0.993Probably Damaging2.18Pathogenic0.10Tolerated0.34300.1458-3-3-5.4-16.04
c.2762T>C
L921P
2D
AIThe SynGAP1 missense variant L921P is recorded in gnomAD (ID 6‑33443314‑T‑C) but has no ClinVar submission. Functional prediction tools cluster into two groups: benign calls from REVEL, PROVEAN, ESM1b, and AlphaMissense‑Optimized; pathogenic calls from polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM. AlphaMissense‑Default is uncertain. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is inconclusive because the votes are split (two benign, one pathogenic, one uncertain). Foldetta, a protein‑folding stability predictor that combines FoldX‑MD and Rosetta outputs, has no reported result for this variant. Consequently, the evidence is evenly divided, with high‑accuracy tools not providing a decisive verdict. The variant is therefore inconclusive; it does not contradict ClinVar status, which currently has no entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.608892Disordered0.943282Binding0.3110.8450.3756-33443314-T-C16.20e-7-2.087Likely Benign0.393AmbiguousLikely Benign0.215Likely Benign-1.83Neutral0.998Probably Damaging0.958Probably Damaging2.39Pathogenic0.00Affected3.7750.35810.1343-3-3-5.4-16.04
c.2774T>C
L925P
2D
AIThe SynGAP1 missense variant L925P is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include only ESM1b, whereas the remaining tools—REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus—predict a pathogenic or likely pathogenic impact. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized classifies the variant as pathogenic, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports it as likely pathogenic. Foldetta results are not available for this variant. Overall, the preponderance of evidence from multiple in silico predictors indicates that the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.483068Structured0.977963Binding0.2900.8520.125-2.733Likely Benign0.985Likely PathogenicLikely Pathogenic0.501Likely Pathogenic-5.12Deleterious1.000Probably Damaging0.999Probably Damaging1.28Pathogenic0.00Affected0.30830.1996-3-3-5.4-16.04
c.2792T>C
L931P
2D
AIThe SynGAP1 missense variant L931P is not reported in ClinVar and is absent from gnomAD. Prediction tools show a strong bias toward pathogenicity: SIFT, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, PROVEAN, and AlphaMissense‑Default all predict a deleterious effect, whereas only REVEL indicates a benign outcome. High‑accuracy assessments reinforce this trend: the SGM consensus—derived from the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—classifies the variant as likely pathogenic, and AlphaMissense‑Optimized returns an uncertain result. Foldetta predictions are unavailable. Overall, the preponderance of evidence points to a pathogenic impact for L931P, and this conclusion is consistent with the absence of any ClinVar annotation, so there is no contradiction with existing clinical databases.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.549308Disordered0.989212Binding0.3350.8560.375-8.624Likely Pathogenic0.950Likely PathogenicAmbiguous0.376Likely Benign-3.43Deleterious1.000Probably Damaging0.999Probably Damaging2.38Pathogenic0.01Affected0.32030.1698-3-3-5.4-16.04
c.2963T>C
L988P
2D
AIThe SynGAP1 missense variant L988P is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is inconclusive (2 pathogenic vs. 2 benign). Foldetta results are unavailable. Overall, the majority of predictions (five pathogenic vs. four benign) lean toward pathogenicity. Thus, the variant is most likely pathogenic, and this conclusion does not contradict any existing ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.827927Disordered0.918781Binding0.3600.9130.750-3.848Likely Benign0.703Likely PathogenicLikely Benign0.216Likely Benign-2.96Deleterious0.977Probably Damaging0.900Possibly Damaging2.62Benign0.00Affected0.32820.1698-3-3-5.4-16.04
c.3002T>C
L1001P
2D
AIThe SynGAP1 missense variant L1001P is listed in ClinVar with an “Uncertain” status and is not reported in gnomAD. Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT all predict a pathogenic impact. The SGM‑Consensus, which aggregates the majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as “Likely Benign.” High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus (majority vote) also indicates benign. The Foldetta protein‑folding stability analysis is unavailable for this variant. Overall, the majority of evidence—including high‑accuracy tools—points to a benign effect, and this conclusion does not contradict the ClinVar “Uncertain” designation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.754692Disordered0.958507Binding0.2690.9020.375Uncertain 1-3.071Likely Benign0.209Likely BenignLikely Benign0.113Likely Benign-1.02Neutral0.966Probably Damaging0.690Possibly Damaging2.65Benign0.00Affected4.3240.33220.0929-3-3-5.4-16.04
c.3065T>C
L1022P
2D
AIThe SynGAP1 missense variant L1022P is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools cluster into two groups: benign predictions come from REVEL, PROVEAN, ESM1b, and AlphaMissense‑Optimized, while pathogenic predictions arise from polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as benign; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is inconclusive (two pathogenic, two benign), and Foldetta data are unavailable. Overall, the balance of evidence favors a pathogenic interpretation, and this assessment does not conflict with ClinVar status because no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.859585Disordered0.986981Binding0.3390.7520.500-2.532Likely Benign0.643Likely PathogenicLikely Benign0.177Likely Benign-2.22Neutral0.995Probably Damaging0.925Probably Damaging2.49Pathogenic0.01Affected0.33320.1589-3-3-5.4-16.04
c.3071T>C
L1024P
2D
AIThe SynGAP1 missense variant L1024P is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Default. The SGM Consensus, which takes a majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is inconclusive (2 benign vs 2 pathogenic). Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of standard prediction tools lean toward pathogenicity, while high‑accuracy methods are inconclusive. Thus, the variant is most likely pathogenic based on the available predictions, and this assessment does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.862302Disordered0.992699Binding0.3270.7530.500-4.385Likely Benign0.730Likely PathogenicLikely Benign0.149Likely Benign-2.42Neutral0.999Probably Damaging0.974Probably Damaging2.43Pathogenic0.03Affected0.31870.2033-3-3-5.4-16.04
c.3083T>C
L1028P
2D
AIThe SynGAP1 missense variant L1028P is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN). Only AlphaMissense‑Default predicts a pathogenic outcome. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; the Foldetta protein‑folding stability analysis is unavailable. Taken together, the majority of evidence points to a benign impact for this variant, and there is no ClinVar annotation to contradict this conclusion.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.899122Disordered0.995137Binding0.3640.7300.500-3.080Likely Benign0.594Likely PathogenicLikely Benign0.215Likely Benign-0.42Neutral0.004Benign0.010Benign2.70Benign0.25Tolerated0.28460.1763-3-3-5.4-16.04
c.3095T>C
L1032P
2D
AIThe SynGAP1 missense variant L1032P has no ClinVar entry and is not reported in gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, and the SGM‑Consensus score all classify the change as benign or likely benign. AlphaMissense‑Optimized also predicts a benign outcome, whereas SIFT uniquely flags the variant as pathogenic. The AlphaMissense‑Default assessment is uncertain, and no Foldetta stability data are available. High‑accuracy analyses reinforce the benign consensus: AlphaMissense‑Optimized reports a benign effect, and the SGM‑Consensus (derived from the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates benign. Foldetta results are missing, so they do not influence the interpretation. Overall, the majority of computational evidence supports a benign classification, which is consistent with the absence of a ClinVar pathogenic annotation. Thus, the variant is most likely benign, and this conclusion does not contradict ClinVar status, as no ClinVar pathogenic claim exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.865454Disordered0.995318Binding0.3650.7350.500-2.560Likely Benign0.449AmbiguousLikely Benign0.142Likely Benign-0.71Neutral0.012Benign0.017Benign2.64Benign0.05Affected0.30240.2330-3-3-5.4-16.04
c.3272T>C
L1091P
2D
AIThe SynGAP1 missense variant L1091P is listed in gnomAD (ID 6‑33443824‑T‑C) but has no ClinVar entry. Functional prediction tools cluster into two groups: benign predictions come from REVEL, PROVEAN, and ESM1b, while pathogenic predictions are reported by polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Default. AlphaMissense‑Optimized returns an uncertain result, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is a 2‑vs‑2 tie, leaving it inconclusive. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of tools (five pathogenic vs three benign) predict a deleterious effect, and the high‑accuracy AlphaMissense‑Optimized score is uncertain. Consequently, the variant is most likely pathogenic based on current predictions, and this assessment does not contradict any ClinVar status, as none is reported.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.924947Disordered0.984454Binding0.3760.8891.0006-33443824-T-C-4.139Likely Benign0.871Likely PathogenicAmbiguous0.180Likely Benign-1.25Neutral0.997Probably Damaging0.939Probably Damaging2.45Pathogenic0.04Affected3.7750.31990.1918-3-3-5.4-16.04
c.3326T>C
L1109P
2D
AIThe SynGAP1 missense variant L1109P is listed in ClinVar with an uncertain significance (ClinVar ID 1730257.0) and is not reported in gnomAD. Functional prediction tools uniformly classify the substitution as benign: REVEL, PROVEAN, PolyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all return benign scores. No tool predicts pathogenicity. High‑accuracy assessments corroborate this: AlphaMissense‑Optimized indicates a benign effect, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports a likely benign outcome. Foldetta, a protein‑folding stability predictor combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the computational evidence overwhelmingly supports a benign classification, which does not contradict the ClinVar uncertain status. Thus, the variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.856457Disordered0.948334Binding0.3430.8930.875Conflicting 2-5.313Likely Benign0.120Likely BenignLikely Benign0.151Likely Benign-0.52Neutral0.002Benign0.003Benign2.65Benign0.07Tolerated4.3220.31590.2330-3-3-5.4-16.04
c.3386T>C
L1129P
2D
AIThe SynGAP1 missense variant L1129P is listed in ClinVar with an “Uncertain” status and is not reported in gnomAD. Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT all predict a pathogenic impact. The SGM‑Consensus, which aggregates the majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as “Likely Benign.” High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus (majority vote) also indicates benign. The Foldetta protein‑folding stability analysis is unavailable for this variant. Overall, the majority of evidence—including high‑accuracy tools—points to a benign effect, and this conclusion does not contradict the current ClinVar “Uncertain” status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.903857Disordered0.876543Binding0.3390.9090.875Uncertain 2-2.991Likely Benign0.154Likely BenignLikely Benign0.432Likely Benign0.27Neutral0.971Probably Damaging0.773Possibly Damaging5.44Benign0.00Affected4.3240.30170.2231-3-3-5.4-16.04
c.3491T>C
L1164P
2D
AIThe SynGAP1 missense variant L1164P has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect include PROVEAN, ESM1b, and FATHMM, while those that predict a pathogenic impact are REVEL, polyPhen‑2 (HumDiv and HumVar), SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as Likely Benign. High‑accuracy assessments show AlphaMissense‑Optimized as Pathogenic, SGM‑Consensus as Likely Benign, and Foldetta results are unavailable. Overall, the majority of tools (seven pathogenic vs. three benign) predict a deleterious effect, indicating that the variant is most likely pathogenic. This prediction does not contradict ClinVar status, as no ClinVar classification exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.517562Disordered0.853935Binding0.3250.8150.375-3.928Likely Benign0.997Likely PathogenicLikely Pathogenic0.573Likely Pathogenic-2.16Neutral0.999Probably Damaging0.999Probably Damaging5.41Benign0.04Affected0.31730.1414-3-3-5.4-16.04
c.3539T>C
L1180P
2D
AISynGAP1 missense variant L1180P is not reported in ClinVar and has no entry in gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, and FATHMM, while those that predict a pathogenic impact are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as “Likely Benign.” High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, whereas the SGM‑Consensus remains likely benign; Foldetta results are unavailable. Overall, the balance of evidence, including the consensus prediction and the higher number of benign calls, suggests the variant is most likely benign, and this conclusion does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignCoiled-coil0.626927Disordered0.559845Binding0.5910.6720.250-4.564Likely Benign0.994Likely PathogenicLikely Pathogenic0.213Likely Benign-1.37Neutral0.992Probably Damaging0.930Probably Damaging2.65Benign0.00Affected0.35560.1155-3-3-5.4-16.04
c.3575T>C
L1192P
2D
AIThe SynGAP1 missense variant L1192P is not reported in ClinVar and has no gnomAD entry. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, and FATHMM, while those that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus, which is a majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as Likely Benign. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, whereas the SGM‑Consensus remains benign; Foldetta results are unavailable. Overall, the balance of evidence leans toward a benign interpretation, and this assessment does not contradict any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignCoiled-coil0.575842Disordered0.441757Uncertain0.7620.6090.625-4.610Likely Benign0.989Likely PathogenicLikely Pathogenic0.181Likely Benign-1.94Neutral0.997Probably Damaging0.959Probably Damaging2.65Benign0.05Affected0.35150.1053-3-3-5.4-16.04
c.3614T>C
L1205P
2D
AIThe SynGAP1 missense variant L1205P is listed in ClinVar with an “Uncertain” status and is not reported in gnomAD. All available in silico predictors classify the change as pathogenic: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a benign effect. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized is pathogenic, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is “Likely Pathogenic.” Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the computational evidence strongly indicates that the variant is pathogenic, which contradicts the current ClinVar designation of uncertainty.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.595080Disordered0.552471Binding0.8800.5760.375Uncertain 1-16.878Likely Pathogenic1.000Likely PathogenicLikely Pathogenic0.536Likely Pathogenic-5.91Deleterious1.000Probably Damaging0.999Probably Damaging1.45Pathogenic0.00Affected0.35590.1053-3-3-5.4-16.04
c.3626T>C
L1209P
2D
AIThe SynGAP1 missense variant L1209P is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include only REVEL, which scores the variant as benign. All other evaluated tools predict a pathogenic impact: PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is also pathogenic. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic and the SGM‑Consensus as pathogenic; Foldetta results are unavailable. Based on the overwhelming agreement among pathogenic predictions and the lack of benign consensus, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.595080Disordered0.583711Binding0.8990.5740.375-17.259Likely Pathogenic1.000Likely PathogenicLikely Pathogenic0.448Likely Benign-5.92Deleterious1.000Probably Damaging0.999Probably Damaging1.45Pathogenic0.00Affected0.36460.1053-3-3-5.4-16.04
c.3647T>C
L1216P
2D
AIThe SynGAP1 missense variant L1216P is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly indicate a deleterious effect: REVEL, PROVEAN, PolyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as pathogenic. No tool predicts a benign outcome. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also reports the variant as likely pathogenic. High‑accuracy assessments further support this view: AlphaMissense‑Optimized predicts pathogenicity, and the SGM‑Consensus confirms a likely pathogenic status. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the consensus of available predictions strongly suggests that the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.580690Disordered0.504713Binding0.8630.5630.250-16.029Likely Pathogenic1.000Likely PathogenicLikely Pathogenic0.524Likely Pathogenic-5.28Deleterious1.000Probably Damaging0.999Probably Damaging2.13Pathogenic0.00Affected0.32810.1048-3-3-5.4-16.04
c.3668T>C
L1223P
2D
AIThe SynGAP1 missense variant L1223P is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly indicate a deleterious effect: REVEL, PROVEAN, PolyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as pathogenic. No tool predicts a benign outcome. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also reports the variant as Likely Pathogenic. High‑accuracy assessments confirm this: AlphaMissense‑Optimized predicts pathogenicity, and the SGM‑Consensus agrees. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Based on the concordant pathogenic predictions and the lack of benign evidence, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.608892Disordered0.436267Uncertain0.8680.5400.375-14.728Likely Pathogenic1.000Likely PathogenicLikely Pathogenic0.500Likely Pathogenic-5.17Deleterious1.000Probably Damaging0.990Probably Damaging1.45Pathogenic0.01Affected0.34130.2352-3-3-5.4-16.04
c.3671T>C
L1224P
2D
AIThe SynGAP1 missense variant L1224P is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). In silico predictors that agree on a benign effect include REVEL and SIFT, whereas the remaining tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus—consistently predict a pathogenic outcome. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic, and the SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is also likely pathogenic. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the preponderance of predictions indicates that the variant is most likely pathogenic, and this conclusion is not contradicted by ClinVar status, which contains no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.525368Disordered0.441554Uncertain0.8710.5430.500-11.727Likely Pathogenic0.981Likely PathogenicLikely Pathogenic0.149Likely Benign-3.18Deleterious0.998Probably Damaging0.948Probably Damaging2.36Pathogenic0.07Tolerated0.36180.1053-3-3-5.4-16.04
c.3701T>C
L1234P
2D
AIThe SynGAP1 missense variant L1234P is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include only REVEL, whereas the remaining tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also classifies the variant as Likely Pathogenic. High‑accuracy assessments further support this view: AlphaMissense‑Optimized predicts Pathogenic, and the SGM‑Consensus confirms a Likely Pathogenic status. Foldetta results are unavailable, so they do not influence the overall assessment. Based on the collective evidence, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.599170Disordered0.575096Binding0.8440.5270.125-14.931Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.319Likely Benign-5.19Deleterious0.999Probably Damaging0.969Probably Damaging1.45Pathogenic0.01Affected0.32010.2483-3-3-5.4-16.04
c.3722T>C
L1241P
2D
AIThe SynGAP1 missense variant L1241P is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include only REVEL, whereas the remaining tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also classifies the variant as Likely Pathogenic. High‑accuracy assessments show AlphaMissense‑Optimized as Pathogenic and the SGM‑Consensus as Likely Pathogenic; Foldetta results are unavailable. Based on the preponderance of pathogenic predictions and the lack of benign consensus, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.545602Disordered0.488880Uncertain0.8280.5410.375-16.301Likely Pathogenic1.000Likely PathogenicLikely Pathogenic0.471Likely Benign-5.42Deleterious1.000Probably Damaging0.999Probably Damaging1.61Pathogenic0.00Affected0.36400.1048-3-3-5.4-16.04
c.3743T>C
L1248P
2D
AIThe SynGAP1 missense variant L1248P is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include only REVEL, whereas the remaining tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also classifies the variant as Likely Pathogenic. High‑accuracy assessments further support this view: AlphaMissense‑Optimized predicts pathogenicity, and the SGM‑Consensus agrees. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the preponderance of evidence indicates that the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.834292Disordered0.371716Uncertain0.8800.5620.625-14.647Likely Pathogenic1.000Likely PathogenicLikely Pathogenic0.410Likely Benign-5.45Deleterious1.000Probably Damaging0.999Probably Damaging1.64Pathogenic0.00Affected0.35960.0848-3-3-5.4-16.04
c.3797T>C
L1266P
2D
AIThe SynGAP1 missense variant L1266P is reported in gnomAD (6‑33447845‑T‑C) but has no ClinVar entry. Prediction tools cluster into two groups: benign predictions are made only by REVEL, whereas all other evaluated algorithms (PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized) predict a pathogenic effect. High‑accuracy assessments further support a deleterious outcome: AlphaMissense‑Optimized returns a pathogenic score, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates “Likely Pathogenic.” The Foldetta stability analysis is unavailable for this variant. Overall, the consensus of both general and high‑accuracy predictors points to a pathogenic impact, and this conclusion is not contradicted by any ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.433034Structured0.802655Binding0.8680.6020.0006-33447845-T-C-16.566Likely Pathogenic1.000Likely PathogenicLikely Pathogenic0.424Likely Benign-5.83Deleterious0.999Probably Damaging0.977Probably Damaging2.10Pathogenic0.00Affected3.7750.31500.2283-3-3-5.4-16.04
c.3803T>C
L1268P
2D
AIThe SynGAP1 missense variant L1268P is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, and FATHMM. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM Consensus, which takes a majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is inconclusive (2 pathogenic vs. 2 benign). Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of high‑accuracy predictors (5 vs. 4) indicate a pathogenic impact. This conclusion is not contradicted by ClinVar status, which contains no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Coiled-coil0.458154Structured0.804315Binding0.8590.6290.000-9.062Likely Pathogenic0.991Likely PathogenicLikely Pathogenic0.091Likely Benign-1.03Neutral0.970Probably Damaging0.637Possibly Damaging2.65Benign0.24Tolerated0.32610.1053-3-3-5.4-16.04
c.3818T>C
L1273P
2D
AIThe SynGAP1 missense variant L1273P is not reported in ClinVar (ClinVar status: not listed) but is present in the gnomAD database (gnomAD ID: 6‑33447866‑T‑C). Functional prediction tools uniformly indicate a deleterious effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the variant as pathogenic. No tool in the dataset predicts a benign outcome. High‑accuracy assessments corroborate this: AlphaMissense‑Optimized predicts pathogenic, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports the variant as likely pathogenic. The Foldetta protein‑folding stability analysis is unavailable for this variant. Overall, the consensus of predictive algorithms strongly supports a pathogenic classification, and this assessment does not contradict the ClinVar status, which simply lacks an entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.599170Disordered0.773625Binding0.7470.6770.5006-33447866-T-C-9.443Likely Pathogenic0.997Likely PathogenicLikely Pathogenic0.523Likely Pathogenic-5.87Deleterious0.997Probably Damaging0.950Probably Damaging2.12Pathogenic0.00Affected3.7750.38360.1343-3-3-5.4-16.04
c.3851T>C
L1284P
2D
AIThe SynGAP1 missense variant L1284P is not reported in ClinVar (no ClinVar ID) but is present in gnomAD (ID 6‑33447899‑T‑C). Prediction tools that agree on a benign effect include REVEL, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM. The SGM Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is inconclusive because it yields a 2‑to‑2 split. Foldetta results are unavailable. Overall, the balance of evidence slightly favors a pathogenic interpretation (five pathogenic versus four benign predictions). This assessment does not conflict with ClinVar, as the variant has no ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.812494Disordered0.824557Binding0.4410.7480.8756-33447899-T-C-2.451Likely Benign0.076Likely BenignLikely Benign0.191Likely Benign-3.05Deleterious0.990Probably Damaging0.722Possibly Damaging2.48Pathogenic0.01Affected3.7750.33070.0848-3-3-5.4-16.04
c.3872T>C
L1291P
2D
AIThe SynGAP1 missense variant L1291P is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include REVEL, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM. The SGM Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is inconclusive (two benign vs two pathogenic votes). Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, five tools predict pathogenicity while four predict benignity, giving a slight tilt toward a pathogenic interpretation. Because there is no ClinVar assertion, this prediction does not contradict any existing clinical classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.827927Disordered0.863458Binding0.5790.7970.625-3.322Likely Benign0.243Likely BenignLikely Benign0.417Likely Benign-4.32Deleterious0.990Probably Damaging0.856Possibly Damaging2.48Pathogenic0.01Affected0.30780.2162-3-3-5.4-16.04
c.3875T>C
L1292P
2D
AISynGAP1 missense variant L1292P is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Functional prediction tools cluster into two groups: benign predictions come from REVEL, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized; pathogenic predictions come from PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM. The SGM Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, yields a 2‑to‑2 split and is therefore inconclusive. Foldetta, a protein‑folding stability method that combines FoldX‑MD and Rosetta outputs, has no available result for this variant. With half the tools indicating benign and half indicating pathogenic, the overall computational evidence is ambiguous. Consequently, the variant is neither clearly benign nor pathogenic based on current predictions, and there is no ClinVar entry to contradict this uncertainty.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.779859Disordered0.882643Binding0.5860.8000.625-3.761Likely Benign0.264Likely BenignLikely Benign0.311Likely Benign-4.58Deleterious0.971Probably Damaging0.773Possibly Damaging2.46Pathogenic0.01Affected0.38550.1220-3-3-5.4-16.04
c.3896T>C
L1299P
2D
AIThe SynGAP1 missense variant L1299P is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split: benign calls come from REVEL, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized, while pathogenic calls come from PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. Grouping by consensus, the majority of predictors (five out of nine) favor a benign effect, and the SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also reports a likely benign outcome. High‑accuracy assessments further support this: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus (majority vote) is likely benign; Foldetta data are unavailable. Consequently, the variant is most likely benign according to the available computational evidence, and this assessment does not contradict any ClinVar annotation because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.771762Disordered0.896323Binding0.3980.8320.750-2.589Likely Benign0.222Likely BenignLikely Benign0.322Likely Benign-4.06Deleterious0.971Probably Damaging0.690Possibly Damaging2.67Benign0.01Affected0.35520.1309-3-3-5.4-16.04
c.3932T>C
L1311P
2D
AIThe SynGAP1 missense variant L1311P is listed in ClinVar (ID 833866.0) as Benign and is present in gnomAD (variant ID 6‑33451806‑T‑C). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only polyPhen‑2 HumDiv predicts a pathogenic outcome. The high‑accuracy consensus from SGM (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) yields a Likely Benign classification, and AlphaMissense‑Optimized also reports Benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, is not available for this variant. Overall, the majority of computational evidence supports a benign effect, which is consistent with the ClinVar benign annotation and does not contradict the database status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.816150Disordered0.968153Binding0.3930.9070.750Likely Benign 16-33451806-T-C16.21e-7-1.831Likely Benign0.079Likely BenignLikely Benign0.123Likely Benign-0.52Neutral0.579Possibly Damaging0.335Benign2.72Benign0.18Tolerated3.7750.31810.1794-3-3-5.4-16.04
c.3953T>C
L1318P
2D
AIThe SynGAP1 missense variant L1318P is listed in gnomAD (ID 6‑33451827‑T‑C) but has no ClinVar entry. Functional prediction tools that agree on a benign effect include REVEL, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and polyPhen‑2 HumVar, while pathogenic predictions come from PROVEAN, polyPhen‑2 HumDiv, and SIFT. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely benign classification. High‑accuracy assessments further support benignity: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus (majority vote) also indicates benign. Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact for this variant, and this conclusion does not contradict any ClinVar status, as no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.887230Disordered0.968271Binding0.3990.8650.7506-33451827-T-C-2.307Likely Benign0.116Likely BenignLikely Benign0.126Likely Benign-2.90Deleterious0.813Possibly Damaging0.212Benign3.98Benign0.00Affected3.7750.34240.1411-3-3-5.4-16.04
c.3986T>C
L1329P
2D
AIThe SynGAP1 missense variant L1329P is listed in gnomAD (ID 6‑33451860‑T‑C) but has no ClinVar entry. Functional prediction tools cluster into two groups: benign predictions come from REVEL, ESM1b, and FATHMM, while pathogenic predictions are reported by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and AlphaMissense‑Default. AlphaMissense‑Optimized is uncertain. The SGM Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, yields a tie and is therefore inconclusive. No Foldetta stability assessment is available. Overall, the majority of high‑confidence predictors (five pathogenic vs three benign) lean toward a pathogenic effect. Because ClinVar contains no classification, there is no conflict with existing clinical annotation. Thus, based on current in silico evidence, the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.930790Disordered0.924905Binding0.3360.7480.8756-33451860-T-C-2.903Likely Benign0.951Likely PathogenicAmbiguous0.165Likely Benign-3.74Deleterious0.994Probably Damaging0.993Probably Damaging3.04Benign0.00Affected3.7750.33960.1794-3-3-5.4-16.04
c.398T>C
L133P
2D
AIThe SynGAP1 missense variant L133P is not reported in ClinVar (ClinVar status: none) and is absent from gnomAD (gnomAD ID: none). Prediction tools that agree on a benign effect are REVEL and FATHMM, whereas the remaining tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. ESM1b remains uncertain. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default (pathogenic), ESM1b (uncertain), FATHMM (benign), and PROVEAN (pathogenic), yields a pathogenic consensus. Foldetta, a protein‑folding stability method, has no available result for this variant. Overall, the preponderance of evidence indicates that the variant is most likely pathogenic, and this conclusion does not contradict any existing ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.422041Structured0.718429Binding0.3200.8960.250-7.744In-Between0.982Likely PathogenicLikely Pathogenic0.342Likely Benign-3.16Deleterious0.700Possibly Damaging0.483Possibly Damaging3.52Benign0.00Affected0.32700.1048-3-3-5.4-16.04
c.410T>C
L137P
2D
AIThe SynGAP1 missense variant L137P is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL and FATHMM, whereas the remaining tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN)—all predict a pathogenic or likely pathogenic outcome. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized classifies the variant as pathogenic, and the SGM‑Consensus indicates it is likely pathogenic. The Foldetta protein‑folding stability analysis is unavailable for this variant. Overall, the majority of computational evidence points to a pathogenic effect, and this conclusion does not contradict any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.553315Disordered0.639549Binding0.3770.8970.375-11.067Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.377Likely Benign-3.77Deleterious0.998Probably Damaging0.995Probably Damaging3.59Benign0.00Affected0.36200.1177-3-3-5.4-16.04
c.449T>C
L150P
2D
AIThe SynGAP1 missense variant L150P is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL and FATHMM, whereas the remaining tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN)—all predict a pathogenic or likely pathogenic outcome. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized classifies the variant as pathogenic, and the SGM‑Consensus indicates it is likely pathogenic. The Foldetta protein‑folding stability analysis is unavailable for this variant. Overall, the majority of computational evidence points to a pathogenic effect, and this conclusion does not contradict any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.494003Structured0.505752Binding0.2990.8390.625-12.881Likely Pathogenic0.995Likely PathogenicLikely Pathogenic0.320Likely Benign-3.90Deleterious0.998Probably Damaging0.995Probably Damaging3.64Benign0.00Affected0.35570.1543-3-3-5.4-16.04
c.479T>C
L160P
2D
AIThe SynGAP1 missense variant L160P is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. Tools that predict a pathogenic effect comprise PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The high‑accuracy consensus, SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, yields a majority pathogenic vote (3 pathogenic vs. 1 benign) and is labeled “Likely Pathogenic.” AlphaMissense‑Optimized independently predicts pathogenicity. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Based on the collective predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status, as none is currently assigned.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.454136Structured0.526760Binding0.2750.7280.125-15.939Likely Pathogenic0.969Likely PathogenicLikely Pathogenic0.283Likely Benign-3.06Deleterious0.001Benign0.000Benign3.86Benign0.00Affected0.35890.1484-3-3-5.4-16.04
c.518T>C
L173P
2D
AIThe SynGAP1 missense variant L173P is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, and FATHMM, whereas tools that agree on a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. The high‑accuracy AlphaMissense‑Optimized score is uncertain, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive because it yields a 2‑to‑2 split; Foldetta results are not available. Consequently, the computational evidence is evenly divided, providing no clear advantage for either benign or pathogenic classification. The variant is therefore most likely inconclusive based on current predictions, and this assessment does not contradict any ClinVar status because the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.534167Disordered0.491566Uncertain0.3900.6310.375-8.758Likely Pathogenic0.918Likely PathogenicAmbiguous0.135Likely Benign-2.38Neutral0.838Possibly Damaging0.466Possibly Damaging3.92Benign0.15Tolerated0.33180.1382-3-3-5.4-16.04
c.560T>C
L187P
2D
AIThe SynGAP1 missense variant L187P is listed in gnomAD (ID 6‑33435202‑T‑C) but has no ClinVar entry. Functional prediction tools split in two groups: benign predictions come from REVEL and FATHMM, whereas the remaining tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN)—all indicate pathogenicity. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized predicts pathogenic, and the SGM‑Consensus classifies the variant as Likely Pathogenic. No Foldetta stability result is available, so it does not influence the overall assessment. Based on the preponderance of pathogenic predictions, the variant is most likely pathogenic, and this conclusion is not contradicted by ClinVar status, which currently reports no classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.465241Structured0.428046Uncertain0.3670.6250.3756-33435202-T-C16.20e-7-13.192Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.320Likely Benign-5.17Deleterious0.917Possibly Damaging0.548Possibly Damaging3.70Benign0.01Affected3.4790.36040.1484-3-3-5.4-16.04
c.593T>C
L198P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L198P has no ClinVar entry and is not reported in gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, Rosetta, and FATHMM, while pathogenic predictions are made by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized; FoldX, Foldetta, and premPS are inconclusive. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as Likely Pathogenic, and Foldetta as uncertain. Overall, the majority of evidence points toward a deleterious effect. Thus, the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.444081Structured0.431715Uncertain0.5720.4850.125-12.250Likely Pathogenic0.997Likely PathogenicLikely Pathogenic1.55Ambiguous0.30.40Likely Benign0.98Ambiguous0.65Ambiguous0.491Likely Benign-5.87Deleterious0.997Probably Damaging0.916Probably Damaging3.33Benign0.00Affected0.38820.1582-3-3-5.4-16.04
c.641T>C
L214P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L214P is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include only FATHMM, while the remaining 15 tools (REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, SGM‑Consensus, and the consensus of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) uniformly predict a pathogenic impact. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized scores the variant as pathogenic; the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates a likely pathogenic outcome; and Foldetta, which integrates FoldX‑MD and Rosetta stability predictions, also classifies the variant as pathogenic. Based on the overwhelming agreement among predictive algorithms, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.155435Structured0.372604Uncertain0.8180.3020.125-11.348Likely Pathogenic0.999Likely PathogenicLikely Pathogenic3.38Destabilizing1.37.51Destabilizing5.45Destabilizing1.30Destabilizing0.930Likely Pathogenic-5.98Deleterious0.997Probably Damaging0.916Probably Damaging5.76Benign0.00Affected0.34480.1553-3-3-5.4-16.04
c.737T>C
L246P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L246P is not reported in ClinVar and is absent from gnomAD. Prediction tools cluster into two groups: the single benign prediction comes from FATHMM, while all other evaluated algorithms (SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) uniformly predict a pathogenic effect. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized indicates pathogenicity, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is labeled Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts pathogenicity. No prediction or folding stability result is missing or inconclusive. Based on the consensus of these tools, the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.472492Structured0.302312Uncertain0.8590.3640.000-16.581Likely Pathogenic1.000Likely PathogenicLikely Pathogenic6.42Destabilizing0.38.72Destabilizing7.57Destabilizing1.79Destabilizing0.944Likely Pathogenic-6.30Deleterious0.997Probably Damaging0.916Probably Damaging4.67Benign0.00Affected0.37310.1582-3-3-5.4-16.04
c.791T>C
L264P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L264P is listed in ClinVar with an “Uncertain” status and is not reported in gnomAD. Prediction tools that assess pathogenicity all converge on a deleterious effect: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict pathogenicity. No tool in the dataset reports a benign outcome. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is “Likely Pathogenic”; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, is pathogenic. Based on the unanimous computational evidence, the variant is most likely pathogenic, a conclusion that contradicts the current ClinVar “Uncertain” classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.185198Structured0.323473Uncertain0.9390.2640.000Uncertain 1-12.285Likely Pathogenic1.000Likely PathogenicLikely Pathogenic5.73Destabilizing0.36.57Destabilizing6.15Destabilizing2.65Destabilizing0.767Likely Pathogenic-6.43Deleterious1.000Probably Damaging0.999Probably Damaging0.49Pathogenic0.00Affected0.32390.1053-3-3-5.4-16.04
c.797T>C
L266P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L266P is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly indicate a deleterious effect. Benign predictions: none. Pathogenic predictions: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments corroborate this: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; Foldetta, which integrates FoldX‑MD and Rosetta outputs, also predicts pathogenic. No conflicting benign evidence is present. Therefore, the variant is most likely pathogenic, and this conclusion is consistent with the absence of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.232838Structured0.297157Uncertain0.9480.2640.000-15.752Likely Pathogenic0.999Likely PathogenicLikely Pathogenic7.08Destabilizing0.14.02Destabilizing5.55Destabilizing2.31Destabilizing0.654Likely Pathogenic-6.06Deleterious1.000Probably Damaging0.999Probably Damaging1.53Pathogenic0.00Affected0.31580.1021-3-3-5.4-16.04
c.821T>C
L274P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L274P is not reported in ClinVar (ClinVar status: not listed) and is absent from gnomAD (no gnomAD ID). Prediction tools that assess pathogenicity uniformly classify the variant as deleterious: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict a pathogenic effect. No tool in the dataset predicts a benign outcome. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized indicates pathogenicity; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also reports Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, predicts a pathogenic impact. Based on the unanimous computational evidence, the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.066181Structured0.377483Uncertain0.8660.1950.250-14.667Likely Pathogenic0.997Likely PathogenicLikely Pathogenic5.62Destabilizing1.54.49Destabilizing5.06Destabilizing1.66Destabilizing0.804Likely Pathogenic-6.30Deleterious1.000Probably Damaging0.999Probably Damaging0.00Pathogenic0.00Affected0.35350.0625-3-3-5.4-16.04
c.851T>C
L284P
2D
AIThe SynGAP1 missense variant L284P is listed in ClinVar as Pathogenic (ClinVar ID 3344808.0) and is not reported in gnomAD. Prediction tools that assess functional impact uniformly classify the variant as pathogenic: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a benign effect. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also predicts pathogenic. Based on the unanimous computational evidence, the variant is most likely pathogenic, and this conclusion aligns with its ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.094817Structured0.371601Uncertain0.9500.2550.000Likely Pathogenic1-15.588Likely Pathogenic1.000Likely PathogenicLikely Pathogenic5.83Destabilizing0.25.81Destabilizing5.82Destabilizing1.89Destabilizing0.794Likely Pathogenic-6.17Deleterious1.000Probably Damaging0.999Probably Damaging1.64Pathogenic0.00Affected0.35400.1021-3-3-5.4-16.04
c.857T>C
L286P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L286P is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly indicate a deleterious effect. Benign predictions: none. Pathogenic predictions: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments corroborate this: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. Based on the consensus of all available predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.122885Structured0.385647Uncertain0.9320.2600.000-14.982Likely Pathogenic0.999Likely PathogenicLikely Pathogenic5.43Destabilizing0.96.38Destabilizing5.91Destabilizing2.10Destabilizing0.878Likely Pathogenic-6.43Deleterious1.000Probably Damaging0.999Probably Damaging1.47Pathogenic0.00Affected0.37190.1182-3-3-5.4-16.04
c.869T>C
L290P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L290P is not reported in ClinVar and is absent from gnomAD. Prediction tools that assess pathogenicity unanimously favor a deleterious effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) all predict pathogenicity. No tool in the dataset predicts a benign outcome; the remaining tools (FoldX, Rosetta, Foldetta, premPS) return uncertain results, which are treated as unavailable evidence. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized is pathogenic, SGM‑Consensus is likely pathogenic, and Foldetta is inconclusive. Based on the collective predictions, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.127496Structured0.399723Uncertain0.9040.2550.000-11.796Likely Pathogenic0.973Likely PathogenicLikely Pathogenic0.79Ambiguous0.11.10Ambiguous0.95Ambiguous0.56Ambiguous0.727Likely Pathogenic-6.43Deleterious1.000Probably Damaging0.999Probably Damaging2.01Pathogenic0.03Affected0.36460.1703-3-3-5.4-16.04
c.950T>C
L317P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L317P is not reported in ClinVar (ClinVar status: not listed) and is absent from gnomAD (gnomAD ID: none). Prediction tools that assess pathogenicity unanimously classify the variant as deleterious: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tools predict a benign effect, so the benign group is empty. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts Pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts Pathogenic. Based on the collective predictions, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status because the variant is not yet reported there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.106997Structured0.394031Uncertain0.8740.2400.125-14.778Likely Pathogenic0.999Likely PathogenicLikely Pathogenic3.61Destabilizing1.44.29Destabilizing3.95Destabilizing1.26Destabilizing0.654Likely Pathogenic-6.43Deleterious1.000Probably Damaging0.999Probably Damaging1.82Pathogenic0.00Affected0.34050.1153-3-3-5.4-16.04
c.968T>C
L323P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L323P is listed in ClinVar with an “Uncertain” status and is not reported in gnomAD. Prediction tools that assess pathogenicity uniformly classify the variant as pathogenic: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool in the dataset predicts a benign effect. High‑accuracy assessments corroborate this: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates “Likely Pathogenic”; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, also predicts pathogenic. Based on the unanimous computational evidence, the variant is most likely pathogenic, which does not contradict its current ClinVar “Uncertain” classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.268042Structured0.428564Uncertain0.9560.3690.000Uncertain 1-12.507Likely Pathogenic0.998Likely PathogenicLikely Pathogenic3.39Destabilizing0.68.46Destabilizing5.93Destabilizing2.20Destabilizing0.762Likely Pathogenic-4.80Deleterious0.999Probably Damaging0.977Probably Damaging0.59Pathogenic0.01Affected4.293980.36780.1221-3-3-5.4-16.04201.968.20.00.10.60.3XPotentially PathogenicThe iso-butyl side chain of Leu323, located at the beginning of an anti-parallel β sheet strand (res. Ala322-Asp330), packs against multiple hydrophobic leucine residues (e.g., Leu264, Leu266, Leu284, Leu286). In contrast, in the variant simulations, the less bulky cyclic five-membered pyrrolidine ring of Pro323 cannot fill the hydrophobic space as effectively as the branched hydrocarbon side chain of leucine. Notably, the backbone amide group of Leu323 forms a hydrogen bond with the backbone carbonyl group of Cys285. Pro323 cannot form this bond due to the absence of the backbone amide group, resulting in partial unfolding of the anti-parallel β sheet end in the variant simulations.
c.974T>C
L325P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L325P is not reported in ClinVar (ClinVar status: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that assess pathogenicity all agree on a deleterious effect: SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the variant as pathogenic. No tool predicts a benign outcome. High‑accuracy methods reinforce this consensus: AlphaMissense‑Optimized predicts pathogenicity; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates pathogenicity; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, reports a pathogenic effect. No predictions or stability results are missing or inconclusive. Based on the unanimous computational evidence, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.352862Structured0.424577Uncertain0.9550.4360.000-16.130Likely Pathogenic0.999Likely PathogenicLikely Pathogenic5.49Destabilizing0.37.27Destabilizing6.38Destabilizing1.89Destabilizing0.607Likely Pathogenic-4.37Deleterious0.999Probably Damaging0.977Probably Damaging1.33Pathogenic0.00Affected0.33930.1903-3-3-5.4-16.04
c.980T>C
L327P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L327P (ClinVar ID 660421) is classified as Pathogenic in ClinVar and is not reported in gnomAD. Prediction tools that assess functional impact uniformly indicate a deleterious effect: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict pathogenicity, leaving no tools in the benign category. High‑accuracy assessments further support this: AlphaMissense‑Optimized is Pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, is Pathogenic. Based on the unanimous computational evidence, the variant is most likely pathogenic, and this conclusion aligns with its ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.335645Structured0.409189Uncertain0.9390.4900.000Pathogenic/Likely path. 4-16.602Likely Pathogenic0.999Likely PathogenicLikely Pathogenic5.38Destabilizing0.14.00Destabilizing4.69Destabilizing2.62Destabilizing0.658Likely Pathogenic-5.97Deleterious1.000Probably Damaging0.999Probably Damaging1.52Pathogenic0.01Affected3.38230.39210.1703-3-3-5.4-16.04221.769.40.10.00.60.1XPotentially PathogenicThe backbone amide group of Leu327, located in the middle of an anti-parallel β sheet strand (res. Ala322-Asp330), forms a hydrogen bond with the carbonyl group of Gly344 on a neighboring β strand (res. Lys336-Pro349) in the WT simulations. In contrast, in the variant simulations, the introduction of Pro327 destabilizes the hydrogen bonding between the two anti-parallel β strands because proline lacks the backbone amide group altogether. Additionally, in the WT simulations, the iso-butyl side chain of Leu327 packs against multiple hydrophobic residues (e.g., Leu274, V400, Val343), whereas the less bulky cyclic five-membered pyrrolidine ring of Pro327 cannot fill the same space as effectively. Thus, although no large-scale unfolding is observed during the variant simulations, the residue swap is likely to cause severe problems for the correct C2 domain folding, which could also affect the SynGAP-membrane association.10.1016/j.ajhg.2020.11.011
c.1019C>A
A340E
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant A340E is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, SIFT, and polyPhen‑2 HumVar. Those that predict a pathogenic effect are polyPhen‑2 HumDiv, ESM1b, FATHMM, and AlphaMissense‑Default. Predictions that are inconclusive or unavailable are FoldX, Rosetta, Foldetta, and AlphaMissense‑Optimized. The high‑accuracy consensus from SGM (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) reports a likely pathogenic outcome, while the protein‑folding stability method Foldetta is uncertain. AlphaMissense‑Optimized also yields an uncertain result. Overall, the majority of evidence points toward a pathogenic impact, and this is consistent with the lack of ClinVar annotation; there is no contradiction with ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.390993Structured0.410781Uncertain0.5580.4850.250-8.225Likely Pathogenic0.803Likely PathogenicAmbiguous0.63Ambiguous0.41.55Ambiguous1.09Ambiguous0.06Likely Benign0.138Likely Benign-0.33Neutral0.625Possibly Damaging0.252Benign1.91Pathogenic0.39Tolerated0.14180.21600-1-5.358.04
c.1052C>A
A351D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 A351D missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, SIFT, AlphaMissense‑Optimized, and polyPhen‑2 HumVar. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, and FATHMM; AlphaMissense‑Default and ESM1b are uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as benign, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) leaning toward pathogenic due to two pathogenic and two uncertain calls. Overall, the majority of tools predict a benign outcome, and this does not contradict the lack of ClinVar annotation. Thus, based on the available predictions, the variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.216401Structured0.362025Uncertain0.9250.3420.000-7.917In-Between0.543AmbiguousLikely Benign-0.02Likely Benign0.0-0.12Likely Benign-0.07Likely Benign0.49Likely Benign0.114Likely Benign-3.61Deleterious0.842Possibly Damaging0.321Benign1.77Pathogenic0.11Tolerated0.15350.13860-2-5.344.01
c.1061C>A
A354D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A354D is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, PROVEAN, polyPhen‑2 (HumDiv and HumVar), and SIFT. Those that predict a pathogenic effect are FATHMM and AlphaMissense‑Default. Four tools (Foldetta, premPS, ESM1b, and Rosetta) return uncertain results and are treated as unavailable evidence. High‑accuracy assessments show AlphaMissense‑Optimized predicts a benign outcome, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) favors a pathogenic interpretation. Foldetta’s stability prediction is uncertain. Overall, the majority of consensus tools lean toward a benign effect, and there is no ClinVar annotation to contradict this assessment. Thus, the variant is most likely benign based on the available predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.203355Structured0.381329Uncertain0.8820.3350.125-7.914In-Between0.725Likely PathogenicLikely Benign0.22Likely Benign0.11.10Ambiguous0.66Ambiguous0.57Ambiguous0.087Likely Benign-1.49Neutral0.255Benign0.053Benign1.75Pathogenic0.07Tolerated0.17590.13450-2-5.344.01
c.1196C>A
A399D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A399D is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. Those that agree on a pathogenic effect are REVEL, FoldX, SIFT, ESM1b, and AlphaMissense‑Default. The remaining tools—Rosetta, Foldetta, premPS, and AlphaMissense‑Optimized—return uncertain or inconclusive results. High‑accuracy methods give no definitive verdict: AlphaMissense‑Optimized is uncertain, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is a tie and thus unavailable, and Foldetta is uncertain. Overall, the majority of available predictions (five pathogenic vs. four benign) lean toward pathogenicity. Therefore, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.394753Structured0.407674Uncertain0.9390.4900.125-10.441Likely Pathogenic0.943Likely PathogenicAmbiguous2.45Destabilizing0.21.17Ambiguous1.81Ambiguous0.91Ambiguous0.525Likely Pathogenic-1.84Neutral0.421Benign0.054Benign5.38Benign0.05Affected0.15330.17600-2-5.344.01
c.1211C>A
A404E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A404E is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. In contrast, the majority of tools predict a pathogenic impact: FoldX, Rosetta, Foldetta, premPS, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized all indicate pathogenicity, and the SGM‑Consensus score is “Likely Pathogenic.” High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized predicts pathogenic; the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is “Likely Pathogenic”; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, also predicts pathogenicity. Based on the preponderance of pathogenic predictions, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.232838Structured0.415505Uncertain0.9650.3550.000-13.639Likely Pathogenic0.992Likely PathogenicLikely Pathogenic2.16Destabilizing0.13.04Destabilizing2.60Destabilizing1.51Destabilizing0.163Likely Benign-2.77Deleterious0.179Benign0.033Benign4.02Benign0.02Affected0.14230.23830-1-5.358.04
c.1232T>G
I411S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I411S is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include only FATHMM, whereas all other evaluated algorithms—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the variant as pathogenic. High‑accuracy methods further support a deleterious impact: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. No prediction or folding stability result is missing or inconclusive. Based on the overwhelming consensus of pathogenic predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because the variant is not yet catalogued in ClinVar.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.116183Structured0.339366Uncertain0.9270.1980.000-13.763Likely Pathogenic0.994Likely PathogenicLikely Pathogenic3.59Destabilizing0.23.83Destabilizing3.71Destabilizing1.91Destabilizing0.603Likely Pathogenic-5.50Deleterious1.000Probably Damaging1.000Probably Damaging3.30Benign0.00Affected0.22620.1487-1-2-5.3-26.08
c.1262C>A
A421E
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant A421E is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split: benign calls come from REVEL, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and FATHMM, whereas pathogenic calls are made by ESM1b, PROVEAN, AlphaMissense‑Default, AlphaMissense‑Optimized, Rosetta, premPS, and the SGM‑Consensus score (Likely Pathogenic). Stability‑based methods give mixed results: FoldX is uncertain, Foldetta is uncertain, and Rosetta alone predicts pathogenic. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized predicts pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta remains uncertain. Overall, the majority of evidence, including the high‑accuracy tools, points to a pathogenic impact for A421E, and this conclusion does not conflict with the absence of a ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.067594Structured0.404927Uncertain0.9650.2570.000-11.993Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.63Ambiguous0.22.07Destabilizing1.35Ambiguous1.30Destabilizing0.233Likely Benign-4.24Deleterious0.368Benign0.144Benign3.44Benign0.14Tolerated0.12880.18300-1-5.358.04
c.1298C>A
A433E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A433E is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, PROVEAN, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic outcome are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b. Two tools (premPS and AlphaMissense‑Default) give uncertain results. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized is benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields a benign prediction; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also reports benign. No prediction is missing or inconclusive. Overall, the preponderance of evidence indicates that the variant is most likely benign, and this conclusion does not contradict the ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.098513Structured0.352258Uncertain0.9380.3020.000-8.210Likely Pathogenic0.506AmbiguousLikely Benign-0.20Likely Benign0.00.15Likely Benign-0.03Likely Benign0.58Ambiguous0.148Likely Benign-1.65Neutral0.998Probably Damaging0.824Possibly Damaging3.42Benign0.18Tolerated0.07830.16950-1-5.358.04
c.1313C>A
A438D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 A438D missense variant is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show mixed results: benign predictions come from REVEL, polyPhen‑2 HumVar, and FATHMM; pathogenic predictions come from PROVEAN, polyPhen‑2 HumDiv, SIFT, and AlphaMissense‑Default; the remaining tools (FoldX, Rosetta, Foldetta, premPS, ESM1b, AlphaMissense‑Optimized) are uncertain. High‑accuracy assessments indicate that AlphaMissense‑Optimized is inconclusive, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is pathogenic, and Foldetta is also inconclusive. Overall, the majority of evidence points toward a pathogenic effect. This conclusion is not contradicted by ClinVar status, which has no entry for this variant. Thus, based on the available predictions, the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.147574Structured0.290154Uncertain0.9290.2930.000-7.410In-Between0.808Likely PathogenicAmbiguous1.60Ambiguous0.10.70Ambiguous1.15Ambiguous0.92Ambiguous0.175Likely Benign-3.07Deleterious0.859Possibly Damaging0.124Benign4.10Benign0.04Affected0.14900.19410-2-5.344.01
c.1343C>A
A448D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A448D is not reported in ClinVar (ClinVar status: none) and is absent from gnomAD (gnomAD ID: none). Prediction tools that agree on a benign effect include only FATHMM, whereas the remaining 13 tools (SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) uniformly predict a pathogenic impact. High‑accuracy methods further support this: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is “Likely Pathogenic”; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, is pathogenic. No prediction or folding result is missing or inconclusive. Based on the collective evidence, the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.225814Structured0.292774Uncertain0.9730.2570.000-17.290Likely Pathogenic1.000Likely PathogenicLikely Pathogenic8.13Destabilizing0.24.35Destabilizing6.24Destabilizing1.40Destabilizing0.662Likely Pathogenic-5.93Deleterious0.999Probably Damaging0.992Probably Damaging3.13Benign0.00Affected0.15410.17410-2-5.344.01
c.1349C>A
A450E
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant A450E is listed in ClinVar with an uncertain significance and is not reported in gnomAD. Prediction tools that classify the variant as benign include SIFT and FATHMM, whereas the majority of tools predict it to be pathogenic: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized is pathogenic; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is likely pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, also predicts pathogenicity. No predictions are inconclusive. Overall, the evidence strongly favors a pathogenic impact for A450E, which does not contradict the current ClinVar status of uncertain significance.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.321458Structured0.306281Uncertain0.9630.2340.000Uncertain 1-16.578Likely Pathogenic0.989Likely PathogenicLikely Pathogenic3.86Destabilizing0.25.23Destabilizing4.55Destabilizing1.59Destabilizing0.653Likely Pathogenic-4.67Deleterious0.999Probably Damaging0.992Probably Damaging3.38Benign0.07Tolerated3.37320.08230.16950-1-5.358.04240.1-82.60.00.00.70.0XXPotentially PathogenicThe methyl group of Ala450, located in an α helix (res. Asn440-Thr458), packs against hydrophobic residues in the inter-helix space (e.g., Leu692). In the variant simulations, the carboxylate group of the Glu450 side chain rotates outward, away from the hydrophobic niche, where it does not form any lasting salt bridges or H-bonds. Although the residue swap does not negatively affect the protein structure based on the simulations, it is possible that the introduction of the negatively charged residue adversely affects the folding process or tertiary assembly.
c.1361T>G
I454S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I454S is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include only FATHMM, whereas all other evaluated algorithms—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the variant as pathogenic. High‑accuracy methods further support a deleterious impact: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. No prediction or folding stability result is missing or inconclusive. Based on the overwhelming agreement among both general and high‑accuracy predictors, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.254060Structured0.312811Uncertain0.9650.1820.000-13.025Likely Pathogenic0.998Likely PathogenicLikely Pathogenic4.50Destabilizing0.14.45Destabilizing4.48Destabilizing2.20Destabilizing0.574Likely Pathogenic-5.83Deleterious1.000Probably Damaging1.000Probably Damaging3.26Benign0.00Affected0.21160.0800-1-2-5.3-26.08
c.1382C>A
A461D
2D
AIThe SynGAP1 missense variant A461D is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL and FATHMM. The majority of tools predict a pathogenic impact: premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). FoldX and Foldetta are inconclusive, providing no definitive evidence. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus as likely pathogenic, and Foldetta remains uncertain. Overall, the preponderance of evidence indicates that A461D is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.179055Structured0.292531Uncertain0.9360.1510.125-14.918Likely Pathogenic0.990Likely PathogenicLikely Pathogenic0.89Ambiguous1.12.18Destabilizing1.54Ambiguous1.09Destabilizing0.477Likely Benign-5.47Deleterious0.997Probably Damaging0.792Possibly Damaging3.32Benign0.01Affected0.15330.20160-2-5.344.01
c.1406C>A
A469D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A469D is listed in ClinVar with an uncertain significance and is not reported in gnomAD. Prediction tools that assess the variant’s effect fall into two groups: the single benign prediction from SIFT, and a consensus of pathogenic predictions from the remaining 15 tools (REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM Consensus). High‑accuracy methods further support a deleterious impact: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also indicates pathogenic. Taken together, the overwhelming majority of evidence points to a pathogenic effect, which is consistent with the ClinVar uncertain status rather than contradicting it.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.278302Structured0.343926Uncertain0.9100.2760.000Uncertain 1-14.643Likely Pathogenic0.999Likely PathogenicLikely Pathogenic5.09Destabilizing0.24.16Destabilizing4.63Destabilizing1.68Destabilizing0.738Likely Pathogenic-3.48Deleterious0.999Probably Damaging0.996Probably Damaging-1.34Pathogenic0.21Tolerated3.37340.13720.15830-2-5.344.01237.0-58.2-0.20.10.80.1XXPotentially PathogenicThe methyl group of Ala469, located in an α helix (res. Ala461–Phe476), interacts with hydrophobic residues (e.g., Trp572, Leu588, Met470) in an inter-helix space formed by two other α helices (res. Glu582–Ser604, res. Arg563–Gly580). In the variant simulations, Asp469 introduces a negatively charged and bulky side chain into the hydrophobic niche. Consequently, the side chain of Asp469 rotates outward, allowing the carboxylate group to form a salt bridge with the guanidinium group of Arg575 on the protein surface. This interaction affects the continuity of the parent α helix (Ala461–Phe476). Due to the importance of hydrophobic packing, the structural effects could be more pronounced during actual protein folding.
c.1469C>A
A490D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A490D is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that assess pathogenicity are unanimous: AlphaMissense‑Default, AlphaMissense‑Optimized, ESM1b, FATHMM, PROVEAN, SIFT, polyPhen‑2 (HumDiv and HumVar), REVEL, premPS, FoldX, Rosetta, and Foldetta all classify the variant as pathogenic. No tool predicts a benign effect, so the benign group is empty. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) also reports pathogenic. Based on the collective predictions, the variant is most likely pathogenic, and this assessment is consistent with the absence of ClinVar evidence.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.120615Structured0.322979Uncertain0.9380.2100.125-16.643Likely Pathogenic0.997Likely PathogenicLikely Pathogenic3.33Destabilizing0.14.23Destabilizing3.78Destabilizing1.33Destabilizing0.946Likely Pathogenic-5.70Deleterious1.000Probably Damaging0.998Probably Damaging-1.48Pathogenic0.00Affected0.15320.17410-2-5.344.01
c.1478C>A
A493D
2D
AISynGAP1 missense variant A493D is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly indicate a deleterious effect: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the substitution as pathogenic. No tool predicts a benign outcome. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts pathogenicity; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports “Likely Pathogenic”; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also predicts pathogenicity. Consequently, the variant is most likely pathogenic, and this assessment is consistent with the absence of a ClinVar entry (no contradiction).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.102787Structured0.340081Uncertain0.9660.1820.000-16.834Likely Pathogenic0.999Likely PathogenicLikely Pathogenic4.45Destabilizing1.53.59Destabilizing4.02Destabilizing1.60Destabilizing0.925Likely Pathogenic-5.25Deleterious1.000Probably Damaging0.998Probably Damaging-1.41Pathogenic0.01Affected0.14370.15410-2-5.344.01
c.149T>G
I50S
2D
AIThe SynGAP1 I50S missense variant is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, and FATHMM all classify it as benign. In contrast, SIFT and AlphaMissense‑Default predict a pathogenic impact. AlphaMissense‑Optimized yields an uncertain result, and Foldetta (a protein‑folding stability method combining FoldX‑MD and Rosetta outputs) has no available prediction for this residue. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely benign classification. High‑accuracy assessments therefore point to a benign outcome: AlphaMissense‑Optimized is inconclusive, SGM‑Consensus is likely benign, and Foldetta data are missing. Based on the collective evidence, the variant is most likely benign, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.295083Structured0.449965Uncertain0.5450.7080.000-4.257Likely Benign0.946Likely PathogenicAmbiguous0.209Likely Benign-2.03Neutral0.334Benign0.099Benign3.74Benign0.00Affected0.26260.0800-1-2-5.3-26.08
c.1502T>G
I501S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I501S is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect are FATHMM and AlphaMissense‑Optimized; all other evaluated algorithms (SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default) predict a pathogenic impact. High‑accuracy assessments further support this: AlphaMissense‑Optimized indicates a benign change, whereas the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) and Foldetta (combining FoldX‑MD and Rosetta outputs) both predict pathogenicity. Overall, the preponderance of evidence points to a pathogenic effect for I501S. This conclusion is not contradicted by ClinVar status, which currently contains no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.079919Structured0.366596Uncertain0.8860.1530.000-9.914Likely Pathogenic0.677Likely PathogenicLikely Benign3.23Destabilizing0.22.40Destabilizing2.82Destabilizing1.79Destabilizing0.511Likely Pathogenic-5.14Deleterious1.000Probably Damaging1.000Probably Damaging3.43Benign0.04Affected0.23700.0858-1-2-5.3-26.08
c.1526C>A
A509D
2D
AIThe SynGAP1 missense variant A509D is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly indicate a deleterious effect: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as pathogenic. No tool predicts a benign outcome. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts pathogenicity; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) yields a “Likely Pathogenic” verdict; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also reports a pathogenic effect. Consequently, the variant is most likely pathogenic based on the collective predictions, and this assessment does not contradict any ClinVar status, as none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.025762Structured0.250110Uncertain0.9230.2560.000-17.026Likely Pathogenic0.973Likely PathogenicLikely Pathogenic4.02Destabilizing1.63.09Destabilizing3.56Destabilizing1.36Destabilizing0.915Likely Pathogenic-4.94Deleterious0.963Probably Damaging0.844Possibly Damaging-1.40Pathogenic0.00Affected0.16100.13600-2-5.344.01
c.1529T>G
I510S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I510S is listed in ClinVar as Pathogenic (ClinVar ID 449946.0) and is not reported in gnomAD. Prediction tools that assess the variant’s effect all converge on a deleterious outcome: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) all indicate pathogenicity. No tool predicts a benign effect. High‑accuracy assessments further support this: AlphaMissense‑Optimized is uncertain, SGM‑Consensus is pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. Based on the collective evidence, the variant is most likely pathogenic, and this prediction aligns with its ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.025762Structured0.250630Uncertain0.9450.2730.000Likely Pathogenic 1-11.661Likely Pathogenic0.955Likely PathogenicAmbiguous4.00Destabilizing0.13.78Destabilizing3.89Destabilizing2.34Destabilizing0.926Likely Pathogenic-4.63Deleterious1.000Probably Damaging0.999Probably Damaging-1.44Pathogenic0.00Affected3.37350.23950.0858-1-2-5.3-26.08201.445.9-0.40.20.00.3XPotentially PathogenicIle510 is located in the middle of an α-helix (res. Gly502-Tyr518) within the inter-helix space of three helices (res. Gly502-Tyr518, Ala533-Val560, and res. Glu582-Met603). In the WT simulations, the sec-butyl side chain of Ile510 hydrophobically packs with other residues in the inter-helix space (e.g., Leu506, Leu610, Ile514, Ile602, Leu598). In the variant simulations, the hydroxyl group of Ser510 forms a hydrogen bond with the backbone atoms of Leu506 and Gly511 in the same α-helix, which could further weaken the α-helix integrity. This α-helix already shows weakness in the WT simulations due to Gly511. Although the simulations do not show large-scale effects, the residue swap could have a substantial impact due to the fundamental role of hydrophobic packing during protein folding.
c.152T>G
I51S
2D
AIThe SynGAP1 missense variant I51S is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. Tools that predict a pathogenic effect are SIFT and AlphaMissense‑Default. The remaining tools, ESM1b and AlphaMissense‑Optimized, are uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) resolves to benign (2 benign vs. 1 pathogenic vote). Foldetta, a protein‑folding stability method, has no available result for this variant. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.291804Structured0.454181Uncertain0.6060.7100.000-7.603In-Between0.879Likely PathogenicAmbiguous0.220Likely Benign-1.39Neutral0.182Benign0.099Benign4.15Benign0.00Affected0.31420.0957-1-2-5.3-26.08
c.1541T>G
I514S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I514S is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include only FATHMM, whereas all other evaluated algorithms—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the variant as pathogenic. High‑accuracy methods further support a deleterious impact: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. No prediction or folding stability result is missing or inconclusive. Based on the overwhelming consensus of pathogenic predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because the variant is not yet catalogued in ClinVar.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.049374Structured0.221408Uncertain0.9480.2660.000-12.512Likely Pathogenic0.986Likely PathogenicLikely Pathogenic4.03Destabilizing0.23.70Destabilizing3.87Destabilizing2.11Destabilizing0.625Likely Pathogenic-5.86Deleterious1.000Probably Damaging1.000Probably Damaging2.82Benign0.00Affected0.22960.0530-1-2-5.3-26.08
c.1547C>A
A516D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A516D is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include only SIFT, which scores the substitution as tolerated. In contrast, the majority of algorithms predict a pathogenic impact: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Uncertain or inconclusive results come from FoldX, Rosetta, Foldetta, and premPS. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized is pathogenic, the SGM‑Consensus is likely pathogenic, while Foldetta remains uncertain. Overall, the preponderance of evidence indicates that A516D is most likely pathogenic, and this conclusion does not contradict the absence of a ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.067594Structured0.167423Uncertain0.9380.2840.000-14.621Likely Pathogenic0.991Likely PathogenicLikely Pathogenic0.65Ambiguous0.21.04Ambiguous0.85Ambiguous0.62Ambiguous0.725Likely Pathogenic-5.17Deleterious0.999Probably Damaging0.998Probably Damaging-1.23Pathogenic0.15Tolerated0.18900.16790-2-5.344.01
c.1586T>G
I529S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I529S is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, FoldX, Foldetta, premPS, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote) all indicate benign or likely benign. In contrast, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM predict pathogenicity, while Rosetta remains uncertain. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized scores benign, the SGM‑Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts benign stability. Overall, the majority of evidence supports a benign classification and is consistent with the absence of a ClinVar assertion. Therefore, the variant is most likely benign and does not contradict ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.318242Structured0.019545Uncertain0.9010.4030.000-0.171Likely Benign0.197Likely BenignLikely Benign0.13Likely Benign0.3-0.53Ambiguous-0.20Likely Benign0.00Likely Benign0.383Likely Benign1.62Neutral0.979Probably Damaging0.820Possibly Damaging-1.14Pathogenic0.40Tolerated0.24020.0887-1-2-5.3-26.08
c.1598C>A
A533E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A533E is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are ESM1b and FATHMM, while AlphaMissense‑Default remains uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as pathogenic, and Foldetta as benign. Overall, the majority of evidence points to a benign impact. This conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.179055Structured0.026324Uncertain0.8430.3930.000-10.810Likely Pathogenic0.553AmbiguousLikely Benign-0.13Likely Benign0.0-0.26Likely Benign-0.20Likely Benign0.43Likely Benign0.314Likely Benign-1.89Neutral0.259Benign0.107Benign-1.18Pathogenic0.18Tolerated0.11470.14980-1-5.358.04
c.1610C>A
A537E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A537E is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, premPS, PROVEAN, SIFT, ESM1b, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM; AlphaMissense‑Default is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. No prediction or stability result is missing or inconclusive. Based on the overall consensus of the available tools, the variant is most likely benign, and this conclusion does not contradict any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.116183Structured0.037313Uncertain0.9280.3620.000-5.120Likely Benign0.450AmbiguousLikely Benign-0.14Likely Benign0.10.00Likely Benign-0.07Likely Benign0.23Likely Benign0.378Likely Benign-1.78Neutral0.987Probably Damaging0.838Possibly Damaging-1.04Pathogenic1.00Tolerated0.13470.15660-1-5.358.04
c.1622C>A
A541D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A541D is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include SIFT and FoldX, whereas a larger group—SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, and AlphaMissense‑Default—consistently predict pathogenicity. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. Overall, the majority of evidence points to a pathogenic impact. This conclusion does not contradict ClinVar status, as no ClinVar classification exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.050641Structured0.029947Uncertain0.9550.3650.000-11.510Likely Pathogenic0.864Likely PathogenicAmbiguous0.36Likely Benign0.00.65Ambiguous0.51Ambiguous0.65Ambiguous0.571Likely Pathogenic-3.18Deleterious1.000Probably Damaging0.998Probably Damaging-1.15Pathogenic0.14Tolerated0.15810.19020-2-5.344.01
c.1649C>A
A550D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A550D is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely converge on a deleterious effect. Benign predictions: none. Pathogenic predictions: REVEL, FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized. Uncertain predictions: Rosetta and Foldetta. High‑accuracy assessments further support a damaging outcome: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; Foldetta, which integrates FoldX‑MD and Rosetta outputs, remains uncertain. Overall, the overwhelming majority of evidence indicates a pathogenic effect. Based on the aggregate predictions, the variant is most likely pathogenic, and this is not contradicted by ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.018106Structured0.007241Uncertain0.9540.2650.000-18.844Likely Pathogenic0.999Likely PathogenicLikely Pathogenic2.51Destabilizing0.11.46Ambiguous1.99Ambiguous1.01Destabilizing0.879Likely Pathogenic-5.43Deleterious0.999Probably Damaging0.971Probably Damaging-1.32Pathogenic0.01Affected0.13330.17830-2-5.344.01
c.1709C>A
A570D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A570D is not reported in ClinVar (ClinVar status: not listed) and is absent from gnomAD (gnomAD ID: none). Prediction tools that assess pathogenicity unanimously classify the variant as deleterious: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a benign effect, so the benign group is empty. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized predicts Pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts Pathogenic. Based on the collective evidence, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.046336Structured0.054494Uncertain0.9320.2630.000-14.117Likely Pathogenic0.997Likely PathogenicLikely Pathogenic2.47Destabilizing1.22.33Destabilizing2.40Destabilizing1.36Destabilizing0.805Likely Pathogenic-5.31Deleterious1.000Probably Damaging0.998Probably Damaging-1.28Pathogenic0.03Affected0.20060.22060-2-5.344.01
c.1730C>A
A577E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 A577E missense variant is not reported in ClinVar (ClinVar ID None) and has no entries in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, PROVEAN, and SIFT, whereas those that agree on a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is classified as Likely Pathogenic. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, while Foldetta (combining FoldX‑MD and Rosetta outputs) is also uncertain; Rosetta and premPS are inconclusive. Overall, the majority of evaluated tools (five pathogenic vs. four benign) and the SGM‑Consensus support a pathogenic classification. Thus, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.113710Structured0.019074Uncertain0.9130.2390.000-9.607Likely Pathogenic0.794Likely PathogenicAmbiguous0.29Likely Benign0.00.72Ambiguous0.51Ambiguous0.62Ambiguous0.419Likely Benign-1.91Neutral0.999Probably Damaging0.996Probably Damaging-1.12Pathogenic0.76Tolerated0.14870.17990-1-5.358.04
c.1751T>G
I584S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 I584S missense variant is not reported in ClinVar (ClinVar ID None) and has no entries in gnomAD (gnomAD ID None). Prediction tools that agree on pathogenicity include SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. No tool predicts a benign effect. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as likely pathogenic, and Foldetta as pathogenic. No contradictory evidence is present. Based on the overwhelming consensus of pathogenic predictions, the variant is most likely pathogenic, and this assessment does not conflict with the ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.059222Structured0.046673Uncertain0.8460.2440.000-13.379Likely Pathogenic0.945Likely PathogenicAmbiguous3.15Destabilizing0.12.53Destabilizing2.84Destabilizing1.70Destabilizing0.710Likely Pathogenic-5.54Deleterious1.000Probably Damaging0.997Probably Damaging-1.18Pathogenic0.03Affected0.23910.0858-1-2-5.3-26.08
c.1754C>A
A585E
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant A585E is not reported in ClinVar (status: None) and is absent from gnomAD. Prediction tools cluster into two groups: the single benign call comes from SIFT, while all other evaluated algorithms—including REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus—label the change as pathogenic or likely pathogenic. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized predicts pathogenic; the SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates likely pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also reports pathogenic. Thus, the variant is most likely pathogenic based on the collective predictions, and this assessment does not contradict any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.060549Structured0.055884Uncertain0.8800.2440.000-14.715Likely Pathogenic0.993Likely PathogenicLikely Pathogenic5.38Destabilizing0.73.70Destabilizing4.54Destabilizing1.42Destabilizing0.539Likely Pathogenic-2.59Deleterious1.000Probably Damaging0.998Probably Damaging-1.30Pathogenic0.28Tolerated0.11600.12120-1-5.358.04
c.1766T>G
I589S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I589S is not reported in ClinVar and is absent from gnomAD. Prediction tools that assess pathogenicity all converge on a deleterious effect: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all indicate a pathogenic or likely pathogenic outcome. No tool in the dataset predicts a benign effect. High‑accuracy assessments reinforce this consensus: AlphaMissense‑Optimized classifies the variant as pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports it as likely pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability predictions, also labels it pathogenic. Based on the uniform predictions, the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.018415Structured0.084536Uncertain0.9270.2140.000-15.223Likely Pathogenic0.998Likely PathogenicLikely Pathogenic3.62Destabilizing0.14.12Destabilizing3.87Destabilizing2.21Destabilizing0.954Likely Pathogenic-5.98Deleterious1.000Probably Damaging1.000Probably Damaging-1.99Pathogenic0.00Affected0.27860.1130-1-2-5.3-26.08
c.1772C>A
A591D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A591D is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL and FATHMM, whereas the remaining evaluated algorithms (AlphaMissense‑Default, ESM1b, PROVEAN, polyPhen‑2 HumDiv/HumVar, SIFT, premPS, FoldX‑MD, Rosetta, Foldetta, and the SGM Consensus) uniformly predict a pathogenic or likely pathogenic outcome; FoldX‑MD is uncertain but does not counter the overall trend. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts pathogenic. Based on the preponderance of pathogenic predictions and the absence of benign evidence, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.018787Structured0.093848Uncertain0.8820.1850.000-14.747Likely Pathogenic0.990Likely PathogenicLikely Pathogenic1.55Ambiguous0.22.77Destabilizing2.16Destabilizing1.40Destabilizing0.414Likely Benign-5.02Deleterious0.919Possibly Damaging0.495Possibly Damaging3.42Benign0.00Affected0.15500.17410-2-5.344.01
c.17C>A
A6D
2D
AIThe SynGAP1 missense variant A6D is reported in gnomAD (ID 6‑33420281‑C‑A) but has no ClinVar entry. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as benign. Only SIFT predicts it to be pathogenic, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) labels it “Likely Benign.” High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized is benign, and the SGM‑Consensus is also likely benign; Foldetta results are not available. Overall, the consensus of the majority of tools, including the high‑accuracy methods, indicates that the variant is most likely benign, and this conclusion does not contradict any ClinVar status (none is reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.566480Disordered0.549054Binding0.3770.9200.8756-33420281-C-A-3.340Likely Benign0.210Likely BenignLikely Benign0.211Likely Benign0.34Neutral0.117Benign0.010Benign4.07Benign0.00Affected4.3210.19450.2530-20-5.344.01
c.1802C>A
A601E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A601E is listed in ClinVar with an “Uncertain” status and is not reported in gnomAD. Prediction tools that assess pathogenicity largely agree: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict a pathogenic effect, while only FATHMM predicts a benign outcome. High‑accuracy assessments reinforce this consensus: AlphaMissense‑Optimized indicates pathogenicity; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports “Likely Pathogenic”; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also predicts pathogenicity. No predictions or stability results are missing or inconclusive. Based on the overwhelming agreement among these tools, the variant is most likely pathogenic, which does not contradict its current ClinVar “Uncertain” classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.008895Structured0.174517Uncertain0.9550.1560.000Conflicting 2-16.752Likely Pathogenic0.992Likely PathogenicLikely Pathogenic6.68Destabilizing0.85.76Destabilizing6.22Destabilizing1.24Destabilizing0.588Likely Pathogenic-4.98Deleterious1.000Probably Damaging0.999Probably Damaging2.54Benign0.00Affected3.37350.13460.14440-1-5.358.04240.0-82.30.00.00.70.1XXXPotentially PathogenicThe methyl side chain of Ala601, located on an α helix (res. Glu582-Met603), packs hydrophobically against other hydrophobic residues in the inter-helix space (e.g., Phe597, Leu598, Leu506, Phe608).In the variant simulations, the carboxylate group of Glu601 faces the inter-helix space and is forced to shift slightly away from the hydrophobic niche. Additionally, in two of the simulations, Glu601 forms a salt bridge with Arg499, causing the otherwise stable salt bridge between Arg499 and Glu496 at the outer surface of an α helix (res. Leu489-Glu519) to break due to the residue swap.These effects suggest that the protein folding process could be seriously affected. Moreover, due to its location at the GAP-Ras interface, it could also impact the complex formation with the GTPase.
c.1805T>G
I602S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I602S is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly indicate a deleterious effect. Benign predictions: none. Pathogenic predictions: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments corroborate this: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, also predicts pathogenic. No conflicting benign evidence is available. Therefore, based on the consensus of all available predictions, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.010221Structured0.186541Uncertain0.9630.1710.000-15.558Likely Pathogenic0.983Likely PathogenicLikely Pathogenic3.50Destabilizing0.13.79Destabilizing3.65Destabilizing2.04Destabilizing0.935Likely Pathogenic-5.89Deleterious1.000Probably Damaging0.999Probably Damaging-2.01Pathogenic0.00Affected0.22130.1087-1-2-5.3-26.08
c.1877T>G
I626S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I626S is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include only FATHMM, whereas all other evaluated algorithms—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the variant as pathogenic. High‑accuracy methods further support a deleterious impact: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. No prediction or folding stability result is missing or inconclusive. Based on the overwhelming consensus of pathogenic predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because the variant is not yet catalogued in ClinVar.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.109221Structured0.040732Uncertain0.9700.2230.000-14.449Likely Pathogenic0.992Likely PathogenicLikely Pathogenic3.80Destabilizing0.04.54Destabilizing4.17Destabilizing2.16Destabilizing0.706Likely Pathogenic-5.41Deleterious1.000Probably Damaging1.000Probably Damaging3.04Benign0.00Affected0.23080.0858-1-2-5.3-26.08
c.1880C>A
A627D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A627D is not reported in ClinVar (ClinVar status: not listed) and is absent from gnomAD (gnomAD ID: none). Prediction tools that assess pathogenicity unanimously classify the variant as deleterious: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool in the dataset predicts a benign effect. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, predicts pathogenic. All available evidence points to a damaging impact. Consequently, the variant is most likely pathogenic based on current predictions, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.100716Structured0.037862Uncertain0.9700.2100.000-16.603Likely Pathogenic0.999Likely PathogenicLikely Pathogenic6.09Destabilizing1.35.83Destabilizing5.96Destabilizing1.58Destabilizing0.726Likely Pathogenic-5.93Deleterious0.999Probably Damaging0.961Probably Damaging2.43Pathogenic0.00Affected0.15020.18160-2-5.344.01
c.1889T>G
I630S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I630S is not reported in ClinVar (ClinVar ID None) and has no entry in gnomAD (gnomAD ID None). Prediction tools that agree on a pathogenic effect include SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. No tool predicts a benign outcome. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as likely pathogenic, and Foldetta as pathogenic. No contradictory evidence is present. Based on the overwhelming consensus of pathogenic predictions, the variant is most likely pathogenic, and this assessment does not conflict with the ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.040537Structured0.036106Uncertain0.9660.2360.000-12.527Likely Pathogenic0.952Likely PathogenicAmbiguous3.61Destabilizing0.13.74Destabilizing3.68Destabilizing2.25Destabilizing0.851Likely Pathogenic-3.86Deleterious1.000Probably Damaging0.981Probably Damaging-1.44Pathogenic0.00Affected0.23630.0858-1-2-5.3-26.08
c.1901C>A
A634D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A634D is not reported in ClinVar (ClinVar status: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that assess pathogenicity all agree on a deleterious effect: SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the variant as pathogenic. No tool predicts a benign outcome. High‑accuracy methods reinforce this consensus: AlphaMissense‑Optimized predicts pathogenicity; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates pathogenicity; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, reports a pathogenic effect. No predictions or stability results are missing or inconclusive. Based on the unanimous computational evidence, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.085092Structured0.052058Uncertain0.9320.2420.000-16.727Likely Pathogenic0.998Likely PathogenicLikely Pathogenic5.26Destabilizing0.54.24Destabilizing4.75Destabilizing1.79Destabilizing0.731Likely Pathogenic-5.98Deleterious0.999Probably Damaging0.996Probably Damaging2.49Pathogenic0.00Affected0.17900.18160-2-5.344.01
c.2000T>G
I667S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I667S is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include only FATHMM, whereas all other evaluated algorithms—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the variant as pathogenic. High‑accuracy methods further support a deleterious impact: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. No prediction or folding stability result is missing or inconclusive. Based on the overwhelming consensus of pathogenic predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because the variant is not yet catalogued in ClinVar.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.142424Structured0.083597Uncertain0.9270.3790.000-14.328Likely Pathogenic0.993Likely PathogenicLikely Pathogenic3.69Destabilizing0.13.97Destabilizing3.83Destabilizing2.48Destabilizing0.690Likely Pathogenic-5.90Deleterious1.000Probably Damaging0.995Probably Damaging2.96Benign0.00Affected0.24620.0858-1-2-5.3-26.08
c.2048T>G
I683S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I683S is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect are limited to FATHMM, whereas the majority of tools predict a pathogenic impact: SGM‑Consensus, REVEL, FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. High‑accuracy methods give a consistent pathogenic signal: AlphaMissense‑Optimized is uncertain, SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is Pathogenic. No prediction or folding stability result is missing or inconclusive; all available evidence points to a deleterious effect. Based on the collective predictions, the variant is most likely pathogenic, and this assessment does not contradict the ClinVar status, which currently has no classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.200174Structured0.143268Uncertain0.8480.3140.000-11.443Likely Pathogenic0.950Likely PathogenicAmbiguous2.53Destabilizing0.21.94Ambiguous2.24Destabilizing1.35Destabilizing0.552Likely Pathogenic-5.88Deleterious1.000Probably Damaging0.989Probably Damaging3.29Benign0.05Affected0.19360.1320-1-2-5.3-26.08
c.206T>G
I69S
2D
AIThe SynGAP1 I69S missense variant has no ClinVar record and is not listed in gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict any ClinVar annotation (none exists). Thus, the variant is most likely benign based on current predictive data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.575842Disordered0.466129Uncertain0.4370.7860.375-1.880Likely Benign0.634Likely PathogenicLikely Benign0.152Likely Benign-0.78Neutral0.824Possibly Damaging0.507Possibly Damaging4.14Benign0.00Affected0.26720.0782-1-2-5.3-26.08
c.2081C>A
A694D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 A694D missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, PROVEAN, FATHMM, and polyPhen‑2 HumVar. Those that predict a pathogenic effect are premPS, polyPhen‑2 HumDiv, SIFT, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments are inconclusive: AlphaMissense‑Optimized is uncertain, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is a 2‑vs‑2 tie, and Foldetta is uncertain. Consequently, the variant’s functional impact remains ambiguous. The predictions do not contradict ClinVar status, as no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.127496Structured0.352199Uncertain0.9380.2690.000-9.542Likely Pathogenic0.841Likely PathogenicAmbiguous0.35Likely Benign0.11.04Ambiguous0.70Ambiguous1.01Destabilizing0.163Likely Benign-2.47Neutral0.918Possibly Damaging0.375Benign3.48Benign0.05Affected0.20850.22160-2-5.344.01
c.2120C>A
A707D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A707D is not reported in ClinVar (status: None) and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, FATHMM, AlphaMissense‑Optimized, and Foldetta. Tools that predict a pathogenic effect are SGM‑Consensus, AlphaMissense‑Default, ESM1b, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. Two tools give uncertain results: premPS and Rosetta. High‑accuracy methods give a mixed picture: AlphaMissense‑Optimized predicts benign, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts likely pathogenic, and Foldetta predicts benign. Overall, the majority of evidence points to a pathogenic impact, and this assessment does not contradict any ClinVar classification because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.203355Structured0.371229Uncertain0.9270.3650.000-9.160Likely Pathogenic0.772Likely PathogenicLikely Benign0.29Likely Benign0.0-0.61Ambiguous-0.16Likely Benign0.89Ambiguous0.225Likely Benign-3.16Deleterious0.996Probably Damaging0.983Probably Damaging3.39Benign0.02Affected0.13760.17410-2-5.344.01
c.2162T>G
I721S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I721S is listed in ClinVar with an “Uncertain” status and is not reported in gnomAD. Prediction tools that assess the variant’s effect fall into two groups: the single benign prediction comes from REVEL, while all other evaluated algorithms (FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized) predict a pathogenic outcome. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized reports pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is “Likely Pathogenic,” and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts pathogenic. No predictions are missing or inconclusive. Based on the overwhelming consensus of pathogenic predictions, the variant is most likely pathogenic, which does not contradict its current ClinVar “Uncertain” classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.394753Structured0.454550Uncertain0.9570.4370.125Uncertain 1-14.032Likely Pathogenic0.996Likely PathogenicLikely Pathogenic3.91Destabilizing0.13.96Destabilizing3.94Destabilizing2.28Destabilizing0.466Likely Benign-5.26Deleterious1.000Probably Damaging1.000Probably Damaging2.21Pathogenic0.00Affected3.5090.26060.1110-1-2-5.3-26.08203.349.3-0.10.0-1.10.0XUncertainThe sec-butyl side chain of Ile721, located on an α-helix (res. Leu714-Arg726), engages in hydrophobic packing with other residues in the hydrophobic inter-helix space, such as Phe420, Tyr417, His693, and Leu717. In the variant simulations, the hydroxyl side chain of Ser721 forms hydrogen bonds with nearby residues, such as Leu717 and His693. Although no major structural changes are observed during the variant simulations, the hydrophilic residue Ser721 could disrupt the hydrophobic packing during folding. However, because the model ends abruptly at the C-terminus, no definite conclusions can be drawn based on the simulations.
c.2171C>A
A724D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A724D is not reported in ClinVar or gnomAD. Prediction tools that indicate a benign effect include REVEL, whereas the majority of other in silico predictors (PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized) predict a pathogenic impact. Four methods (FoldX, Rosetta, Foldetta, premPS) returned uncertain results and are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely pathogenic; Foldetta remains uncertain. Overall, the preponderance of evidence points to a pathogenic effect for A724D, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.476583Structured0.458050Uncertain0.9230.4830.250-12.233Likely Pathogenic0.977Likely PathogenicLikely Pathogenic1.06Ambiguous0.20.86Ambiguous0.96Ambiguous0.60Ambiguous0.335Likely Benign-4.44Deleterious1.000Probably Damaging0.998Probably Damaging2.03Pathogenic0.00Affected0.15960.18120-2-5.344.01
c.2189T>G
I730S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I730S is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). Tools that predict a pathogenic effect are PolyPhen‑2 HumDiv and PolyPhen‑2 HumVar; AlphaMissense‑Default remains uncertain. High‑accuracy assessments—AlphaMissense‑Optimized, the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), and Foldetta (combining FoldX‑MD and Rosetta outputs)—all uniformly predict a benign impact. Based on the collective evidence, the variant is most likely benign, and this conclusion does not contradict any ClinVar status, as no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.733139Disordered0.420109Uncertain0.5910.6190.750-6.220Likely Benign0.349AmbiguousLikely Benign0.25Likely Benign0.2-0.12Likely Benign0.07Likely Benign0.47Likely Benign0.123Likely Benign-0.51Neutral1.000Probably Damaging0.967Probably Damaging3.60Benign0.34Tolerated0.26460.0903-1-2-5.3-26.08
c.2258C>A
A753D
2D
AISynGAP1 missense variant A753D is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Consensus from multiple in‑silico predictors indicates a benign effect: REVEL, PROVEAN, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized all score benign, while only polyPhen‑2 HumDiv predicts pathogenic. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy tools corroborate this view: AlphaMissense‑Optimized reports a benign outcome, SGM‑Consensus likewise indicates Likely Benign, and Foldetta (a protein‑folding stability method combining FoldX‑MD and Rosetta) has no available result for this variant. Overall, the computational evidence overwhelmingly supports a benign classification, and this conclusion does not contradict the ClinVar status. Thus, the variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.521092Disordered0.722781Binding0.3810.8730.625-5.836Likely Benign0.408AmbiguousLikely Benign0.113Likely Benign-1.66Neutral0.669Possibly Damaging0.265Benign2.60Benign0.60Tolerated0.21510.22000-2-5.344.01
c.2300T>G
I767S
2D
AIThe SynGAP1 missense variant I767S is not reported in ClinVar and is absent from gnomAD. Consensus predictions from multiple in‑silico tools cluster around a benign effect: REVEL, PROVEAN, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized all indicate benign. Only polyPhen‑2 HumDiv flags it as pathogenic, while AlphaMissense‑Default remains uncertain. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely benign outcome. High‑accuracy assessments further support this: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus likewise indicates likely benign; Foldetta results are not available. Taken together, the preponderance of evidence points to a benign classification for I767S, and this assessment does not conflict with the absence of a ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.321458Structured0.927771Binding0.3690.8720.125-3.030Likely Benign0.388AmbiguousLikely Benign0.126Likely Benign-0.64Neutral0.925Possibly Damaging0.329Benign4.13Benign0.25Tolerated0.32420.1782-1-2-5.3-26.08
c.2321C>A
A774D
2D
AIThe SynGAP1 missense variant A774D is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a Likely Benign classification. High‑accuracy assessments show AlphaMissense‑Optimized as Benign and the SGM‑Consensus as Likely Benign; the Foldetta protein‑folding stability analysis is unavailable. Overall, the majority of evidence points to a benign impact, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.450668Structured0.905168Binding0.3360.8970.250-4.455Likely Benign0.603Likely PathogenicLikely Benign0.123Likely Benign-0.46Neutral0.570Possibly Damaging0.386Benign4.21Benign0.06Tolerated0.16450.17930-2-5.344.01
c.2351C>A
A784D
2D
AIThe SynGAP1 missense variant A784D is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Only AlphaMissense‑Default predicts a pathogenic outcome. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict any ClinVar annotation (none is present). Thus, the variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.801317Disordered0.708872Binding0.3140.8960.625-3.784Likely Benign0.766Likely PathogenicLikely Benign0.206Likely Benign-1.21Neutral0.411Benign0.237Benign2.68Benign0.16Tolerated0.18240.21930-2-5.344.01
c.23T>G
I8S
2D
AIThe SynGAP1 missense variant I8S is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only SIFT predicts a pathogenic outcome. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a “Likely Benign” classification. High‑accuracy assessments further support a benign prediction: AlphaMissense‑Optimized is benign, and the SGM‑Consensus is likely benign; Foldetta results are not available. Based on the preponderance of evidence, the variant is most likely benign, and this conclusion does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.490133Structured0.543080Binding0.3410.9160.625-1.577Likely Benign0.122Likely BenignLikely Benign0.266Likely Benign0.18Neutral0.107Benign0.006Benign4.02Benign0.00Affected0.27260.0910-1-2-5.3-26.08
c.2441C>A
A814D
2D
AIThe SynGAP1 missense variant A814D is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, ESM1b, and FATHMM, whereas a majority of tools (PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default) predict a pathogenic impact; AlphaMissense‑Optimized is uncertain. High‑accuracy assessments are inconclusive: AlphaMissense‑Optimized is uncertain, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is a tie and thus unavailable, and Foldetta (combining FoldX‑MD and Rosetta outputs) has no reported result. Overall, the balance of evidence from the consensus of standard predictors points to a pathogenic effect. This conclusion does not contradict ClinVar status, as no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
SH3-binding motif0.411940Structured0.814830Binding0.3680.9020.250-5.641Likely Benign0.939Likely PathogenicAmbiguous0.158Likely Benign-2.56Deleterious0.968Probably Damaging0.810Possibly Damaging2.59Benign0.01Affected0.17400.21670-2-5.344.01
c.2456C>A
A819E
2D
AIThe SynGAP1 missense variant A819E is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include only REVEL, which scores the variant as benign. In contrast, the majority of tools predict a pathogenic impact: PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the variant as pathogenic. ESM1b is uncertain, and no Foldetta stability assessment is available. High‑accuracy methods give a consistent pathogenic signal: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports the variant as Likely Pathogenic, and Foldetta data are unavailable. Based on the preponderance of pathogenic predictions and the lack of any benign consensus, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none is reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.694846Disordered0.707644Binding0.3170.8920.625-7.333In-Between0.982Likely PathogenicLikely Pathogenic0.292Likely Benign-2.85Deleterious0.999Probably Damaging0.977Probably Damaging2.19Pathogenic0.00Affected0.11890.20370-1-5.358.04
c.2480T>G
I827S
2D
AIThe SynGAP1 missense variant I827S is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, and FATHMM, while those that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. The high‑accuracy consensus from SGM (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is Likely Benign, and AlphaMissense‑Optimized is classified as Uncertain. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of evidence points to a benign impact. This conclusion is not contradicted by ClinVar, which has no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.590140Disordered0.636272Binding0.3830.8840.625-3.693Likely Benign0.849Likely PathogenicAmbiguous0.140Likely Benign-0.42Neutral0.999Probably Damaging0.996Probably Damaging2.70Benign0.29Tolerated0.28910.0512-1-2-5.3-26.08
c.2591C>A
A864E
2D
AIThe SynGAP1 missense variant A864E is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are SIFT and FATHMM; AlphaMissense‑Default is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also favors a benign outcome. Foldetta, which evaluates protein‑folding stability, has no available result for this variant. Overall, the majority of evidence points to a benign impact. This conclusion is consistent with the lack of ClinVar annotation and does not contradict any existing clinical database.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.549308Disordered0.611966Binding0.2690.7880.250-5.508Likely Benign0.350AmbiguousLikely Benign0.153Likely Benign0.10Neutral0.138Benign0.070Benign2.45Pathogenic0.04Affected0.12040.20370-1-5.358.04
c.2594C>A
A865D
2D
AIThe SynGAP1 missense variant A865D is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. Only polyPhen‑2 HumDiv predicts a pathogenic outcome, while AlphaMissense‑Default remains uncertain. The high‑accuracy consensus from SGM (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) classifies the variant as Likely Benign, and AlphaMissense‑Optimized also predicts Benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of evidence points to a benign effect, and this assessment does not contradict any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.521092Disordered0.626222Binding0.2710.7880.250-4.635Likely Benign0.515AmbiguousLikely Benign0.123Likely Benign-0.57Neutral0.611Possibly Damaging0.346Benign2.71Benign0.36Tolerated0.15630.15600-2-5.344.01
c.2624C>A
A875D
2D
AIThe SynGAP1 missense variant A875D is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, ESM1b, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (2 vs 2) and Foldetta data are unavailable. Overall, the majority of standard tools (5 pathogenic vs 4 benign) lean toward a pathogenic interpretation, but the high‑accuracy predictions are mixed or missing. Thus, the variant is most likely pathogenic based on the available predictions, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.545602Disordered0.632173Binding0.2730.8720.250-3.268Likely Benign0.645Likely PathogenicLikely Benign0.149Likely Benign-2.78Deleterious0.992Probably Damaging0.913Probably Damaging2.68Benign0.02Affected0.16480.20350-2-5.344.01
c.2636C>A
A879E
2D
AIThe SynGAP1 missense variant A879E is reported in gnomAD (variant ID 6‑33443188‑C‑A) but has no ClinVar entry. Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Tools that predict a pathogenic outcome are PolyPhen‑2 HumDiv and PolyPhen‑2 HumVar. AlphaMissense‑Default is uncertain, and Foldetta (a protein‑folding stability method combining FoldX‑MD and Rosetta outputs) has no available result for this variant. High‑accuracy predictions specifically show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; Foldetta data is missing. Overall, the majority of evidence points to a benign effect, and this assessment does not contradict any ClinVar status because none is assigned.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.608892Disordered0.622695Binding0.2770.8740.2506-33443188-C-A16.20e-7-3.786Likely Benign0.503AmbiguousLikely Benign0.070Likely Benign-0.27Neutral0.872Possibly Damaging0.659Possibly Damaging2.70Benign0.27Tolerated3.7750.11200.1903-10-5.358.04
c.2639C>A
A880D
2D
AIThe SynGAP1 missense variant A880D is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumVar, ESM1b, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are polyPhen‑2 HumDiv and SIFT, while AlphaMissense‑Default remains uncertain. High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as benign, the SGM Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicating a likely benign outcome, and no Foldetta stability result is available. Based on the overall consensus of the available predictions, the variant is most likely benign, and this assessment does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.703578Disordered0.621441Binding0.3090.8740.250-4.571Likely Benign0.493AmbiguousLikely Benign0.127Likely Benign-1.29Neutral0.918Possibly Damaging0.401Benign2.60Benign0.03Affected0.16640.19040-2-5.344.01
c.2657C>A
A886E
2D
AIThe SynGAP1 missense variant A886E is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are SIFT and FATHMM. AlphaMissense‑Default is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also favors a benign outcome. Foldetta, which would provide a protein‑folding stability estimate, has no available result for this variant. Overall, the preponderance of evidence points to a benign impact. This conclusion is not contradicted by ClinVar, which contains no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.716283Disordered0.619166Binding0.3590.9220.500-3.747Likely Benign0.422AmbiguousLikely Benign0.096Likely Benign-1.31Neutral0.423Benign0.230Benign2.17Pathogenic0.00Affected0.14830.20080-1-5.358.04
c.2663C>A
A888D
2D
AIThe SynGAP1 missense variant A888D is not reported in ClinVar and has no entries in gnomAD, indicating it is not catalogued in these databases. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, and AlphaMissense‑Optimized all classify the change as benign, while SIFT uniquely predicts it as pathogenic. The consensus prediction from SGM (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is “Likely Benign.” High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized reports benign, SGM‑Consensus is likely benign, and Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact, and this conclusion does not conflict with the absence of a ClinVar assertion.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.784345Disordered0.575860Binding0.3520.9280.625-3.870Likely Benign0.526AmbiguousLikely Benign0.078Likely Benign-1.52Neutral0.077Benign0.097Benign2.56Benign0.00Affected0.16460.13860-2-5.344.01
c.2696T>G
I899S
2D
AIThe SynGAP1 missense variant I899S is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as benign, while the single pathogenic call comes from SIFT. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely benign consensus. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus likewise indicates likely benign; Foldetta results are not available. Overall, the majority of evidence points to a benign impact, and this conclusion does not conflict with the ClinVar record, which contains no assertion for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.675549Disordered0.443727Uncertain0.2920.9280.375-0.857Likely Benign0.340Likely BenignLikely Benign0.082Likely Benign-0.38Neutral0.003Benign0.004Benign2.88Benign0.00Affected0.28380.0840-1-2-5.3-26.08
c.2702C>A
A901E
2D
AIThe SynGAP1 missense variant A901E is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumVar, SIFT, ESM1b, and FATHMM. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as Likely Benign. High‑accuracy assessments show AlphaMissense‑Optimized as Uncertain, while Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact. This conclusion is consistent with the lack of ClinVar annotation, so there is no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.595080Disordered0.489838Uncertain0.3060.9170.375-4.350Likely Benign0.802Likely PathogenicAmbiguous0.082Likely Benign-0.53Neutral0.800Possibly Damaging0.300Benign2.64Benign0.12Tolerated0.14330.24240-1-5.358.04
c.2705C>A
A902D
2D
AIThe SynGAP1 missense variant A902D is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), which collectively suggest a likely benign outcome. In contrast, polyPhen‑2 (HumDiv and HumVar), SIFT, and AlphaMissense‑Default predict a pathogenic impact. The high‑accuracy AlphaMissense‑Optimized result is uncertain, and Foldetta stability analysis is unavailable. Overall, the balance of evidence leans toward a benign interpretation, and this assessment does not contradict any ClinVar annotation because no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.675549Disordered0.517703Binding0.3190.9190.375-5.273Likely Benign0.823Likely PathogenicAmbiguous0.101Likely Benign-1.21Neutral0.986Probably Damaging0.787Possibly Damaging2.59Benign0.00Affected0.16530.16090-2-5.344.01
c.2753C>A
A918D
2D
AIThe SynGAP1 missense variant A918D is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, and AlphaMissense‑Optimized, while polyPhen‑2 (HumDiv and HumVar) and SIFT all predict a pathogenic outcome. AlphaMissense‑Default remains uncertain. The high‑accuracy consensus from SGM (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) classifies the variant as Likely Benign, and AlphaMissense‑Optimized independently predicts Benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of evidence—including the high‑accuracy tools—points to a benign impact. This conclusion is consistent with the lack of ClinVar annotation; there is no contradictory ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.632174Disordered0.891459Binding0.3170.8600.250-4.281Likely Benign0.445AmbiguousLikely Benign0.102Likely Benign-0.99Neutral0.961Probably Damaging0.721Possibly Damaging2.64Benign0.01Affected0.20370.24120-2-5.344.01
c.2768T>G
I923S
2D
AIThe SynGAP1 missense variant I923S is not reported in ClinVar and has no entry in gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact for I923S. This conclusion is not contradicted by ClinVar status, which has no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.562014Disordered0.964857Binding0.2920.8520.250-0.002Likely Benign0.760Likely PathogenicLikely Benign0.094Likely Benign-0.61Neutral0.912Possibly Damaging0.529Possibly Damaging2.73Benign0.33Tolerated0.33000.1455-1-2-5.3-26.08
c.2804C>A
A935D
2D
AIThe SynGAP1 missense variant A935D is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL and ESM1b, while pathogenic predictions are made by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Default. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized is uncertain, but the SGM‑Consensus—derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—classifies the variant as likely pathogenic. Foldetta, a protein‑folding stability method that integrates FoldX‑MD and Rosetta outputs, was not available for this variant. Overall, the preponderance of evidence points to a pathogenic impact for A935D, and this conclusion does not conflict with the current ClinVar status, which contains no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.736850Disordered0.980490Binding0.2860.8650.625-4.089Likely Benign0.817Likely PathogenicAmbiguous0.247Likely Benign-2.69Deleterious1.000Probably Damaging0.999Probably Damaging2.31Pathogenic0.00Affected0.18320.18600-2-5.344.01
c.2807C>A
A936D
2D
AIThe SynGAP1 missense variant A936D is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, SIFT, FATHMM, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (2 benign vs 2 pathogenic), and Foldetta results are unavailable. Overall, the majority of evidence points toward a benign impact. This conclusion does not contradict any ClinVar annotation, as no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.812494Disordered0.973218Binding0.3190.8740.625-4.162Likely Benign0.686Likely PathogenicLikely Benign0.115Likely Benign-1.63Neutral0.801Possibly Damaging0.339Benign2.48Pathogenic0.02Affected0.17780.16600-2-5.344.01
c.2930C>A
A977D
2D
AIThe SynGAP1 missense variant A977D is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include SGM‑Consensus (Likely Benign), REVEL, PROVEAN, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. High‑accuracy methods give a consistent benign signal: AlphaMissense‑Optimized predicts benign, SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates likely benign, while Foldetta’s protein‑folding stability assessment is unavailable. Overall, the majority of evidence points to a benign impact for A977D, and this conclusion does not contradict any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.882776Disordered0.975330Binding0.3060.8840.625-4.007Likely Benign0.717Likely PathogenicLikely Benign0.130Likely Benign-1.15Neutral0.990Probably Damaging0.892Possibly Damaging3.96Benign0.01Affected0.22530.26510-2-5.344.01
c.2990C>A
A997D
2D
AIThe SynGAP1 missense variant A997D is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only SIFT predicts a pathogenic outcome. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as Likely Benign. High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized is benign, and the SGM‑Consensus is Likely Benign. Foldetta results are not available for this variant. Overall, the majority of evidence points to a benign effect, and this is consistent with the lack of any ClinVar pathogenic annotation. Thus, the variant is most likely benign and does not contradict ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.754692Disordered0.948624Binding0.2730.9010.500-5.251Likely Benign0.319Likely BenignLikely Benign0.131Likely Benign-1.09Neutral0.411Benign0.120Benign4.15Benign0.00Affected0.18150.21430-2-5.344.01
c.2993C>A
A998D
2D
AIThe SynGAP1 missense variant A998D is not reported in ClinVar and has no entry in gnomAD. Consensus from multiple in‑silico predictors shows a split: benign calls come from REVEL, PROVEAN, ESM1b, FATHMM, and AlphaMissense‑Optimized, while pathogenic calls arise from polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. AlphaMissense‑Default remains uncertain. The high‑accuracy assessment indicates that AlphaMissense‑Optimized predicts a benign effect, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also reports a likely benign outcome, and Foldetta data are unavailable. Overall, the majority of robust predictors lean toward a benign impact. Therefore, the variant is most likely benign, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.759478Disordered0.951758Binding0.3180.9020.500-5.481Likely Benign0.365AmbiguousLikely Benign0.122Likely Benign-1.55Neutral0.971Probably Damaging0.690Possibly Damaging4.09Benign0.00Affected0.17540.21430-2-5.344.01
c.2999T>G
I1000S
2D
AIThe SynGAP1 missense variant I1000S is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include SGM‑Consensus (Likely Benign), REVEL, PROVEAN, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, and the SGM‑Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also predicts benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of evidence (seven benign vs. three pathogenic predictions) supports a benign classification. This conclusion is consistent with the lack of ClinVar annotation, so there is no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.745909Disordered0.957020Binding0.2930.9040.625-3.694Likely Benign0.587Likely PathogenicLikely Benign0.151Likely Benign-0.38Neutral0.946Possibly Damaging0.673Possibly Damaging2.80Benign0.19Tolerated0.25010.1270-1-2-5.3-26.08
c.3110T>G
I1037S
2D
AIThe SynGAP1 missense variant I1037S is not reported in ClinVar and has no entries in gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), which classifies the variant as Likely Benign. Only AlphaMissense‑Default predicts a pathogenic outcome, while AlphaMissense‑Optimized is uncertain and Foldetta (a protein‑folding stability method combining FoldX‑MD and Rosetta) has no available result for this variant. Based on the overall consensus of the majority of tools, the variant is most likely benign, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.939629Disordered0.986140Binding0.3090.7740.625-2.247Likely Benign0.935Likely PathogenicAmbiguous0.120Likely Benign0.43Neutral0.032Benign0.017Benign2.83Benign0.27Tolerated0.26340.1110-1-2-5.3-26.08
c.3116T>G
I1039S
2D
AIThe SynGAP1 missense variant I1039S is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, and FATHMM all classify the substitution as benign. In contrast, SIFT and AlphaMissense‑Default predict a pathogenic impact. The high‑accuracy AlphaMissense‑Optimized score is uncertain, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports a likely benign outcome. No Foldetta stability assessment is available. Overall, the majority of evidence points to a benign effect, and this is consistent with the lack of ClinVar annotation; there is no contradiction with ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.969315Disordered0.979204Binding0.2920.8060.625-1.688Likely Benign0.829Likely PathogenicAmbiguous0.171Likely Benign-0.20Neutral0.032Benign0.008Benign2.76Benign0.03Affected0.29170.1294-1-2-5.3-26.08
c.3134C>A
A1045D
2D
AIThe SynGAP1 missense variant A1045D is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that reach consensus all indicate a benign effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and FATHMM all score the variant as benign. AlphaMissense‑Optimized also predicts a benign outcome, whereas AlphaMissense‑Default remains uncertain. The SGM‑Consensus, which aggregates the majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as “Likely Benign.” No tools predict pathogenicity. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized is benign, and the SGM‑Consensus is likely benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the collective predictions strongly suggest that A1045D is most likely benign, and this conclusion is consistent with the absence of any ClinVar pathogenic annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.975609Disordered0.948874Binding0.3520.8820.750-5.734Likely Benign0.418AmbiguousLikely Benign0.066Likely Benign-1.00Neutral0.411Benign0.172Benign2.64Benign0.16Tolerated0.19540.21020-2-5.344.01
c.3239C>A
A1080E
2D
AIThe SynGAP1 missense variant A1080E is not reported in ClinVar (ClinVar ID None) but is present in gnomAD (ID 6‑33443791‑C‑A). Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, and FATHMM. Tools that predict a pathogenic outcome are polyPhen‑2 (HumDiv and HumVar), SIFT, and AlphaMissense‑Default. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as Likely Benign. AlphaMissense‑Optimized is uncertain, and no Foldetta stability assessment is available. High‑accuracy evidence therefore points to a benign or uncertain impact: AlphaMissense‑Optimized is inconclusive, SGM‑Consensus is benign, and Foldetta data are missing. Overall, the balance of predictions leans toward a benign effect, and this conclusion does not contradict the ClinVar status, which currently has no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.912647Disordered0.981457Binding0.3030.9000.7506-33443791-C-A-3.672Likely Benign0.855Likely PathogenicAmbiguous0.090Likely Benign-1.50Neutral0.901Possibly Damaging0.540Possibly Damaging4.00Benign0.01Affected3.7750.13940.2437-10-5.358.04
c.3242C>A
A1081D
2D
AIThe SynGAP1 missense variant A1081D is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumVar, ESM1b, FATHMM, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) which classifies the variant as Likely Benign. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, SIFT, and AlphaMissense‑Default. The high‑accuracy AlphaMissense‑Optimized result is Uncertain, and the Foldetta protein‑folding stability assessment is unavailable. Overall, the majority of evidence points to a benign impact. This conclusion is not contradicted by ClinVar status, as no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.874069Disordered0.979759Binding0.2880.8950.750-4.603Likely Benign0.892Likely PathogenicAmbiguous0.095Likely Benign-1.84Neutral0.611Possibly Damaging0.404Benign3.97Benign0.04Affected0.20690.26000-2-5.344.01
c.3305C>A
A1102D
2D
AIThe SynGAP1 missense variant A1102D is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Optimized. Only FATHMM predicts a pathogenic outcome, while AlphaMissense‑Default remains uncertain. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized is benign, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also favors benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the preponderance of evidence indicates that the variant is most likely benign, and this conclusion does not contradict the ClinVar status, which currently contains no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.915074Disordered0.962659Binding0.3880.8590.875-4.647Likely Benign0.388AmbiguousLikely Benign0.081Likely Benign-1.38Neutral0.033Benign0.028Benign2.27Pathogenic0.12Tolerated0.20450.29840-2-5.344.01
c.3344T>G
I1115S
2D
AIThe SynGAP1 missense variant I1115S is catalogued in gnomAD (ID 6‑33443896‑T‑G) but has no ClinVar entry. Functional prediction tools uniformly indicate a benign effect: REVEL, PROVEAN, PolyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all score the variant as benign. No tool predicts pathogenicity. High‑accuracy assessments corroborate this: AlphaMissense‑Optimized is benign, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is “Likely Benign.” Foldetta results are unavailable. Overall, the consensus of all available predictions is benign, and this is consistent with the absence of a ClinVar pathogenic classification. Thus, the variant is most likely benign and does not contradict ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.889439Disordered0.892339Binding0.3080.9120.7506-33443896-T-G-0.579Likely Benign0.073Likely BenignLikely Benign0.128Likely Benign0.67Neutral0.000Benign0.001Benign2.88Benign0.14Tolerated4.3220.29860.1453-2-1-5.3-26.08
c.3398T>G
I1133S
2D
AIThe SynGAP1 missense variant I1133S is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. No tool predicts a pathogenic outcome; AlphaMissense‑Default is uncertain. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates a likely benign classification. High‑accuracy assessments confirm this: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus (majority vote) is likely benign. Foldetta results are unavailable, so they do not influence the assessment. Overall, the collective evidence strongly supports a benign impact for I1133S, and this conclusion does not contradict any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.919029Disordered0.832785Binding0.3160.8920.750-4.034Likely Benign0.492AmbiguousLikely Benign0.186Likely Benign-0.60Neutral0.007Benign0.016Benign5.70Benign0.08Tolerated0.27620.1110-1-2-5.3-26.08
c.3449C>A
A1150D
2D
AIThe SynGAP1 missense variant A1150D is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, and ESM1b, whereas those that agree on a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, FATHMM, and AlphaMissense‑Default. The high‑accuracy AlphaMissense‑Optimized tool returns an uncertain result, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (2 pathogenic vs. 2 benign). Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of evaluated tools (five pathogenic vs. three benign) predict a pathogenic impact. Thus, the variant is most likely pathogenic based on current predictions, and this assessment does not contradict any ClinVar status because the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.762850Disordered0.795712Binding0.3710.8310.625-3.923Likely Benign0.859Likely PathogenicAmbiguous0.156Likely Benign-2.30Neutral0.995Probably Damaging0.940Probably Damaging2.30Pathogenic0.01Affected0.17540.21430-2-5.344.01
c.3467C>A
A1156D
2D
AIThe SynGAP1 missense variant A1156D is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL and ESM1b, whereas the remaining tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized classifies the variant as pathogenic, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports it as Likely Pathogenic. No Foldetta stability prediction is available for this variant. Overall, the majority of computational evidence indicates that A1156D is most likely pathogenic, and this conclusion does not contradict any ClinVar status because no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.720929Disordered0.871395Binding0.2940.8610.500-3.497Likely Benign0.999Likely PathogenicLikely Pathogenic0.350Likely Benign-4.45Deleterious0.999Probably Damaging0.998Probably Damaging1.59Pathogenic0.00Affected0.16620.20580-2-5.344.01
c.3497C>A
A1166D
2D
AIThe SynGAP1 missense variant A1166D is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, and FATHMM. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a Likely Benign classification. High‑accuracy assessments show AlphaMissense‑Optimized as Pathogenic, while the SGM‑Consensus remains Likely Benign; Foldetta results are unavailable. Overall, the majority of evidence (five benign vs. four pathogenic) and the consensus score lean toward a benign interpretation, with no conflict with ClinVar status. Thus, the variant is most likely benign, although the AlphaMissense‑Optimized prediction introduces some uncertainty.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.575842Disordered0.811691Binding0.3810.8030.375-4.204Likely Benign0.978Likely PathogenicLikely Pathogenic0.417Likely Benign-1.56Neutral0.999Probably Damaging0.977Probably Damaging5.29Benign0.42Tolerated0.17090.21040-2-5.344.01
c.3503T>G
I1168S
2D
AISynGAP1 missense variant I1168S has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, and the SGM‑Consensus (Likely Benign). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as pathogenic, whereas the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates a likely benign outcome; Foldetta results are unavailable. Overall, the evidence is split, with an equal number of benign and pathogenic calls, and the high‑accuracy predictions are contradictory. Therefore, the variant is not conclusively predicted to be benign or pathogenic, and there is no conflict with ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.642678Disordered0.763262Binding0.4230.7960.500-2.212Likely Benign0.972Likely PathogenicLikely Pathogenic0.442Likely Benign-1.46Neutral0.998Probably Damaging0.958Probably Damaging5.67Benign0.01Affected0.32470.1540-1-2-5.3-26.08
c.3512C>A
A1171D
2D
AIThe SynGAP1 missense variant A1171D is not reported in ClinVar and has no entries in gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumVar, ESM1b, and FATHMM, while those that predict a pathogenic effect are polyPhen‑2 HumDiv, SIFT, and AlphaMissense‑Default. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is “Likely Benign.” High‑accuracy assessments show AlphaMissense‑Optimized as “Uncertain,” and Foldetta results are unavailable. Overall, the balance of evidence from multiple independent predictors and the SGM‑Consensus points to a benign impact for A1171D. This conclusion is consistent with the absence of a ClinVar classification, so there is no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignCoiled-coil0.599170Disordered0.702689Binding0.4720.7750.500-3.897Likely Benign0.814Likely PathogenicAmbiguous0.312Likely Benign-0.80Neutral0.611Possibly Damaging0.326Benign5.34Benign0.02Affected0.19520.24940-2-5.344.01
c.3518T>G
I1173S
2D
AIThe SynGAP1 missense variant I1173S is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Optimized, and polyPhen‑2 HumVar, while those that predict a pathogenic effect are polyPhen‑2 HumDiv and SIFT. AlphaMissense‑Default is uncertain, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates a likely benign outcome. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact for I1173S, and this conclusion does not contradict any ClinVar status, as none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignCoiled-coil0.501700Disordered0.653145Binding0.5210.7560.375-2.416Likely Benign0.557AmbiguousLikely Benign0.455Likely Benign-1.18Neutral0.625Possibly Damaging0.265Benign5.45Benign0.02Affected0.27960.0512-1-2-5.3-26.08
c.3605T>G
I1202S
2D
AIThe SynGAP1 missense variant I1202S is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include only REVEL, whereas the remaining tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also classifies the variant as Likely Pathogenic. High‑accuracy assessments show AlphaMissense‑Optimized as Pathogenic and the SGM‑Consensus as Likely Pathogenic; Foldetta results are not available. Based on the collective evidence, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.529623Disordered0.510422Binding0.8740.5930.250-11.877Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.431Likely Benign-4.68Deleterious0.999Probably Damaging0.996Probably Damaging1.80Pathogenic0.00Affected0.30210.0640-1-2-5.3-26.08
c.362C>A
A121D
2D
AIThe SynGAP1 missense variant A121D is not reported in ClinVar and has no entry in gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are SIFT and AlphaMissense‑Default. The SGM‑Consensus, which aggregates the majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus also indicates Likely Benign. No Foldetta stability prediction is available for this variant. Overall, the majority of computational evidence points to a benign impact, and this is consistent with the absence of a ClinVar pathogenic classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.779859Disordered0.661304Binding0.3620.8880.750-3.626Likely Benign0.595Likely PathogenicLikely Benign0.096Likely Benign-0.89Neutral0.244Benign0.050Benign4.06Benign0.03Affected0.18760.19450-2-5.344.01
c.368C>A
A123D
2D
AIThe SynGAP1 missense variant A123D is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumVar, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, SIFT, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a Likely Benign classification. High‑accuracy assessments show AlphaMissense‑Optimized as Benign and the SGM‑Consensus as Likely Benign; the Foldetta stability analysis is unavailable. Overall, the majority of evidence points to a benign impact, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.521092Disordered0.689505Binding0.3240.8860.750-3.515Likely Benign0.692Likely PathogenicLikely Benign0.168Likely Benign-1.17Neutral0.718Possibly Damaging0.218Benign4.15Benign0.01Affected0.23250.28930-2-5.344.01
c.3698T>G
I1233S
2D
AIThe SynGAP1 missense variant I1233S is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split: benign calls come from REVEL and FATHMM, whereas the majority of other predictors—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized—classify the change as pathogenic. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely pathogenic verdict. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts pathogenic, and the SGM‑Consensus likewise indicates likely pathogenic. Foldetta, a protein‑folding stability method that combines FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the preponderance of evidence points to a pathogenic effect, and this conclusion does not conflict with the ClinVar status, which currently has no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.525368Disordered0.564054Binding0.8810.5310.125-8.066Likely Pathogenic0.991Likely PathogenicLikely Pathogenic0.184Likely Benign-3.60Deleterious0.946Possibly Damaging0.673Possibly Damaging2.53Benign0.00Affected0.28480.0910-1-2-5.3-26.08
c.3716C>A
A1239D
2D
AIThe SynGAP1 missense variant A1239D is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, polyPhen‑2 (HumDiv and HumVar), ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, SIFT, and FATHMM. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (two benign vs. two pathogenic votes). Foldetta results are unavailable. Overall, the majority of evidence (six benign vs. three pathogenic predictions) supports a benign classification. This conclusion does not contradict ClinVar status, as the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Coiled-coil0.541878Disordered0.534779Binding0.8870.5420.250-6.177Likely Benign0.326Likely BenignLikely Benign0.104Likely Benign-2.60Deleterious0.270Benign0.136Benign2.36Pathogenic0.00Affected0.15210.20620-2-5.344.01
c.371C>A
A124E
2D
AIThe SynGAP1 missense variant A124E is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as Likely Benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact for A124E, and this conclusion does not contradict any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.509769Disordered0.699139Binding0.3400.8830.750-3.444Likely Benign0.667Likely PathogenicLikely Benign0.208Likely Benign-1.21Neutral0.993Probably Damaging0.733Possibly Damaging4.11Benign0.01Affected0.14980.22330-1-5.358.04
c.3758C>A
A1253E
2D
AIThe SynGAP1 missense variant A1253E is not reported in ClinVar and is absent from gnomAD, indicating no known population frequency data. Functional prediction tools uniformly classify the variant as benign: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict a benign effect. No tool in the dataset predicts pathogenicity. High‑accuracy assessments corroborate this benign classification: AlphaMissense‑Optimized reports benign, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates “Likely Benign.” Foldetta results are not available, so they do not influence the assessment. Overall, the variant is most likely benign, and this conclusion is consistent with the absence of a ClinVar pathogenic annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignCoiled-coil0.661982Disordered0.391377Uncertain0.8810.5500.750-1.744Likely Benign0.166Likely BenignLikely Benign0.059Likely Benign2.03Neutral0.301Benign0.209Benign3.03Benign0.98Tolerated0.09480.17040-1-5.358.04
c.3776T>G
I1259S
2D
AIThe SynGAP1 missense variant I1259S is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL and FATHMM, whereas the majority of tools predict a pathogenic impact: PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic, and the SGM‑Consensus is labeled “Likely Pathogenic.” No Foldetta stability prediction is available, so it does not influence the assessment. Overall, the preponderance of evidence indicates that the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status because the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.494003Structured0.576405Binding0.8850.5740.250-12.269Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.426Likely Benign-2.76Deleterious0.999Probably Damaging0.996Probably Damaging2.53Benign0.01Affected0.30040.1110-1-2-5.3-26.08
c.3785T>G
I1262S
2D
AIThe SynGAP1 missense variant I1262S is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include only REVEL, whereas the remaining tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN)—all predict a pathogenic or likely pathogenic impact. High‑accuracy assessments further support this: AlphaMissense‑Optimized classifies the variant as pathogenic, and the SGM‑Consensus also reports it as likely pathogenic. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Based on the collective evidence, the variant is most likely pathogenic, and this conclusion is not contradicted by ClinVar status, which currently has no entry for I1262S.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.497853Structured0.707863Binding0.8860.5760.125-15.167Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.483Likely Benign-4.98Deleterious0.999Probably Damaging0.996Probably Damaging1.80Pathogenic0.00Affected0.29430.1110-1-2-5.3-26.08
c.3788T>G
I1263S
2D
AIThe SynGAP1 missense variant I1263S is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include only REVEL, whereas the remaining tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN)—all predict a pathogenic or likely pathogenic impact. High‑accuracy assessments further support a deleterious outcome: AlphaMissense‑Optimized is pathogenic, and the SGM‑Consensus is labeled likely pathogenic. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the preponderance of evidence indicates that the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status because the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.425610Structured0.740957Binding0.8670.5740.000-8.074Likely Pathogenic0.995Likely PathogenicLikely Pathogenic0.493Likely Benign-4.97Deleterious0.984Probably Damaging0.825Possibly Damaging1.80Pathogenic0.00Affected0.32420.0910-1-2-5.3-26.08
c.3836C>A
A1279D
2D
AIThe SynGAP1 missense variant A1279D is catalogued in gnomAD (ID 6‑33447884‑C‑A) but has no ClinVar entry. Across the spectrum of in‑silico predictors, every tool listed—REVEL, PROVEAN, PolyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently classifies the substitution as benign. No pathogenic predictions are reported. Grouping by agreement, all available tools fall into the benign category, with no tools indicating pathogenicity. High‑accuracy assessments further support this view: AlphaMissense‑Optimized predicts benign, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports a likely benign outcome. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no result for this variant and is therefore considered unavailable. Based on the collective evidence, the variant is most likely benign, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.842060Disordered0.814139Binding0.4850.7240.7506-33447884-C-A-3.914Likely Benign0.172Likely BenignLikely Benign0.087Likely Benign1.38Neutral0.000Benign0.000Benign2.89Benign0.35Tolerated3.7750.15050.2062-20-5.344.01
c.3842C>A
A1281D
2D
AIThe SynGAP1 missense variant A1281D is reported in gnomAD (ID 6‑33447890‑C‑A) but has no ClinVar entry. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as benign. In contrast, polyPhen‑2 (HumDiv and HumVar) predict it to be pathogenic. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, yields a “Likely Benign” verdict. High‑accuracy assessments reinforce this: AlphaMissense‑Optimized is benign, and the SGM‑Consensus is also benign; Foldetta results are not available. Overall, the majority of evidence points to a benign impact, and this conclusion does not conflict with ClinVar status, as no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.823549Disordered0.821556Binding0.4340.7210.8756-33447890-C-A-5.183Likely Benign0.178Likely BenignLikely Benign0.054Likely Benign-0.76Neutral0.901Possibly Damaging0.516Possibly Damaging2.68Benign0.15Tolerated4.3240.21050.2462-20-5.344.01
c.3881C>A
A1294D
2D
AIThe SynGAP1 missense variant A1294D is listed in gnomAD (ID 6‑33447929‑C‑A) but has no ClinVar entry. Functional prediction tools show mixed results: benign calls come from REVEL, ESM1b, and AlphaMissense‑Optimized, whereas pathogenic predictions are reported by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM; AlphaMissense‑Default remains uncertain. High‑accuracy assessment further clarifies the picture: AlphaMissense‑Optimized predicts a benign effect, while the SGM Consensus—derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—leans toward pathogenicity. No Foldetta stability analysis is available for this variant. Overall, the majority of evidence points to a pathogenic effect, which is consistent with the lack of a benign ClinVar classification and the presence of the variant in a general population database. Thus, the variant is most likely pathogenic, and this prediction does not contradict any ClinVar status because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.784345Disordered0.895011Binding0.5650.8060.6256-33447929-C-A-4.179Likely Benign0.369AmbiguousLikely Benign0.224Likely Benign-4.17Deleterious0.999Probably Damaging0.995Probably Damaging2.14Pathogenic0.00Affected3.7750.18930.2262-20-5.344.01
c.38T>G
I13S
2D
AIThe SynGAP1 missense variant I13S is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only SIFT predicts a pathogenic outcome. The high‑accuracy consensus methods also support a benign classification: AlphaMissense‑Optimized is benign, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is “Likely Benign.” No Foldetta stability result is available, so it does not influence the assessment. Overall, the majority of evidence points to a benign effect for I13S, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.486429Structured0.482657Uncertain0.3180.9160.375-1.756Likely Benign0.187Likely BenignLikely Benign0.264Likely Benign0.20Neutral0.024Benign0.002Benign4.06Benign0.00Affected0.32920.1682-1-2-5.3-26.08
c.3935C>A
A1312D
2D
AIThe SynGAP1 missense variant A1312D is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, ESM1b, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT; AlphaMissense‑Default is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also favors a benign outcome (2 benign vs. 1 pathogenic, with one uncertain). Foldetta, a protein‑folding stability method, has no available result for this variant. Overall, the balance of evidence, particularly from the high‑accuracy tools, indicates that the variant is most likely benign, and this conclusion does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.767246Disordered0.971112Binding0.3920.9020.750-4.419Likely Benign0.398AmbiguousLikely Benign0.272Likely Benign-2.74Deleterious0.997Probably Damaging0.995Probably Damaging3.11Benign0.00Affected0.22890.29930-2-5.344.01
c.3956C>A
A1319D
2D
AIThe SynGAP1 missense variant A1319D is reported in gnomAD (ID 6‑33451830‑C‑A) but has no ClinVar entry. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict benign. In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT predict pathogenic. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates a likely benign outcome. High‑accuracy assessments confirm this: AlphaMissense‑Optimized is benign, and the SGM‑Consensus (majority of the same four tools) is benign. Foldetta results are unavailable. Overall, the preponderance of evidence points to a benign impact for A1319D, and this conclusion is not contradicted by any ClinVar classification (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.842060Disordered0.960481Binding0.4540.8510.7506-33451830-C-A-5.156Likely Benign0.297Likely BenignLikely Benign0.208Likely Benign-0.85Neutral0.971Probably Damaging0.813Possibly Damaging4.08Benign0.01Affected3.7750.22900.2702-20-5.344.01
c.3965C>A
A1322D
2D
AIThe SynGAP1 missense variant A1322D is catalogued in gnomAD (ID 6‑33451839‑C‑A) but has no ClinVar entry. Across the spectrum of in‑silico predictors, every tool listed—REVEL, PROVEAN, PolyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently classifies the substitution as benign. No pathogenic predictions are reported. Grouping by consensus, all available tools fall into the benign category, with no tools indicating pathogenicity. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts benign, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports “Likely Benign.” Foldetta, a protein‑folding stability method that integrates FoldX‑MD and Rosetta outputs, has no result for this variant, so its status is unavailable. Based on the collective evidence, the variant is most likely benign, and this assessment does not contradict any ClinVar status (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.887230Disordered0.921040Binding0.4660.8250.8756-33451839-C-A-5.744Likely Benign0.284Likely BenignLikely Benign0.092Likely Benign0.70Neutral0.013Benign0.004Benign4.17Benign0.45Tolerated3.7750.22460.3134-20-5.344.01
c.3992T>G
I1331S
2D
AIThe SynGAP1 I1331S variant is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, ESM1b, and FATHMM. Tools that agree on a pathogenic effect include PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized predicts pathogenicity, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is inconclusive due to a 2‑to‑2 split, and Foldetta results are unavailable. Overall, the majority of evidence (six pathogenic vs. three benign predictions) indicates that the variant is most likely pathogenic. This conclusion is consistent with the lack of ClinVar annotation and does not contradict any existing database status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.921076Disordered0.941705Binding0.3590.7520.875-3.014Likely Benign0.997Likely PathogenicLikely Pathogenic0.230Likely Benign-3.40Deleterious0.984Probably Damaging0.969Probably Damaging3.30Benign0.00Affected0.29290.0836-1-2-5.3-26.08
c.4022C>A
A1341E
2D
AIThe SynGAP1 missense variant A1341E is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as benign, while the single pathogenic call comes from SIFT. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely benign consensus. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus likewise indicates likely benign. Foldetta stability analysis is not available for this variant. Overall, the majority of evidence points to a benign impact, and this conclusion is consistent with the absence of any ClinVar pathogenic annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.823549Disordered0.980111Binding0.3830.6961.000-3.217Likely Benign0.307Likely BenignLikely Benign0.056Likely Benign-1.18Neutral0.012Benign0.015Benign4.05Benign0.01Affected0.16330.26240-1-5.358.04
c.422T>G
I141S
2D
AIThe SynGAP1 missense variant I141S is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that indicate a benign effect include REVEL, polyPhen‑2 HumVar, and FATHMM, whereas those that predict a pathogenic effect comprise PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Pathogenic). High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic and the SGM‑Consensus also as Likely Pathogenic; the Foldetta protein‑folding stability analysis is unavailable. Overall, the majority of evidence points toward a pathogenic impact for I141S, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.465241Structured0.577021Binding0.3670.8770.500-11.874Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.267Likely Benign-3.28Deleterious0.567Possibly Damaging0.249Benign3.56Benign0.00Affected0.28850.0840-1-2-5.3-26.08
c.44C>A
A15E
2D
AIThe SynGAP1 missense variant A15E is reported in gnomAD (ID 6‑33420308‑C‑A) but has no ClinVar entry. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as benign. Only SIFT predicts it to be pathogenic. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates a likely benign outcome. High‑accuracy assessments confirm this: AlphaMissense‑Optimized is benign, and the SGM‑Consensus is likely benign; Foldetta results are not available. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict any ClinVar status (none is provided).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.436924Structured0.466055Uncertain0.3300.9120.3756-33420308-C-A-3.423Likely Benign0.277Likely BenignLikely Benign0.169Likely Benign0.46Neutral0.406Benign0.040Benign4.13Benign0.00Affected4.3210.15630.1908-10-5.358.04
c.476T>G
I159S
2D
AIThe SynGAP1 missense variant I159S is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, and FATHMM. Tools that agree on a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. The high‑accuracy AlphaMissense‑Optimized tool rates the variant as uncertain, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑vs‑2 split, and Foldetta results are unavailable. Overall, the majority of available predictions (five pathogenic vs. three benign) lean toward pathogenicity. Thus, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.454136Structured0.529953Binding0.2780.7310.125-13.684Likely Pathogenic0.905Likely PathogenicAmbiguous0.241Likely Benign-1.70Neutral0.995Probably Damaging0.979Probably Damaging3.85Benign0.00Affected0.28540.0712-1-2-5.3-26.08
c.497C>A
A166D
2D
AIThe SynGAP1 missense variant A166D is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, and FATHMM, while those that agree on a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. The high‑accuracy consensus method SGM (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is inconclusive, yielding a 2‑to‑2 split. AlphaMissense‑Optimized rates the variant as uncertain, and Foldetta (combining FoldX‑MD and Rosetta outputs) has no available result for this change. Overall, the majority of tools predict a pathogenic impact, and there is no ClinVar annotation to contradict this assessment. Thus, the variant is most likely pathogenic based on current computational predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.425610Structured0.505037Binding0.3840.6580.125-12.171Likely Pathogenic0.900Likely PathogenicAmbiguous0.144Likely Benign-2.21Neutral0.877Possibly Damaging0.580Possibly Damaging4.02Benign0.01Affected0.20310.26940-2-5.344.01
c.512C>A
A171D
2D
AIThe SynGAP1 missense variant A171D is not reported in ClinVar and has no entries in gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, and FATHMM. Tools that predict a pathogenic effect are SIFT and AlphaMissense‑Default. AlphaMissense‑Optimized is uncertain, and no Foldetta stability assessment is available. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments therefore lean toward a benign interpretation: AlphaMissense‑Optimized is inconclusive, SGM‑Consensus is benign, and Foldetta data are missing. Based on the collective predictions, the variant is most likely benign, and this conclusion does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.562014Disordered0.492272Uncertain0.3580.6520.375-6.977Likely Benign0.908Likely PathogenicAmbiguous0.144Likely Benign-1.45Neutral0.244Benign0.037Benign4.15Benign0.01Affected0.16340.24620-2-5.344.01
c.56C>A
A19D
2D
AIThe SynGAP1 missense variant A19D is listed in gnomAD (ID 6‑33420320‑C‑A) but has no ClinVar entry. Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumVar, ESM1b, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic outcome are polyPhen‑2 HumDiv, SIFT, and AlphaMissense‑Default. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as “Likely Benign.” High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; Foldetta stability analysis is unavailable. Overall, the majority of evidence points to a benign effect, and this conclusion does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.529623Disordered0.443393Uncertain0.3780.9060.5006-33420320-C-A21.30e-6-3.746Likely Benign0.573Likely PathogenicLikely Benign0.055Likely Benign-0.08Neutral0.588Possibly Damaging0.054Benign4.07Benign0.00Affected4.3210.25080.2734-20-5.344.01
c.575C>A
A192E
2D
AIThe SynGAP1 missense variant A192E is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL and FATHMM, whereas the majority of tools predict a pathogenic impact: PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic, and the SGM‑Consensus is labeled Likely Pathogenic. The protein‑folding stability method Foldetta has no available result for this variant. Overall, the preponderance of evidence from both general and high‑accuracy predictors indicates that the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status because no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.422041Structured0.428195Uncertain0.3210.5890.125-12.188Likely Pathogenic0.997Likely PathogenicLikely Pathogenic0.268Likely Benign-3.52Deleterious0.997Probably Damaging0.888Possibly Damaging3.93Benign0.01Affected0.09390.16280-1-5.358.04
c.578C>A
A193D
2D
AIThe SynGAP1 missense variant A193D is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect are REVEL and FATHMM, while the remaining tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. The high‑accuracy AlphaMissense‑Optimized model classifies the variant as pathogenic. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default (pathogenic), ESM1b (uncertain), FATHMM (benign), and PROVEAN (pathogenic), also yields a pathogenic consensus. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the preponderance of evidence from both general and high‑accuracy predictors indicates that A193D is most likely pathogenic, and this assessment does not contradict any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.429200Structured0.428386Uncertain0.3100.5770.125-7.488In-Between0.998Likely PathogenicLikely Pathogenic0.217Likely Benign-3.46Deleterious0.997Probably Damaging0.916Probably Damaging3.99Benign0.01Affected0.16880.18350-2-5.344.01
c.584C>A
A195E
2D
AIThe SynGAP1 missense variant A195E is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL and FATHMM, whereas the majority of tools predict a pathogenic impact: PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Pathogenic). High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized classifies the variant as pathogenic; the SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates a likely pathogenic outcome. Foldetta results are unavailable, so they do not influence the overall assessment. Based on the preponderance of evidence, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.346032Structured0.430388Uncertain0.3630.5330.125-10.909Likely Pathogenic0.987Likely PathogenicLikely Pathogenic0.237Likely Benign-3.20Deleterious0.997Probably Damaging0.879Possibly Damaging4.12Benign0.02Affected0.08550.18770-1-5.358.04
c.614T>G
I205S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 I205S missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, SIFT, FATHMM, AlphaMissense‑Optimized, and polyPhen‑2 HumVar. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, and ESM1b. Tools with uncertain or inconclusive results (FoldX, Rosetta, Foldetta, premPS, AlphaMissense‑Default) are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as uncertain. Overall, the majority of available predictions lean toward a benign impact, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
PH0.264545Structured0.409933Uncertain0.8210.4140.125-8.694Likely Pathogenic0.518AmbiguousLikely Benign1.17Ambiguous0.20.95Ambiguous1.06Ambiguous0.88Ambiguous0.178Likely Benign-2.73Deleterious0.838Possibly Damaging0.368Benign4.12Benign0.24Tolerated0.23460.0800-1-2-5.3-26.08
c.617T>G
I206S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 I206S missense variant is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FATHMM, and polyPhen‑2 HumVar. All other evaluated algorithms (SGM‑Consensus, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) predict a pathogenic or likely pathogenic impact. High‑accuracy assessments further support a deleterious outcome: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability predictions, is pathogenic. Based on the preponderance of evidence from these tools, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.298791Structured0.405123Uncertain0.8630.3910.125-13.711Likely Pathogenic0.993Likely PathogenicLikely Pathogenic3.73Destabilizing0.33.89Destabilizing3.81Destabilizing1.74Destabilizing0.251Likely Benign-4.86Deleterious0.838Possibly Damaging0.368Benign3.63Benign0.00Affected0.21890.0728-1-2-5.3-26.08
c.638T>G
I213S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 I213S missense variant is not reported in ClinVar and is absent from gnomAD. Prediction tools largely agree on a deleterious effect: FATHMM is the sole benign predictor, while all other evaluated algorithms (SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv/HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) classify the change as pathogenic. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized predicts pathogenic, SGM‑Consensus indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts pathogenic. No prediction or stability result is missing or inconclusive. Based on the consensus of these tools, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status, as no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.158265Structured0.372201Uncertain0.8500.2950.125-12.858Likely Pathogenic0.997Likely PathogenicLikely Pathogenic2.00Destabilizing1.12.95Destabilizing2.48Destabilizing1.53Destabilizing0.879Likely Pathogenic-4.88Deleterious0.995Probably Damaging0.829Possibly Damaging5.83Benign0.00Affected0.22900.0800-1-2-5.3-26.08
c.695C>A
A232D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A232D is not reported in ClinVar (ClinVar ID None) and has no entry in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include FoldX, polyPhen‑2 HumVar, and FATHMM. Those that predict a pathogenic effect comprise REVEL, PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM Consensus. Uncertain or inconclusive results are reported for Rosetta, Foldetta, and premPS. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also as pathogenic, while Foldetta remains uncertain. Overall, the majority of available predictions support a pathogenic impact. Thus, the variant is most likely pathogenic, and this assessment does not contradict the ClinVar status, which currently has no classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.254060Structured0.307228Uncertain0.8780.3050.000-13.956Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.14Likely Benign0.21.55Ambiguous0.85Ambiguous0.77Ambiguous0.725Likely Pathogenic-2.50Deleterious0.845Possibly Damaging0.348Benign5.78Benign0.02Affected0.20660.28960-2-5.344.01
c.707C>A
A236E
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant A236E is not reported in ClinVar and is present in gnomAD (ID 6‑33435558‑C‑A). Functional prediction tools show a split assessment: benign calls come from FATHMM, Rosetta, and the protein‑folding stability method Foldetta; pathogenic calls come from REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and the SGM‑Consensus score. When grouped by agreement, the benign‑predicting tools (FATHMM, Rosetta, Foldetta) represent one consensus, while the pathogenic‑predicting tools (REVEL, premPS, PROVEAN, polyPhen‑2, SIFT, ESM1b, AlphaMissense‑Default, SGM‑Consensus) form the opposing consensus. High‑accuracy methods give mixed results: AlphaMissense‑Optimized is uncertain; SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is likely pathogenic; Foldetta, combining FoldX‑MD and Rosetta outputs, is benign. Overall, the majority of predictions lean toward pathogenicity, and this does not contradict the ClinVar status, which has no reported classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.185198Structured0.329926Uncertain0.7750.3300.0006-33435558-C-A16.20e-7-10.844Likely Pathogenic0.835Likely PathogenicAmbiguous-0.75Ambiguous0.20.28Likely Benign-0.24Likely Benign1.08Destabilizing0.844Likely Pathogenic-4.24Deleterious0.998Probably Damaging0.900Possibly Damaging6.06Benign0.02Affected3.40140.10750.1970-10-5.358.04
c.710C>A
A237D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A237D is not reported in ClinVar (ClinVar status: none) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include only FATHMM, while the remaining tools—SGM‑Consensus, REVEL, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default—consistently predict pathogenicity. Two tools, FoldX and AlphaMissense‑Optimized, return uncertain results. High‑accuracy assessments further support a deleterious impact: the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) favors pathogenicity, AlphaMissense‑Optimized is uncertain, and Foldetta predicts a destabilizing, pathogenic effect. Overall, the evidence overwhelmingly indicates that the variant is pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.200174Structured0.334699Uncertain0.7190.3520.000-8.880Likely Pathogenic0.921Likely PathogenicAmbiguous1.23Ambiguous0.43.49Destabilizing2.36Destabilizing1.20Destabilizing0.769Likely Pathogenic-3.97Deleterious0.969Probably Damaging0.704Possibly Damaging5.88Benign0.05Affected0.14190.23020-2-5.344.01
c.728T>G
I243S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I243S is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that assess pathogenicity largely agree: SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict a pathogenic effect. Only FATHMM predicts a benign outcome. High‑accuracy methods reinforce the pathogenic signal: AlphaMissense‑Optimized is pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta) is pathogenic. No predictions are missing or inconclusive. Based on the consensus of these tools, the variant is most likely pathogenic, and this assessment does not contradict the absence of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.363090Structured0.344471Uncertain0.8420.3470.000-14.097Likely Pathogenic0.975Likely PathogenicLikely Pathogenic2.52Destabilizing0.22.22Destabilizing2.37Destabilizing1.71Destabilizing0.802Likely Pathogenic-3.55Deleterious0.995Probably Damaging0.795Possibly Damaging5.52Benign0.00Affected0.26580.0600-1-2-5.3-26.08
c.746C>A
A249E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A249E has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect are SIFT and FATHMM. The majority of other in‑silico predictors (SGM‑Consensus, REVEL, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) classify the variant as pathogenic; FoldX is uncertain and is not counted as evidence for either side. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. Based on the preponderance of pathogenic predictions and the absence of benign evidence, the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.505461Disordered0.255452Uncertain0.8100.3360.125-13.519Likely Pathogenic0.991Likely PathogenicLikely Pathogenic1.60Ambiguous1.22.59Destabilizing2.10Destabilizing1.02Destabilizing0.818Likely Pathogenic-3.29Deleterious0.997Probably Damaging0.879Possibly Damaging5.64Benign0.09Tolerated0.07990.15090-1-5.358.04
c.803T>G
I268S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I268S is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that assess pathogenicity all agree that the variant is deleterious: SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify it as pathogenic. No tool predicts a benign effect. High‑accuracy methods reinforce this consensus: AlphaMissense‑Optimized predicts pathogenicity; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also predicts pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, indicates a destabilizing, pathogenic effect. All available predictions are concordant and supportive. Based on these computational assessments, the variant is most likely pathogenic, and this conclusion does not contradict any existing ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.216401Structured0.314336Uncertain0.9510.2640.000-13.032Likely Pathogenic0.998Likely PathogenicLikely Pathogenic4.93Destabilizing0.14.54Destabilizing4.74Destabilizing2.10Destabilizing0.841Likely Pathogenic-5.34Deleterious0.999Probably Damaging0.996Probably Damaging1.53Pathogenic0.00Affected0.20370.0530-1-2-5.3-26.08
c.812C>A
A271D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A271D is listed in ClinVar as Pathogenic (ClinVar ID 2019732.0) and is not reported in gnomAD. Prediction tools that assess functional impact uniformly classify the variant as pathogenic: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a benign effect. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also predicts pathogenic. Based on the unanimous computational evidence, the variant is most likely pathogenic, and this conclusion aligns with its ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.125101Structured0.413873Uncertain0.9390.2200.125Pathogenic 1-18.590Likely Pathogenic0.999Likely PathogenicLikely Pathogenic4.71Destabilizing0.42.67Destabilizing3.69Destabilizing1.59Destabilizing0.706Likely Pathogenic-5.52Deleterious1.000Probably Damaging0.999Probably Damaging0.62Pathogenic0.00Affected3.38190.15650.15410-2-5.344.01226.2-63.40.00.00.90.1XXXXPotentially PathogenicThe methyl group of Ala271, located near the end of an anti-parallel β sheet strand (res. Arg259-Arg272), packs against multiple hydrophobic residues such as Val400, Val306, and Leu274 in the WT simulations. In the variant simulations, the carboxylate group of Asp271 is not suitable for the hydrophobic niche, causing the hydrophobic residues to make room for the swapped residue. Additionally, the carboxylate group of the Asp271 side chain forms hydrogen bonds with the backbone amide groups of Arg272 and Ala399 in the β sheet, or even forms a salt bridge with the amino group of the Lys394 side chain. This directly affects the integrity of the anti-parallel β sheet at the end. In short, the residue swap disrupts the C2 domain packing during folding, which could weaken the stability of the SynGAP-membrane association.
c.875C>A
A292E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A292E is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include REVEL, whereas the remaining tools—FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. High‑accuracy assessments further support this view: AlphaMissense‑Optimized classifies the variant as pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) labels it likely pathogenic, and Foldetta, which integrates FoldX‑MD and Rosetta outputs, also predicts pathogenicity. Based on the collective evidence, the variant is most likely pathogenic, and this conclusion does not contradict the ClinVar status, which currently has no entry for A292E.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.247041Structured0.362042Uncertain0.9290.2560.000-14.282Likely Pathogenic0.999Likely PathogenicLikely Pathogenic6.07Destabilizing1.23.82Destabilizing4.95Destabilizing1.54Destabilizing0.475Likely Benign-4.60Deleterious1.000Probably Damaging0.998Probably Damaging1.69Pathogenic0.02Affected0.14440.22050-1-5.358.04
c.902C>A
A301D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A301D is not reported in ClinVar and is absent from gnomAD. Consensus from multiple in‑silico predictors shows a predominance of benign calls: REVEL, FoldX, premPS, PROVEAN, SIFT, and FATHMM all predict benign, whereas polyPhen‑2 (HumDiv and HumVar) and ESM1b predict pathogenic. Tools with uncertain outputs—Rosetta, Foldetta, and AlphaMissense‑Default—do not provide decisive evidence. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized classifies the variant as benign; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also yields a benign verdict; Foldetta remains inconclusive. Taken together, the preponderance of evidence indicates that A301D is most likely benign, and this assessment does not conflict with the absence of a ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.429200Structured0.258424Uncertain0.6470.2720.375-10.276Likely Pathogenic0.488AmbiguousLikely Benign-0.37Likely Benign0.2-1.15Ambiguous-0.76Ambiguous0.23Likely Benign0.224Likely Benign-0.35Neutral0.999Probably Damaging0.995Probably Damaging4.17Benign0.07Tolerated0.15990.17050-2-5.344.01
c.956C>A
A319D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 A319D missense variant is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions from REVEL, FoldX, premPS, PROVEAN, SIFT, and AlphaMissense‑Optimized; pathogenic predictions from polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, yields a likely pathogenic verdict (3/4 pathogenic votes). High‑accuracy assessments further support this: AlphaMissense‑Optimized predicts benign, whereas the SGM‑Consensus remains pathogenic. Foldetta, which integrates FoldX‑MD (benign) and Rosetta (uncertain), is considered unavailable. Overall, the majority of evidence points to a pathogenic effect, and this conclusion does not conflict with ClinVar, which has no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.179055Structured0.410405Uncertain0.8790.2540.125-11.144Likely Pathogenic0.752Likely PathogenicLikely Benign-0.02Likely Benign0.2-0.84Ambiguous-0.43Likely Benign0.30Likely Benign0.373Likely Benign-2.38Neutral0.998Probably Damaging0.966Probably Damaging2.01Pathogenic0.20Tolerated0.15040.13600-2-5.344.01
c.965C>A
A322D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 A322D missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Optimized. Only FATHMM predicts a pathogenic outcome. The remaining tools—FoldX, Rosetta, ESM1b, and AlphaMissense‑Default—return uncertain results and are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive, and Foldetta indicates no significant stability change (uncertain). Overall, the preponderance of evidence (seven benign predictions versus one pathogenic) suggests the variant is most likely benign, and this conclusion does not contradict any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.175930Structured0.425745Uncertain0.9380.3340.000-7.184In-Between0.411AmbiguousLikely Benign0.65Ambiguous0.11.35Ambiguous1.00Ambiguous0.34Likely Benign0.246Likely Benign-0.95Neutral0.270Benign0.136Benign1.96Pathogenic0.32Tolerated0.16460.16600-2-5.344.01
c.1232T>C
I411T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 I411T missense variant is not reported in ClinVar (status: None) and has no entries in gnomAD. Prediction tools that agree on a benign effect are limited to FATHMM, while the majority of tools predict a pathogenic impact: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Rosetta’s assessment is uncertain. High‑accuracy methods give consistent pathogenic predictions: AlphaMissense‑Optimized is Pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) is Pathogenic. No prediction or stability result is missing or inconclusive. Based on the collective evidence, the variant is most likely pathogenic, and this conclusion does not contradict the ClinVar status, which currently has no classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.116183Structured0.339366Uncertain0.9270.1980.000-11.258Likely Pathogenic0.992Likely PathogenicLikely Pathogenic2.86Destabilizing0.01.75Ambiguous2.31Destabilizing1.86Destabilizing0.579Likely Pathogenic-4.54Deleterious1.000Probably Damaging0.999Probably Damaging3.31Benign0.00Affected0.09030.13890-1-5.2-12.05
c.1361T>C
I454T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I454T is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include only FATHMM, whereas all other evaluated algorithms—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the variant as pathogenic. High‑accuracy methods further support a deleterious impact: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. No prediction or folding stability result is missing or inconclusive. Based on the overwhelming agreement among these tools, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.254060Structured0.312811Uncertain0.9650.1820.000-9.045Likely Pathogenic0.997Likely PathogenicLikely Pathogenic3.20Destabilizing0.02.83Destabilizing3.02Destabilizing2.02Destabilizing0.502Likely Pathogenic-4.74Deleterious1.000Probably Damaging0.999Probably Damaging3.26Benign0.00Affected0.08770.07080-1-5.2-12.05
c.1448T>C
I483T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I483T is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect are REVEL and FATHMM, whereas the remaining tools—FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. High‑accuracy assessments further support this: AlphaMissense‑Optimized classifies the variant as pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports it as Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also predicts a pathogenic effect. Based on the preponderance of pathogenic predictions and the absence of any benign consensus, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.206376Structured0.415850Uncertain0.7980.2540.000-10.692Likely Pathogenic0.992Likely PathogenicLikely Pathogenic2.32Destabilizing0.02.05Destabilizing2.19Destabilizing1.77Destabilizing0.474Likely Benign-4.24Deleterious1.000Probably Damaging1.000Probably Damaging3.15Benign0.05Affected0.08880.08400-1-5.2-12.05
c.1481T>C
I494T
2D
AIThe SynGAP1 missense variant I494T is not reported in ClinVar (ClinVar status: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include only AlphaMissense‑Optimized. All other evaluated tools—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default—predict a pathogenic impact. High‑accuracy methods give the following results: AlphaMissense‑Optimized predicts benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) predicts likely pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. No predictions are missing or inconclusive. Based on the overwhelming majority of pathogenic predictions, the variant is most likely pathogenic, and this assessment does not contradict the ClinVar status, which is currently unreported.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.155435Structured0.353330Uncertain0.9410.1570.000-10.033Likely Pathogenic0.754Likely PathogenicLikely Benign2.45Destabilizing0.72.12Destabilizing2.29Destabilizing1.73Destabilizing0.907Likely Pathogenic-4.61Deleterious1.000Probably Damaging0.995Probably Damaging-1.38Pathogenic0.01Affected0.10030.06400-1-5.2-12.05
c.149T>C
I50T
2D
AIThe SynGAP1 missense variant I50T is not reported in ClinVar and has no entries in gnomAD. Functional prediction tools largely agree that the change is benign: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, and FATHMM all classify it as benign. In contrast, SIFT and AlphaMissense‑Default predict a pathogenic effect. AlphaMissense‑Optimized returns an uncertain result, and Foldetta (a protein‑folding stability method combining FoldX‑MD and Rosetta outputs) has no available prediction for this variant. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, yields a “Likely Benign” verdict. High‑accuracy assessments therefore point to a benign outcome: AlphaMissense‑Optimized is inconclusive, SGM‑Consensus is benign, and Foldetta data are missing. Based on the collective evidence, the variant is most likely benign, and this conclusion does not contradict any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.295083Structured0.449965Uncertain0.5450.7080.000-5.121Likely Benign0.949Likely PathogenicAmbiguous0.128Likely Benign-1.61Neutral0.092Benign0.037Benign3.76Benign0.00Affected0.09500.07080-1-5.2-12.05
c.1502T>C
I501T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I501T is listed in ClinVar with an uncertain significance and is not reported in gnomAD. Functional prediction tools that agree on a benign effect include REVEL, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Those that predict a pathogenic outcome are FoldX, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and premPS, while Rosetta remains uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as likely benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) as pathogenic. Overall, the majority of predictions lean toward a benign effect, and this does not contradict the ClinVar uncertain status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.079919Structured0.366596Uncertain0.8860.1530.000Uncertain 1-5.996Likely Benign0.252Likely BenignLikely Benign2.40Destabilizing0.11.81Ambiguous2.11Destabilizing1.57Destabilizing0.362Likely Benign-3.48Deleterious1.000Probably Damaging1.000Probably Damaging3.44Benign0.16Tolerated3.37350.09720.06400-1-5.2-12.05214.526.90.00.00.50.0XPotentially PathogenicIle501 is located near a hinge in the middle of an α-helix (res. Leu489-Glu519). The sec-butyl side chain of Ile501 is hydrophobically packed with other residues in the inter-helix space (e.g., Leu500, Tyr497, Phe679) in the WT simulations. In the variant simulations, the hydroxyl group of Thr501 forms a hydrogen bond with the backbone atoms of Tyr497 on the same α-helix, which may weaken the α-helix integrity. Additionally, the polar hydroxyl group of Thr501 is not suitable for the hydrophobic inter-helix space, and thus, the residue swap could affect protein folding. However, Ile501 is followed by Gly502, which facilitates a hinge in the middle of the α-helix, making further weakening caused by Thr501 unlikely to be harmful to the α-helix integrity.
c.1529T>C
I510T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I510T is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include only AlphaMissense‑Optimized. All other evaluated algorithms—SGM‑Consensus, REVEL, FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and Foldetta—classify the variant as pathogenic, while Rosetta remains uncertain. High‑accuracy assessments further support a pathogenic interpretation: AlphaMissense‑Optimized predicts benign, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts likely pathogenic, and Foldetta predicts pathogenic. Consequently, the variant is most likely pathogenic based on the collective predictions, and this assessment does not contradict any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.025762Structured0.250630Uncertain0.9450.2730.000-9.993Likely Pathogenic0.701Likely PathogenicLikely Benign3.08Destabilizing0.21.99Ambiguous2.54Destabilizing1.95Destabilizing0.914Likely Pathogenic-3.63Deleterious1.000Probably Damaging0.997Probably Damaging-1.43Pathogenic0.00Affected0.09600.04400-1-5.2-12.05
c.152T>C
I51T
2D
AIThe SynGAP1 missense variant I51T is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, and FATHMM. Tools that predict a pathogenic effect are SIFT and AlphaMissense‑Default, while AlphaMissense‑Optimized is uncertain. High‑accuracy assessments show that the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is Likely Benign, AlphaMissense‑Optimized remains Uncertain, and no Foldetta stability result is available. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.291804Structured0.454181Uncertain0.6060.7100.000-5.861Likely Benign0.881Likely PathogenicAmbiguous0.135Likely Benign-1.07Neutral0.084Benign0.050Benign4.16Benign0.00Affected0.11800.12650-1-5.2-12.05
c.1541T>C
I514T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I514T has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect are limited to FATHMM, whereas the majority of algorithms—SGM‑Consensus, REVEL, FoldX, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the change as pathogenic. Rosetta reports an uncertain outcome and is not included in the consensus groups. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized predicts pathogenic; the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also predicts pathogenic. Taken together, the evidence overwhelmingly points to a pathogenic effect, and this conclusion is not contradicted by the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.049374Structured0.221408Uncertain0.9480.2660.000-8.820Likely Pathogenic0.963Likely PathogenicLikely Pathogenic2.92Destabilizing0.11.88Ambiguous2.40Destabilizing1.94Destabilizing0.617Likely Pathogenic-4.77Deleterious1.000Probably Damaging1.000Probably Damaging2.82Benign0.00Affected0.09620.04800-1-5.2-12.05
c.1586T>C
I529T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I529T is listed in ClinVar with an “Uncertain” status and is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus “Likely Benign” call. Tools that predict a pathogenic outcome are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also yields a benign prediction; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, predicts benign. Overall, the majority of evidence points to a benign effect, and this is consistent with the ClinVar “Uncertain” classification—there is no contradiction between the predictions and the current ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.318242Structured0.019545Uncertain0.9010.4030.000Uncertain 1-0.539Likely Benign0.336Likely BenignLikely Benign0.22Likely Benign0.20.16Likely Benign0.19Likely Benign0.17Likely Benign0.343Likely Benign0.24Neutral0.872Possibly Damaging0.820Possibly Damaging-1.23Pathogenic0.55Tolerated3.37350.08970.09890-1-5.2-12.05207.229.80.20.00.20.1XPotentially BenignIle529 is located on an α-α loop between the two α-helices (res. Gly502-Tyr518 and Ala533-Val560). In the WT simulations, the sec-butyl side chain of Ile529 faces the membrane interface and shows no specific interactions. In the variant simulations, the hydroxyl group of Thr529 forms a hydrogen bond with the carboxylate side chain of Asp527, but no negative structural changes are observed. However, due to its location near the SynGAP-membrane interface, the effect of the residue swap cannot be fully addressed using the SynGAP solvent-only simulations.
c.1751T>C
I584T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I584T is not reported in ClinVar and is absent from gnomAD. Consensus from most in silico predictors indicates a pathogenic effect: REVEL, FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus score (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) all classify it as likely pathogenic. Only AlphaMissense‑Optimized predicts a benign outcome, while Rosetta and Foldetta are uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus as likely pathogenic, and Foldetta as uncertain. With the overwhelming majority of tools supporting pathogenicity and no ClinVar entry to contradict this, the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.059222Structured0.046673Uncertain0.8460.2440.000-10.413Likely Pathogenic0.765Likely PathogenicLikely Benign2.05Destabilizing0.11.70Ambiguous1.88Ambiguous1.66Destabilizing0.748Likely Pathogenic-4.63Deleterious0.999Probably Damaging0.993Probably Damaging-1.11Pathogenic0.02Affected0.09110.06080-1-5.2-12.05
c.1766T>C
I589T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I589T is not reported in ClinVar (ClinVar status: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that assess pathogenicity all agree that the variant is deleterious: SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict a pathogenic effect. No tool predicts a benign outcome. High‑accuracy methods reinforce this consensus: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also predicts pathogenicity. All available predictions are consistent and conclusive. Based on the unanimous computational evidence, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.018415Structured0.084536Uncertain0.9270.2140.000-12.128Likely Pathogenic0.995Likely PathogenicLikely Pathogenic2.60Destabilizing0.02.54Destabilizing2.57Destabilizing2.07Destabilizing0.935Likely Pathogenic-4.98Deleterious1.000Probably Damaging1.000Probably Damaging-1.97Pathogenic0.02Affected0.11530.12310-1-5.2-12.05
c.1805T>C
I602T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I602T is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly indicate a deleterious effect: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) all classify it as pathogenic or likely pathogenic. No tool reports a benign outcome. High‑accuracy assessments corroborate this trend: AlphaMissense‑Optimized is uncertain, SGM‑Consensus is likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenicity. Consequently, the variant is most likely pathogenic according to the available computational evidence, and this assessment does not contradict any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.010221Structured0.186541Uncertain0.9630.1710.000-12.238Likely Pathogenic0.948Likely PathogenicAmbiguous2.39Destabilizing0.12.14Destabilizing2.27Destabilizing1.94Destabilizing0.931Likely Pathogenic-4.82Deleterious1.000Probably Damaging0.996Probably Damaging-2.00Pathogenic0.00Affected0.08900.09890-1-5.2-12.05
c.1877T>C
I626T
2D
AISynGAP1 missense variant I626T is listed in ClinVar with an uncertain significance (ClinVar ID 3359331.0) and is not reported in gnomAD. Functional prediction tools largely agree on a deleterious effect: pathogenic predictions are returned by REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Only FATHMM predicts a benign outcome, while AlphaMissense‑Optimized is uncertain. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is inconclusive, SGM‑Consensus indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. Overall, the consensus of the majority of tools points to a pathogenic effect, contradicting the current ClinVar uncertain status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.109221Structured0.040732Uncertain0.9700.2230.000Uncertain 1-10.420Likely Pathogenic0.946Likely PathogenicAmbiguous2.94Destabilizing0.12.70Destabilizing2.82Destabilizing2.23Destabilizing0.640Likely Pathogenic-4.18Deleterious1.000Probably Damaging1.000Probably Damaging3.04Benign0.00Affected0.10000.08400-1-5.2-12.05
c.1889T>C
I630T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I630T has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect include PROVEAN, SIFT, and AlphaMissense‑Optimized. Those that predict a pathogenic impact are REVEL, FoldX, Rosetta, Foldetta, premPS, polyPhen‑2 (HumDiv and HumVar), FATHMM, and AlphaMissense‑Default; ESM1b remains uncertain. High‑accuracy assessments further support a deleterious outcome: AlphaMissense‑Optimized indicates benign, whereas the SGM Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) yields a pathogenic majority, and Foldetta also predicts pathogenic. No prediction is missing or inconclusive. Overall, the preponderance of evidence points to a pathogenic effect for I630T, and this conclusion does not conflict with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.040537Structured0.036106Uncertain0.9660.2360.000-7.780In-Between0.754Likely PathogenicLikely Benign2.77Destabilizing0.12.27Destabilizing2.52Destabilizing1.94Destabilizing0.734Likely Pathogenic-2.15Neutral0.997Probably Damaging0.961Probably Damaging-1.46Pathogenic0.35Tolerated0.09850.06400-1-5.2-12.05
c.191T>C
I64T
2D
AIThe SynGAP1 missense variant I64T is not reported in ClinVar (ClinVar ID None) but is present in gnomAD (ID 6‑33425799‑T‑C). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and FATHMM. Those that predict a pathogenic effect are SIFT and AlphaMissense‑Default. AlphaMissense‑Optimized is uncertain. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a Likely Benign outcome. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as Likely Benign, and the Foldetta protein‑folding stability analysis is unavailable. Based on the collective predictions, the variant is most likely benign, and this conclusion does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.422041Structured0.475481Uncertain0.4780.7470.1256-33425799-T-C16.20e-7-3.183Likely Benign0.943Likely PathogenicAmbiguous0.075Likely Benign-0.51Neutral0.092Benign0.007Benign4.08Benign0.00Affected4.3210.09780.0851-10-5.2-12.05
c.2000T>C
I667T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I667T is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include only FATHMM, whereas all other evaluated algorithms—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized scores the variant as pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates a likely pathogenic outcome; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also predicts pathogenicity. Based on the collective evidence, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.142424Structured0.083597Uncertain0.9270.3790.000-11.917Likely Pathogenic0.985Likely PathogenicLikely Pathogenic3.29Destabilizing0.12.44Destabilizing2.87Destabilizing2.23Destabilizing0.676Likely Pathogenic-4.81Deleterious1.000Probably Damaging0.985Probably Damaging2.98Benign0.00Affected0.09670.06080-1-5.2-12.05
c.2048T>C
I683T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I683T has no ClinVar record and is not reported in gnomAD. Prediction tools that agree on a benign effect include SIFT, FATHMM, and AlphaMissense‑Optimized, whereas a majority of tools predict pathogenicity: SGM‑Consensus, REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, and AlphaMissense‑Default. High‑accuracy assessments further support this pattern: AlphaMissense‑Optimized classifies the variant as benign, while the SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates it is likely pathogenic; the Foldetta stability analysis is inconclusive and therefore unavailable. Taken together, the preponderance of evidence points to a pathogenic effect for I683T. This conclusion does not contradict ClinVar status, which currently contains no classification for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.200174Structured0.143268Uncertain0.8480.3140.000-9.891Likely Pathogenic0.775Likely PathogenicLikely Benign1.67Ambiguous0.11.35Ambiguous1.51Ambiguous1.25Destabilizing0.548Likely Pathogenic-4.77Deleterious0.999Probably Damaging0.981Probably Damaging3.29Benign0.08Tolerated0.10900.08800-1-5.2-12.05
c.206T>C
I69T
2D
AIThe SynGAP1 missense variant I69T is listed in gnomAD (ID 6‑33425814‑T‑C) but has no ClinVar entry. Functional prediction tools cluster into two groups: benign predictions come from REVEL, PROVEAN, ESM1b, FATHMM, and AlphaMissense‑Optimized, while pathogenic predictions arise from polyPhen‑2 (HumDiv and HumVar), SIFT, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is classified as “Likely Benign” (three benign votes versus one pathogenic). High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus (majority vote) also indicates benign. Foldetta results are unavailable, so they do not influence the assessment. Overall, the majority of evidence points to a benign effect for I69T, and this conclusion does not contradict any ClinVar status, as none is reported.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.575842Disordered0.466129Uncertain0.4370.7860.3756-33425814-T-C16.20e-7-2.978Likely Benign0.755Likely PathogenicLikely Benign0.116Likely Benign-0.79Neutral0.824Possibly Damaging0.507Possibly Damaging4.15Benign0.00Affected4.3210.10220.0891-10-5.2-12.05
c.2162T>C
I721T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I721T is not reported in ClinVar (ClinVar status: None) and has no entries in gnomAD (gnomAD ID: None). Prediction tools that indicate a benign effect include only REVEL. All other evaluated tools—FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—predict a pathogenic impact. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also classifies the variant as Likely Pathogenic. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts Pathogenic; the SGM Consensus (majority vote) yields Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, predicts Pathogenic. No prediction or folding result is missing or inconclusive. Based on the collective evidence, the variant is most likely pathogenic, and this conclusion does not contradict the ClinVar status, which is currently unreported.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.394753Structured0.454550Uncertain0.9570.4370.125-10.374Likely Pathogenic0.989Likely PathogenicLikely Pathogenic2.73Destabilizing0.02.56Destabilizing2.65Destabilizing2.11Destabilizing0.417Likely Benign-4.18Deleterious1.000Probably Damaging1.000Probably Damaging2.22Pathogenic0.00Affected0.09180.10190-1-5.2-12.05
c.2189T>C
I730T
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant I730T is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, PROVEAN, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and polyPhen‑2 HumVar. Predictions that are inconclusive are premPS and AlphaMissense‑Default. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized scores the variant as benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates a likely benign classification, and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also predicts a benign effect. Overall, the consensus of both general and high‑accuracy predictors points to a benign impact, and this conclusion is consistent with the absence of any ClinVar pathogenic annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.733139Disordered0.420109Uncertain0.5910.6190.750-5.641Likely Benign0.404AmbiguousLikely Benign0.18Likely Benign0.20.12Likely Benign0.15Likely Benign0.54Ambiguous0.103Likely Benign-0.83Neutral0.995Probably Damaging0.934Probably Damaging3.49Benign0.08Tolerated0.10740.08850-1-5.2-12.05
c.2300T>C
I767T
2D
AIThe SynGAP1 missense variant I767T is listed in ClinVar (ID 1044161.0) with an “Uncertain” status and is not reported in gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict benign. Only polyPhen‑2 HumDiv flags the variant as pathogenic, creating a single discordant prediction. The high‑accuracy consensus from SGM (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) yields a “Likely Benign” classification, and AlphaMissense‑Optimized also reports benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the preponderance of evidence points to a benign impact, and this conclusion does not contradict the ClinVar “Uncertain” designation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.321458Structured0.927771Binding0.3690.8720.125Uncertain 1-3.749Likely Benign0.252Likely BenignLikely Benign0.138Likely Benign-0.78Neutral0.625Possibly Damaging0.249Benign4.12Benign0.46Tolerated3.6460.12740.18890-1-5.2-12.05
c.23T>C
I8T
2D
AIThe SynGAP1 missense variant I8T is reported in gnomAD (variant ID 6‑33420287‑T‑C) but has no ClinVar entry. In silico prediction tools largely agree on a benign effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as benign, while only SIFT predicts it to be pathogenic. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates a likely benign outcome. High‑accuracy assessments confirm this: AlphaMissense‑Optimized is benign and the SGM‑Consensus is likely benign; Foldetta results are not available. Overall, the majority of evidence points to a benign impact, and this is consistent with the absence of a ClinVar pathogenic classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.490133Structured0.543080Binding0.3410.9160.6256-33420287-T-C-3.149Likely Benign0.239Likely BenignLikely Benign0.108Likely Benign-0.10Neutral0.047Benign0.006Benign4.03Benign0.00Affected4.3210.09490.1019-10-5.2-12.05
c.2480T>C
I827T
2D
AIThe SynGAP1 missense variant I827T is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, and FATHMM, while those that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely benign classification. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as likely benign, and Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact. This conclusion is not contradicted by ClinVar status, as no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.590140Disordered0.636272Binding0.3830.8840.625-4.586Likely Benign0.874Likely PathogenicAmbiguous0.147Likely Benign-0.47Neutral0.997Probably Damaging0.994Probably Damaging2.74Benign0.40Tolerated0.10020.06850-1-5.2-12.05
c.2696T>C
I899T
2D
AIThe SynGAP1 missense variant I899T is not reported in ClinVar (ClinVar ID None) but is present in gnomAD (ID 6‑33443248‑T‑C). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Only SIFT predicts a pathogenic outcome, while AlphaMissense‑Default remains uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.675549Disordered0.443727Uncertain0.2920.9280.3756-33443248-T-C21.24e-6-2.472Likely Benign0.521AmbiguousLikely Benign0.103Likely Benign-0.25Neutral0.245Benign0.096Benign2.75Benign0.01Affected4.3240.10060.1014-10-5.2-12.05
c.2768T>C
I923T
2D
AIThe SynGAP1 missense variant I923T is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumVar, SIFT, ESM1b, and FATHMM. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a “Likely Benign” classification. High‑accuracy assessments show AlphaMissense‑Optimized as “Uncertain” and the SGM‑Consensus as “Likely Benign”; Foldetta results are not available. Overall, the majority of evidence points to a benign impact. This conclusion is consistent with the lack of ClinVar annotation, so there is no contradiction with ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.562014Disordered0.964857Binding0.2920.8520.250-1.180Likely Benign0.842Likely PathogenicAmbiguous0.097Likely Benign-0.53Neutral0.837Possibly Damaging0.348Benign2.73Benign0.41Tolerated0.13270.17860-1-5.2-12.05
c.2999T>C
I1000T
2D
AIThe SynGAP1 missense variant I1000T is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates the majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as Likely Benign. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as Likely Benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact, and there is no ClinVar status to contradict this conclusion.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.745909Disordered0.957020Binding0.2930.9040.625-4.748Likely Benign0.721Likely PathogenicLikely Benign0.131Likely Benign-0.87Neutral0.896Possibly Damaging0.596Possibly Damaging2.78Benign0.29Tolerated0.10450.15940-1-5.2-12.05
c.3110T>C
I1037T
2D
AIThe SynGAP1 missense variant I1037T is not reported in ClinVar (ClinVar ID None) but is present in gnomAD (ID 6‑33443662‑T‑C). Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and FATHMM. Tools that predict a pathogenic effect are AlphaMissense‑Default and AlphaMissense‑Optimized. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as Likely Benign. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, while the SGM‑Consensus remains Likely Benign; Foldetta results are unavailable. Overall, the majority of predictions (seven benign vs. two pathogenic) indicate that the variant is most likely benign, and this assessment does not contradict the ClinVar status, which currently has no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.939629Disordered0.986140Binding0.3090.7740.6256-33443662-T-C16.21e-7-2.565Likely Benign0.973Likely PathogenicLikely Pathogenic0.066Likely Benign0.40Neutral0.292Benign0.110Benign2.79Benign0.34Tolerated3.7750.10710.2175-10-5.2-12.05
c.3116T>C
I1039T
2D
AIThe SynGAP1 missense variant I1039T is listed in ClinVar with an “Uncertain” status and is present in gnomAD (ID 6‑33443668‑T‑C). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and FATHMM; the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also reports a likely benign outcome. Only AlphaMissense‑Default predicts a pathogenic effect. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign, while a Foldetta stability analysis is unavailable. Overall, the majority of evidence points to a benign impact, and this is consistent with the ClinVar “Uncertain” classification rather than contradicting it.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.969315Disordered0.979204Binding0.2920.8060.625Uncertain 26-33443668-T-C127.43e-6-2.465Likely Benign0.645Likely PathogenicLikely Benign0.193Likely Benign0.45Neutral0.004Benign0.008Benign2.75Benign0.10Tolerated3.7750.12480.2293-10-5.2-12.05
c.3344T>C
I1115T
2D
AIThe SynGAP1 missense variant I1115T is listed in ClinVar (ID 130530) as Benign and is present in gnomAD (variant ID 6‑33443896‑T‑C). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool in the dataset predicts a pathogenic outcome. High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized predicts Benign, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates Likely Benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the computational evidence strongly favors a benign impact, consistent with the ClinVar designation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.889439Disordered0.892339Binding0.3080.9120.750Benign 106-33443896-T-C205361.36e-2-2.670Likely Benign0.068Likely BenignLikely Benign0.100Likely Benign-0.04Neutral0.000Benign0.001Benign2.76Benign0.23Tolerated4.3220.13970.22520-1-5.2-12.05
c.3398T>C
I1133T
2D
AIThe SynGAP1 missense variant I1133T has no ClinVar entry and is present in gnomAD (ID 6‑33443950‑T‑C). Consensus among most tools is benign: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized all predict a benign effect, while AlphaMissense‑Default remains uncertain and no tool predicts pathogenicity. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized reports benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates “Likely Benign,” and Foldetta’s protein‑folding stability analysis is unavailable. Overall, the evidence strongly supports a benign classification, and this conclusion does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.919029Disordered0.832785Binding0.3160.8920.7506-33443950-T-C-4.522Likely Benign0.563AmbiguousLikely Benign0.275Likely Benign-0.30Neutral0.026Benign0.030Benign5.50Benign0.18Tolerated4.3230.10070.1975-10-5.2-12.05
c.3503T>C
I1168T
2D
AIThe SynGAP1 missense variant I1168T is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, and FATHMM, while those that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as “Likely Benign.” AlphaMissense‑Optimized is uncertain, and no Foldetta stability result is available. Overall, the high‑accuracy consensus (SGM‑Consensus) points to a benign outcome, whereas AlphaMissense‑Optimized remains inconclusive. Thus, the variant is most likely benign based on the available predictions, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.642678Disordered0.763262Binding0.4230.7960.500-2.970Likely Benign0.943Likely PathogenicAmbiguous0.426Likely Benign-1.29Neutral0.992Probably Damaging0.933Probably Damaging5.54Benign0.04Affected0.11730.16470-1-5.2-12.05
c.3518T>C
I1173T
2D
AIThe SynGAP1 missense variant I1173T is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, and AlphaMissense‑Optimized. Only SIFT predicts a pathogenic outcome, while AlphaMissense‑Default remains uncertain. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized predicts Benign, and the SGM‑Consensus also indicates Likely Benign; Foldetta results are unavailable. Overall, the preponderance of evidence points to a benign effect for I1173T, and this conclusion is consistent with the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignCoiled-coil0.501700Disordered0.653145Binding0.5210.7560.375-3.162Likely Benign0.441AmbiguousLikely Benign0.405Likely Benign-1.18Neutral0.451Benign0.265Benign5.46Benign0.05Affected0.10160.08210-1-5.2-12.05
c.3605T>C
I1202T
2D
AIThe SynGAP1 missense variant I1202T is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include only REVEL, whereas the remaining tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also classifies the variant as Likely Pathogenic. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts Pathogenic, and the SGM‑Consensus likewise indicates Likely Pathogenic. Foldetta results are unavailable. Overall, the preponderance of evidence points to the variant being most likely pathogenic, and this conclusion does not contradict any ClinVar status, as none is currently assigned.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.529623Disordered0.510422Binding0.8740.5930.250-9.433Likely Pathogenic1.000Likely PathogenicLikely Pathogenic0.407Likely Benign-3.96Deleterious0.997Probably Damaging0.994Probably Damaging1.81Pathogenic0.01Affected0.11180.08460-1-5.2-12.05
c.3698T>C
I1233T
2D
AIThe SynGAP1 missense variant I1233T is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, ESM1b, and FATHMM, whereas those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is inconclusive (2 pathogenic vs 2 benign), and Foldetta results are unavailable. Overall, the majority of evidence points to a pathogenic impact. Thus, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Coiled-coil0.525368Disordered0.564054Binding0.8810.5310.125-6.470Likely Benign0.992Likely PathogenicLikely Pathogenic0.142Likely Benign-2.89Deleterious0.896Possibly Damaging0.596Possibly Damaging2.55Benign0.01Affected0.10180.14190-1-5.2-12.05
c.3776T>C
I1259T
2D
AIThe SynGAP1 missense variant I1259T is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, and FATHMM. Tools that agree on a pathogenic effect include polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized predicts pathogenicity, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (two pathogenic, two benign) and Foldetta results are unavailable. Overall, the majority of evidence (six pathogenic vs. three benign predictions) points to a pathogenic impact. The variant is most likely pathogenic based on current predictions, and this conclusion is not contradicted by any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Coiled-coil0.494003Structured0.576405Binding0.8850.5740.250-10.057Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.399Likely Benign-2.47Neutral0.997Probably Damaging0.994Probably Damaging2.54Benign0.01Affected0.09910.10510-1-5.2-12.05
c.3785T>C
I1262T
2D
AIThe SynGAP1 missense variant I1262T is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly indicate a deleterious effect: REVEL, PROVEAN, PolyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as pathogenic. No tool in the dataset predicts a benign outcome. High‑accuracy assessments corroborate this: AlphaMissense‑Optimized predicts pathogenicity, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports a likely pathogenic status. The Foldetta stability analysis is not available for this variant. Overall, the consensus of all available predictions points to a pathogenic effect, and this conclusion is consistent with the lack of ClinVar annotation, so there is no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.497853Structured0.707863Binding0.8860.5760.125-11.985Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.514Likely Pathogenic-4.14Deleterious0.997Probably Damaging0.994Probably Damaging1.81Pathogenic0.00Affected0.11090.14190-1-5.2-12.05
c.3788T>C
I1263T
2D
AIThe SynGAP1 missense variant I1263T is listed in ClinVar with an “Uncertain” status and is present in the gnomAD database (ID 6‑33446780‑T‑C). Functional prediction tools largely agree on a deleterious effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all report pathogenicity, while only ESM1b predicts a benign outcome. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts pathogenic, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates a likely pathogenic classification. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the consensus of the majority of prediction tools and the high‑accuracy methods points to a pathogenic effect, which aligns with the ClinVar designation of uncertainty but does not contradict it.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicCoiled-coil0.425610Structured0.740957Binding0.8670.5740.000Uncertain 16-33446780-T-C21.24e-6-6.564Likely Benign0.962Likely PathogenicLikely Pathogenic0.529Likely Pathogenic-4.15Deleterious0.946Possibly Damaging0.673Possibly Damaging1.81Pathogenic0.00Affected3.7750.12210.10510-1-5.2-12.05
c.38T>C
I13T
2D
AIThe SynGAP1 missense variant I13T is listed in gnomAD (ID 6‑33420302‑T‑C) but has no ClinVar entry. Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN). Only SIFT predicts a pathogenic outcome, while AlphaMissense‑Default remains uncertain. High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized is benign and the SGM‑Consensus is “Likely Benign.” No Foldetta stability prediction is available, so it does not influence the assessment. Overall, the preponderance of evidence indicates that the variant is most likely benign, and this conclusion is not contradicted by any ClinVar status (none is reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.486429Structured0.482657Uncertain0.3180.9160.3756-33420302-T-C-2.856Likely Benign0.385AmbiguousLikely Benign0.132Likely Benign-0.02Neutral0.024Benign0.003Benign4.07Benign0.00Affected4.3210.14010.1778-10-5.2-12.05
c.3992T>C
I1331T
2D
AIThe SynGAP1 missense variant I1331T is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, ESM1b, and FATHMM. Tools that agree on a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized predicts pathogenic. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is inconclusive (two pathogenic vs. two benign). Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the preponderance of evidence (seven pathogenic vs. three benign predictions) indicates that the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.921076Disordered0.941705Binding0.3590.7520.875-2.953Likely Benign0.999Likely PathogenicLikely Pathogenic0.170Likely Benign-2.69Deleterious0.947Possibly Damaging0.950Probably Damaging3.32Benign0.00Affected0.11150.15500-1-5.2-12.05
c.422T>C
I141T
2D
AIThe SynGAP1 missense variant I141T is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. Tools that predict a pathogenic effect comprise PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus, which aggregates the majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Pathogenic. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized predicts pathogenicity, and the SGM‑Consensus (majority vote) also indicates Likely Pathogenic. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no reported result for this variant, so its contribution is unavailable. Overall, the majority of computational evidence points to a pathogenic effect, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.465241Structured0.577021Binding0.3670.8770.500-10.580Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.251Likely Benign-2.81Deleterious0.272Benign0.167Benign3.57Benign0.00Affected0.11650.12140-1-5.2-12.05
c.476T>C
I159T
2D
AIThe SynGAP1 missense variant I159T is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, and FATHMM. Tools that predict a pathogenic effect comprise polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is inconclusive (two pathogenic vs. two benign votes). Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. High‑accuracy AlphaMissense‑Optimized predicts pathogenic, while AlphaMissense‑Default also predicts pathogenic. Given that six of the seven individual tools predict pathogenicity versus three predicting benign, the variant is most likely pathogenic. This prediction does not contradict ClinVar status, as the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.454136Structured0.529953Binding0.2780.7310.125-12.422Likely Pathogenic0.970Likely PathogenicLikely Pathogenic0.218Likely Benign-1.69Neutral0.981Probably Damaging0.966Probably Damaging3.86Benign0.00Affected0.10690.06850-1-5.2-12.05
c.614T>C
I205T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I205T is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. No tool predicts a pathogenic outcome; the remaining predictions (FoldX, premPS, AlphaMissense‑Default) are uncertain. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized scores the variant as benign; the SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates a likely benign effect; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, classifies the variant as benign. Taken together, the consensus of both general and high‑accuracy predictors indicates that I205T is most likely benign, and this conclusion is consistent with the absence of any ClinVar pathogenic annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignPH0.264545Structured0.409933Uncertain0.8210.4140.125-6.869Likely Benign0.450AmbiguousLikely Benign0.65Ambiguous0.00.28Likely Benign0.47Likely Benign0.81Ambiguous0.118Likely Benign-2.19Neutral0.421Benign0.156Benign4.16Benign0.15Tolerated0.09330.05410-1-5.2-12.05
c.617T>C
I206T
2D
AIThe SynGAP1 I206T missense variant is not reported in ClinVar (ClinVar ID None) and has no entry in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. In contrast, the majority of tools predict a pathogenic impact: SGM‑Consensus (Likely Pathogenic), FoldX, Rosetta, Foldetta, premPS, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy methods give consistent results: AlphaMissense‑Optimized is pathogenic; the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. No predictions or stability results are missing or inconclusive. Based on the overall evidence, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because the variant is not currently listed.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.298791Structured0.405123Uncertain0.8630.3910.125-10.812Likely Pathogenic0.973Likely PathogenicLikely Pathogenic2.43Destabilizing0.52.68Destabilizing2.56Destabilizing1.94Destabilizing0.252Likely Benign-3.78Deleterious0.421Benign0.156Benign3.65Benign0.00Affected0.08300.06690-1-5.2-12.05
c.638T>C
I213T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 I213T missense variant is not reported in ClinVar and is absent from gnomAD. Prediction tools largely agree on a deleterious effect: FATHMM is the sole benign predictor, while the remaining evidence—SGM‑Consensus (Likely Pathogenic), REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently indicates pathogenicity. FoldX, Rosetta, and Foldetta provide uncertain results. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta remains uncertain. Overall, the preponderance of evidence supports a pathogenic classification for I213T, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.158265Structured0.372201Uncertain0.8500.2950.125-11.080Likely Pathogenic0.997Likely PathogenicLikely Pathogenic1.46Ambiguous0.81.32Ambiguous1.39Ambiguous1.49Destabilizing0.882Likely Pathogenic-3.99Deleterious0.948Possibly Damaging0.588Possibly Damaging5.82Benign0.00Affected0.09050.07080-1-5.2-12.05
c.728T>C
I243T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I243T is not reported in ClinVar and is absent from gnomAD. Prediction tools largely agree on a deleterious effect: SGM‑Consensus, REVEL, FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default all classify the variant as pathogenic. Only FATHMM predicts a benign outcome, while Foldetta, AlphaMissense‑Optimized, and Rosetta return uncertain results, which are treated as unavailable evidence. High‑accuracy assessments further support a pathogenic interpretation: AlphaMissense‑Optimized is uncertain, SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is Likely Pathogenic, and Foldetta remains uncertain. Overall, the preponderance of evidence indicates that I243T is most likely pathogenic, and this conclusion does not contradict the current ClinVar status, which contains no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.363090Structured0.344471Uncertain0.8420.3470.000-9.102Likely Pathogenic0.922Likely PathogenicAmbiguous2.15Destabilizing0.21.52Ambiguous1.84Ambiguous1.72Destabilizing0.816Likely Pathogenic-3.06Deleterious0.982Probably Damaging0.702Possibly Damaging5.55Benign0.01Affected0.10270.05410-1-5.2-12.05
c.803T>C
I268T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I268T is not reported in ClinVar (ClinVar status: none) and is absent from gnomAD (gnomAD ID: none). Prediction tools that agree on pathogenicity include SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized; no tool predicts a benign effect. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized predicts pathogenicity, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also predicts pathogenicity, and Foldetta (combining FoldX‑MD and Rosetta outputs) indicates a destabilizing, pathogenic effect. All available predictions are concordant and point to a deleterious impact. Consequently, the variant is most likely pathogenic, and this assessment does not contradict the ClinVar status, which simply lacks an entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.216401Structured0.314336Uncertain0.9510.2640.000-10.753Likely Pathogenic0.997Likely PathogenicLikely Pathogenic3.44Destabilizing0.13.19Destabilizing3.32Destabilizing1.93Destabilizing0.828Likely Pathogenic-4.24Deleterious0.997Probably Damaging0.994Probably Damaging1.53Pathogenic0.00Affected0.08820.06380-1-5.2-12.05
c.806T>C
I269T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I269T is not reported in ClinVar (no ClinVar entry) but is present in gnomAD (variant ID 6‑33437711‑T‑C). Among general in‑silico predictors, only SIFT classifies the change as benign, whereas the remaining tools that provide a definitive call (REVEL, Rosetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default) all predict a pathogenic effect. High‑accuracy assessments give a more nuanced view: AlphaMissense‑Optimized is uncertain; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates a likely pathogenic outcome; and Foldetta, which integrates FoldX‑MD and Rosetta stability predictions, also reports a pathogenic effect. Based on the preponderance of pathogenic predictions and the high‑accuracy consensus, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.216401Structured0.343787Uncertain0.9370.2440.1256-33437711-T-C21.24e-6-9.376Likely Pathogenic0.887Likely PathogenicAmbiguous1.97Ambiguous0.12.10Destabilizing2.04Destabilizing1.38Destabilizing0.727Likely Pathogenic-3.70Deleterious0.997Probably Damaging0.994Probably Damaging1.72Pathogenic0.09Tolerated3.38190.08330.0808-10-5.2-12.05
c.1235T>G
L412W
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L412W is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include only FATHMM, whereas all other evaluated algorithms—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the variant as pathogenic. High‑accuracy methods further support a deleterious impact: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. No prediction or folding stability result is missing or inconclusive. Based on the overwhelming consensus of pathogenic predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because the variant is not yet catalogued in ClinVar.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.122885Structured0.331108Uncertain0.9370.1960.000-13.436Likely Pathogenic0.999Likely PathogenicLikely Pathogenic8.44Destabilizing0.49.91Destabilizing9.18Destabilizing1.65Destabilizing0.503Likely Pathogenic-5.53Deleterious1.000Probably Damaging0.998Probably Damaging3.19Benign0.00Affected0.05860.2664-2-2-4.773.05
c.1304T>G
L435W
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant L435W is listed in ClinVar with an uncertain significance and is not reported in gnomAD. Prediction tools that agree on a benign effect include only FATHMM. The majority of other in silico predictors (REVEL, FoldX, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) classify the change as pathogenic, and the SGM‑Consensus score is “Likely Pathogenic.” High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized predicts pathogenicity, the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates likely pathogenic, while Foldetta’s stability analysis is inconclusive. Overall, the computational evidence strongly favors a pathogenic effect, which does not contradict the ClinVar uncertain status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.229226Structured0.333584Uncertain0.9540.2920.000Uncertain 1-14.889Likely Pathogenic0.992Likely PathogenicLikely Pathogenic2.11Destabilizing0.10.69Ambiguous1.40Ambiguous1.66Destabilizing0.572Likely Pathogenic-5.63Deleterious1.000Probably Damaging0.998Probably Damaging3.15Benign0.00Affected3.37290.05360.2496-2-2-4.773.05242.2-25.20.00.00.30.1XPotentially PathogenicThe iso-butyl side chain of Leu435, located in an α helix (res. Met414-Glu436), packs against other hydrophobic residues in an interhelix space (e.g., Val699, Val447, Leu489, Leu439) in the WT simulations. In the variant simulations, the indole ring of Trp435 fits into the same niche despite its considerably bulkier size. Additionally, the side chain forms an H-bond with the backbone carbonyl of Leu696 in an α helix (res. Asp684-Gln702). Although no apparent negative changes are observed during the variant simulation, the size difference between the swapped residues could affect the protein folding process.
c.1607T>G
L536W
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L536W is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a deleterious effect include REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized; all of these classify the variant as pathogenic. Tools that are inconclusive (FoldX, Rosetta, Foldetta) do not provide evidence for or against pathogenicity. High‑accuracy assessments further support a damaging impact: AlphaMissense‑Optimized predicts pathogenicity, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic, while Foldetta’s stability analysis is uncertain. Based on the collective evidence, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.137348Structured0.042188Uncertain0.9310.3410.000-14.169Likely Pathogenic0.970Likely PathogenicLikely Pathogenic1.07Ambiguous0.61.31Ambiguous1.19Ambiguous1.33Destabilizing0.897Likely Pathogenic-5.92Deleterious1.000Probably Damaging0.999Probably Damaging-1.50Pathogenic0.00Affected0.08430.2577-2-2-4.773.05
c.1646T>G
L549W
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L549W is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include Rosetta and Foldetta, whereas the remaining tools—REVEL, SIFT, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, SGM Consensus, and premPS—consistently predict a pathogenic or likely pathogenic impact. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, SGM Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as likely pathogenic, and Foldetta as benign. Overall, the preponderance of evidence points to a pathogenic effect for L549W. This conclusion does not contradict ClinVar status, as no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.025762Structured0.007921Uncertain0.9550.2810.000-14.277Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.76Ambiguous0.4-0.19Likely Benign0.29Likely Benign1.06Destabilizing0.763Likely Pathogenic-5.23Deleterious1.000Probably Damaging0.999Probably Damaging-1.30Pathogenic0.04Affected0.06990.1632-2-2-4.773.05
c.1991T>G
L664W
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L664W is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely converge on a deleterious effect: benign calls are made only by REVEL and FATHMM, whereas the remaining 13 predictors—including FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the substitution as pathogenic. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts pathogenicity; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates likely pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, reports a pathogenic effect. Consequently, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.100716Structured0.089318Uncertain0.9370.3390.000-17.438Likely Pathogenic0.998Likely PathogenicLikely Pathogenic7.81Destabilizing0.53.17Destabilizing5.49Destabilizing1.57Destabilizing0.479Likely Benign-5.99Deleterious1.000Probably Damaging0.984Probably Damaging2.84Benign0.00Affected0.05430.2272-2-2-4.773.05
c.2054T>G
L685W
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L685W is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include only FATHMM, while the majority of tools (REVEL, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus) predict a pathogenic impact. FoldX, Rosetta, and Foldetta provide uncertain results and are not considered evidence for either side. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus as likely pathogenic, and Foldetta as uncertain. Taken together, the preponderance of evidence indicates that the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation because no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.175930Structured0.162061Uncertain0.9130.2800.000-15.885Likely Pathogenic0.998Likely PathogenicLikely Pathogenic1.53Ambiguous0.21.14Ambiguous1.34Ambiguous1.14Destabilizing0.509Likely Pathogenic-5.99Deleterious1.000Probably Damaging0.984Probably Damaging3.23Benign0.00Affected0.07000.2328-2-2-4.773.05
c.2642T>G
L881W
2D
AIThe SynGAP1 missense variant L881W is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are SIFT and FATHMM. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a Likely Benign classification. High‑accuracy assessments show AlphaMissense‑Optimized as Benign and the SGM‑Consensus as Likely Benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact for the variant, and this conclusion does not contradict any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.703578Disordered0.629350Binding0.2990.8740.250-6.646Likely Benign0.231Likely BenignLikely Benign0.075Likely Benign-0.96Neutral0.014Benign0.008Benign2.44Pathogenic0.00Affected0.06620.3288-2-2-4.773.05
c.305T>G
L102W
2D
AIThe SynGAP1 missense variant L102W is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote) which classifies the variant as Likely Benign. In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT all predict a pathogenic impact. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized returns Benign, and the SGM‑Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates Likely Benign. No Foldetta stability prediction is available. Overall, the majority of evidence points to a benign effect for L102W, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.795062Disordered0.696014Binding0.3570.8850.625-5.833Likely Benign0.202Likely BenignLikely Benign0.125Likely Benign-1.42Neutral0.996Probably Damaging0.984Probably Damaging4.09Benign0.00Affected0.08210.3078-2-2-4.773.05
c.3203T>G
L1068W
2D
AIThe SynGAP1 missense variant L1068W is not reported in ClinVar (ClinVar status: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, and AlphaMissense‑Optimized, whereas polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and FATHMM all predict a pathogenic outcome; AlphaMissense‑Default remains uncertain. High‑accuracy assessments further refine the picture: AlphaMissense‑Optimized remains benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) resolves as pathogenic, and Foldetta’s protein‑folding stability analysis is unavailable. Overall, the majority of evidence points toward a pathogenic impact for L1068W. This conclusion is not contradicted by ClinVar, which contains no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.947281Disordered0.981041Binding0.3620.9070.875-8.574Likely Pathogenic0.342AmbiguousLikely Benign0.151Likely Benign-1.96Neutral0.994Probably Damaging0.884Possibly Damaging2.46Pathogenic0.00Affected0.07420.3763-2-2-4.773.05
c.3227T>G
L1076W
2D
AIThe SynGAP1 missense variant L1076W is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, and ESM1b, whereas those that predict a pathogenic effect are polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Default. The high‑accuracy AlphaMissense‑Optimized tool returns an uncertain result, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (2 pathogenic vs. 2 benign). Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of evaluated predictors (five pathogenic vs. three benign) lean toward a pathogenic interpretation. This prediction is not contradicted by ClinVar status, as the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.922952Disordered0.989617Binding0.3010.8920.750-6.377Likely Benign0.822Likely PathogenicAmbiguous0.183Likely Benign-1.40Neutral1.000Probably Damaging0.996Probably Damaging2.38Pathogenic0.02Affected0.07490.3740-2-2-4.773.05
c.3275T>G
L1092W
2D
AIThe SynGAP1 missense variant L1092W is not reported in ClinVar (ClinVar status: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, and FATHMM, while those that agree on a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. Two tools give uncertain results: ESM1b and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as benign, and Foldetta is unavailable. Overall, the majority of conventional tools predict pathogenicity, but the high‑accuracy consensus leans toward a benign interpretation. Thus, the variant is most likely benign based on the most reliable predictions, and this conclusion does not contradict the absence of a ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.924947Disordered0.985431Binding0.3850.8901.000-7.014In-Between0.804Likely PathogenicAmbiguous0.120Likely Benign-2.00Neutral0.999Probably Damaging0.968Probably Damaging2.58Benign0.03Affected0.07870.4033-2-2-4.773.05
c.3431T>G
L1144W
2D
AIThe SynGAP1 missense variant L1144W is not reported in ClinVar (ClinVar status: none) but is present in gnomAD (ID 6‑33444466‑T‑G). Prediction tools that agree on a benign effect include ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that agree on a pathogenic effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized predicts benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑to‑2 split; Foldetta results are unavailable. Overall, the majority of predictions (six pathogenic vs. three benign) indicate a pathogenic impact. This conclusion is not contradicted by ClinVar status, which has no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.950334Disordered0.726803Binding0.2770.8401.0006-33444466-T-G16.20e-7-5.745Likely Benign0.707Likely PathogenicLikely Benign0.575Likely Pathogenic-2.87Deleterious1.000Probably Damaging0.995Probably Damaging5.36Benign0.01Affected4.3240.07030.3166-2-2-4.773.05
c.3905T>G
L1302W
2D
AIThe SynGAP1 missense variant L1302W is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that agree on a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and FATHMM; ESM1b is uncertain and not counted. High‑accuracy assessments show AlphaMissense‑Optimized predicting benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) predicts pathogenic. Foldetta results are unavailable. Overall, the majority of predictions (five pathogenic vs. three benign) lean toward pathogenicity, and this is consistent with the SGM Consensus result. Therefore, the variant is most likely pathogenic based on current computational evidence, and this does not contradict any ClinVar status because no ClinVar claim exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.784345Disordered0.889642Binding0.4290.8420.875-7.133In-Between0.297Likely BenignLikely Benign0.290Likely Benign-4.20Deleterious0.996Probably Damaging0.946Probably Damaging1.49Pathogenic0.00Affected0.06710.2530-2-2-4.773.05
c.557T>G
L186W
2D
AIThe SynGAP1 missense variant L186W has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect are REVEL and FATHMM, whereas the remaining tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN)—all predict a pathogenic or likely pathogenic outcome. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized classifies the variant as pathogenic, and the SGM‑Consensus reports it as Likely Pathogenic. No Foldetta stability prediction is available for this variant. Overall, the preponderance of evidence from both general and high‑accuracy tools indicates that the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar status, as no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.458154Structured0.428613Uncertain0.3970.6170.500-16.177Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.274Likely Benign-4.78Deleterious0.996Probably Damaging0.819Possibly Damaging3.46Benign0.00Affected0.05390.3138-2-2-4.773.05
c.587T>G
L196W
2D
AIThe SynGAP1 missense variant L196W has no ClinVar entry (ClinVar status: not reported) and is absent from gnomAD. Prediction tools that indicate a benign effect include REVEL and FATHMM, whereas the remaining tools—PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN)—all predict a pathogenic outcome. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic, and the SGM‑Consensus is labeled Likely Pathogenic. Foldetta results are unavailable. Overall, the preponderance of evidence points to a pathogenic effect for this variant, and this conclusion does not contradict any ClinVar status because no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.284882Structured0.429452Uncertain0.4890.5210.125-12.148Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.293Likely Benign-4.91Deleterious0.992Probably Damaging0.869Possibly Damaging3.58Benign0.00Affected0.05510.2718-2-2-4.773.05
c.599T>G
L200W
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L200W is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL and FATHMM, whereas the majority of tools (SGM‑Consensus, FoldX, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, and Foldetta) predict a pathogenic impact. Two tools (AlphaMissense‑Optimized and Rosetta) provide inconclusive results and are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as Likely Pathogenic (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN), and Foldetta as Pathogenic, the latter integrating stability predictions from FoldX‑MD and Rosetta. Overall, the preponderance of evidence indicates that the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.366687Structured0.428168Uncertain0.6870.4530.125-11.550Likely Pathogenic0.824Likely PathogenicAmbiguous2.90Destabilizing1.01.95Ambiguous2.43Destabilizing1.20Destabilizing0.200Likely Benign-2.93Deleterious0.999Probably Damaging0.970Probably Damaging3.98Benign0.02Affected0.06270.2893-2-2-4.773.05
c.1028T>G
V343G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V343G is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include only REVEL, which scores the variant as benign. All other evaluated algorithms—FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default—classify the variant as pathogenic. AlphaMissense‑Optimized is uncertain, providing no definitive direction. High‑accuracy assessments further support pathogenicity: the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. Thus, the preponderance of evidence indicates that V343G is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.291804Structured0.383911Uncertain0.8820.4970.250-11.332Likely Pathogenic0.926Likely PathogenicAmbiguous2.49Destabilizing0.14.40Destabilizing3.45Destabilizing1.68Destabilizing0.421Likely Benign-5.84Deleterious0.898Possibly Damaging0.996Probably Damaging1.60Pathogenic0.00Affected0.19820.3341-1-3-4.6-42.08
c.1037T>G
V346G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V346G is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). All available in‑silico predictors classify it as pathogenic: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a benign effect. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also yields a pathogenic verdict; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, reports pathogenic. With all evidence converging on a deleterious impact and no ClinVar annotation to contradict, the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.260850Structured0.350921Uncertain0.9490.4610.000-12.779Likely Pathogenic0.969Likely PathogenicLikely Pathogenic4.24Destabilizing0.24.62Destabilizing4.43Destabilizing2.15Destabilizing0.667Likely Pathogenic-6.03Deleterious0.991Probably Damaging0.999Probably Damaging1.50Pathogenic0.00Affected0.23780.2522-1-3-4.6-42.08
c.1043T>G
V348G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V348G is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect are limited to REVEL, which scores the variant as benign. All other evaluated algorithms—FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the variant as pathogenic. High‑accuracy methods reinforce this assessment: AlphaMissense‑Optimized predicts pathogenicity, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also predicts pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) indicates a pathogenic effect. No prediction or stability result is missing or inconclusive. Based on the overwhelming agreement among pathogenic predictions and the lack of a benign consensus, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.170161Structured0.346556Uncertain0.9510.4140.000-12.793Likely Pathogenic0.964Likely PathogenicLikely Pathogenic3.97Destabilizing0.25.70Destabilizing4.84Destabilizing2.23Destabilizing0.419Likely Benign-6.18Deleterious0.637Possibly Damaging0.989Probably Damaging1.56Pathogenic0.00Affected0.22290.2082-1-3-4.6-42.08
c.1049T>G
V350G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V350G lies in the C2 domain. ClinVar has no entry for this variant, and it is not reported in gnomAD. Prediction tools that classify it as benign include REVEL, polyPhen‑2 HumDiv, and AlphaMissense‑Optimized. The remaining tools—FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, and AlphaMissense‑Default—predict it to be pathogenic. High‑accuracy methods give the following results: AlphaMissense‑Optimized predicts benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. All predictions are available and consistent. Based on the preponderance of pathogenic calls, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.179055Structured0.353227Uncertain0.9310.3710.000-12.267Likely Pathogenic0.597Likely PathogenicLikely Benign2.57Destabilizing0.04.25Destabilizing3.41Destabilizing1.93Destabilizing0.330Likely Benign-5.46Deleterious0.435Benign0.920Probably Damaging1.61Pathogenic0.02Affected0.23160.2522-1-3-4.6-42.08
c.104T>G
V35G
2D
AIThe SynGAP1 missense variant V35G is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is benign. High‑accuracy methods give the following results: AlphaMissense‑Optimized predicts benign; the SGM Consensus also predicts benign; Foldetta (a protein‑folding stability method combining FoldX‑MD and Rosetta outputs) has no available result for this variant. Based on the collective predictions, the variant is most likely benign, and this assessment does not contradict any ClinVar status because the variant is not currently catalogued in ClinVar.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.613573Disordered0.434838Uncertain0.3600.8510.375-3.614Likely Benign0.109Likely BenignLikely Benign0.143Likely Benign0.66Neutral0.693Possibly Damaging0.824Possibly Damaging4.41Benign0.00Affected0.15140.2618-1-3-4.6-42.08
c.1094T>G
V365G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V365G is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that assess pathogenicity unanimously classify the variant as pathogenic: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. No tool predicts a benign effect. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized is uncertain, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. All available evidence points to a pathogenic effect. Therefore, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.414856Structured0.441505Uncertain0.9230.6080.250-13.020Likely Pathogenic0.944Likely PathogenicAmbiguous4.18Destabilizing0.24.83Destabilizing4.51Destabilizing2.18Destabilizing0.576Likely Pathogenic-5.88Deleterious0.688Possibly Damaging0.989Probably Damaging1.66Pathogenic0.00Affected0.18350.2717-1-3-4.6-42.08
c.1199T>G
V400G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 V400G missense variant has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect are polyPhen‑2 HumDiv and FATHMM; all other evaluated algorithms (REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) predict a pathogenic outcome. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability predictions, is pathogenic. No prediction or stability result is missing or inconclusive. Based on the overwhelming agreement among both general and high‑accuracy tools, the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.398279Structured0.415488Uncertain0.9510.4510.000-11.508Likely Pathogenic0.969Likely PathogenicLikely Pathogenic4.84Destabilizing0.15.40Destabilizing5.12Destabilizing2.40Destabilizing0.819Likely Pathogenic-5.70Deleterious0.335Benign0.920Probably Damaging5.27Benign0.00Affected0.22960.2522-1-3-4.6-42.08
c.1235T>C
L412S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L412S is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a deleterious effect: SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (both HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized all return pathogenic or likely pathogenic scores, whereas only FATHMM predicts a benign outcome. High‑accuracy assessments reinforce this trend: AlphaMissense‑Optimized indicates pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta stability outputs) also predicts pathogenic. No prediction is inconclusive or missing. Consequently, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation (none available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.122885Structured0.331108Uncertain0.9370.1960.000-13.884Likely Pathogenic0.999Likely PathogenicLikely Pathogenic4.03Destabilizing0.24.20Destabilizing4.12Destabilizing2.01Destabilizing0.557Likely Pathogenic-5.53Deleterious1.000Probably Damaging1.000Probably Damaging3.22Benign0.00Affected0.28210.0505-3-2-4.6-26.08
c.1271T>G
V424G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 V424G missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include only FATHMM. All other evaluated algorithms—REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized scores the variant as pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields a pathogenic consensus (3 pathogenic vs. 1 benign); and Foldetta, which integrates FoldX‑MD and Rosetta stability predictions, also classifies the variant as pathogenic. No predictions are missing or inconclusive. Based on the collective evidence, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status because the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.050641Structured0.411431Uncertain0.9730.2480.000-13.697Likely Pathogenic0.978Likely PathogenicLikely Pathogenic3.90Destabilizing0.14.84Destabilizing4.37Destabilizing2.44Destabilizing0.622Likely Pathogenic-6.26Deleterious0.994Probably Damaging1.000Probably Damaging3.34Benign0.00Affected0.13960.2029-1-3-4.6-42.08
c.1301T>G
V434G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V434G has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect are SIFT and FATHMM, while the remaining tools (REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default) all predict a pathogenic impact. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as pathogenic, and Foldetta as pathogenic. Taken together, the overwhelming majority of evidence indicates a deleterious effect. Therefore, the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.158265Structured0.342846Uncertain0.9540.3060.000-12.519Likely Pathogenic0.809Likely PathogenicAmbiguous3.08Destabilizing0.04.37Destabilizing3.73Destabilizing1.91Destabilizing0.564Likely Pathogenic-5.16Deleterious1.000Probably Damaging1.000Probably Damaging3.39Benign0.07Tolerated0.17580.2408-1-3-4.6-42.08
c.1304T>C
L435S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L435S is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that assess pathogenicity largely agree: SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict a pathogenic effect. Only FATHMM predicts a benign outcome. High‑accuracy methods reinforce the pathogenic signal: AlphaMissense‑Optimized is pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta) is pathogenic. No predictions are missing or inconclusive. Based on the consensus of these tools, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.229226Structured0.333584Uncertain0.9540.2920.000-12.662Likely Pathogenic0.996Likely PathogenicLikely Pathogenic4.18Destabilizing0.04.09Destabilizing4.14Destabilizing1.83Destabilizing0.596Likely Pathogenic-5.63Deleterious1.000Probably Damaging1.000Probably Damaging3.18Benign0.01Affected0.27050.0505-3-2-4.6-26.08
c.1322T>G
V441G
2D
3DClick to see structure in 3D Viewer
AISynGAP1 variant V441G is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into three groups: benign predictions come from REVEL, FoldX, SIFT, FATHMM, and AlphaMissense‑Optimized; pathogenic predictions arise from PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b; the remaining tools (Rosetta, Foldetta, premPS, AlphaMissense‑Default) give uncertain results. High‑accuracy assessments further refine the picture: AlphaMissense‑Optimized remains benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) favors pathogenic, and Foldetta is inconclusive. Taken together, the majority of evidence points to a benign effect, but the SGM Consensus and several individual pathogenic predictors introduce uncertainty. Therefore, the variant is most likely benign based on the overall prediction landscape, and this assessment does not contradict the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.161087Structured0.259875Uncertain0.9180.2490.000-12.380Likely Pathogenic0.478AmbiguousLikely Benign0.18Likely Benign0.01.25Ambiguous0.72Ambiguous0.95Ambiguous0.273Likely Benign-5.88Deleterious0.841Possibly Damaging0.997Probably Damaging3.41Benign0.24Tolerated0.16640.1715-1-3-4.6-42.08
c.1340T>G
V447G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 V447G missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL and FATHMM, while the remaining tools—FoldX, Rosetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default—consistently predict a pathogenic impact. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as pathogenic. No prediction or stability result is missing or inconclusive. Overall, the preponderance of evidence indicates that V447G is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation because the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.250310Structured0.283801Uncertain0.9700.2430.000-13.648Likely Pathogenic0.861Likely PathogenicAmbiguous3.81Destabilizing0.14.62Destabilizing4.22Destabilizing2.28Destabilizing0.499Likely Benign-5.43Deleterious1.000Probably Damaging1.000Probably Damaging3.31Benign0.01Affected0.18630.2240-1-3-4.6-42.08
c.1355T>G
V452G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 V452G missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include only FATHMM, whereas the remaining tools—REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default—consistently predict a pathogenic impact. AlphaMissense‑Optimized is uncertain, providing no definitive direction. High‑accuracy assessments further support pathogenicity: the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) yields a pathogenic verdict, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts pathogenicity. AlphaMissense‑Optimized remains uncertain. Overall, the preponderance of evidence indicates that V452G is most likely pathogenic, and this conclusion does not contradict any existing ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.335645Structured0.315167Uncertain0.9700.2290.000-13.410Likely Pathogenic0.946Likely PathogenicAmbiguous3.70Destabilizing0.13.37Destabilizing3.54Destabilizing2.46Destabilizing0.570Likely Pathogenic-6.92Deleterious1.000Probably Damaging1.000Probably Damaging3.17Benign0.00Affected0.19480.2567-1-3-4.6-42.08
c.1418T>G
V473G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V473G has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect include only FATHMM, while the remaining eleven tools (REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default) uniformly predict a pathogenic impact. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is uncertain, the SGM Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) votes pathogenic, and Foldetta also predicts pathogenic. No predictions are missing or inconclusive. Consequently, the variant is most likely pathogenic based on the collective evidence, and this conclusion does not contradict any ClinVar status, as none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.191378Structured0.362529Uncertain0.8840.2390.000-14.782Likely Pathogenic0.936Likely PathogenicAmbiguous3.45Destabilizing0.03.40Destabilizing3.43Destabilizing2.69Destabilizing0.683Likely Pathogenic-6.91Deleterious1.000Probably Damaging1.000Probably Damaging3.13Benign0.00Affected0.18850.2567-1-3-4.6-42.08
c.1577T>G
V526G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 V526G missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on pathogenicity include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default; no tool predicts it benign. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as pathogenic. All available evidence points to a deleterious effect. Consequently, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.139895Structured0.023118Uncertain0.9430.4030.000-15.811Likely Pathogenic0.926Likely PathogenicAmbiguous3.21Destabilizing0.34.79Destabilizing4.00Destabilizing2.19Destabilizing0.935Likely Pathogenic-6.92Deleterious1.000Probably Damaging1.000Probably Damaging-1.49Pathogenic0.00Affected0.16360.1837-1-3-4.6-42.08
c.1607T>C
L536S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L536S is not reported in ClinVar and is absent from gnomAD. Prediction tools that assess pathogenicity uniformly indicate a deleterious effect: REVEL, Rosetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as pathogenic. The only inconclusive result is from FoldX, which is listed as uncertain. No tool predicts a benign outcome. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports likely pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also predicts pathogenic. Consequently, the variant is most likely pathogenic based on the collective predictions, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.137348Structured0.042188Uncertain0.9310.3410.000-12.996Likely Pathogenic0.968Likely PathogenicLikely Pathogenic1.45Ambiguous0.33.08Destabilizing2.27Destabilizing1.51Destabilizing0.909Likely Pathogenic-5.78Deleterious1.000Probably Damaging1.000Probably Damaging-1.47Pathogenic0.00Affected0.28490.0577-3-2-4.6-26.08
c.1646T>C
L549S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L549S is catalogued in gnomAD (ID 6‑33438889‑T‑C) but has no ClinVar entry. Functional prediction tools largely converge on a deleterious effect: SIFT reports a benign change, whereas the remaining 10 evaluated algorithms (SGM‑Consensus, REVEL, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized) all predict pathogenicity. The high‑accuracy predictors reinforce this trend: AlphaMissense‑Optimized returns a pathogenic score, and the SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates likely pathogenic. Foldetta, which integrates FoldX‑MD and Rosetta outputs, is inconclusive. No evidence from FoldX or Rosetta alone is available. Consequently, the variant is most likely pathogenic, and this assessment does not conflict with ClinVar, which contains no classification for this allele.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.025762Structured0.007921Uncertain0.9550.2810.0006-33438889-T-C16.20e-7-13.018Likely Pathogenic0.999Likely PathogenicLikely Pathogenic1.76Ambiguous0.41.03Ambiguous1.40Ambiguous1.01Destabilizing0.801Likely Pathogenic-4.85Deleterious1.000Probably Damaging1.000Probably Damaging-1.14Pathogenic0.34Tolerated3.37350.29650.0305-2-3-4.6-26.08
c.1661T>G
V554G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 V554G missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include only FATHMM, while the remaining eleven tools—REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default—consistently predict a pathogenic impact. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as pathogenic, and Foldetta as pathogenic. No predictions are missing or inconclusive. Overall, the variant is most likely pathogenic based on the collective evidence, and this conclusion does not contradict any ClinVar annotation because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.020522Structured0.007349Uncertain0.9550.2260.000-13.879Likely Pathogenic0.942Likely PathogenicAmbiguous3.31Destabilizing0.14.13Destabilizing3.72Destabilizing2.40Destabilizing0.594Likely Pathogenic-6.96Deleterious0.997Probably Damaging1.000Probably Damaging3.21Benign0.00Affected0.16190.1548-1-3-4.6-42.08
c.1664T>G
V555G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 V555G missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on pathogenicity include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default; no tool predicts it benign. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as pathogenic. No predictions are inconclusive or missing. Based on the collective evidence, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status because the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.013265Structured0.008218Uncertain0.9430.2250.000-13.327Likely Pathogenic0.899Likely PathogenicAmbiguous2.07Destabilizing0.12.22Destabilizing2.15Destabilizing1.07Destabilizing0.798Likely Pathogenic-6.35Deleterious0.984Probably Damaging1.000Probably Damaging-1.39Pathogenic0.01Affected0.19940.1677-1-3-4.6-42.08
c.1679T>G
V560G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 V560G missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include only SIFT, whereas the majority of tools (REVEL, Rosetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default) predict a pathogenic impact. Uncertain results come from FoldX, Foldetta, and AlphaMissense‑Optimized. High‑accuracy assessments show that the SGM Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is pathogenic, AlphaMissense‑Optimized is uncertain, and Foldetta is uncertain. Overall, the preponderance of evidence indicates that V560G is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation because no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.021381Structured0.013872Uncertain0.8530.2040.000-12.485Likely Pathogenic0.799Likely PathogenicAmbiguous0.66Ambiguous0.12.12Destabilizing1.39Ambiguous1.80Destabilizing0.753Likely Pathogenic-5.87Deleterious0.981Probably Damaging1.000Probably Damaging-1.25Pathogenic0.19Tolerated0.17380.2036-1-3-4.6-42.08
c.1703T>G
V568G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V568G is not reported in ClinVar (ClinVar status: not listed) but is present in gnomAD (gnomAD ID 6‑33440755‑T‑G). Prediction tools that agree on a pathogenic effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. No tools predict a benign outcome. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as Pathogenic. Based on the collective evidence, the variant is most likely pathogenic, and this conclusion does not contradict the ClinVar status, which simply lacks an entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.024826Structured0.053503Uncertain0.9370.2570.0006-33440755-T-G-15.135Likely Pathogenic0.938Likely PathogenicAmbiguous3.39Destabilizing0.14.45Destabilizing3.92Destabilizing2.34Destabilizing0.933Likely Pathogenic-6.81Deleterious1.000Probably Damaging0.999Probably Damaging-1.46Pathogenic0.00Affected3.37350.18220.1877-3-1-4.6-42.08
c.1886T>G
V629G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 V629G missense change is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include only FATHMM, whereas the remaining eleven tools (REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default) uniformly predict a pathogenic outcome; AlphaMissense‑Optimized is uncertain. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is uncertain, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is pathogenic, and Foldetta (combining FoldX‑MD and Rosetta) is pathogenic. Taken together, the overwhelming majority of evidence indicates that V629G is likely pathogenic, and this conclusion does not contradict any ClinVar annotation because no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.040537Structured0.034796Uncertain0.9700.2360.000-13.150Likely Pathogenic0.871Likely PathogenicAmbiguous3.81Destabilizing0.04.52Destabilizing4.17Destabilizing1.94Destabilizing0.678Likely Pathogenic-6.47Deleterious1.000Probably Damaging1.000Probably Damaging3.07Benign0.00Affected0.19030.2240-1-3-4.6-42.08
c.1991T>C
L664S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L664S is listed in ClinVar as Benign (ClinVar ID 2429773.0) and is present in gnomAD (ID 6‑33441250‑T‑C). Prediction tools that report a benign effect include only FATHMM; all other evaluated algorithms (REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) predict a pathogenic impact, and the SGM‑Consensus score is “Likely Pathogenic.” High‑accuracy methods give the following results: AlphaMissense‑Optimized predicts Pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also yields Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts Pathogenic. Based on the overwhelming majority of pathogenic predictions—including the high‑accuracy tools—the variant is most likely pathogenic, which contradicts its ClinVar benign classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.100716Structured0.089318Uncertain0.9370.3390.000Likely Benign 16-33441250-T-C16.20e-7-16.498Likely Pathogenic0.997Likely PathogenicLikely Pathogenic3.75Destabilizing0.23.63Destabilizing3.69Destabilizing2.77Destabilizing0.543Likely Pathogenic-5.99Deleterious1.000Probably Damaging0.996Probably Damaging2.85Benign0.00Affected3.38280.20910.0896-3-2-4.6-26.08215.550.10.00.0-0.20.2XPotentially BenignThe iso-butyl side chain of L664, located on an α-helix (res. Ser641-Glu666), hydrophobically interacts with residues in the inter-helix space between three helices (res. Glu617-Asn635, res. Glu582-Met603, and res. Ser641-Glu666), such as Ile589, Phe663, and Met660. In the variant simulations, the hydroxyl group of Ser664 forms hydrogen bonds with the backbone carbonyl oxygen of another helix residue, such as Met660 or Gln661. This interaction is known to destabilize hydrogen bonding in the α-helix, but this effect was not observed in the simulations. Additionally, Ser664 occasionally forms hydrogen bonds with the carboxylate group of Asp586 on another α-helix (res. Glu582-Met603), which could minimally influence the tertiary structure assembly. Despite these interactions, no major negative effects on the protein structure were observed during the simulations.
c.2054T>C
L685S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L685S is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include only FATHMM, whereas the remaining tools—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic or likely pathogenic impact. High‑accuracy assessments further support this: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates likely pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, also predicts pathogenic. Based on the collective evidence, the variant is most likely pathogenic, and this conclusion does not contradict any existing ClinVar annotation because no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.175930Structured0.162061Uncertain0.9130.2800.000-12.303Likely Pathogenic0.999Likely PathogenicLikely Pathogenic3.08Destabilizing0.22.95Destabilizing3.02Destabilizing1.24Destabilizing0.520Likely Pathogenic-5.99Deleterious1.000Probably Damaging0.996Probably Damaging3.27Benign0.01Affected0.28440.0505-3-2-4.6-26.08
c.2096T>G
V699G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V699G has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect include FATHMM and AlphaMissense‑Optimized, while the remaining tools (REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b) uniformly predict a pathogenic impact. High‑accuracy assessments further support this: AlphaMissense‑Optimized predicts benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields a pathogenic verdict; and Foldetta also predicts pathogenic. Consequently, the variant is most likely pathogenic based on the collective predictions, and this assessment does not contradict any ClinVar status, as none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.069024Structured0.432975Uncertain0.9350.3150.000-11.912Likely Pathogenic0.481AmbiguousLikely Benign2.22Destabilizing0.03.25Destabilizing2.74Destabilizing1.77Destabilizing0.514Likely Pathogenic-5.11Deleterious0.972Probably Damaging0.999Probably Damaging3.37Benign0.01Affected0.18300.2240-1-3-4.6-42.08
c.2237T>G
V746G
2D
AIThe SynGAP1 missense variant V746G is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only SIFT predicts a pathogenic outcome. High‑accuracy assessments reinforce the benign prediction: AlphaMissense‑Optimized scores benign, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also yields benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Based on the collective predictions, V746G is most likely benign, and this conclusion does not contradict any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.808535Disordered0.576597Binding0.3360.8670.875-2.971Likely Benign0.113Likely BenignLikely Benign0.035Likely Benign-0.89Neutral0.136Benign0.270Benign2.74Benign0.02Affected0.18970.2550-1-3-4.6-42.08
c.2240T>G
V747G
2D
AIThe SynGAP1 missense variant V747G is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is benign. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus as benign, and Foldetta results are unavailable. Overall, the consensus of the available predictions indicates that V747G is most likely benign, and this conclusion does not contradict any ClinVar status because the variant has not been reported there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.816150Disordered0.594069Binding0.3430.8730.750-3.883Likely Benign0.188Likely BenignLikely Benign0.069Likely Benign-1.22Neutral0.589Possibly Damaging0.917Probably Damaging2.56Benign0.00Affected0.19600.2374-1-3-4.6-42.08
c.2423T>G
V808G
2D
AIThe SynGAP1 V808G missense variant is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, polyPhen‑2 (HumDiv and HumVar), ESM1b, and AlphaMissense‑Optimized. Tools that agree on a pathogenic effect are PROVEAN, SIFT, and FATHMM; AlphaMissense‑Default is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized predicts benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts pathogenic. Foldetta results are unavailable. Overall, the majority of individual predictors (five benign vs. three pathogenic) support a benign classification, and this is not contradicted by any ClinVar annotation. Thus, based on the available predictions, the variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
SH3-binding motif0.699094Disordered0.856438Binding0.2890.9030.500-6.635Likely Benign0.460AmbiguousLikely Benign0.268Likely Benign-2.94Deleterious0.069Benign0.135Benign2.27Pathogenic0.00Affected0.19250.3336-1-3-4.6-42.08
c.2510T>G
V837G
2D
AIThe SynGAP1 missense variant V837G is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. In contrast, polyPhen‑2 (both HumDiv and HumVar models) predict a pathogenic impact. The SGM‑Consensus, which aggregates the majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized predicts Benign, and the SGM‑Consensus also indicates Likely Benign. Foldetta results are not available, so they do not influence the overall assessment. Based on the preponderance of evidence, the variant is most likely benign, and this conclusion does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.525368Disordered0.626284Binding0.3180.8710.125-2.599Likely Benign0.315Likely BenignLikely Benign0.187Likely Benign0.93Neutral0.997Probably Damaging0.999Probably Damaging3.18Benign1.00Tolerated0.22600.2422-1-3-4.6-42.08
c.2522T>G
V841G
2D
AIThe SynGAP1 missense variant V841G is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect are REVEL and FATHMM, while the remaining tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default—consistently predict a pathogenic outcome. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, whereas the SGM Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) favors pathogenicity. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the preponderance of evidence points to a pathogenic effect for V841G, and this conclusion does not contradict any ClinVar annotation, as none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.622677Disordered0.616495Binding0.2610.8730.125-10.054Likely Pathogenic0.913Likely PathogenicAmbiguous0.288Likely Benign-4.11Deleterious0.997Probably Damaging0.999Probably Damaging2.51Benign0.00Affected0.23510.2422-1-3-4.6-42.08
c.2537T>C
L846S
2D
AIThe SynGAP1 missense variant L846S is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely converge on a deleterious effect: REVEL classifies it as benign, whereas the remaining 11 predictors (PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized) all predict pathogenicity. The SGM‑Consensus, which aggregates the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also reports the variant as Likely Pathogenic. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts pathogenicity, and the SGM‑Consensus result is consistent with a likely pathogenic classification. Foldetta predictions are unavailable. Taken together, the preponderance of evidence indicates that the variant is most likely pathogenic, and this assessment does not conflict with the current ClinVar status, which contains no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.653063Disordered0.589606Binding0.3490.8250.500-10.944Likely Pathogenic0.977Likely PathogenicLikely Pathogenic0.366Likely Benign-3.44Deleterious0.999Probably Damaging0.998Probably Damaging2.25Pathogenic0.00Affected0.31280.1070-3-2-4.6-26.08
c.2579T>G
V860G
2D
AIThe SynGAP1 missense variant V860G is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Prediction tools cluster into two groups: the benign group includes REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized; the pathogenic group contains only SIFT. High‑accuracy assessments reinforce the benign prediction: AlphaMissense‑Optimized is benign, the SGM Consensus (derived from the majority of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is benign, while Foldetta results are unavailable. Overall, the collective evidence indicates that V860G is most likely benign, and this conclusion does not contradict the ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.545602Disordered0.518121Binding0.2690.8030.250-3.471Likely Benign0.173Likely BenignLikely Benign0.198Likely Benign-1.54Neutral0.012Benign0.009Benign4.11Benign0.00Affected0.23120.2547-1-3-4.6-42.08
c.257T>G
V86G
2D
AIThe SynGAP1 missense variant V86G is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, polyPhen‑2 HumDiv, ESM1b, and FATHMM. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumVar, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is inconclusive due to a 2‑to‑2 split. Foldetta, which evaluates protein‑folding stability via FoldX‑MD and Rosetta, has no available result for this variant. Overall, the majority of evidence (five pathogenic versus four benign predictions) indicates that V86G is most likely pathogenic, and this conclusion does not contradict any ClinVar status because the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.685117Disordered0.552911Binding0.2950.8870.500-4.212Likely Benign0.989Likely PathogenicLikely Pathogenic0.130Likely Benign-2.50Deleterious0.307Benign0.824Possibly Damaging3.74Benign0.00Affected0.23210.2547-1-3-4.6-42.08
c.2597T>G
V866G
2D
AIThe SynGAP1 missense variant V866G is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and polyPhen‑2 HumVar. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized predicts benign, and the SGM Consensus—derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—also indicates benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the consensus of the majority of prediction tools and the high‑accuracy methods points to a benign impact for V866G, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.599170Disordered0.638070Binding0.2660.7880.250-1.519Likely Benign0.136Likely BenignLikely Benign0.124Likely Benign-2.30Neutral0.912Possibly Damaging0.993Probably Damaging2.69Benign0.07Tolerated0.25480.2157-1-3-4.6-42.08
c.263T>G
V88G
2D
AIThe SynGAP1 missense variant V88G is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. Tools that predict a pathogenic effect are SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (2 vs 2) and Foldetta results are unavailable. Overall, the majority of predictions (5 benign vs. 4 pathogenic) and the lack of a ClinVar pathogenic classification suggest that V88G is most likely benign, with no contradiction to existing ClinVar data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.703578Disordered0.552910Binding0.3230.8700.500-8.588Likely Pathogenic0.989Likely PathogenicLikely Pathogenic0.084Likely Benign-2.40Neutral0.024Benign0.208Benign3.68Benign0.00Affected0.26080.2609-1-3-4.6-42.08
c.2642T>C
L881S
2D
AIThe SynGAP1 missense variant L881S is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are SIFT and FATHMM. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a Likely Benign classification. High‑accuracy assessments show AlphaMissense‑Optimized as Benign and the SGM‑Consensus as Likely Benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact for the L881S variant, and this conclusion does not contradict any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.703578Disordered0.629350Binding0.2990.8740.250-3.063Likely Benign0.169Likely BenignLikely Benign0.051Likely Benign-0.49Neutral0.068Benign0.012Benign2.49Pathogenic0.00Affected0.33630.0850-3-2-4.6-26.08
c.269T>G
V90G
2D
AIThe SynGAP1 missense variant V90G is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and FATHMM. Only SIFT predicts a pathogenic outcome, while AlphaMissense‑Default remains uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, and the SGM Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also yields a benign verdict. Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict any ClinVar annotation (none is present). Thus, the variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.570702Disordered0.542047Binding0.3430.8730.500-2.617Likely Benign0.358AmbiguousLikely Benign0.094Likely Benign-0.55Neutral0.024Benign0.208Benign4.00Benign0.00Affected0.20470.2936-1-3-4.6-42.08
c.2732T>G
V911G
2D
AIThe SynGAP1 missense variant V911G is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). All available in silico predictors classify the variant as benign: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts pathogenicity, so the benign group includes every listed predictor, while the pathogenic group is empty. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts benign; the SGM Consensus—derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—also yields a benign verdict. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, is not available for this variant. Overall, the computational evidence overwhelmingly supports a benign effect, and this conclusion does not contradict any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.685117Disordered0.724137Binding0.3270.9140.375-2.754Likely Benign0.222Likely BenignLikely Benign0.124Likely Benign-0.04Neutral0.004Benign0.003Benign2.74Benign0.16Tolerated0.23070.3360-1-3-4.6-42.08
c.2747T>G
V916G
2D
AIThe SynGAP1 missense variant V916G is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. High‑accuracy assessments show AlphaMissense‑Optimized as benign, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also predicts benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of evidence points to a benign impact. This conclusion is consistent with the lack of ClinVar annotation; there is no contradiction with ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.642678Disordered0.835395Binding0.3080.8790.250-1.950Likely Benign0.091Likely BenignLikely Benign0.093Likely Benign-0.63Neutral0.666Possibly Damaging0.917Probably Damaging2.69Benign0.05Affected0.24200.2681-1-3-4.6-42.08
c.2975T>G
V992G
2D
AIThe SynGAP1 missense variant V992G is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). All available in silico predictors classify the variant as benign: REVEL, PROVEAN, PolyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts pathogenicity, so the benign group includes every listed predictor, while the pathogenic group is empty. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts benign; the SGM Consensus—derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—also yields a benign verdict. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the computational evidence overwhelmingly supports a benign effect, and this conclusion does not contradict any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.754692Disordered0.921728Binding0.3310.9170.750-1.906Likely Benign0.080Likely BenignLikely Benign0.067Likely Benign-0.28Neutral0.056Benign0.086Benign4.21Benign0.16Tolerated0.21140.2612-1-3-4.6-42.08
c.305T>C
L102S
2D
AIThe SynGAP1 missense variant L102S is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as Likely Benign. High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized predicts Benign, and the SGM‑Consensus likewise indicates Likely Benign. No Foldetta stability analysis is available, so it does not influence the assessment. Overall, the majority of evidence points to a benign impact for the L102S variant, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.795062Disordered0.696014Binding0.3570.8850.625-3.260Likely Benign0.105Likely BenignLikely Benign0.174Likely Benign0.54Neutral0.984Probably Damaging0.969Probably Damaging4.18Benign0.00Affected0.27850.1752-3-2-4.6-26.08
c.3203T>C
L1068S
2D
AIThe SynGAP1 missense variant L1068S is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools largely agree on a benign effect: REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the variant as benign, while only SIFT predicts it as pathogenic. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a “Likely Benign” consensus. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized is benign and the SGM‑Consensus is likely benign; Foldetta results are not available. Based on the preponderance of evidence, the variant is most likely benign, and this conclusion does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.947281Disordered0.981041Binding0.3620.9070.875-6.297Likely Benign0.211Likely BenignLikely Benign0.175Likely Benign-0.57Neutral0.032Benign0.017Benign2.59Benign0.00Affected0.28100.1853-3-2-4.6-26.08
c.3227T>C
L1076S
2D
AIThe SynGAP1 missense variant L1076S is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, and ESM1b, whereas polyPhen‑2 (HumDiv and HumVar), FATHMM, and AlphaMissense‑Default all predict a pathogenic outcome. High‑accuracy assessments are less decisive: AlphaMissense‑Optimized is uncertain; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is inconclusive (two benign vs. two pathogenic votes); and Foldetta results are unavailable. Consequently, the evidence is evenly split between benign and pathogenic predictions. The variant is therefore most likely of uncertain significance, and this assessment does not contradict the absence of a ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.922952Disordered0.989617Binding0.3010.8920.750-2.975Likely Benign0.913Likely PathogenicAmbiguous0.225Likely Benign0.55Neutral0.999Probably Damaging0.983Probably Damaging2.43Pathogenic0.75Tolerated0.30450.1178-3-2-4.6-26.08
c.3233T>G
V1078G
2D
AIThe SynGAP1 missense variant V1078G is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are SIFT and AlphaMissense‑Default. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized is benign, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is benign (3 benign vs 1 pathogenic). Foldetta, a protein‑folding stability method, has no available result for this variant. Overall, the majority of evidence indicates a benign impact. This conclusion is not contradicted by ClinVar status, which has no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.882776Disordered0.986989Binding0.2940.8980.750-3.270Likely Benign0.699Likely PathogenicLikely Benign0.168Likely Benign-0.54Neutral0.157Benign0.292Benign3.85Benign0.00Affected0.20410.2693-1-3-4.6-42.08

Found 8751 rows. Show 800 rows per page. Page 1/11 « Previous | Next »